cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
71748,Zirconium praseodymium yellow zircon,269-075-7,68187-15-5,Not Classified,REACH registration C&L,106,Not classified:106
71752,"poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]",427-280-0,176429-27-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H335:0;H315:0;H400:0;H410:0;H318:0
71755,Tetraphenylphthalic anhydride,225-253-6,4741-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
71759,4-chloro-3-nitrobenzonitrile,213-364-2,939-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H302:1;H332:1;H312:1
71763,Dihydro-5-octylfuran-2(3H)-one,218-971-6,2305-05-7,Skin Irrit. 2,REACH registration C&L,1719,H315:105;Not classified:1614;H335:91;H319:96
71768,"4'-Chloro-3,4-dihydroxybenzophenone",603-838-0,134612-84-3,Skin Sens. 1,Notified C&L,1,H317:1
71772,"2,3-dihydrophthalazine-1,4-dione",215-893-4,1445-69-8,Not Classified,Notified C&L,2,Not classified:1;H302:1;H335:1;H315:1;H319:1
71779,Triethylammonium hydrogen sulphate,259-057-7,54272-29-6,,Notified C&L,6,H314:4;H318:2;Not classified:2
71780,"1-deoxy-1-(methylamino)-D-glucitol, compound with antimonic acid (1:1)",205-108-3,133-51-7,Not Classified,Notified C&L,2,Not classified:1;H302:1;H332:1;H411:1
71781,"3-[(7aS)-7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl]propanoic acid",435-830-6,1944-63-4,Eye Dam. 1,REACH registration C&L,2,H318:2
71782,"3,5-dimethylbenzoic acid",207-876-5,499-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
71783,Lithium tantalum trioxide,234-757-5,12031-66-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H302:39;H332:39;H312:39;Not classified:1
71791,Sodium iodide,231-679-3,7681-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1,REACH registration C&L,506,H372:247;H315:232;H319:232;H400:187;H335:81;Not classified:39;H302:8;H373:4;H410:2;H314:1;H317:1
71792,Methyl 2-oxocyclopentanecarboxylate,233-962-7,10472-24-9,Not Classified,Notified C&L,5,Not classified:2;H335:3;H315:3;H319:3;H302:2
71794,"(2Z)-(5-amino-1,2,4-thiadiazol-3-yl){[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}acetic acid",616-285-5,76028-96-1,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H334:1;H317:1;Not classified:1;H335:1;H315:1;H319:1
71799,"1,4-Androstadiene-3,17-dione, 2-Naphthol-Complex",600-487-5,103799-56-0,Aquatic Chronic 2,Notified C&L,1,H411:1
71803,Chlorobutanol hemihydrate,611-927-0,6001-64-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H302:61;H335:41;H315:42;H319:42
71806,Sodium hydrogen fumarate,227-535-4,5873-57-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H335:15;H315:16;H319:17
71814,"3,4,4-TRIMETHYLOXAZOLIDINE",616-253-0,75673-43-7,Not Classified,Notified C&L,55,Not classified:35;H335:20;H315:20;H331:20;H302:20;H318:20
71816,Decyltriethoxysilane,220-940-7,2943-73-9,,Notified C&L,6,H315:6;H319:6
71822,"α-D-Mannopyranosyl fluoride, tetrakis(2,2-dimethylpropanoate)",606-107-4,187269-63-2,Not Classified,Notified C&L,1,Not classified:1
71826,Benzyltrimethylammonium bromide,226-320-2,5350-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H302:5
71828,"Residual oils (petroleum), catalytic dewaxed;Baseoil - unspecified",294-843-3,91770-57-9,Carc. 1B,Harmonised C&L,0,H350:0
71829,"3,5-diiodotyrosine",200-620-3,66-02-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:38;H335:39;H315:39;H319:39
71830,"1,2-dibromo(phenyl)ethane",202-253-4,93-52-7,Skin Corr. 1B,Notified C&L,61,H314:61;H318:2
71831,"Fatty acids, vegetable-oil, Me esters",273-606-8,68990-52-3,Not Classified,REACH registration C&L,270,Not classified:270
71832,"[1,1'-Bicyclohexyl]-4-one,4'-propyl-,",617-391-4,82832-73-3,Aquatic Chronic 1,REACH registration C&L,1,H410:1
71834,"2-Propenoic acid, 3-(2-bromo-5-fluorophenyl)-",606-497-6,202865-70-1,,Notified C&L,4,H335:4;H315:4;H319:4
71838,"2,6-dichlorobenzyl thiocyanate",231-401-0,7534-64-7,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
71839,"Cadmium sulfide (CdS), copper chloride-doped",272-541-2,68877-00-9,Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H361:1;H350:1;H302:1;H341:1;H372:1;H413:1
71840,Dicalcium pyrophosphate,232-221-5,7790-76-3,Not Classified,REACH registration C&L,54,Not classified:11;H335:43;H315:43;H319:43
71841,(+)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenylcarbamate,602-936-0,123441-03-2,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,15,H411:10;H301:9;H332:9;H312:9;H300:5;H372:1;Not classified:1;H335:1
71852,Tetrabutyltin,215-960-8,1461-25-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,59,H315:55;H400:54;H330:10;H302:12;H341:7;H410:55;H372:54;H318:11;H317:10;H360:7;H361:3;H301:44;H319:45;H312:44;H311:4;H331:1;H335:1;H314:1
71853,"2,3-dimethylpentan-3-ol",209-866-6,595-41-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H335:38;H315:38;H319:38
71854,Cholesterol,200-353-2,57-88-5,Not Classified,REACH registration C&L,221,Not classified:218;H361:3
71855,3'-Acetamidoacetophenone,616-120-7,7463-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
71859,Iron tungsten tetraoxide,237-622-9,13870-24-1,Not Classified,Notified C&L,1,Not classified:1
71860,"Diammonium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']hydroxyferrate(2-)",270-232-7,68413-60-5,Not Classified,REACH registration C&L,11,Not classified:11
71861,Azelaic acid,204-669-1,123-99-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1140,H315:512;H319:1068;Not classified:71;H335:25;H302:1
71862,"1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates",291-990-5,90529-57-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,442,H318:441;H302:441;H315:441;Not classified:1
71866,Dibutyl Sulfate [Alkylating Agent],613-047-2,625-22-9,Acute Tox. 4,Notified C&L,43,H302:42;H301:1
71867,"Fatty acids, tall-oil, compds. with oleylamine",288-315-1,85711-55-3,Skin Sens. 1A;Eye Dam. 1;STOT RE 2,REACH registration C&L,188,H318:104;H317:130;H373:46;H413:83;H302:83;H315:141
71871,"trans-1,2-dicyanocyclobutane",221-722-4,3211-20-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
71872,5-α-17-β-hydroxyandrostan-3-one benzoate,213-891-8,1057-07-4,Repr. 2,Notified C&L,38,H361:38
71875,3-methylthiophene-2-carbaldehyde,227-418-8,5834-16-2,,Notified C&L,5,H335:5;H315:5;H319:5
71879,3-(1-pyrrolidinyl)propiophenone hydrochloride,212-633-1,833-86-3,Skin Irrit. 2,REACH registration C&L,39,H315:39;H335:38;H319:38
71885,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and ethenylbenzene",607-498-4,25036-16-2,Not Classified,Notified C&L,3,Not classified:3
71887,Dipotassium adipate,242-838-1,19147-16-1,Eye Irrit. 2B,REACH registration C&L,11,H320:2;Not classified:9
71893,heptan-3-one;butyl ethyl ketone,203-388-1,106-35-4,Flam. Liq. 3;Eye Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H226:0;H332:0;H319:0
71895,4-Cyano-3-fluorobenzoic Acid,605-777-5,176508-81-9,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,197,H318:194;H302:196;H335:196;H315:197;H319:3;H332:1;H312:1
71896,Silicon tetrafluoride,232-015-5,7783-61-1,Press. Gas (Liq.);Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,153,H318:8;H330:126;H314:153;H280:88;H310:39;H300:39;H331:27;H362:1
71900,"(7E,9Z)-dodecadienyl acetate",259-127-7,54364-62-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,179,H411:172;H315:179;H319:90;H335:1
71901,"2,4,6-trimethylbenzene-1,3-diamine",221-456-9,3102-70-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,42,H302:42;H411:2;H315:42;H319:42;H335:39;H332:39;H312:39
71902,N-ethyl-2-nitro-4-(trifluoromethyl)aniline,250-160-2,30377-62-9,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
71903,"3,3´-[(2,5-dichloro-1,4-phenylene)bis[imino(1-acetyl-2-oxo-2,1-ethanediyl)azo]]bis(4-chlorbenzoic acid)",611-531-8,57440-77-4,Not Classified,Notified C&L,1,Not classified:1
71907,Octyl phenylacetate,204-545-7,122-45-2,Not Classified,Notified C&L,88,Not classified:88
71909,"paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride",217-615-7,1910-42-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H335:0;H315:0;H400:0;H330:0;H410:0;H319:0;H372:0;H311:0
71911,"Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-[(1-oxo-2-propen-1-yl)oxy]-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1)",611-060-8,53879-55-3,Not Classified,Notified C&L,26,Not classified:26
71912,"2-methylcyclohexanol, mixed isomers",209-512-0,583-59-5,Acute Tox. 4,Harmonised C&L,0,H332:0
71914,Ammonium salicylate,208-444-9,528-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
71917,"Fenugreek, ext.",283-415-1,84625-40-1,Skin Irrit. 2,REACH registration C&L,1482,H315:10;Not classified:1468;H226:5;H319:2
71919,"1-hydroxymethyl-5,5-dimethylhydantoin",204-132-1,116-25-6,Not Classified,Notified C&L,138,Not classified:73;H317:38;H302:60;H315:27;H319:27;H335:4
71925,Endo-8-azabicyclo[3.2.1]octan-3-ol hydrochloride,238-356-6,14383-51-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
71928,"Oleic acid, monoester with propane-1,2-diol",215-549-3,1330-80-9,Not Classified,Notified C&L,293,Not classified:268;H411:25
71932,Oxiranetetracarbonitrile,221-691-7,3189-43-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;H312:38;H301:1;H315:1;H331:1;H319:1;H311:1
71938,3-Nitrophthalonitrile,450-650-8,51762-67-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
71939,"2,2,8-trimethyl-4H-1,3-dioxino[4,5-c]pyridine-5-methanol",214-498-4,1136-52-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H302:1;H332:1;H312:1
71940,"Fatty acids, tallow, hydrogenated, reaction products with diethylenetriamine, carboxymethylated",296-465-4,92704-34-2,Not Classified,Notified C&L,3,Not classified:3
71944,"N,N'-diphenylformamidine",210-720-9,622-15-1,,Notified C&L,6,H335:4;H315:4;H302:6;H319:4;H312:4
71945,Triethylammonium dihydrogen phosphate,233-389-2,10138-93-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,87,H318:83;H302:83;H335:83;H315:87;H319:4
71951,HEPARINE ESTER BENZYLIQUE,922-696-3,122177-97-3,Not Classified,REACH registration C&L,2,Not classified:2
71958,4-tert-butoxybenzylamine,283-723-6,84697-13-2,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H302:1;H335:1;H314:1
71959,styrene oxide;(epoxyethyl)benzene;phenyloxirane,202-476-7,96-09-3,Acute Tox. 4;Eye Irrit. 2;Carc. 1B,Harmonised C&L,0,H319:0;H350:0;H312:0
71961,Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate,213-510-5,961-69-3,Eye Irrit. 2,REACH registration C&L,15,H319:15
71962,"3,5-bis(trifluoromethyl)benzyl alcohol",251-168-9,32707-89-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
71964,(±)-2-aminobutan-1-ol,235-940-2,13054-87-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
71966,N-glycyl-L-proline,211-880-2,704-15-4,Eye Irrit. 2,Notified C&L,39,H319:39;H335:1;H315:1
71967,"BUTENEDIOIC ACID (2Z)-, DISODIUM SALT, REACTION PRODUCTS WITH DISODIUM PHOSPHONATE",604-342-7,143239-08-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,21,H317:21;H411:21
71973,2-amino-6-benzothiazolyl thiocyanate,230-524-7,7170-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
71974,Dicopper hydroxide phosphate,235-285-2,12158-74-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,74,H410:27;H302:27;H411:27;H400:27;H335:46;H315:46;H319:46;Not classified:1
71978,2-benzylidenecyclohexan-1-one,227-144-9,5682-83-7,,Notified C&L,4,H335:4;H315:4;H319:4
71980,4-hydroxybenzoic acid,202-804-9,99-96-7,Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,283,H318:224;H335:179;H315:51;H319:56;Not classified:4;H302:2
71983,Isovaleryl chloride,203-552-2,108-12-3,Flam. Liq. 2;Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,243,H290:85;H331:122;H225:95;H314:243;H318:121;H335:103;H226:70
71985,Triisobutylphosphine sulphide,223-621-0,3982-87-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,52,H315:38;H319:38;Not classified:14
71987,Sodium 3-[[3-methoxy-4-[(4-methoxyphenyl)azo]phenyl]azo]benzenesulphonate,264-129-6,63405-85-6,Acute Tox. 4,REACH registration C&L,12,H302:7;Not classified:5
71990,4-fluorophenethylic alcohol,231-499-5,7589-27-7,,Notified C&L,6,H315:6;H319:6;H335:1;H302:1;H312:1
71993,9H-xanthen-9-ol,201-996-1,90-46-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H335:1;H315:1;H302:1;H411:1;H319:1
71996,Anthranilonitrile,217-549-9,1885-29-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,136,H335:47;H315:49;H302:48;H332:48;H312:47;H319:132;H317:46;H311:5;H320:1;H301:1;H331:1
71999,N-[5-bromo-2-(2-nitrophenyl)sulfanyl-phenyl]formamide,918-636-0,,Acute Tox. 4,REACH registration C&L,2,H302:2
72003,"1,1'-(methylimino)dipropan-2-ol",224-536-1,4402-30-6,Skin Corr. 1B,REACH registration C&L,97,H314:92;H318:83;Not classified:5
72004,"Ethyl 2,4-dioxovalerate",210-447-5,615-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72006,"2-hydroxypropane-1,3-diyl distearate",207-992-6,504-40-5,Not Classified,Notified C&L,2,Not classified:2
72008,2-allylcyclohexan-1-one,202-352-2,94-66-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:39;H332:39;H319:39;H312:39
72009,"4-thioxo-1H-pyrimidine-2,6-diammonium sulphate",279-657-2,81012-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
72014,2-[(6-amino-2-naphthyl)sulphonyl]ethanol,257-750-9,52218-35-6,Not Classified,Notified C&L,2047,Not classified:2047
72017,"N,N'-bis(1,4-dimethylpentyl)-p-phenylenediamine",221-375-9,3081-14-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H410:40;H317:40;H302:40;H400:15;H411:25;H412:1
72029,7-chloro-1H-indole,258-865-7,53924-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H302:1;H332:1;H312:1
72031,"(6R,7R,14S)-7,8-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-O-methyl-6,14-ethano-17-normorphine",917-585-1,,Not Classified,Notified C&L,1,Not classified:1
72033,CYCLOPROPYLACETYLENE,614-067-4,6746-94-7,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,55,H318:54;H315:55;H412:54;H225:50;H226:5;H335:1;H319:1
72037,"Dodecanoic acid, ester with 1,2-propanediol",253-462-2,37321-62-3,Aquatic Chronic 2,REACH registration C&L,2,H411:2
72041,"3,5-Dibromoanthranilic Acid",612-060-0,609-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
72042,Ethyl piperidine-3-carboxylate,276-211-9,71962-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,39,H412:1;H335:39;H315:39;H319:39
72043,"α,4-dibromotoluene",209-636-5,589-15-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A,REACH registration C&L,62,H317:13;H302:1;H315:2;H319:2;H334:51;H314:60;H318:3;H335:2;H290:2
72046,"2,2,2-Trifluoroethyl trifluoromethanesulfonate",612-977-6,6226-25-1,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,52,H330:39;H301:39;H314:40;H335:11;H315:11;H319:11;H331:1;H302:1
72048,Mazindol,244-857-0,22232-71-9,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:38;H300:38;H331:39;H301:1;H411:1
72050,"Amines, N-tallow alkyltrimethylenedi-, acetates",263-188-5,61791-54-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,55,H302:34;H314:35;H400:55;H318:20;H315:20;H372:1
72051,Tin,231-141-8,7440-31-5,Not Classified,REACH registration C&L,791,Not classified:544;H335:218;H319:229;H413:11;H302:21;H315:9;H331:8;H400:8;H332:10;H311:8;H372:10;H228:6;H260:1;H334:1
72053,"Propanamide, N-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[2-(2-chloro-4-nitrophenyl)diazenyl]phenyl]-",612-884-0,61968-52-3,Not Classified,Notified C&L,1,Not classified:1
72054,4-nitro-o-anisic acid,219-998-6,2597-56-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
72061,1-((4-methoxyphenyl)ethynyl)-4-(trans-4-propylcyclohexyl)benzene,433-760-0,116903-47-0,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
72066,"1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-, reaction products with guanidine hydrochloride N,N'-bis(mixed Ph, tolyl and xylyl) derivs.",275-170-4,71077-14-0,Not Classified,REACH registration C&L,44,Not classified:2;H302:42
72067,Disodium 3(or 5)-[[4-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-1-naphthyl]azo]salicylate,252-305-5,34977-63-4,Aquatic Chronic 3,REACH registration C&L,13,H412:10;Not classified:3
72070,4-bromo-2-methylbenzoic acid,272-437-7,68837-59-2,Acute Tox. 3,Notified C&L,46,H301:40;H335:6;H315:7;H319:7;H302:1
72071,Triphenylvinylphosphonium bromide,225-740-3,5044-52-0,,Notified C&L,5,H335:4;H315:5;H319:5
72077,"O,O'-diacetylmorphine hydrochloride",216-124-5,1502-95-0,Acute Tox. 2;Acute Tox. 2,Notified C&L,58,H310:40;H300:40;H334:18;H317:18;H302:17;H332:17;H301:1;H331:1;H361:1;H362:1;H330:1
72078,Potassium methanesulphonate,219-202-7,2386-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:41;H319:41;H317:1;H302:1
72081,"conjugated linoleic acid, methyl ester",924-147-3,,Not Classified,Notified C&L,6,Not classified:6
72082,1-vinylnaphthalene,212-560-5,826-74-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,43,H335:42;H315:43;H302:38;H411:38;H319:43
72085,"Boronia megastigma, ext.",294-926-4,91771-36-7,Aquatic Chronic 3,Notified C&L,1457,H412:1455;H226:25;H317:2;H411:2;H315:1
72086,"cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride",417-430-3,63645-17-0,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H301:0;H411:0;H373:0
72087,"Sodium 1-(1'-naphthylazo)naphth-2-ol-3,6-disulphonate",227-489-5,5858-33-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
72093,N2-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-arginine,248-904-6,28217-22-3,Acute Tox. 3,Notified C&L,38,H301:38
72098,"2,3,5-trichloro-6-methoxypyridine",250-697-2,31557-34-3,Aquatic Chronic 2,Notified C&L,16,H411:16
72103,"2,7-dimethylnaphthalene",209-477-1,582-16-1,Not Classified,Notified C&L,3,Not classified:3
72104,"5-(butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxy-cyclohex-1-one",604-064-6,138164-12-2,Acute Tox. 4;Skin Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H315:194;H400:194;H361:194;H410:194;H302:194
72107,"Pitch, coal tar, low-temp., oxidized;Pitch Residue, oxidised;[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 °C to 180 °C (158 °F to 356 °F). Composed primarily of a complex mixture of hydrocarbons.]",292-654-0,90669-59-3,Carc. 1B,Harmonised C&L,0,H350:0
72111,"4-chlorobenzene-1,3-diamine",225-877-9,5131-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:46;H319:47;H351:4;H301:1;H350:1;H332:1;H411:1;H312:1;H317:1;H341:1
72113,Cefaloridine,200-052-6,50-59-9,Skin Sens. 1,Notified C&L,38,H317:38
72114,Decyl acetate,203-942-2,112-17-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1561,H410:12;H400:12;Not classified:1548;H315:1;H331:1;H225:1;H302:1;H318:1
72121,"Avermectin A1a, 25-cyclohexyl-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-oxo-",606-890-2,220119-16-4,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,29,H317:29;H410:29
72123,"Sodium 3-oxo-1,2-benzisothiazole-2(3H)-propanesulphonate 1,1-dioxide",256-966-0,51099-80-0,Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,1,H302:1;H350:1;H312:1
72125,"2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione",442-780-9,173838-67-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
72130,"4-[[2,5-dichloro-4-[(dimethylamino)sulphonyl]phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide",279-061-2,79102-65-1,Not Classified,Notified C&L,31,Not classified:31
72132,"Distillates (petroleum), light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-053-6,64741-52-2,Carc. 1A,Harmonised C&L,0,H350:0
72133,Bromocyclopropylmagnesium,607-262-0,23719-80-4,Water-react. 2;Skin Corr. 1B,Notified C&L,69,H261:42;H314:69;H260:26;H225:29;H318:1
72135,"4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenylpiperidine-1-butyramide monohydrochloride",252-082-4,34552-83-5,Acute Tox. 3,Notified C&L,106,H301:106;H412:1;H362:1;H361:1
72137,"Sodium [disulphamoyl-29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-), disodium salt",276-210-3,71962-07-7,Not Classified,Notified C&L,1,Not classified:1
72138,Shale oil pitch,447-790-7,,Skin Sens. 1;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1;H373:1
72139,Calcium oxide,215-138-9,1305-78-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,2496,H318:2222;H335:1424;H315:1448;H302:464;H314:727;H319:188;Not classified:130;H370:4;H317:1;H372:2;H312:1;H371:1
72140,(alpha-cyanobenzyl)malonic acid diethyl ester,922-463-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H302:1;H335:1;H315:1;H319:1
72141,"Coconut oil, ethoxylated",614-115-4,67762-35-0,Not Classified,Notified C&L,83,Not classified:83
72142,Oct-4-yne,217-730-2,1942-45-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:39;H304:44;H226:41;H319:39;H225:4
72151,"Chromate(3-), bis[4-[[2,6-dihydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-3-methylbenzenesulfonato(3-)]-, sodium",286-949-3,85407-93-8,Not Classified,Notified C&L,1,Not classified:1
72153,N-[3-(dimethylamino)propyl]formamide,227-652-0,5922-69-0,Eye Irrit. 2,Notified C&L,153,H319:128;H318:25;H317:25;H302:25;H314:25
72154,1-pentylallyl butyrate,240-555-8,16491-54-6,Not Classified,Notified C&L,1421,Not classified:1421
72158,2-ethyl-2-(3-methoxyphenyl)-butanenitrile,609-861-2,40692-21-5,Not Classified,REACH registration C&L,2,Not classified:2
72160,"Titanium, [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,3a,8a-.eta.)-1,5,6,7-tetrahydro-2-methyl-s-indacen-1-yl]silanaminato(2-)-.kappa.N][1,2,3,4-.eta.)-1,3-pentadiene]-",433-370-0,210301-31-8,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1;H314:1
72161,5'-Chloro-2'-hydroxy-3'-nitroacetophenone,617-643-3,84942-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
72162,"N-(1,4-dimethylpentyl)-N'-phenylbenzene-1,4-diamine",221-374-3,3081-01-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,129,H317:129;H410:129;H400:129;H302:33;H315:16
72163,Pentatriacontan-18-one,207-993-1,504-53-0,Not Classified,REACH registration C&L,71,Not classified:8;H335:62;H315:63;H319:63
72167,[2-[2-[4-(dimethylamino)phenyl]vinyl]-6-methyl-4H-pyran-4-ylidene]malononitrile,257-137-6,51325-91-8,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H335:38;H315:39;H332:39;H319:39;H228:40;H302:2;H312:1
72169,cinnamosma fragrans,921-269-9,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H315:2;H304:2;H226:2;H411:2;H319:2;H317:2
72170,tetrahydro-2-furylmethanol;tetrahydrofurfuryl alcohol,202-625-6,97-99-4,Eye Irrit. 2;Repr. 1B,Harmonised C&L,0,H319:0;H360:0
72173,Eclipta prostrata dry purified extract,468-170-2,,Not Classified,Notified C&L,1,Not classified:1
72176,"1,3,5-triazine-2,4,6-triyltrinitrilohexamethanol",208-503-9,531-18-0,Skin Sens. 1,Notified C&L,1,H317:1
72178,"2,6-di-tert-butylnaphthalene",223-461-1,3905-64-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H302:38;H400:38
72179,Thiophosphoryl trichloride,223-622-6,3982-91-0,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Notified C&L,43,H330:43;H302:43;H314:43;H290:1;H318:2;H335:1
72180,"Trisodium 4-amino-3-[[4-[[[4-[(4-amino-2-hydroxyphenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-5-hydroxy-6-[(4-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",275-000-9,70900-28-6,,Notified C&L,54,Not classified:51;H315:3;H319:3
72181,"[1,1'-Bicyclohexyl]-4-carboxylic acid, 4'-propyl-, (cis,trans)-",605-606-4,171337-48-7,Not Classified,Notified C&L,1,Not classified:1
72183,N-[(4-aminophenyl)sulphonyl]-N-(5-methylisoxazol-3-yl)acetamide,242-446-0,18607-98-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H335:38;H315:38;H319:38
72184,tert-dodecanethiol,246-619-1,25103-58-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,584,H413:211;H317:260;H315:482;H319:482;H410:239;H400:222;Not classified:80;H336:25;H304:25;H332:29;H373:28;H411:52;H335:3;H300:3;H302:1;H312:1;H372:1
72186,"Fatty acids, rape-oil, reaction products with 2-[(2-aminoethyl)amino]ethanol",297-841-0,93763-23-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,4,H302:3;H314:3;H400:3;H317:1;H315:1;H319:1
72187,Dimethyl 4-nitrophthalate,210-212-7,610-22-0,Acute Tox. 4,Notified C&L,38,H302:38
72188,"Alcohols, C14-16, ethoxylated",500-347-2,157707-41-0,Not Classified,Notified C&L,1,Not classified:1
72191,"Fatty acids, soya, Bu esters",306-182-0,96508-01-9,Aquatic Chronic 4,Notified C&L,2,H413:2
72195,2-Hydroxyethyl starch,618-410-9,9005-27-0,Not Classified,Notified C&L,22,Not classified:22
72196,"Poly(oxy-1,2-ethanediyl), a-(nonylphenyl)-w-hydroxy-, branched (7-11EO)",931-013-8,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,4,H318:4;H302:4;H411:4
72197,"Hydrazinecarboximidamide, 2-[(2-hydroxyphenyl)methylene]-, reaction products with 2-undecanone",270-151-7,68411-85-8,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1
72199,4-nitrobenzaldehyde,209-084-5,555-16-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,65,H335:22;H315:23;H412:14;H319:63;H317:52;H361:2;H302:2;H341:3;H312:2
72201,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl pivalate",268-259-4,68039-44-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1519,H411:1286;H315:1286;H319:1286;Not classified:233
72205,o-cyanobenzamide,241-224-0,17174-98-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,88,H335:87;H315:88;H412:83;H302:88;H332:88;H319:88;H312:88
72211,"malathion (ISO);1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;[containing ≤ 0.03 % isomalathion]",204-497-7,121-75-5,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H302:0;H400:0
72213,"Meat extracts, chicken",307-886-0,97766-25-1,Not Classified,Notified C&L,25,Not classified:25
72216,Trimethyl orthoacetate,215-892-9,1445-45-0,Flam. Liq. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,96,H317:45;H319:26;H225:91;H315:31;Not classified:7;H335:4
72226,"2,3-dimethyl-3-buten-2-ol",233-963-2,10473-13-9,Flam. Liq. 3,REACH registration C&L,28,H226:28;H302:1
72227,Magnesium glycerophosphate,213-149-3,927-20-8,Not Classified,REACH registration C&L,42,Not classified:10;H315:32;H319:32
72228,"2,3,4,5,6-pentafluoroanisole",206-866-8,389-40-2,Flam. Liq. 3,Notified C&L,44,H226:44
72229,4-methoxy-3-nitrobenzenesulphonyl chloride,244-788-6,22117-79-9,Skin Corr. 1B,Notified C&L,1,H314:1
72230,9-oxabicyclo[6.1.0]non-4-ene,211-308-1,637-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
72231,"(S)-N-(tetrahydro-2,5-dioxo-3-furyl)formamide",251-589-8,33605-73-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
72235,"Reaction products of tetrabromophthalic anhydride with 2,2'-oxydiethanol and methyloxirane",616-436-5,77098-07-8,Not Classified,REACH registration C&L,32,Not classified:7;H412:25
72236,"4-amino-2,5-dichlorobenzenesulphonic acid",201-836-0,88-50-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,43,H315:42;H319:42;H302:40;H335:39;Not classified:1
72239,Ethyl (4-chlorophenyl)acetate,237-906-2,14062-24-9,Acute Tox. 4,REACH registration C&L,41,H302:41;H335:1;H315:1;H332:1;H319:1
72241,"(S)-4-isopropyloxazolidine-2,5-dione",221-692-2,3190-70-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H318:1;H335:1;H315:1
72245,"2,3-dihydro-2,2,6-trimethylbenzaldehyde",204-133-7,116-26-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1680,H315:1680;H302:1324;H411:2;H319:1679;H317:1642;H412:1322;H335:38
72246,N-(3-amino-4-ethoxyphenyl)acetamide,241-100-6,17026-81-2,Eye Irrit. 2,Notified C&L,38,H319:38
72248,trans-2-phenylcyclopropanecarbonyl chloride,213-365-8,939-87-7,Skin Corr. 1B,Notified C&L,38,H314:38
72250,4-amino-N-(4-amino-6-oxo-5H-pyrimidin-2-yl)benzenesulfonamide,605-738-2,174863-37-7,Not Classified,REACH registration C&L,38,Not classified:38
72251,5-oxohexanoic acid,221-511-7,3128-06-1,,Notified C&L,5,H315:5;H319:5
72255,cobalt carbonate,208-169-4,513-79-1,Skin Sens. 1;Resp. Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H317:0;H360:0
72258,"Disodium 4,4'-bis[[4-anilino-6-[(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",241-883-4,17958-73-5,Not Classified,Notified C&L,4,Not classified:4
72266,"[2,9,16,23-tetrachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",240-183-6,16040-69-0,Not Classified,Notified C&L,95,Not classified:95
72267,"2,4-dichloro-3,5-xylenol",205-109-9,133-53-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,47,H318:41;H302:44;H335:4;H315:5;H319:6;H314:2;H410:2;H400:1;H317:1
72268,Sodium trifluoroacetate,220-879-6,2923-18-4,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H410:38;H300:38;H400:38;H335:6;H315:6;H319:6;H302:1;H332:1;H312:1;H412:1
72269,"[3S-(3α,3aβ,5α,8α,8aβ)]-decahydro-α,α,3,8-tetramethylazulene-5-methanol",222-546-0,3526-75-8,Flam. Liq. 3,Notified C&L,1374,H226:1374
72273,C.I. Solvent Yellow 146,600-937-0,109945-04-2,Eye Dam. 1,Notified C&L,48,H318:42;Not classified:6
72276,"2-chloro-1,3-dinitrobenzene",210-107-6,606-21-3,,Notified C&L,4,H301:4;H400:4;H330:4;H410:4;H373:4;H311:4
72281,"Propene-1,2,3-tricarboxylic acid",207-877-0,499-12-7,Not Classified,Notified C&L,88,Not classified:88
72282,"Hexanedinitrile, hydrogenated, distn. residues",272-376-6,68815-47-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H335:1;H412:1;H302:1;H314:1;H312:1;H318:1;H317:1
72284,"(1,1,3,3-tetramethyl-1,3-disiloxanediyl)dimethanol",227-417-2,5833-59-0,Not Classified,Notified C&L,27,Not classified:27
72285,Phenylacetonitrile,205-410-5,140-29-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 1,REACH registration C&L,1690,H330:1690;H301:1483;H311:1690;H302:207;H319:5;H335:1;H315:1
72286,4-chloro-3-nitroaniline,211-231-3,635-22-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,44,H330:43;H300:43;H373:43;H411:44;H310:43;H301:1;H315:1;H331:1;H319:1;H311:1
72288,Dilithium peroxide,234-758-0,12031-80-0,Ox. Sol. 2;Skin Corr. 1A;Eye Dam. 1,Notified C&L,69,H272:44;H318:39;H314:69;H271:25
72289,4-p-toluoylbutyric acid,212-632-6,833-85-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72290,(±)-octan-3-ol,243-713-4,20296-29-1,Not Classified,Notified C&L,29,Not classified:28;H315:1;H319:1
72293,"Fatty acids, C16-18, 2,2-bis(hydroxymethyl)-1,3-propanediyl esters",292-889-9,91002-13-0,Not Classified,Notified C&L,7,Not classified:7
72295,4-methyl-2-phenyl-2-pentenal,247-869-4,26643-91-4,Not Classified,Notified C&L,132,Not classified:87;H335:44;H315:45;H319:44;H317:1
72298,2-Bromo-5-nitrobenzoic Acid,619-009-1,943-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
72299,Tris(2-hydroxyethyl)methylammonium methyl sulphate,249-655-6,29463-06-7,Not Classified,REACH registration C&L,137,Not classified:137
72302,"7(S),20(R)-dihydroxy-16(R)-methyl-10-phenyl-24-oxa[14]cytochalasa-6(12),13(E),21(E)-triene-1,23-dione",239-000-2,14930-96-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Repr. 2,Notified C&L,45,H361:44;H330:45;H310:45;H300:45;H351:1
72307,"2,6-Dimethoxypyridine-3-carboxylic acid",605-471-1,16727-43-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
72308,2-Chloro-4-methyl-3-nitropyridine,607-192-0,23056-39-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H302:4;H332:4;H312:4
72309,Triethoxyoctylsilane,220-941-2,2943-75-1,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,760,H411:34;H315:668;Not classified:59;H335:95;H319:152;H301:1;H331:1;H361:1;H413:1;H311:1;H226:1
72312,"1,1'-dithiobis[hexahydro-2H-azepin-2-one]",245-910-0,23847-08-7,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,12,H317:11;H411:7;H319:11;H315:4;Not classified:1
72317,[10B]orthoboric acid,237-478-7,13813-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,40,H361:38;H335:38;H315:38;H319:38;H360:2
72322,"1-(2,5-disulfo-phenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid ethyl ester, disodium salt",925-170-1,,Not Classified,Notified C&L,1,Not classified:1
72324,"Glycerides, C14-22 mono-",273-607-3,68990-53-4,Not Classified,REACH registration C&L,101,Not classified:101
72325,"Ravensara aromatica, ext.",294-842-8,91770-56-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,107,H315:106;H304:105;H226:107;H411:105;H319:103;H317:107;H340:2;H351:2;H341:2;H412:1
72326,3-methylstyrene,202-889-2,100-80-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:46;H315:44;H304:43;H226:47;H332:42;H319:43;H411:1
72329,Dibutyldithioxodistannathiane,239-740-6,15666-29-2,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H312:1;H400:1
72330,"Citric acid, zirconium salt",245-252-4,22830-18-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,24,H315:23;H319:23;Not classified:1
72332,Thiazole-5-carboxylic acid,238-545-3,14527-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:4;H319:4
72335,Uracil,200-621-9,66-22-8,Not Classified,REACH registration C&L,16,Not classified:14;H335:1;H315:1;H319:1;H361:1
72336,"5,6,7,8-tetrahydro-2-naphthol",214-410-4,1125-78-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H302:1;H332:1;H312:1
72338,(S)-2-amino-4-methylpentan-1-ol,231-400-5,7533-40-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:44;H319:44;H318:1;H302:1;H314:1
72339,Calcium(II) isooctanoate,284-090-9,84777-61-7,Not Classified,Notified C&L,5,Not classified:3;H413:2
72340,propyl propionate,203-389-7,106-36-5,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H226:0;H332:0
72345,5-chlorosulphonyl-2-anisic acid,257-507-7,51904-91-7,,Notified C&L,6,H314:5;H335:1;H315:1;H319:1
72348,"Oils, fish, sulfated, ammonium salt",269-134-7,68187-91-7,Not Classified,Notified C&L,6,Not classified:6
72350,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,1'-methylenebis(4-isocyanatocyclohexane) and .alpha.,.alpha.',.alpha.''-1,2,3",615-966-4,73324-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:35;H315:35;H319:51
72351,Extract from tea tree,614-679-1,68647-73-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;Aquatic Acute 1,Notified C&L,227,H315:227;H400:91;H302:226;H226:128;H319:139;H360:89;H304:98;H411:96;H317:97;H335:39;H361:10;H336:10;H410:1;H312:1
72352,Hydrogen bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),276-844-0,72797-03-6,Not Classified,Notified C&L,1,Not classified:1
72354,"Sodium 2,3-dihydro-2-thioxo-1H-benzimidazole-5-sulphonate",258-862-0,53918-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,41,H335:41;H315:41;H319:41
72357,4'-aminoacetophenone,202-801-2,99-92-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,132,H302:132;H332:83;H312:83;H335:45;H315:46;H319:46
72360,"Dimethyl[4-[4-(dimethylamino)-α-phenylbenzylidene]-2,5-cyclohexadien-1-ylidene]ammonium hydrogen sulphate",240-185-7,16044-24-9,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,52,H318:43;H302:43;H410:42;H400:40;H361:40;Not classified:9;H411:1;H315:1
72361,"2,4,5-Trifluorophenylacetic Acid",466-070-3,209995-38-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
72364,reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene),400-830-7,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
72365,6-(2-phenylacetamido)penicillanic acid,200-506-3,61-33-6,Skin Sens. 1,Notified C&L,74,H317:74;H334:36;H412:35;H400:35;H302:1
72367,potassium lauroyl wheat aminoacids,928-348-7,,Eye Dam. 1,REACH registration C&L,2,H318:2
72369,"Benzene, ethenyl-, polymer with 1-methyl-4-(1-methylethenyl)cyclohexene",613-618-6,64536-06-7,Not Classified,Notified C&L,19,Not classified:19
72375,p-(dimethylamino)cinnamonitrile,251-044-4,32444-63-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H312:39;H315:1;H319:1
72381,"Disodium 3-(5-chloro-2-hydroxyphenylazo)-4,5-dihydroxynaphthalene-2,7-disulphonate",213-894-4,1058-92-0,Not Classified,REACH registration C&L,25,Not classified:25
72382,7-methoxy-1H-indole,221-690-1,3189-22-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:39;H302:39;H335:43;H315:44;H319:5
72384,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tris(1-methyl-C11-17-alkyl) esters",297-554-0,93573-19-4,Not Classified,Notified C&L,3,Not classified:3
72387,Diethyl (3-aminopropyl)phosphonate,224-535-6,4402-24-8,,Notified C&L,6,H314:6
72389,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl methacrylate",223-509-1,3934-23-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H302:38;H335:44;H315:44;H319:44
72394,Benzyl p-tolyl ether,212-636-8,834-25-3,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H318:38;H317:38;H410:38;H400:38
72404,Tetrahydro-4H-pyran-4-ol,218-210-8,2081-44-9,Eye Dam. 1,REACH registration C&L,46,H318:41;H335:4;H315:4;H319:5;H302:2;H332:2;H312:1
72407,"Oils, palm kernel, hydrogenated",283-093-2,84540-04-5,Not Classified,Notified C&L,25,Not classified:25
72410,"Trimenthol, triester with boric acid, stereoisomer",263-701-2,62697-74-9,,Notified C&L,4,H335:4;H315:4;H319:4
72414,"Jujube, Zizyphus jujuba, ext.",289-965-9,90045-99-1,Flam. Liq. 3,Notified C&L,50,H226:25;H224:25
72416,4-(4-hydroxy-3-methoxyphenyl)butan-2-one,204-548-3,122-48-5,Not Classified,Notified C&L,1420,Not classified:1412;H335:5;H315:8;H319:5
72418,5-methyl-2-(p-tolyl)benzoxazole,240-308-4,16155-94-5,Not Classified,Notified C&L,31,Not classified:31
72420,3-Bromo-4'-fluorodiphenyl ether,610-583-9,50904-38-6,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H318:38;H302:38;H410:38;H400:38;H335:1;H315:1;H319:1
72421,3-(2-chlorophenoxy)propionic acid,230-521-0,7170-45-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72423,3-hydroxy-α-methyltyrosine,200-232-4,55-40-3,Eye Irrit. 2,Notified C&L,47,H319:38;H315:9
72424,"nonane-1,9-diyl diacrylate",484-500-8,107481-28-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
72429,polyester,932-015-1,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT SE 3;Aquatic Acute 1,Notified C&L,1,H335:1;H400:1;H302:1;H226:1;H332:1;H336:1;H314:1;H312:1
72430,α-(4-chlorophenyl)pyridine-2-methanol,248-592-1,27652-89-7,Acute Tox. 4,Notified C&L,40,H302:39;H335:1;H315:2;H332:1;H319:2;H312:1
72435,"1-(4-aminophenyl)-2,2,2-trifluoroethan-1-one",245-709-8,23516-79-2,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H303:1;H335:1;H315:1;H319:1
72437,21229_ESS_308067-11-0,608-532-0,308067-13-2,Eye Irrit. 2,Notified C&L,8,H319:7;Not classified:1
72439,"2-methyl-1,3-propanediol",412-350-5,,Not Classified,REACH registration C&L,79,Not classified:78;H335:1;H315:1;H319:1
72444,"Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-802-5,68478-21-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
72445,"Fatty acids, C14-18 and C16-22-unsatd., calcium lithium salts",307-933-5,97808-16-7,Not Classified,Notified C&L,5,Not classified:5
72446,Enzymatic Digest of Gelatin and Meat,922-756-9,,Not Classified,Notified C&L,1,Not classified:1
72453,"Fatty acids, rape-oil",288-314-6,85711-54-2,Not Classified,Notified C&L,6,Not classified:6
72456,"Products of roasting of ""slags, steelmaking, vanadium",922-716-0,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;Muta. 1B;Carc. 1B;Repr. 1B;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H340:1;H334:1;H412:1;H350:1;H302:1;H373:1;H332:1;H319:1;H317:1;H360:1
72457,"Hexanoic acid, 6-(acetyloxy)-, ethyl ester",600-625-4,104986-28-9,Not Classified,Notified C&L,53,Not classified:53
72459,"Phosphoric acid, reaction products with diethanolamine, ethanolamine and triethanolamine",286-711-9,85338-36-9,Not Classified,Notified C&L,1,Not classified:1
72460,5-methyl-3-phenylisoxazole-4-carboxylic acid,214-497-9,1136-45-4,,Notified C&L,5,H302:5
72461,Methyl 2-ethylacetoacetate,257-381-3,51756-08-2,Not Classified,Notified C&L,93,Not classified:88;H335:5;H315:5;H319:5;H227:1
72462,Dodecyltriphenylphosphonium bromide,239-538-8,15510-55-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
72463,Anacardic acid,234-268-7,11034-77-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72464,"Bambusa vulgaris, ext.",294-923-8,91771-33-4,Not Classified,Notified C&L,40,Not classified:39;H319:1;H225:1
72468,Diethylaluminium chloride,202-477-2,96-10-6,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,237,H250:237;H314:237;H260:143;H318:173;H261:38;H225:74;H400:4;H224:4;H336:5;H410:4;H252:6;H335:1;H361:1;H304:1;H372:1
72469,"L-aspartic acid, compound with L-lysine (1:1)",248-423-1,27348-32-9,Not Classified,Notified C&L,2,Not classified:2
72472,"4-Butyl-4''-ethyl-2',3'-difluor-1,1':4',1''-terphenyl",610-428-5,486406-09-1,Not Classified,REACH registration C&L,1,Not classified:1
72474,1-ethyl-2-nitrobenzene,210-299-1,612-22-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:38;H335:38;H315:39;H319:39;H412:1
72486,Pyrazinecarbonitrile,243-369-5,19847-12-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:45;H315:46;H302:46;H332:46;H319:46;H312:46;H301:1;H311:1;H331:1
72489,"(4R)-4-methyl-1,3-dioxolan-2-one",605-425-0,16606-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:39;H315:40;H319:41
72497,Xanthen-9-one,201-997-7,90-47-1,Acute Tox. 3,Notified C&L,40,H301:39;H315:1;H319:1
72498,2-bromo-p-toluidine,209-515-7,583-68-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,46,H301:45;H311:45;H331:40;H315:6;H319:6;H335:1;H330:1;H373:1
72500,"4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride",261-867-0,59703-00-3,Not Classified,REACH registration C&L,20,Not classified:4;H318:2;H314:16;H290:1
72502,Tricarbonyl(methylcyclopentadienyl)manganese,235-166-5,12108-13-3,Acute Tox. 3;Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,559,H301:65;H400:508;H330:107;H410:69;H310:516;H300:494;H315:51;H372:56;H311:43;H351:38
72503,"Pistacia lentiscus, ext.",290-174-6,90082-82-9,Not Classified,Notified C&L,307,Not classified:185;H413:87;H317:97;H304:96;H315:30;H226:10;H411:3;H410:6;H319:2;H400:1;H412:1
72504,"Benzene, C9-13-alkyl derivs., distn. residues, sulfonated, sodium salts",305-989-5,95465-76-2,Eye Irrit. 2,Notified C&L,441,H319:441
72506,"Trisodium 5-[(3-carboxylato-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-2-oxido-3-methylbenzoate",249-076-9,28546-93-2,Eye Irrit. 2,Notified C&L,9,H319:9
72509,Benzoxonium chloride,243-008-1,19379-90-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,37,H302:37;H335:5;H315:32;H319:5;H331:31;H400:34;H410:33;H318:31;H411:1
72512,Thulium,231-140-2,7440-30-4,Flam. Sol. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:39;H319:39;H228:46;H260:4;Not classified:3
72516,"[R-(R*,S*)]-(β-hydroxy-α-methylphenethyl)methylammonium nitrate",279-658-8,81012-98-8,Acute Tox. 4,Notified C&L,38,H302:38
72517,(+)-trans-p-Menth-2-ene,610-616-7,5113-93-9,Flam. Liq. 3,Notified C&L,38,H226:38
72520,"Linseed oil, maleated, mono-Et ester",294-472-7,91722-71-3,Not Classified,Notified C&L,1,Not classified:1
72524,"Disodium 4,4'-bis[[4-[(2-hydroxypropyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",243-566-6,20179-35-5,Not Classified,Notified C&L,2,Not classified:2
72525,"1,1-dimethylsilacyclohexane",223-730-3,4040-74-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
72528,Potassium 4-acetoacetylaminobenzenesulphonate,274-569-0,70321-85-6,Not Classified,REACH registration C&L,136,Not classified:136
72530,"(Z,Z)-1,1,3,3-tetrabutyl-1,3-bis[(1-oxooctadec-9-enyl)oxy]distannoxane",267-223-5,67827-59-2,Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H400:55;H410:55;H341:55;H372:55;H360:55
72536,Amoxapine,237-867-1,14028-44-5,Acute Tox. 4,Notified C&L,45,H302:45;H341:1;H370:1
72540,"4,4'-oxybis(ethylenethio)diphenol",404-590-4,90884-29-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
72548,Cadmium iodate,232-224-1,7790-81-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38;H302:38;H332:38;H312:38
72549,"[1R-(1α,2β,4β,6α)]-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane",243-411-2,19894-99-6,Flam. Liq. 3;Acute Tox. 3;STOT SE 3,REACH registration C&L,2,H226:2;H335:2;H331:2
72550,Disilver oxide,243-957-1,20667-12-3,Ox. Sol. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,339,H318:290;H410:231;H271:225;H400:225;H272:53;H335:38;H315:38;H319:38;H314:7;Not classified:3;H361:1
72552,4-methylbenzyl alcohol,209-639-1,589-18-4,Eye Irrit. 2,REACH registration C&L,282,H319:282;H335:45;H315:46
72562,Diammonium ethyl phosphate,246-500-4,24856-79-9,Skin Corr. 1B,Notified C&L,1,H314:1
72564,Octadecane,209-790-3,593-45-3,Asp. Tox. 1,REACH registration C&L,1531,H304:1416;Not classified:108;H335:10;H315:11;H319:11
72565,Bromopentylmagnesium,211-747-9,693-25-4,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,69,H250:38;H314:69;H260:64;H225:26;H261:4;H224:4
72567,3-methylthiazolidine-2-thione,217-614-1,1908-87-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,5,H412:4;H302:4;H318:1;H317:1
72569,8-isopropyl-8-azabicyclo[3.2.1]oct-3-yl endo-(±)-formylphenylacetate,244-858-6,22235-74-1,Acute Tox. 2;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2,REACH registration C&L,2,H330:1;H300:1;H319:1;H312:1;H317:1;Not classified:1
72570,"Gases (petroleum), C2-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]",272-205-5,68783-65-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
72573,"Fennel, ext.",283-414-6,84625-39-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1726,H315:1619;H351:1644;H400:1404;H410:1433;H304:1645;H341:1644;H226:1346;H317:1645;Not classified:80;H411:27;H227:2
72574,Sodium 6-amino-5-[(4-anilinosulphonylphenyl)azo]-4-hydroxynaphthalene-2-sulphonate,273-839-5,69029-99-8,,Notified C&L,1,H412:1
72579,"Urea, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine",607-497-9,25036-13-9,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,478,H226:442;H319:444;H412:33;Not classified:1
72582,Tris(methylphenyl) phosphate,215-548-8,1330-78-5,Skin Sens. 1;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1754,H400:1542;H361:1211;H410:1407;H373:460;H317:543;H302:537;H312:541;H411:289;H370:90;H319:35;H371:26;H340:19;Not classified:5;H372:2;H360:1
72583,"Disodium [2,2'-binaphtho[2,1-b]thiophene]-1,1'-diyl disulphate",224-601-4,4425-36-9,Not Classified,Notified C&L,1,Not classified:1
72584,4-morpholinoacetonitrile,227-366-6,5807-02-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:40;H319:41;H335:2;H315:3;H332:2;H312:1;H310:2;H300:1
72590,Dimethyl[3-[(1-oxooctadecyl)amino]propyl][2-oxo-2-(tetradecyloxy)ethyl]ammonium chloride,272-964-2,68921-83-5,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H318:4;H317:3;H410:3;H400:3
72591,Gadolinium trichloride,233-386-6,10138-52-0,Skin Irrit. 2,Notified C&L,47,H315:46;H319:8;H335:4;Not classified:1
72592,Salicylaldehyde oxime,202-353-8,94-67-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:43;H335:44;H315:45;H319:45
72595,6-chloro-1H-indazol-3-amine,240-925-9,16889-21-7,,Notified C&L,1,H335:1;H315:1;H319:1
72597,Aziridine-2-carbonitrile,251-725-6,33898-53-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,38,H301:38;H335:38;H315:38;H331:38;H318:38;H311:38
72598,Tetrabutylammonium Azide,619-423-2,993-22-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H301:43;H335:42;H315:43;H400:42;H410:42;H319:43;H311:5;H331:1;H228:1
72603,"1,3,5-trimethylcyclohexane",217-417-0,1839-63-0,Flam. Liq. 2,Notified C&L,39,H225:39
72609,"4-isopropyl-2,6-dinitrophenol",223-855-3,4097-47-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H301:1;H335:1;H315:1;H319:1
72610,Prop-2-ynyl methacrylate,237-599-5,13861-22-8,,Notified C&L,5,H226:5;H335:5;H315:5;H319:5
72611,4-fluorophenylacetonitrile,207-286-8,459-22-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H335:43;H315:49;H302:47;H332:47;H319:49;H312:47;H301:2;H330:1;H311:2;H331:1
72612,"2,2’-(Hydroxyimino)Bis-ethanesulfonic acid, disodium salt",603-787-4,133986-51-3,Eye Irrit. 2,Notified C&L,3,H319:2;H412:1
72614,Disodium hydrogen bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(3-),235-628-6,12392-64-2,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,112,H412:79;H317:63;H319:76;Not classified:22;H318:14;H315:13
72615,Bis[bis(2-hydroxyethyl)ammonium] sulphite,308-475-9,98072-25-4,Not Classified,Notified C&L,1,Not classified:1
72619,1-[2-[2-(3-methoxypropoxy)propoxy]ethoxy]butane,618-542-7,9038-95-3,Not Classified,Notified C&L,1445,Not classified:523;H332:335;H413:127;H330:329;H302:200;H315:139;H319:194;H372:49;H335:35;H331:17
72620,Phendimetrazine hydrogen tartrate,200-051-0,50-58-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,41,H301:39;H332:38;H315:38;H319:38;H302:2
72621,α-chlorocinnamaldehyde,242-237-4,18365-42-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
72623,"1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, polymer with 2-methyloxirane and oxirane",614-308-3,68133-47-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H315:59;H319:60
72628,"[2R-[2α(E),3β]]-2-[2-(3,4-dihydro-6-methoxy-1(2H)-naphthylidene)ethyl]-2-ethyl-3-hydroxycyclopentan-1-one",257-409-4,51773-49-0,Aquatic Chronic 3,REACH registration C&L,3,H412:3
72630,"Boron potassium oxide (B5KO8), tetrahydrate",602-489-1,12229-13-9,Repr. 2,Notified C&L,501,H361:461;H360:38;H319:20;Not classified:2
72634,Methyl cyclopentanecarboxylate,225-049-7,4630-80-2,Acute Tox. 4,Notified C&L,40,H302:39;H226:2
72637,"2-chloro-1,1-dimethoxyethane",202-624-0,97-97-2,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,89,H412:64;H302:89;H226:89;H332:31;H312:25
72639,"1-amino-9,10-dihydro-4-[4-[[(4-methylphenyl)sulphonyl]oxy]anilino]-9,10-dioxoanthracene-2-sulphonic acid, sodium salt",287-582-1,85536-94-3,Not Classified,Notified C&L,3,Not classified:3
72642,Chrome tin pink sphene,269-073-6,68187-12-2,Not Classified,REACH registration C&L,105,Not classified:104;H373:1
72644,"2,3-Difluoro-4-[trans-4-(trans-4-ethylcyclohexyl)-cyclohexyl]-toluene",605-720-4,174350-08-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
72645,Lauroyl chloride,203-941-7,112-16-3,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,191,H290:59;H314:190;H318:85;H317:84;H302:8;H301:4;H335:2;H315:1;H319:1;H332:1
72650,2-ethoxy-1-methylethyl acetate;2PG1EEA,259-370-9,54839-24-6,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0,H336:0;H226:0
72651,"Boric acid (H2B4O7), dipotassium salt, tetrahydrate",601-707-2,12045-78-2,Repr. 2,Notified C&L,49,H361:41;H360:6;Not classified:2;H412:1
72653,Aluminium arsenide,245-255-0,22831-42-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H301:42;H331:42;H400:38;H373:4
72660,4-formyl-2-methoxyphenyl isobutyrate,243-956-6,20665-85-4,Not Classified,REACH registration C&L,1564,Not classified:1564;H317:1
72662,Cycloheptane,206-030-2,291-64-5,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,94,H304:77;H225:78;H412:13
72664,"3-(allyloxy)-2,2-bis[(allyloxy)methyl]propanol",216-008-4,1471-17-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,39,H412:39;H315:39;H319:39
72667,"2,2'-[[4-[(3,5-dinitro-2-thienyl)azo]phenyl]imino]bisethyl diacetate",255-940-6,42783-06-2,Not Classified,REACH registration C&L,37,Not classified:37
72668,"2,3,6,7-tetrahydro-11-oxo-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxylic acid",259-824-6,55804-65-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1;H302:1;H332:1;H312:1
72669,"reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C",406-640-0,136920-07-5,Skin Sens. 1,Harmonised C&L,0,H317:0
72672,Tridecyl stearate,250-696-7,31556-45-3,Not Classified,Notified C&L,40,Not classified:40
72678,Dilithium titanate,234-759-6,12031-82-2,Not Classified,REACH registration C&L,2,Not classified:2
72680,"trans-3-methylenecyclopropane-1,2-dicarboxylic acid",207-874-4,499-02-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
72681,"Quaternary ammonium compounds, C12-18-alkyl(hydroxyethyl)dimethyl, chlorides",288-474-7,85736-63-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,75,H302:75;H314:75;H400:75;H373:31
72683,"Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",286-046-4,85186-63-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H410:83;H302:83;H400:83
72688,"Poly[oxy(methyl-1,2-ethanediyl)], α-octadecyl-ω-hydroxy-",607-655-7,25231-21-4,Not Classified,Notified C&L,122,Not classified:122
72689,Lithium dinonylnaphthalenesulphonate,248-903-0,28214-91-7,Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:25;H319:50;H315:26;Not classified:1
72691,Vinyl valerate,227-533-3,5873-43-8,Flam. Liq. 3;Aquatic Acute 1,Notified C&L,38,H226:38;H400:38
72692,(2H8)styrene,242-995-6,19361-62-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,47,H226:46;H332:46;H315:45;H319:45;Not classified:1;H302:1;H314:1;H312:1;H412:1
72693,"4-[[]3-(4,5-dihydro-1,2-oxazol-3-yl)-4-methanesulfonyl-2-methylbenzoyl]-1-methyl-1H-pyrazol-5-ol",606-699-4,210631-68-8,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,221,H410:221;H400:221;H360:221
72694,"Poly(oxy-1,2-ethanediyl), a-(4-nonylphenyl)-[?]-hydroxy-, phosphate",610-709-2,51609-41-7,Skin Corr. 1C;Eye Irrit. 2,Notified C&L,473,H319:447;H314:471;H318:23;H411:25;Not classified:1;H315:1
72695,"trans-(±)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylic acid",211-883-9,705-16-8,Not Classified,Notified C&L,1,Not classified:1
72696,3-nitroanilinium chloride,251-421-3,33240-96-9,Acute Tox. 4,Notified C&L,1,H302:1
72698,Dibutyltin bis(2-ethylhexanoate),220-481-2,2781-10-4,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,118,H400:99;H410:100;H314:42;H318:3;H317:41;H302:7;H341:59;H370:1;H372:59;H360:61;Not classified:7;H319:5;H361:5;H310:4;H301:6;H411:4;H413:2;H373:1;H315:1
72700,Pent-4-enoyl chloride,700-100-0,39716-58-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,74,H318:2;H302:1;H226:74;H314:74
72701,"Linseed oil, maleated, mono-Et ester, ammonium salt",294-473-2,91722-72-4,Not Classified,Notified C&L,1,Not classified:1
72702,Sodium 1-aminonaphthalene-2-sulphonate,262-671-8,61240-37-7,Not Classified,Notified C&L,8,Not classified:7;H335:1;H315:1;H319:1
72705,Bemegride,200-588-0,64-65-3,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:38;H300:39;H331:38;H330:1;H310:1
72707,"Sulfuric acid, zinc salt, hydrate (1:1:6)",604-163-4,13986-24-8,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H318:33;H302:33;H410:33;H400:33
72709,4-nitrophthalic acid,210-215-3,610-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
72715,Tetramethylammonium toluene-p-sulphonate,223-625-2,3983-91-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
72716,Tetraphenylthiophene,217-545-7,1884-68-0,Aquatic Chronic 4,Notified C&L,38,H413:38
72718,"Pistachio, ext.",290-173-0,90082-81-8,Flam. Liq. 3,Notified C&L,26,H226:25;H225:1
72719,Polyethylene glycol mono(tert-octylph-enyl) ether9036-19-5,618-541-1,9036-19-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,3955,H318:2423;H302:2386;H412:1644;H411:1892;H319:1277;Not classified:148;H315:168;H410:67;H400:49;H334:1
72720,"4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, [2S-[2α,5α,6β(S*)]]-",261-868-6,59703-84-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,7,H334:4;H317:5;H302:1;H332:1;Not classified:1
72721,"Alcohols, C10-16, ethoxylated, sulfosuccinates, bis[mono(hydroxyethyl)ammonium] salts",500-346-7,157627-96-8,Not Classified,Notified C&L,1,Not classified:1
72722,"4,4'-(ethane-1,2-diyl)bismorpholine",217-026-5,1723-94-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,50,H318:39;H335:39;H315:47;H317:8;H319:8;Not classified:3
72724,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl formate",214-853-3,1200-67-5,Not Classified,Notified C&L,91,Not classified:90;H412:1;H315:1
72726,"Cobalt, compound with samarium (7:2)",235-573-8,12305-84-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
72729,"Fatty acids, C14-18 and C16-22-unsatd., compds. with diethanolamine",287-975-8,85631-28-3,Not Classified,Notified C&L,1,Not classified:1
72731,"Benzeneacetic acid, 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethyl-",616-390-6,76811-98-8,Not Classified,Notified C&L,3,Not classified:1;H302:2
72732,4-(p-hydroxyphenyl)butan-2-ol,274-056-1,69617-84-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H315:1
72733,"propyl 3,4,5-trihydroxybenzoate",204-498-2,121-79-9,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
72734,"2,6-dinitrotoluene",210-106-0,606-20-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H301:0;H331:0;H412:0;H361:0;H350:0;H341:0;H373:0;H311:0
72735,Lignite,603-338-2,129521-66-0,Not Classified,Notified C&L,59,Not classified:59
72737,chrysoidine C,286-946-7,85407-90-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2,Harmonised C&L,0,H318:0;H302:0;H341:0;H315:0
72740,"Lithium, 12-hydroxyoctadecanoate sebacate complexes",272-377-1,68815-49-6,Not Classified,Notified C&L,43,Not classified:43
72741,2-ethoxy-2-methylpropane,211-309-7,637-92-3,Flam. Liq. 2;STOT SE 3,REACH registration C&L,149,H336:115;H225:124;H335:26;H315:41;H319:42;H224:22;H304:10;H331:5;Not classified:4;H400:1;H412:1;H332:1;H310:1
72742,Pentyl butyrate,208-739-2,540-18-1,Flam. Liq. 3,Notified C&L,1283,H226:1244;H335:42;H315:42;H319:43;Not classified:1
72744,3-[[(2-methylphenyl)amino]carbonyl]-2-naphthyl chloroacetate,252-463-5,35245-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72745,phosphorus pentachloride,233-060-3,10026-13-8,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;STOT RE 2,Harmonised C&L,0,H330:0;H302:0;H373:0;H314:0
72747,"Androstan-17-ol, 2,3:16,17-diepoxy-, acetate, (2α,3α,5α,16α,17α)-",604-546-6,146902-95-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
72748,"[[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cobaltate(2-)",239-001-8,14931-83-0,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Repr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H334:1;H302:1;H341:1;H410:1;H411:1;H317:1;H360:1
72749,"Naphthalene-2,7-diol",209-478-7,582-17-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H335:64;H315:65;H319:65;H318:14;H317:14;H411:13;H302:11;Not classified:3
72750,N-[3-(dimethylamino)propyl]palmitamide monoacetate,280-756-8,83763-68-2,Not Classified,Notified C&L,3,Not classified:3
72751,Disodium 7-amino-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate,228-589-1,6300-50-1,Not Classified,REACH registration C&L,146,Not classified:146
72753,"3-aminonaphthalene-1,5-disulphonic acid",205-020-5,131-27-1,Eye Irrit. 2,REACH registration C&L,11,H319:9;Not classified:2
72756,4-chlorobutyrophenone,213-362-1,939-52-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72757,"Camphor tree, Cinnamomum camphora linalooliferum, ext.",294-760-2,91745-89-0,Skin Irrit. 2,Notified C&L,1452,H315:1426;H400:28;H410:28;H304:30;H226:55;H317:30;Not classified:25;H412:26;H319:4;H411:1
72758,3-Methoxy-4-methylbenzonitrile,609-141-8,3556-60-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,3,H301:2;H315:3;H331:2;H319:3;H311:2;H335:2;H302:1;H332:1;H312:1
72760,Cyclohexen-1-yltoluene,245-131-6,22618-51-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H318:38;H413:38;H335:38;H315:38
72767,"Jojoba, ext.",289-964-3,90045-98-0,Not Classified,Notified C&L,134,Not classified:134
72769,Tetrafluorogermane,232-011-3,7783-58-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:45;H314:46;H331:7;H372:6;H280:8;H330:1;H362:1;H335:1
72772,"4-[(4,6-dihydroxypyrimidin-2-yl)amino]benzonitrile",609-425-1,374067-80-8,Not Classified,REACH registration C&L,1,Not classified:1
72784,Ethyl 3-hydroxyhexanoate,218-973-7,2305-25-1,Not Classified,Notified C&L,1455,Not classified:1455
72792,Tubocurarine chloride,200-356-9,57-94-3,Acute Tox. 2,Notified C&L,40,H300:39;H301:1;H311:1;H331:1
72794,"1,3-Diazaspiro[4,4]non-1-en-4-one, 2-butyl, hydrochloride",604-785-6,151257-01-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39
72795,2-piperazin-1-ylethylamine,205-411-0,140-31-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H314:0;H312:0;H317:0
72797,Bis(C12-15-alkyl) carbonate,401-240-2,,Not Classified,Notified C&L,2,Not classified:2
72799,"1,2,3-Propanetriol, 2-hydroxyethyl ethers, dihydrogen phosphates",297-555-6,93573-20-7,Not Classified,Notified C&L,2,Not classified:2
72800,"1H-Benzimidazole, 2,5,6-trichloro-",605-523-3,16865-11-5,Not Classified,Notified C&L,1,Not classified:1
72801,4-bromo-2-chloroaniline,254-118-4,38762-41-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H302:45;H332:45;H312:41;H373:4;H311:4;H335:2;H315:3;H319:3
72804,1-methyl-1H-indole-3-carbaldehyde,242-750-3,19012-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
72807,4-amino-6-chlorotoluene-3-sulphonic acid,201-837-6,88-51-7,Eye Irrit. 2,REACH registration C&L,202,H319:200;H335:109;H315:110;Not classified:2
72808,Pargyline,209-101-6,555-57-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H301:40;H335:39;H315:40;H331:38;H319:40;H311:38
72816,"Alcohols, C12-14 (even numbered), ethoxyated, sulfated, triisopropanolamine-NH4 salt",605-725-1,174450-50-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,92,H318:92;H315:92
72817,"5H,6H,7H,8H-imidazo[1,5-c]pyrimidin-5-one",604-459-3,14509-66-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72821,Tetradifon,204-134-2,116-29-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,198,H410:195;H302:198;H400:195
72824,"tetrabromobisphenol-A;2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol",201-236-9,79-94-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
72833,"Naphtha (petroleum), light catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-056-2,64741-55-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
72834,Kaolin,310-194-1,1332-58-7,Not Classified,Notified C&L,1758,Not classified:1533;H315:83;H319:96;H372:64;H373:63;H334:5;H370:4;H350:4;H335:1
72835,(2-acetoxyethyl)trimethylammonium bromide,200-622-4,66-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
72837,Hydratropaldehyde,202-255-5,93-53-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1526,H317:1411;H315:1526;H319:1526;H412:3;H361:1403;H335:45;H351:1;H400:1;H341:1;H411:1;H318:1
72839,Atracurium besilate,264-743-4,64228-81-5,Acute Tox. 3,Notified C&L,72,H301:52;H330:18;H310:18;H300:17;H302:3;H311:2;H412:1;H372:1;H335:1;H315:1;H319:1;H312:1
72840,5-amino-2-chloropyridine,226-322-3,5350-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,110,H335:109;H315:110;H319:110;H302:5;H332:5;H312:5
72841,cadmium carbonate,208-168-9,513-78-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H340:0;H400:0;H350:0;H302:0;H410:0;H332:0;H312:0;H372:0
72846,1-[[5-(dimethylamino)-1-naphthyl]sulphonyl]aziridine,257-508-2,51908-46-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H332:38;H312:38;H351:38
72847,"Trisodium bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(3-)]chromate(3-)",276-843-5,72797-02-5,Not Classified,Notified C&L,5,Not classified:5
72854,"3-[(6-deoxy-α-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyran-4-one",208-322-5,522-12-3,Not Classified,Notified C&L,2,Not classified:2
72855,4‐(Cyclohexylmethyl)cyclohexan‐1‐amine,609-450-8,37621-85-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
72856,2-[[2-(2-hydroxyethoxy)-4-nitrophenyl]amino]ethanol,428-840-7,59820-43-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,15,H335:8;H315:8;H319:15;H302:7
72860,4'-hydroxyacetophenone,202-802-8,99-93-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,284,H412:134;H319:244;H302:136;H335:94;H315:95
72861,cadmium iodide,232-223-6,7790-80-9,Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H400:0;H351:0;H410:0;H373:0
72863,Hexanal,200-624-5,66-25-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1842,H226:1842;H315:48;H319:1839;H317:35;H335:5;Not classified:1
72864,(chloromethyl)phosphonic dichloride,217-848-4,1983-26-2,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H335:38;H314:38
72866,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(dimethylamino)propyl]amino]sulfonyl sulfo derivs., sodium salts",291-011-1,90295-20-8,Not Classified,Notified C&L,120,Not classified:83;H412:37;H314:37
72867,"dioctylbis(pentane-2,4-dionato-O,O')tin",483-270-6,54068-28-9,Skin Sens. 1;STOT SE 2,REACH registration C&L,3,H317:3;H371:2;H361:1;H411:1
72868,"Calcium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate",245-009-2,22454-86-0,Not Classified,Notified C&L,4,Not classified:4
72869,Methicillin,200-505-8,61-32-5,Acute Tox. 4,Notified C&L,39,H302:39
72870,"Dodecahydro-3,8,8,11a-tetramethyl-5H-3,5a-epoxynaphth[2,1-c]oxepin",260-686-4,57345-19-4,Aquatic Chronic 4,REACH registration C&L,1448,H413:110;Not classified:1336;H335:1;H315:2;H319:1
72872,D-cysteine hydrochloride,251-043-9,32443-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
72876,Streptomycin,200-355-3,57-92-1,Repr. 2,Notified C&L,169,H361:169;H351:38
72878,"17-hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate",209-864-5,595-33-5,Carc. 2;STOT RE 2,Notified C&L,123,H373:43;H351:92;H341:32;H350:30;H360:77;H362:29;H302:18;H332:17;H312:17;H334:1;H361:2;H317:1;H372:2;H413:2
72879,di-μ-chloro-bis(η-allyl)palladium,234-579-8,12012-95-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:40;H315:46;H319:46;H302:8;H332:4;H312:4;H317:5;H226:4;H314:4;H412:1
72880,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortallow alkyl derivs.",291-479-7,90411-99-7,Skin Corr. 1B,Notified C&L,1,H314:1
72885,"Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-803-0,68478-22-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
72886,N-ethyl-o-toluidine,202-354-3,94-68-8,Acute Tox. 3;Eye Irrit. 2;Carc. 2,Notified C&L,136,H301:129;H319:124;H351:83;H335:40;H315:41;H331:41;H311:46;Not classified:6;H330:6;H373:5;H300:1;H310:1;H412:1;H350:1;H370:1
72887,Urea phosphate,224-534-0,4401-74-5,Skin Corr. 1B,Notified C&L,4,H314:3;Not classified:1
72891,"Sodium 4-[(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)azo]-2,5-dichlorobenzenesulphonate",274-105-7,69762-08-9,Not Classified,REACH registration C&L,68,Not classified:68
72894,"dodemorph acetate;4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate",250-778-2,31717-87-0,Skin Corr. 1C;Skin Sens. 1A;STOT RE 2;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H373:0;H314:0;H317:0
72897,Trimanganese bis(orthophosphate),237-997-9,14154-09-7,STOT RE 2,REACH registration C&L,4,H373:1;Not classified:3
72901,Sodium selenate,236-501-8,13410-01-0,Acute Tox. 2;Skin Irrit. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,83,H315:6;H400:79;H330:8;H300:9;H410:83;H373:82;H301:74;H331:75;H372:1;H401:1
72902,3-(methylthio)hexan-1-ol,257-380-8,51755-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1471,H335:1443;H315:1332;H319:1332;Not classified:27
72912,isoheptane,250-610-8,31394-54-4,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H225:0;H336:0;H304:0;H410:0
72913,"2-chloro-1,3,2-dioxaphospholane 2-oxide",229-560-6,6609-64-9,Skin Corr. 1B,Notified C&L,41,H314:41;H318:2;H335:1;H242:1;H290:1;H412:1
72914,"1-(3,4-dimethoxyphenyl)-2-nitropropene",204-547-8,122-47-4,Skin Sens. 1,Notified C&L,38,H317:38
72915,"Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), ethoxylated, chlorides",614-407-1,68308-62-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,3,H302:3;H314:3
72916,Apramycin,253-460-1,37321-09-8,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H315:1
72921,Sulphur tetrafluoride,232-013-4,7783-60-0,Press. Gas (Liq.);Skin Corr. 1A;Acute Tox. 1,Notified C&L,110,H330:110;H314:110;H280:110;H335:39
72925,"fenthion (ISO);O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate",200-231-9,55-38-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 3;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H331:0;H400:0;H302:0;H341:0;H410:0;H312:0;H372:0
72926,Tetrabutylammonium tetrahydroborate,251-658-2,33725-74-5,Not Classified,REACH registration C&L,104,Not classified:4;H261:100;H314:99;H315:1;H319:1;H335:1;H318:2
72932,Adipiodone,210-105-5,606-17-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
72936,"2,3-dimethylpyridine",209-514-1,583-61-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H335:45;H315:46;H302:46;H226:46;H318:40;H331:4;H319:6;H312:5;Not classified:1;H332:1
72937,Triphenylarsine oxide,214-571-0,1153-05-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H301:38;H331:38;H400:38
72938,Alkenyl dicarboxylamide,425-620-2,,Not Classified,REACH registration C&L,4,Not classified:4
72941,Dichlorodiphenylstannane,214-496-3,1135-99-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Acute 1,Notified C&L,47,H335:44;H315:44;H400:39;H302:47;H332:44;H319:44;H312:47
72952,Allyl p-toluenesulphonate,225-480-0,4873-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
72955,"2,2'-difluoro-1,1'-biphenyl",206-863-1,388-82-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:38;H315:38;H319:38;Not classified:3
72957,Rubidium nitrate,236-060-1,13126-12-0,Ox. Sol. 2,REACH registration C&L,78,H272:75;H335:42;H315:47;H319:47;H271:3;Not classified:1
72959,"Stains, biological, Wright's",273-541-5,68988-92-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,6,H302:5;H319:4;H335:1;H315:1;H332:2;H312:1
72962,"1,3,4,6,7,9,9b-heptaazaphenalene-2,5,8-triamine",216-122-4,1502-47-2,Not Classified,REACH registration C&L,34,Not classified:34
72963,Dipotassium 2-ethylhexyl phosphate,268-022-5,67989-97-3,Not Classified,Notified C&L,85,Not classified:85
72964,"1,2,3,4-tetrahydro-6-nitro-quinoxaline",414-270-6,41959-35-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
72969,"1,2,3-tribromopropane",202-478-8,96-11-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43,H335:38;H315:43;H351:38;H302:43;H332:39;H319:43;H312:39;H341:4
72975,"3,3-dimethylpentane",209-230-8,562-49-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H225:0;H336:0;H304:0;H410:0
72978,"Benzoic acid, 2-amino-, 2-(dimethylamino)ethyl ester, monoacetate",618-474-8,901129-82-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H318:83;H302:83;H412:83
72981,"[1R-(1α,3β,5α)]-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol",243-410-7,19894-98-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
72982,"Oleic acid, compound with 2-(diethylamino)ethanol (1:1)",267-784-6,67923-77-7,Not Classified,Notified C&L,1,Not classified:1
72983,"4,5'-dibenzamido-1,1'-iminodianthraquinone",204-916-3,128-89-2,Eye Irrit. 2,Notified C&L,38,H319:38
72985,"Fats and Glyceridic oils, Mauritia flexuosa",609-677-2,394239-67-9,Not Classified,Notified C&L,2,Not classified:2
72986,"Fatty acids, olive-oil, 2-ethylhexyl esters",295-681-6,92113-73-0,Not Classified,Notified C&L,2,Not classified:2
72990,Ruthenocene,215-065-2,1287-13-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
72992,Methoxyacetaldehyde,233-693-5,10312-83-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H225:38;H302:38;H319:38;H312:38;H317:38
72998,"Plane tree, Platanus occidentalis, ext.",290-175-1,90082-83-0,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
73001,"1-ethylpiperazine-2,3-dione",261-866-5,59702-31-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:46;H319:46;H302:1
73002,Phenyl chloroformate,217-547-8,1885-14-9,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,153,H290:45;H335:90;H412:5;H330:147;H302:153;H314:107;H318:54;H315:46;H317:53;Not classified:2;H319:1;H413:1;H227:1;H313:1
73004,"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)",430-940-0,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
73005,Ethylphenacemide,201-998-2,90-49-3,,Notified C&L,4,H302:4;H335:1;H315:1;H319:1
73007,"Reaction products of 5-ethylidene-bicyclo[2.2.1]hept-2-ene and 2-methoxyphenol, hydrogenated",418-110-6,224790-80-1,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1290,H411:1290;H315:1286;H317:4
73009,2-(methylamino)butan-1-ol,248-591-6,27646-79-3,Flam. Liq. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1;H227:1
73013,"zinc sulphate (anhydrous) ;zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate)",231-793-3,7733-02-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H302:0;H410:0;H400:0
73017,α-hydrazino-m-cresol dihydrochloride,279-659-3,81012-99-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:38;H335:39;H315:39;H319:1
73018,N-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)thio]acetamide,461-890-8,443965-79-5,Aquatic Chronic 3,Notified C&L,2,H412:2
73020,"4-methyl-4-phenyl-1,3-dioxane",214-854-9,1200-73-3,Acute Tox. 4,Notified C&L,38,H302:38
73029,"Tris[(1-oxooctadec-9-en-1-yl)anthranilato-O1,O2]chromium",304-021-9,94232-92-5,Not Classified,Notified C&L,83,Not classified:83
73031,Guanidine Hydroiodide,606-268-0,19227-70-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3,H302:2;H332:1;H315:3;H319:3;H335:1
73038,1-bromo-4-(chloromethyl)benzene,209-638-6,589-17-3,Skin Corr. 1B,Notified C&L,45,H314:45;H335:6;H319:2;H290:1;H318:1
73044,1-methyl-1H-indole-3-ethylamine,231-377-1,7518-21-0,Acute Tox. 4,Notified C&L,38,H302:38
73046,"Oils, vegetable, sodium salts",269-135-2,68187-93-9,Not Classified,Notified C&L,3,Not classified:3
73049,(carboxylatomethyl)hexadecyldimethylammonium,211-748-4,693-33-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,65,H317:6;H315:47;H319:51;H302:12;H318:3
73051,Endo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetate,244-859-1,22235-81-0,Not Classified,Notified C&L,3,Not classified:2;H302:1
73053,Cyclohexyl-((diethoxy-methyl-silanyl)-methyl)-amine,454-780-6,,Not Classified,Notified C&L,2,Not classified:2
73054,Nonamethylenediamine,211-470-3,646-24-2,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,48,H413:5;H317:5;H302:5;H314:10;H335:38;H315:38;H319:38;H318:1
73059,"Fatty acids, sunflower-oil",283-413-0,84625-38-7,Not Classified,Notified C&L,105,Not classified:104;H318:1
73066,"Hexanedinitrile, hydrogenated, high-boiling fraction",270-153-8,68411-90-5,Skin Corr. 1B,Notified C&L,9,H314:9;H302:4;H335:3;H312:2;H412:2;H317:2;H311:1;H318:2
73067,Diisooctyl maleate,215-547-2,1330-76-3,Not Classified,Notified C&L,1,Not classified:1
73073,Lithium phenoxide,209-086-6,555-24-8,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
73074,2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride,420-200-5,,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H317:0;H302:0;H412:0
73076,Holmium trichloride,233-387-1,10138-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:45;H319:45;Not classified:1
73078,Fluridil-amin,608-146-2,279228-81-8,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1
73080,"1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine",227-367-1,5807-14-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,63,H318:5;H302:3;H314:45;H412:3;Not classified:18
73084,Sodium 4-hydroxyphenylglyoxylate,259-205-0,54537-30-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
73085,Fluspirilene,217-418-6,1841-19-6,Acute Tox. 3;Aquatic Chronic 1,Notified C&L,1,H410:1;H301:1
73087,Butane-1-sulphonyl chloride,219-204-8,2386-60-9,Skin Corr. 1B;STOT SE 3,Notified C&L,80,H335:39;H314:80;H330:35;H302:35;H318:2;H290:1;H341:1;H227:1
73088,N-[2-(diethylamino)ethyl]stearamide,240-924-3,16889-14-8,Skin Irrit. 2;Skin Sens. 1,Notified C&L,42,H317:41;H315:42;H319:1
73090,"Terminalia bellerica, ext.",296-078-0,92202-43-2,Not Classified,Notified C&L,1,Not classified:1
73094,1-bromo-4-pentylbenzene,472-220-9,51554-95-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H318:2;H410:2;H315:3;H400:2;H319:1
73096,"Sodium hydrogen [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]ferrate(2-)",235-627-0,12389-75-2,Not Classified,REACH registration C&L,18,Not classified:17;H319:1
73099,"2,7-dinitro-9H-fluoren-9-one",250-695-1,31551-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
73102,4-fluorophenetole,207-287-3,459-26-7,Acute Tox. 4,Notified C&L,38,H302:38
73106,Lypressin,200-050-5,50-57-7,Acute Tox. 4,Notified C&L,39,H332:39
73109,1-(2-hydroxy-5-methoxyphenyl)ethan-1-one,211-882-3,705-15-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H318:39;H335:46;H315:47;H319:8
73110,Diethyl bis(2-hydroxyethyl)aminomethylphosphonate,220-482-8,2781-11-5,Not Classified,REACH registration C&L,86,Not classified:33;H302:40;H341:9;H317:4
73111,diethyl sulphate,200-589-6,64-67-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H302:0;H332:0;H314:0;H312:0
73116,"Barium chloride (BaCl2), dihydrate",600-412-6,10326-27-9,Acute Tox. 3;Acute Tox. 4,Notified C&L,172,H301:143;H332:172;H302:29
73122,Potassium hexafluoroarsenate,241-102-7,17029-22-0,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H410:43;H301:43;H331:43;H400:40;H373:4;H350:1;H302:1;H319:1;H314:1;H311:1
73123,2-(2-ethoxyethoxy)ethyl acetate,203-940-1,112-15-2,Eye Irrit. 2,REACH registration C&L,815,H319:729;Not classified:84;H315:55;H336:18;H335:2;H019:1
73125,"Fatty acids, C16-22, compds. with diethanolamine",271-701-9,68604-60-4,Not Classified,Notified C&L,2,Not classified:2
73127,1-phenylpropan-1-ol,202-256-0,93-54-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,311,H302:77;H315:237;H319:13
73128,barium carbonate,208-167-3,513-77-9,Acute Tox. 4,Harmonised C&L,0,H302:0
73132,Pentachlorobenzenethiol,205-107-8,133-49-3,Eye Irrit. 2,Notified C&L,40,H319:40
73133,"Naphtha (petroleum), heavy catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-055-7,64741-54-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
73137,Cobalt aluminate blue spinel,310-193-6,1345-16-0,Not Classified,REACH registration C&L,895,Not classified:336;H335:544;H315:544;H319:544;H400:13;H302:2;H410:2;H317:1;H334:1;H411:1
73138,3-chloro-4-hydrazinobenzenesulphonic acid,229-611-2,6628-76-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
73141,"Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol",272-378-7,68815-50-9,Not Classified,Notified C&L,61,Not classified:31;H412:17;H318:11;H411:7;H360:7;H315:2;H319:2;H317:1
73142,"2-bromo-6-(1,3-dioxolan-2-yl)pyridine",251-873-1,34199-87-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
73143,2-bromo-4-tert-butylphenol,218-602-9,2198-66-5,Acute Tox. 4;Eye Irrit. 2A;Aquatic Chronic 2,REACH registration C&L,6,H302:4;H411:2;H315:5;H319:5;H332:2;H312:2;Not classified:1
73144,3-ethoxy-2-nitropyridine,277-676-0,74037-50-6,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H228:38;H226:1
73146,"Sodium 4-[[3-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",274-675-7,70571-81-2,Aquatic Chronic 2,REACH registration C&L,80,H411:5;Not classified:38;H412:37
73149,Tridodecyl trithiophosphite,216-751-4,1656-63-9,Not Classified,Notified C&L,50,Not classified:50
73150,Tetrapropylammonium hexafluorophosphate,235-167-0,12110-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
73152,3-methyl-2-phenylvaleroyl 1-methyl-4-piperidyl fumarate,211-233-4,635-32-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
73158,"1,3-[di-tert-butyl]thiourea",223-732-4,4041-95-6,,Notified C&L,5,H302:5;H335:1;H315:1;H332:1;H319:1;H312:1
73160,"o-(p-isocyanatobenzyl)phenyl isocyanate;diphenylmethane-2,4'-diisocyanate",227-534-9,5873-54-1,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Resp. Sens. 1;Carc. 2;STOT RE 2,Harmonised C&L,0,H335:0;H315:0;H351:0;H334:0;H373:0;H332:0;H319:0;H317:0
73161,"Benzenesulfonic acid, 4-chloro-2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(3-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]-5-methyl-, ammonium salt (1:2)",604-984-8,154946-66-4,Not Classified,Notified C&L,52,Not classified:52
73162,2-ethylbutyraldehyde,202-623-5,97-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1456,H335:1408;H315:1406;H319:1410;H225:159;H226:10
73163,"Hexadecane-1,16-diol",231-794-9,7735-42-4,Skin Irrit. 2,Notified C&L,38,H315:38
73166,"Diphosphoric acid, compd. with piperazine (1:1)",457-330-7,66034-17-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,6,H412:6;H319:6
73170,Methylsilane,213-598-5,992-94-9,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,182,H220:182;H280:182;H332:38;H312:38;H335:22;H315:22;H336:22;H319:22
73171,3-methyl-5-propylcyclohex-2-enone,223-069-0,3720-16-9,Aquatic Chronic 3,REACH registration C&L,364,H412:14;H315:350;H319:337;H335:1;H302:1;H332:1;H311:1
73172,[No public or meaningful name is available],479-640-1,,Not Classified,Notified C&L,2037,Not classified:2037
73176,3-methylbenzothiazol-2(3H)-one hydrazone hydrochloride,238-428-7,14448-67-0,Acute Tox. 3;Eye Irrit. 2,Notified C&L,2,H301:2;H319:2
73177,"Alcohols, C16-18 and C18-unsatd., ethoxylated, sulfates, sodium salts",500-345-1,157627-95-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,86,H318:85;H315:86;H412:2;H319:1
73178,"[(2,2,8-trimethyl-4H-1,3-dioxino[4,5-c]pyridin-5-yl)methyl] hydrogen succinate",302-393-7,94108-52-8,Acute Tox. 4,Notified C&L,1,H302:1
73179,Cobalt chromite blue green spinel,269-072-0,68187-11-1,Not Classified,REACH registration C&L,325,Not classified:319;H373:4;H317:2
73183,"N,N'-(10,15,16,17-tetrahydro-5,10,15,17-tetraoxo-5H-dinaphtho[2,3-a:2',3'-i]carbazole-6,9-diyl)bis(benzamide)",219-169-9,2379-81-9,Skin Sens. 1,REACH registration C&L,24,H317:8;Not classified:16
73185,4-methoxyphthalic acid,217-546-2,1885-13-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
73187,2-(methylthio)ethanol,226-090-3,5271-38-5,Not Classified,Notified C&L,97,Not classified:90;H302:7;H332:7;H312:3
73188,nickel bis(4-cyclohexylbutyrate),223-463-2,3906-55-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H372:0;H317:0;H360:0
73194,3-(2'-phenoxyethoxy)propylamine,427-870-8,6903-18-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H302:0;H315:0;H412:0
73195,"3,5-dinitrobenzamide",204-499-8,121-81-3,Acute Tox. 4,Notified C&L,42,H302:42
73196,Dimagnesium silicide,245-254-5,22831-39-6,Water-react. 2,Notified C&L,212,H261:212
73197,"Sodium 1-amino-4-[[3-[(benzoylamino)methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",267-224-0,67827-60-5,Aquatic Chronic 4,REACH registration C&L,161,H413:16;H412:58;Not classified:78;H411:9
73198,"Hydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]cobaltate(1-)",271-494-5,68568-52-5,Not Classified,Notified C&L,2,Not classified:2
73199,Methyldiphenylsulphonium tetrafluoroborate(1-),234-032-3,10504-60-6,,Notified C&L,6,H314:5;H335:1;H315:1;H319:1;H318:1;H302:1
73200,3-methylisoquinoline,214-412-5,1125-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:51;H315:51;H319:51;H302:1;H332:1;H312:1
73202,Cyclooctane,206-031-8,292-64-8,Flam. Liq. 3,Notified C&L,98,H226:98;H304:27
73203,Codeine N-oxide,222-988-4,3688-65-1,,Notified C&L,2,H302:1;H301:1;H331:1;H334:1;H361:1;H317:1;H362:1
73204,Dibenzyl phosphonate,241-226-1,17176-77-1,,Notified C&L,5,H317:4;H315:5;H319:5
73207,"3-Octanol, 3,7-dimethyl-, potassium salt",607-910-2,263148-42-1,Skin Corr. 1A,Notified C&L,83,H314:83
73210,"(±)-5-amino-1-(2,6- dichloro-a,a,a,- trifluoro-p-tolyl)-4- trifluoromethylsulfinylpyrazole-3-carbonitrile (1:1)",601-663-4,120068-37-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,147,H301:147;H331:142;H400:147;H410:147;H372:147;H311:147;H330:5;H361:1
73211,"Alanine, N,N-bis(carboxymethyl)-, sodium salt (1:3)",605-362-9,164462-16-2,Not Classified,Notified C&L,136,Not classified:100;H290:35;H335:1;H315:1;H319:1
73214,"3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, (-)-, tartrate (1:1)",606-470-9,20233-35-6,Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H336:2;H300:2
73215,Nalidixic acid,206-864-7,389-08-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,96,H334:82;H317:76;H302:10;H351:9;H361:3;H362:2;H301:1;H332:1;H312:1;Not classified:1
73216,"2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-",604-363-1,143491-57-0,Not Classified,Notified C&L,4,Not classified:4
73223,"(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol",616-717-2,79645-27-5,Acute Tox. 4;Acute Tox. 4;Lact.,Notified C&L,6,H332:3;H312:3;H362:2;H373:1;H360:3;H361:2;H301:1;H311:1;H331:1;H302:1
73225,"1,2-dibromo-3-chloropropane",202-479-3,96-12-8,Acute Tox. 3;Muta. 1B;Carc. 1B;STOT RE 2;Aquatic Chronic 3;Repr. 1A,Harmonised C&L,0,H301:0;H340:0;H412:0;H350:0;H373:0;H360:0
73226,Ethyl p-tolylacetate,237-904-1,14062-19-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
73228,"Residual oils (petroleum), hydrotreated solvent dewaxed;Baseoil - unspecified",292-656-1,90669-74-2,Carc. 1B,Harmonised C&L,0,H350:0
73229,Beta-methylphenethylamine,209-479-2,582-22-9,Skin Corr. 1B,Notified C&L,42,H314:42
73231,Calcium glycinate,251-422-9,33242-26-1,Not Classified,Notified C&L,36,Not classified:36
73232,4-oxo-4-(phenylamino)isocrotonic acid,209-102-1,555-59-9,,Notified C&L,4,H335:4;H315:4;H319:4
73236,1-(4-methoxyphenyl)-2-[(3-methoxyphenyl)thio] ethanone,469-300-0,63675-73-0,Aquatic Chronic 2,Notified C&L,1,H411:1
73238,Retinaldehyde,204-135-8,116-31-4,Repr. 1B;Aquatic Chronic 4,Notified C&L,123,H413:84;H360:84;H302:39;H315:40;H317:1
73240,(E)-o-chlorocinnamic acid,213-363-7,939-58-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H301:1;H335:1;H315:1;H319:1
73245,Piperazine dihydrobromide,261-937-0,59813-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
73248,"3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, phenylmethyl ester, hydrochloride (1:1), (3S)-",617-524-6,84048-96-4,Not Classified,REACH registration C&L,2,Not classified:2
73249,m-cyclohexen-1-yltoluene,245-130-0,22618-50-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
73251,"Fatty acids, dehydrated castor-oil, maleated",288-313-0,85711-53-1,Not Classified,Notified C&L,75,Not classified:75
73252,Alkali salt of bis (substituted aryl sulfonyl triazinyl amino sulfonatoaryl) amino hydroxy diazo naphthalene disulfonate,407-420-7,,Not Classified,REACH registration C&L,1,Not classified:1
73255,Lead(IV) fluoride,232-012-9,7783-59-7,,Notified C&L,4,H400:4;H302:4;H373:4;H332:4;H410:4;H360:4
73259,"citric acid, ammonium nickel salt",242-161-1,18283-82-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H372:0;H317:0;H360:0
73260,2-anthrylamine,210-330-9,613-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:39;H319:39;H341:5
73261,1-aminocyclopentanecarboxamide,422-950-9,17193-28-1,Acute Tox. 4;Eye Dam. 1;STOT RE 1,Harmonised C&L,0,H318:0;H302:0;H372:0
73262,"Fats and Glyceridic oils, shea butter",606-306-6,194043-92-0,Not Classified,Notified C&L,54,Not classified:54
73263,"Jerusalem artichoke, ext.",289-963-8,90045-97-9,Not Classified,Notified C&L,10,Not classified:10
73266,(Z)-hex-3-enyl butyrate,240-553-7,16491-36-4,Not Classified,Notified C&L,1654,Not classified:1613;H335:38;H315:41;H319:41
73267,"dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate",432-860-1,255387-46-3,Skin Sens. 1,Harmonised C&L,0,H317:0
73268,Teclozan,226-934-0,5560-78-1,Not Classified,Notified C&L,1,Not classified:1
73269,"4-tert-butyl-2,6-dinitrophenol",223-856-9,4097-49-8,,Notified C&L,5,H315:5;H302:4;H332:4;H319:5;H312:4;H301:1;H331:1;H311:1
73270,(4-chlorophenyl)urea,205-412-6,140-38-5,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H301:38;H335:41;H315:41;H319:41;H317:38;Not classified:1
73275,"3,5-Difluoro-L-phenylalanine, N-BOC protected",606-578-6,205445-52-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
73278,Citrus Oil Distilled,614-678-6,68647-72-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,269,H315:229;H400:142;H410:177;H304:190;H226:203;H317:201;Not classified:40;H411:18;H335:11;H319:12
73282,4-isopropoxybenzoyl chloride,253-229-5,36823-82-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,39,H412:38;H319:38;H314:1
73283,2-hexyldecyl laurate,251-959-9,34362-27-1,Not Classified,Notified C&L,38,Not classified:38
73284,Dodecyldimethyl(3-sulphonatopropyl)ammonium,239-002-3,14933-08-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,90,H335:89;H315:86;H302:83;H332:83;H319:86;H312:83;H318:4;H314:4
73286,Ammonium icosyl sulphate,276-297-8,72018-21-4,Not Classified,Notified C&L,6,Not classified:6
73289,"2-Propenamide, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2-methyl-",610-494-5,5001-88-7,Not Classified,Notified C&L,1,Not classified:1
73293,"4,5,6,7-tetrahydro-N,2-dimethyl-2H-indazol-3-ylammonium hydrogen maleate",245-318-2,22911-97-3,Not Classified,Notified C&L,1,Not classified:1
73294,"2,2',6,6'-tetrachloro-4,4'-isopropylidenediphenol",201-237-4,79-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
73295,"6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine",618-225-3,88965-00-8,Not Classified,REACH registration C&L,7,Not classified:7
73300,"A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide",405-080-4,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H410:0;H400:0
73303,Hex-2-en-1-ol,218-972-1,2305-21-7,Not Classified,Notified C&L,153,Not classified:112;H226:41;H315:5;H319:5;H335:1
73304,Bis(trifluoromethylsulphonyl)methane,207-052-5,428-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
73305,1-nitronaphthalene,201-684-5,86-57-7,Flam. Sol. 2;Acute Tox. 3,Notified C&L,56,H301:56;H228:44;H335:12;H315:12;H351:12;H411:18;H319:12;H331:1;H311:1
73306,Benzophenonehydrazone,226-321-8,5350-57-2,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,7,H317:6;H301:6;H411:6;Not classified:1
73307,"hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate",400-050-7,85153-92-0,Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0
73308,"2,4-dichloropyrimidine",223-508-6,3934-20-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,83,H335:75;H315:77;H319:77;H317:8;H412:1;H411:1;H302:1
73309,"4,5-dichloro-2,3-dihydro-2-phenylpyridazin-3-one",216-917-6,1698-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H302:1
73310,"3,6-dihydro-4,6-dimethyl-2-phenyl-2H-pyran",268-257-3,68039-41-8,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,38,H412:38;H319:38
73312,"Cellulose, acetate butanoate, carboxymethyl ether",605-197-2,160047-24-5,Not Classified,Notified C&L,3,Not classified:3
73315,"Fatty acids, vegetable-oil, esters with sterols, mixed with vegetable-oil glycerides",273-605-2,68990-51-2,Not Classified,REACH registration C&L,89,Not classified:89
73322,1-cyanoallyl acetate,239-743-2,15667-63-7,Acute Tox. 2;Acute Tox. 1;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H331:40;H400:1;H300:1;H410:1;H318:1;H310:1;H311:39;H301:1;H315:1;H319:1
73324,Naphthalene-1-sulphonyl chloride,201-609-6,85-46-1,Skin Corr. 1B,Notified C&L,44,H314:44;H290:1;H318:1
73327,Octadec-1-ene,204-012-9,112-88-9,Asp. Tox. 1,REACH registration C&L,732,H304:652;Not classified:82;H413:9
73328,"Hydrogen (glycinato-N,O)[sulphato(2-)-O,O']ferrate(1-)",241-221-4,17169-60-7,Acute Tox. 5;Eye Irrit. 2,Notified C&L,1,H320:1;H303:1;H315:1;H319:1
73329,"Isobutyl 2,4-dichlorophenoxyacetate",216-992-5,1713-15-1,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,20,H410:17;H317:17;H302:17;H400:17;Not classified:3
73331,(2-bromo-4-fluorophenyl)methanamine hydrochloride,608-273-3,289038-14-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
73332,Terpinene,232-386-3,8013-00-1,Not Classified,Notified C&L,36,Not classified:36
73334,"6,18-dihydrodinaphtho[2,3-i:2',3'-i']benzo[1,2-a:4,5-a']dicarbazole-5,7,12,17,19,24-hexone",218-524-5,2172-33-0,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,20,H317:6;H319:6;Not classified:14;H412:1
73337,4'-(trifluoromethoxy)propiophenone,302-396-3,94108-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
73343,"Tar bases, coal, lutidine fraction;Distillate Bases",293-766-2,91082-52-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
73345,"(1R,2S)-1-phenyl-2-pyrrolidin-1-yl-propan-1-ol;hydrochloride",606-696-8,210558-66-0,Not Classified,REACH registration C&L,2,Not classified:2
73347,Ethyl 2-acetylacetoacetate,210-053-3,603-69-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H315:44;H319:44
73356,"Thiosulfuric acid (H2S2O3), disodium salt, pentahydrate",600-156-5,10102-17-7,Not Classified,Notified C&L,171,Not classified:168;H335:2;H315:3;H319:2;H302:1;H332:1;H312:1
73360,"Gaultheria procumbens, ext.",614-802-9,68917-75-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,95,H302:69;H315:64;H319:69
73362,N-(trimethylsilyl)imidazole,242-040-3,18156-74-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H335:48;H315:49;H319:48;H225:49;H400:34;H302:37;H226:34;H410:34;H411:34;H314:34;H318:35;H360:34;H332:1;H312:1
73363,hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide,418-350-1,,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H341:0;H411:0;H319:0;H317:0
73364,"2,3-difluoroanisole",603-810-8,134364-69-5,Flam. Liq. 3,REACH registration C&L,8,H226:3;H335:5;H315:5;H319:5
73365,"N,N,N'-trimethylpropane-1,3-diamine",224-901-5,4543-96-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,44,H302:38;H226:44;H332:38;H314:44;H312:38;H225:1
73368,"Aspartic acid, N,N'-(2-methyl-1,5-pentanediyl)bis-,tetraethyl ester",605-508-1,168253-59-6,Aquatic Chronic 3,Notified C&L,40,H412:40
73371,1-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one,922-915-2,,Eye Irrit. 2A,REACH registration C&L,1,H319:1
73372,4-methoxy-2-nitrobenzenediazonium,248-284-7,27165-25-9,Unst. Expl.,REACH registration C&L,2,H200:1;Not classified:1
73373,Dl-camphoric anhydride,209-861-9,595-30-2,,Notified C&L,4,H335:4;H315:4;H319:4
73374,"Fatty acids, tall-oil, esters with neopentyl glycol",268-090-6,68002-76-6,Aquatic Chronic 4,Notified C&L,2,H413:2
73376,reaction mass of isomers of: methyldiphenylmethane;dimethyldiphenylmethane,405-470-4,73807-39-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0
73378,"Amides, lard-oil, N,N-bis(hydroxyethyl)",275-092-0,70983-69-6,Not Classified,Notified C&L,1,Not classified:1
73379,1-(p-chlorophenyl)cyclobutanecarboxylic acid,256-847-3,50921-39-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
73382,WANSIM,442-930-3,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
73385,"Gas oils (petroleum), heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-058-3,64741-57-7,Carc. 1B,Harmonised C&L,0,H350:0
73388,"1-(2,4,5-trimethoxyphenyl)ethan-1-one",217-333-4,1818-28-6,Eye Irrit. 2,Notified C&L,38,H319:38
73391,"Leach residues, zinc ore-calcine, zinc cobalt",273-769-5,69012-72-2,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H301:6;H315:6;H400:6;H334:6;H350:6;H302:6;H341:6;H332:6;H410:6;H372:6;H318:6;H317:6;H360:6
73392,2-ethylbutyl cyclopent-2-ene-1-acetate,304-729-8,94278-39-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,113,H302:113;H411:113
73400,Metastannic acid,236-745-5,13472-47-4,Not Classified,Notified C&L,3,Not classified:3
73401,(R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol (R)-acetoxy(phenyl)acetate,929-947-6,,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2A,REACH registration C&L,1,H317:1;H301:1;H319:1
73402,(+)-(1S)-Menthyl chloroformate,616-327-2,7635-54-3,Skin Corr. 1B;Acute Tox. 3,Notified C&L,39,H331:38;H314:39;H290:1;H330:1;H300:1;H318:1;H310:1
73404,3-(4-chlorobenzoyl)propionic acid,223-627-3,3984-34-7,,Notified C&L,5,H335:4;H315:5;H319:5
73406,"2,4-dinitrobenzaldehyde",208-440-7,528-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43;H341:4
73408,"2,2'-Methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)",600-456-6,103597-45-1,Aquatic Chronic 4,Notified C&L,157,H413:157
73412,Tetrahydro-2-isocyanato-2H-pyran,214-783-3,1194-00-9,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H334:1;H227:1;H302:1;H332:1;H319:1;H312:1
73413,Terfenadine,256-710-8,50679-08-8,Aquatic Chronic 4,Notified C&L,40,H413:38;H302:1;Not classified:1
73415,Iron(2+) ethylenediammonium sulphate,264-357-6,63589-59-3,Acute Tox. 4;Skin Irrit. 2,Notified C&L,3,H302:2;H315:2;Not classified:1
73417,"2,2,4,6,7-Pentamethyl-3H-benzofuran-5-sulfonyl chloride",604-956-5,154445-78-0,Skin Corr. 1B,Notified C&L,42,H314:42
73419,"trisodium 2-{}{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}}-4-sulfonatobenzoate, copper complex",423-770-3,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
73426,1-benzyl-4-(1-pyrrolidinyl)piperidine-4-carboxamide,230-489-8,7152-08-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
73427,2-bromo-4-trifluoromethylaniline,261-035-7,57946-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:45;H319:45;H302:7;H332:7;H311:4;H312:3
73428,"2,6-dichloro-3-nitrotoluene",249-776-4,29682-46-0,,Notified C&L,5,H335:5;H315:5;H302:5;H332:4;H319:5;H312:5
73429,4-isopropylresorcinol,245-703-5,23504-03-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H314:1;H302:1;H332:1;H312:1
73432,octadec-9-enedioic acid,802-122-7,4494-16-0,Eye Irrit. 2,REACH registration C&L,19,H319:1;H318:18;H410:18;H400:18
73438,"Hydrocarbons, C9-C10, n-alkanes, isoalkanes, cyclics, <2% aromatics",927-241-2,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,9,H412:9;H304:9;H336:9;H226:9
73440,"2,3-Quinoxalinedione, 6-amino-1,4-dihydro-7-methoxy-",615-027-9,69904-10-5,Not Classified,Notified C&L,34,Not classified:33;H401:1;H411:1
73443,"Terpenes and Terpenoids, turpentine-oil, β-pinene fraction, polymd.",615-156-0,70750-58-2,Not Classified,Notified C&L,69,Not classified:69
73445,N-[3-(dimethylamino)propyl]acrylamide,223-342-4,3845-76-9,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,29,H412:21;H317:23;H319:25;H335:20;H290:3;H318:4;H315:8
73449,"Sodium 1-amino-4-[[3,5-bis[(benzoylamino)methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",267-225-6,67827-61-6,Aquatic Chronic 3,Notified C&L,19,H412:19
73452,"6,7-bis(2-methoxyethoxy)quinazolin-4(3H)-one",605-867-4,179688-29-0,Not Classified,REACH registration C&L,6,Not classified:3;H302:3;H315:1;H319:1
73453,"trans-cyclohexane-1,2-dicarboxylic acid",218-975-8,2305-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
73456,"pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one",602-927-1,123312-89-0,Carc. 2;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H351:0
73459,"Fatty acids, C16-18, iso-Pr esters",292-962-5,91031-58-2,Not Classified,REACH registration C&L,93,Not classified:93
73462,10H-phenothiazine-10-carbonyl chloride,242-699-7,18956-87-1,Skin Corr. 1B,Notified C&L,38,H314:38
73466,DL-lysine,200-740-6,70-54-2,Not Classified,REACH registration C&L,96,Not classified:96
73468,"2,3-epoxy-2,3-dihydro-1,4-naphthoquinone",239-465-1,15448-58-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
73471,"Nitroviolanthrene-5,10-dione",266-134-9,66085-76-5,Not Classified,Notified C&L,1,Not classified:1
73477,"Glycerides, vegetable-oil mono- and di-",307-030-6,97488-91-0,Not Classified,Notified C&L,25,Not classified:25
73478,(E)-2-buten-1-ol,207-996-8,504-61-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H302:1;H226:1;H319:1;H312:1
73479,1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide,423-960-6,139756-01-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H373:0
73480,Magnesium divanadium hexaoxide,237-001-2,13573-13-2,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,4,H335:4;H361:2;H302:3;H341:2;H332:4;H411:3;H372:3;H318:2;H351:1;H300:1;H350:1;H319:1
73487,"(S)-10-[(dimethylamino)methyl]-4 ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7] indolizino [1,2-b]quinoline-3,14-(4H,12H)-dione monohydrochloride",601-607-9,119413-54-6,Muta. 1B;Carc. 2;Repr. 2,Notified C&L,5,H361:1;H340:4;H351:1;H301:1;H335:1;H315:1;H319:1;H302:1;H350:3;H412:2;H300:2;H360:2;H370:1
73488,"Glycerides, C10-18 mono-, di- and tri-",294-595-6,91744-33-1,Not Classified,Notified C&L,7,Not classified:7
73489,Tetrapotassium pyrophosphate,230-785-7,7320-34-5,Eye Irrit. 2,REACH registration C&L,2543,H319:2448;Not classified:62;H335:51;H315:53;H318:32;H302:31
73490,3-methyl-2-butenyl benzoate,225-998-7,5205-11-8,Not Classified,Notified C&L,273,Not classified:235;H411:38
73495,"1-Butyloxy-2,3-difluor-4-(4-propyl-1-cyclohexen-1-yl)-benzen",928-743-4,,Not Classified,REACH registration C&L,2,Not classified:2
73497,2-methyl-5-phenylbenzoxazole,263-330-6,61931-68-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H301:40;H335:39;H315:41;H319:41;H332:1;H312:1
73502,hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate,402-970-4,148292-42-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
73505,Tetramethylammonium hydroxide,200-882-9,75-59-2,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Eye Dam. 1;STOT SE 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,554,H300:300;H411:240;H370:221;H314:552;H372:218;H318:188;H310:266;H311:276;H226:33;H400:34;H412:28;H301:51;H330:4;H224:8;Not classified:2;H413:2;H335:1;H332:2;H290:2;H410:1;H312:1;H331:1;H315:1;H319:1
73510,"(1R,3R)-3-((Z)-2-Chloro-3,3,3-trifluoro-propenyl)-2,2-dimethyl-cyclopropanecarboxylic acid (S)-cyano-(3-phenoxy-phenyl)-methyl ester",618-753-4,91465-08-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,253,H301:253;H400:215;H330:253;H410:253;H311:196;H312:57
73512,Butyl undec-10-enoate,203-670-4,109-42-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1401,H315:1381;H319:1296;Not classified:20
73514,4-methoxyphenylglycolic acid,234-031-8,10502-44-0,,Notified C&L,5,H335:4;H315:5;H319:5
73516,potassium fluoride,232-151-5,7789-23-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H311:0;H331:0
73523,[No public or meaningful name is available],451-550-7,,Not Classified,Notified C&L,37,Not classified:37
73525,Methyl 5-bromovalerate,226-709-7,5454-83-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:2;H319:2;Not classified:1;H335:1
73528,ethyl 2-cyclohexylpropionate,412-280-5,2511-00-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
73529,4-Pentylcyclohexane carbaldehyde,919-665-1,,Not Classified,Notified C&L,1,Not classified:1
73532,N-phenylbenzenesulphonamide,216-832-4,1678-25-7,Aquatic Chronic 3,REACH registration C&L,75,H411:34;H302:41;H335:1;H315:1;H319:1
73534,"Sulfuric acid, mono(C16 and C18-unsatd. alkyl) esters, sodium salts",293-920-9,91648-58-7,Skin Corr. 1A,Notified C&L,1,H314:1
73535,1-phenylpyrazol-5-ylamine,212-563-1,826-85-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:38;H335:38;H315:39;H319:39
73537,"tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)",400-510-7,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
73539,"[[2,2',2''-[29H,31H-phthalocyaninetriyltris(methylene)]tris[1H-isoindole-1,3(2H)-dionato]](2-)-N29,N30,N31,N32]copper",261-638-5,59160-79-1,Not Classified,REACH registration C&L,262,Not classified:262
73545,4-methyl-3-nitrobenzamide,242-752-4,19013-11-7,,Notified C&L,4,H302:4;H335:4;H315:4;H319:4
73556,"[[(phosphonomethyl)imino]bis[ethylenenitrilobis(methylene)]]tetrakisphosphonic acid, ammonium salt",274-798-6,70714-66-8,Aquatic Chronic 3,REACH registration C&L,28,H412:8;H290:5;H318:3;H315:23;H319:20
73558,"2,4-Nonanedione, 3-methyl-",601-256-1,113486-29-6,Not Classified,Notified C&L,98,Not classified:97;H319:1;H335:1;H315:1;H312:1
73560,"3,7-Dimethyloctanenitrile",609-792-8,40188-41-8,Skin Irrit. 2,Notified C&L,49,H315:49;H317:24;H411:24
73561,4-fluoro-2-methyl-1H-indol-5-ol,608-263-9,288385-88-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H335:38;H315:38;H400:38;H302:41;H410:38;H319:38;H312:38;H317:3;Not classified:1
73562,3-chlorobenzaldehyde,209-596-9,587-04-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H335:78;H315:80;H319:79;H302:1;H332:1;H312:1
73563,Ronidazole,231-675-1,7681-76-7,Not Classified,Notified C&L,1,Not classified:1
73564,1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine,600-683-0,105827-78-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:38;H302:39;H400:38;H411:3;H412:1
73566,4-piperidinecarboxylic acid,207-872-3,498-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,204,H335:202;H315:203;H319:203;Not classified:1
73567,(E)-2-methylpent-2-enenitrile,250-694-6,31551-28-7,Flam. Liq. 3,REACH registration C&L,2,H226:2
73568,DS-1293B-E,471-870-0,,Not Classified,Notified C&L,1,Not classified:1
73572,"Alkenes, C>10 α-",265-207-2,64743-02-8,Not Classified,Notified C&L,97,Not classified:62;H304:35;H226:14;H315:14;H411:1
73574,4-(trans-4-Butylcyclohexyl)-benzoic acid,617-480-8,83626-35-1,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1;H315:1;H319:1
73579,Dihexyl fumarate,242-833-4,19139-31-2,Not Classified,Notified C&L,1520,Not classified:1520
73581,"α,α,4-trimethylcyclohexanemethanol",207-871-8,498-81-7,Not Classified,Notified C&L,286,Not classified:261;H317:23;H315:24;H319:24;H412:1
73583,5-nitroisophthalic acid,210-568-3,618-88-2,Eye Irrit. 2,REACH registration C&L,112,H319:112;H335:103;H315:100
73584,"5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-3-methylsalicylic acid",239-098-7,15012-28-9,Not Classified,Notified C&L,1,Not classified:1
73585,2-methyl-4-(phenylmethylene)oxazol-5(4H)-one,212-921-7,881-90-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
73589,"Fatty acids, C16-20 and C16-18-unsatd., Me esters",273-090-4,68937-80-4,Not Classified,Notified C&L,1,Not classified:1
73593,Crotononitrile,225-335-1,4786-20-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,104,H302:103;H332:64;H225:103;H335:38;H315:39;H319:39;H226:1
73596,"9-chloro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-propionate",273-917-9,69224-79-9,,Notified C&L,1,H302:1;H341:1
73601,Dipotassium tartrate,213-067-8,921-53-9,Not Classified,REACH registration C&L,12,Not classified:12
73604,4-[4-(trans-4-Ethylcyclohexyl)-1-cyclohexen-1-yl]-2-fluor-1-trifluormethoxybenzene,927-308-6,,Not Classified,Notified C&L,1,Not classified:1
73606,"Lavender, Lavandula hybrida, ext.",294-470-6,91722-69-9,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1932,H412:341;H317:1843;H319:218;H315:1414;H304:1370;H411:1331;H373:1289;H341:42;H371:41;Not classified:34;H226:2;H318:1
73608,1-ethyl-1H-imidazole,230-403-9,7098-07-9,,REACH registration C&L,45,H318:42;H302:43;H315:41;H412:40;H314:2;H319:1
73613,ethylene thiourea;imidazolidine-2-thione;2-imidazoline-2-thiol,202-506-9,96-45-7,Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H302:0;H360:0
73616,Calcium dibutyrate,227-265-7,5743-36-2,,Notified C&L,1,H335:1;H315:1;H319:1
73618,Deoxyribose-phosphate aldolase EC 4.1.2.4.,444-400-7,9026-97-5,Resp. Sens. 1,REACH registration C&L,3,H334:3
73620,"N,N-dimethyloctadecylamine N-oxide",219-919-5,2571-88-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,14,H315:14;H400:14;H302:7;H410:4;H411:4;H318:14
73621,4-bromo-m-xylene,209-517-8,583-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;H302:1;H332:1;H301:1;H311:1;H331:1
73623,Butyl palmitate,203-829-8,111-06-8,Not Classified,Notified C&L,5,Not classified:5
73626,5-ethylnonan-2-ol,203-078-6,103-08-2,Aquatic Chronic 2,Notified C&L,38,H411:38
73628,"2,3-dichloropropene;2,3-dichloropropylene",201-153-8,78-88-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Aquatic Chronic 3,Harmonised C&L,0,H335:0;H315:0;H412:0;H225:0;H302:0;H341:0;H332:0;H312:0;H318:0
73632,4-formylphenylboronic acid,438-670-5,87199-17-5,Skin Sens. 1,Harmonised C&L,0,H317:0
73633,"4,4-difluorocyclohexane-1-carbonyl chloride",609-458-1,376348-75-3,Flam. Liq. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H227:1
73634,(E)-5-decenyl acetate,253-923-8,38421-90-8,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,128,H411:83;H315:128;H335:38;H319:38
73636,"4,4'-oxydibenzoic acid",218-683-0,2215-89-6,,Notified C&L,6,H335:5;H315:6;H319:6
73637,Ammonium henicosafluorodecanesulphonate,267-709-7,67906-42-7,Not Classified,Notified C&L,5,Not classified:5
73646,Phenyltrimethylsilane,212-192-5,768-32-1,Flam. Liq. 3;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,45,H318:38;H413:38;H226:44;H315:6;H319:6;H302:1;H332:1;H312:1
73653,2-ethoxy-6-hydroxypyrimidin-4(1H)-one,612-185-0,61636-08-6,Aquatic Chronic 3,Notified C&L,1,H412:1
73654,"N-(3-triethoxysilylpropyl)-aza-2,2-diethoxy-2-silacyclopentane",924-785-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
73656,Magnesium ethanolate,219-323-5,2414-98-4,Flam. Sol. 1;Self-heat. 1;Eye Irrit. 2,REACH registration C&L,62,H251:57;H319:57;H228:10;Not classified:5;H351:1
73657,"Fatty acids, C8-16",287-973-7,85631-26-1,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,7,H318:7;H314:1
73659,"1-(2-(Cyclopropylcarbonyl)phenylaminosulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea",603-980-3,136849-15-5,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,49,H319:38;H400:49;H410:11
73663,"2,2'-(vinylenedi-p-phenylene)bisbenzoxazole",216-245-3,1533-45-5,Aquatic Chronic 2,REACH registration C&L,332,H411:16;Not classified:259;H335:41;H315:44;H319:44;H413:16;H317:3
73664,"3,4-dichlorophenylacetic acid",227-368-7,5807-30-7,,Notified C&L,7,H335:6;H315:7;H319:7
73667,Methyldopa,209-089-2,555-30-6,Repr. 2,Notified C&L,2,H361:1;Not classified:1
73668,"4-(3,5,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",267-159-8,67801-39-2,Not Classified,Notified C&L,88,Not classified:88
73671,2-Methoxy-N-methylbenzylamine,614-563-0,6851-80-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:38;H335:38;H315:38;H314:1
73672,"α,α,α-trifluoro-3,5-dinitrotoluene",206-935-2,401-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H335:45;H315:45;H319:46;H331:1;H314:1;H302:1;H332:1;H312:1
73677,Progesterone,200-350-6,57-83-0,Carc. 2;Repr. 1A;Lact.,Notified C&L,245,H362:112;H360:197;H351:209;H361:44;H350:33;H341:1;H340:1
73678,"Dimethyl hydrogen phosphorate, compound with 4-tetrapropyleneaniline",269-016-5,68170-22-9,Not Classified,Notified C&L,1,Not classified:1
73685,"Reaction product of starch, with sodium Z-ethylaminodipropionate",423-610-2,,Not Classified,Notified C&L,5,Not classified:5
73687,Strontium nitrate,233-131-9,10042-76-9,Ox. Sol. 1;Eye Dam. 1,REACH registration C&L,314,H318:149;H271:113;Not classified:85;H335:50;H315:54;H272:115;H302:49;H319:54
73690,"Ethanol, 2-[(4-nitrophenyl)thio]-",603-683-9,13287-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
73692,"3-(2,6,6-trimethyl-1-cyclohexen-1-yl)propen-1-yl acetate",244-736-2,22030-19-9,Not Classified,Notified C&L,88,Not classified:88
73700,"2-hydroxybutanedioic acid - 3-[(E)-2-(1-methyl-1,4,5,6-tetrahydropyrimidin-2-yl)ethenyl]phenol (1:1)",926-299-6,,Acute Tox. 4,Notified C&L,1,H302:1
73702,HSR-2243,415-020-9,,Not Classified,Notified C&L,4,Not classified:4
73703,"1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl acrylate",235-943-9,13057-08-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H335:2;H315:2;H302:1;H332:1;H319:2;H312:1;H226:1
73705,2-chloro-5-fluorophenol,609-539-1,3827-49-4,,Notified C&L,8,H314:7;H302:8;H411:7;H312:8;H335:1;H315:1;H332:1;H319:1
73706,4-bromophenyl acetate,217-668-6,1927-95-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H315:1
73710,Butyl trifluoroacetate,206-699-0,367-64-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,39,H314:38;H225:39
73713,"Tangor, Murcote, ext.",297-672-2,93686-22-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1614,H315:1420;H304:1419;H226:1418;H411:38;H317:1420;H400:1377;H410:1382;Not classified:184;H319:12
73717,"2,2',4'-trichloroacetophenone",224-218-2,4252-78-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,78,H400:34;H302:3;H410:1;H314:6;H318:73;H317:73;H335:42;H315:39;H301:37;H312:34;H332:1;H341:1;H319:1
73719,2-naphthyl methacrylate,233-967-4,10475-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
73725,Di-9-octadecenyl hydrogen phosphate,264-625-2,64051-27-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,54,H318:53;H315:53;Not classified:1
73726,"Dibenz[b,f][1,4]oxazepin-11(10H)-one",221-601-6,3158-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,194,H335:194;H315:194;H319:194
73736,Tetradodecylammonium perchlorate,263-416-3,62120-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
73738,"Glycerides, C14-18 and C16-18-unsatd.",266-947-9,67701-29-5,Not Classified,Notified C&L,39,Not classified:39
73739,"Fatty acids, C18-unsatd., dimers, polymers with bisphenol A, diethylenetriamine, epichlorohydrin, tall-oil fatty acids and triethylenetetramine",604-157-1,139682-51-2,Not Classified,Notified C&L,23,Not classified:22;H317:1;H332:1;H315:1;H319:1
73742,"Sulfurous acid, monosodium salt, reaction products with formaldehyde and phenol, cond. products with formaldehyde, phenol and urea, sodium salts",300-350-7,93925-47-4,,Notified C&L,33,Not classified:33
73744,Quinestrol,205-803-1,152-43-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,63,H350:38;H302:38;H332:38;H312:38;H360:62;H362:24;H351:25
73747,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl acetate",231-710-0,7695-91-2,Not Classified,REACH registration C&L,1910,Not classified:1807;H413:103
73750,Lithium bis(oxalato)borate,456-990-3,244761-29-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,5,H318:4;H317:4;H302:1;H301:3;H335:1;H315:1;H319:1
73755,Barium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,231-494-8,7585-41-3,Not Classified,REACH registration C&L,355,Not classified:334;H302:20;H332:20;H412:1
73756,"Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides",263-185-9,61791-52-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,444,H318:441;H315:442;H314:2;H302:2;H312:2;H400:2;H319:1
73758,"reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)",407-100-7,,Skin Sens. 1,Harmonised C&L,0,H317:0
73759,2-[(hydroxymethyl)amino]-2-methylpropanol,257-824-0,52299-20-4,Not Classified,Notified C&L,6,Not classified:5;H302:1;H332:1
73761,"Esters of tall-oil fatty acids and stearic acid with oligomeric reaction products of 4,4'-Isopropylidenediphenol with 1-chloro-2,3-epoxypropane",606-970-7,222716-77-0,Not Classified,REACH registration C&L,1,Not classified:1
73769,"2,2',2''-Nitrilotriethanol, ethoxylated and propoxylated",500-095-3,37280-83-4,Skin Irrit. 2,Notified C&L,83,H315:83
73770,"10H-dibenzo[b,e]thiin",205-972-1,261-31-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H302:38;H400:39
73771,"Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt",419-260-5,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
73776,Tetraammineplatinum tetrachloroplatinate,237-501-0,13820-46-7,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,42,H318:42;H317:42;H301:42;H334:42
73777,(Z)-octadec-9-enyl oleate,222-980-0,3687-45-4,Not Classified,REACH registration C&L,210,Not classified:171;H335:39;H315:39;H319:39
73779,"4,8-dimethylnona-1,3,7-triene",257-509-8,51911-82-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H335:1;H315:1;H412:1;H226:1;H319:1
73784,2-chlorobenzenediazonium tetrachlorozincate (2:1),238-151-1,14263-92-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H332:38;H312:38;H351:38
73789,"bromofenoxim (ISO);3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime",236-129-6,13181-17-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
73795,Disodium trioxotellurate,233-268-4,10102-20-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,67,H301:51;H311:52;H331:40;H300:16;H330:12
73798,"Trisodium 2-[[4,5-dihydro-3-methyl-5-oxo-1-[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]-1H-pyrazol-4-yl]azo]naphthalene-1,5-disulphonate",243-717-6,20298-05-9,Not Classified,REACH registration C&L,20,Not classified:20
73800,"[5α,7α(S)]-α-tert-butyl-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol hydrochloride",258-396-8,53152-21-9,Acute Tox. 4;Repr. 2,Notified C&L,53,H361:49;H302:51;H334:10;H336:8;H370:8;H317:9;H362:11;H332:4;H330:2;H300:2;H310:1;H360:1;H373:1;H319:1
73803,2'-ethoxy-3-hydroxy-2-naphthanilide,202-185-5,92-74-0,Skin Sens. 1A;Aquatic Chronic 1,REACH registration C&L,85,H317:45;H410:43;H413:38;H400:31;H411:2;Not classified:1;H315:1
73805,"Hydrocarbons, C1-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0.5 °C (– 263 °F to 31 °F).]",271-038-5,68514-36-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
73806,"3-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]propane-1,2-diol",274-106-2,69766-79-6,Skin Sens. 1,Notified C&L,16,H317:15;Not classified:1
73807,2'-methylformanilide,202-355-9,94-69-9,Acute Tox. 4;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,39,H334:38;H302:38;H319:39;H315:1
73809,"1H-Indole, 2-methyl-4-nitro-",609-035-1,3484-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
73813,3-(2-aminoethyl)indol-5-ol,200-058-9,50-67-9,Acute Tox. 3;Repr. 2,Notified C&L,128,H361:127;H301:128;H332:1;H312:1
73815,"tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate",428-070-1,91788-83-9,Acute Tox. 4;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H372:0;H400:0
73822,1-methyl-3-p-tolyltriazene,244-223-3,21124-13-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H302:39;H332:38;H312:38;H351:38;H228:1
73823,Ethyl 2-thenoate,220-554-9,2810-04-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,89,H332:88;H312:88;H335:1;H315:1;H319:1
73826,m-anilinophenol,202-923-6,101-18-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H335:45;H315:46;H319:46;H302:4;H373:1;H318:1;H317:1;H336:1
73829,N-acetylneuraminic acid,205-023-1,131-48-6,,Notified C&L,54,Not classified:44;H319:10;H315:1
73835,Butyl stearate,204-666-5,123-95-5,Not Classified,Notified C&L,987,Not classified:823;H413:83;H335:44;H315:81;H319:43
73836,"Yeast, ext.",232-387-9,8013-01-2,Not Classified,Notified C&L,285,Not classified:260;H225:25
73846,reaction mass of: 1-hexyl acetate;2-methyl-1-pentyl acetate;3-methyl-1-pentyl acetate;4-methyl-1-pentyl acetate;other mixed linear and branched C,421-230-1,88230-35-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
73847,Methylmagnesium chloride,211-629-7,676-58-4,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,149,H318:30;H260:142;H314:149;H225:96;H250:39;H261:7;H226:1;H335:2;H351:1;H224:1
73848,"4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid",407-280-7,71297-11-5,Aquatic Chronic 3,Harmonised C&L,0,H412:0
73849,N-allylaniline,209-633-9,589-09-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:39;H332:39;H319:39;H312:39;H341:1
73850,"Benzenesulfonic acid, 4-hydroxy-, reaction products with formaldehyde, phenol and urea",290-724-5,90218-48-7,Not Classified,Notified C&L,1,Not classified:1
73852,Hexadecyl isocyanate,217-736-5,1943-84-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,109,H301:1;H335:39;H315:103;H319:109;H302:38;H332:38;H312:38;H334:64;H330:33;H331:25;H317:37
73853,Demoxepam,213-515-2,963-39-3,Not Classified,REACH registration C&L,43,Not classified:4;H334:38;H317:38;H302:1
73854,Dibenzyl(2-chloroethyl)ammonium chloride,200-234-5,55-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
73858,2-ethoxynaphthalene-1-carbaldehyde,243-126-3,19523-57-0,Eye Dam. 1,Notified C&L,39,H318:39
73859,"nitric acid, nickel salt",238-076-4,14216-75-2,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H315:0;H400:0;H334:0;H350:0;H272:0;H302:0;H341:0;H332:0;H410:0;H372:0;H318:0;H317:0;H360:0
73860,Holmium phosphate,238-235-8,14298-39-6,Eye Irrit. 2,Notified C&L,38,H319:38
73863,(Z)-docos-13-enoic acid,204-011-3,112-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,97,H335:40;H315:43;H319:42;Not classified:54
73865,"Carbamic acid, N,N'-1,6-hexanediylbis-, C,C'-bis[2-[2-(1-ethylpentyl)-3-oxazolidinyl]ethyl] ester",604-208-8,140921-24-0,Skin Sens. 1,Notified C&L,46,H317:46
73866,Zirconium carbonate oxide,239-744-8,15667-84-2,Not Classified,Notified C&L,1,Not classified:1
73867,"Di-μ-carbonylbis(η5-2,4-cyclopentadien-1-yl)dinickel",235-339-5,12170-92-2,Skin Sens. 1;Resp. Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H334:38;H350:38;H410:38;H317:38
73869,2-morpholinoethyl methacrylate,221-069-5,2997-88-8,Eye Irrit. 2,Notified C&L,40,H319:39;Not classified:1;H315:1
73870,1-bromooctadecane,204-013-4,112-89-0,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,20,H315:19;H319:19;H335:1;Not classified:1
73871,Succinimidyl 6-(biotinamido)hexanoate,615-709-6,72040-63-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1
73875,"Residues (petroleum), vacuum",265-057-8,64741-56-6,Not Classified,REACH registration C&L,126,Not classified:116;H351:10
73876,"Jatropha gossypifolia, ext.",289-961-7,90045-95-7,Not Classified,Notified C&L,1,Not classified:1
73881,2-methyl-2-(methylamino)propan-1-ol,608-121-6,27646-80-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,813,H302:479;H315:669;H319:655;H411:177;Not classified:155;H318:14;H412:11;H335:3
73886,"Carbonic acid, cerium salt",238-665-6,14623-75-7,Aquatic Chronic 4,Notified C&L,8,H413:4;Not classified:4
73887,p-bromo-α-methylbenzylamine,246-200-3,24358-62-1,Skin Corr. 1B,Notified C&L,44,H314:44;H318:2
73888,"5-Amino-N,N'-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodoisophtalamide",474-080-4,,Not Classified,REACH registration C&L,3,Not classified:3
73893,Doxepin hydrochloride,214-966-8,1229-29-4,Acute Tox. 3,Notified C&L,47,H301:46;Not classified:1;H360:1;H410:4;H400:4;H335:1;H315:1;H331:2;H361:2;H319:2;H311:1;H370:1;H362:2
73894,Ethyl 4-hydroxy-3-nitrobenzoate,242-751-9,19013-10-6,,Notified C&L,4,H335:4;H315:4;H319:4
73900,"1-bromo-2,4,5-trichlorobenzene",249-775-9,29682-44-8,Aquatic Chronic 4,Notified C&L,38,H413:38
73901,Haloxyfop-P (Haloxyfop-R),619-184-4,95977-29-0,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39,H412:39;H302:39
73909,"cis-cyclohex-4-ene-1,2-dicarboxylic acid",218-974-2,2305-26-2,,Notified C&L,6,H335:5;H315:6;H319:6
73912,"1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-, 3-[(γ-ω-perfluoro-C6-20-alkyl)thio] derivs., chlorides",275-091-5,70983-60-7,Not Classified,Notified C&L,28,Not classified:15;H315:13;H319:13
73917,"Chromium, 4-hydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]-6(or 7)-[(sulfomethyl)amino]-2-naphthalenesulfonate sodium complexes",286-499-8,85251-86-1,Aquatic Chronic 3,Notified C&L,59,H412:39;Not classified:19;H315:1;H319:1
73920,2-Chloro-5-(chloromethyl)pyridine,615-091-8,70258-18-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,48,H302:45;H314:48;H317:5;H318:1;H332:1;H312:1
73924,4-phenylmorpholin-3-one,608-371-6,29518-11-4,Not Classified,REACH registration C&L,3,Not classified:3
73925,"7,7´-{propane-1,3-diylbis[imino(6-fluoro- heteromonocycldiyl)imino[2-substituted-4,1- phenylene]diazene-2,1-diyl]}dinaphthalene-polysulfonic acid, sodium salt",411-390-0,,Not Classified,REACH registration C&L,1,Not classified:1
73926,C.I. Acid Red 276,612-636-1,61901-44-8,Aquatic Chronic 1,Notified C&L,13,H410:13
73928,(RS)-N-[1-(1-benzothien-2-yl)ethyl]-N-hydroxyurea,601-087-3,111406-87-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:41;H319:38;H332:1;H312:1;H351:1
73930,Toluene-4-sulphonamide,200-741-1,70-55-3,Not Classified,REACH registration C&L,211,Not classified:102;H319:91;H330:16;H412:8;H315:16;H335:9;H361:2
73932,Car-2-en-4-yl methyl ketone,222-771-4,3608-11-5,Not Classified,Notified C&L,88,Not classified:88
73934,Gold monocyanide,208-049-1,506-65-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H400:43;H330:43;H300:43;H410:43;H310:43;H290:1;H315:1;H318:1
73936,"2-vinyl-1,3-dioxolane",223-626-8,3984-22-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H301:41;H335:39;H315:41;H225:42;H319:42;H310:41;H332:1;H300:1
73937,Sodium 4-(4-methyl-3-nitrobenzoylamino)benzenesulphonate,281-719-9,84029-45-8,Not Classified,REACH registration C&L,35,Not classified:35
73939,"Methyl 4-hydroxy-3,5-dimethoxybenzoate",429-050-5,,Not Classified,REACH registration C&L,3,Not classified:2;H315:1;H319:1
73942,reaction mass of: dodecanoic acid;poly(1-7)lactate esters of dodecanoic acid,411-860-5,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
73945,"Fatty acids, tall-oil, compds. with morpholine",268-091-1,68002-77-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
73946,2-methylfuran,208-594-5,534-22-5,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 2,REACH registration C&L,442,H301:403;H315:3;H331:350;H225:441;H373:38;H312:3;H319:91;H330:88;H411:83;H341:4;Not classified:1
73948,"Propane-1,3-diol",207-997-3,504-63-2,Not Classified,REACH registration C&L,495,Not classified:454;H315:42;H302:1;H335:1;H319:1
73951,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with bis(isocyanatomethyl)benzene",610-745-9,51852-81-4,Not Classified,Notified C&L,10,Not classified:10
73953,"Hexanedioic acid, polymer with 1,2-ethanediamine and 12-hydroxyoctadecanoic acid",604-925-6,153743-78-3,Not Classified,Notified C&L,23,Not classified:23
73955,Benzylcarbonylglycyloxy-L-alanine,221-370-1,3079-63-8,Not Classified,Notified C&L,1,Not classified:1
73956,Nicotinaldehyde oxime,214-782-8,1193-92-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H335:42;H315:42;H302:38;H332:38;H319:42;H312:38
73959,(S)-methyl thiobenzoate,227-656-2,5925-68-8,Acute Tox. 4,Notified C&L,1412,H302:1412;H335:38;H315:38;H318:38;H317:38
73971,Dimethylarsinic acid,200-883-4,75-60-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,50,H410:49;H301:48;H331:48;H400:45;H373:4;H330:2;H350:2;H302:2;H311:1;H335:1;H315:1;H351:1;H319:1
73972,"Extract residues (coal), low temp. coal atar alk.;[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]",310-191-5,122384-78-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
73973,(±)-tartaric acid,205-105-7,133-37-9,Eye Dam. 1,Notified C&L,635,H318:314;H335:140;H315:174;H319:271;Not classified:50
73978,Cobalt molybdate,237-358-4,13762-14-6,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H400:8;H334:5;H350:5;H410:8;H341:5;H319:8;H317:9;H360:5;Not classified:32;H335:4;H351:4;H302:4;H411:1;H401:1
73979,"2-[2-[4-(dimethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",259-054-0,54268-66-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:2;H302:2
73980,Diisobutyl glutarate,275-257-7,71195-64-7,Not Classified,Notified C&L,71,Not classified:71
73982,9(or 10)-(sulphooxy)octadecanoic acid,269-018-6,68170-59-2,Not Classified,Notified C&L,1,Not classified:1
73984,"brucine;2,3-dimethoxystrychnine",206-614-7,357-57-3,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H330:0;H300:0
73986,"2-methyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide",239-466-7,15448-99-4,,Notified C&L,1,H302:1
73989,"Ethanol, 2,2',2''-nitrilotris-, homopolymer, reaction products with chloromethane",614-658-7,68609-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
73993,"3,4,5-trimethoxyphenylacetonitrile",236-388-5,13338-63-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H302:43;H332:42;H312:43;H335:5;H315:5;H319:5;H301:1;H311:1;H331:1
74001,Methyl 4-amino-5-thiocyanato-o-anisate,261-639-0,59168-56-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:2;H319:2;Not classified:1
74002,Dierbium trisulphide,235-289-4,12159-66-9,,Notified C&L,4,H261:4;H315:4;H319:4;H335:4
74003,"Glycerides, vegetable-oil",284-877-7,84988-87-4,Not Classified,Notified C&L,19,Not classified:19
74005,"α'-chloro-α,α,α-trifluoro-m-xylene",211-884-4,705-29-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,45,H226:41;H314:45;H319:1;H318:1
74006,4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]piperazine-1-ethanol dihydrochloride,219-321-4,2413-38-9,Acute Tox. 4,Notified C&L,30,H302:29;Not classified:1;H335:2;H315:2;H319:2;H317:2;H361:1;H362:1;H334:1
74008,etofenprox (ISO);2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether,407-980-2,80844-07-1,Lact.;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H362:0
74010,"(6R-trans)-7-amino-8-oxo-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",246-079-7,24209-43-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
74011,Magnesium dimetaphosphate,237-000-7,13573-12-1,Not Classified,REACH registration C&L,4,Not classified:4
74019,Diphenylacetaldehyde,213-433-7,947-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
74020,"2'-(diphenylphosphanyl)-N,N-dimethyl-[1,1'-biphenyl]-2-amine",607-309-5,240417-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,75,H335:74;H315:75;H319:75
74022,Tetradecyloxirane,230-786-2,7320-37-8,Flam. Liq. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,577,H410:4;H400:4;H315:494;H227:3;H317:441;H319:483;H351:444;Not classified:84;H413:41;H335:41
74023,"Phosphoric acid, mixed decyl and lauryl esters, compds. with diethanolamine",284-712-9,84962-17-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
74029,"Poly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxy-, polymer with 2,4-diisocyanato-1-methylBenzene",618-571-5,9050-83-3,Resp. Sens. 1,Notified C&L,181,H334:109;Not classified:47;H317:42;H331:17;H351:17;H332:17
74030,"Benzeneacetic acid, α-amino-2-chloro-, (αS)-",604-231-3,141315-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:1;H319:1;H413:1
74035,"5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca(b)pyridine",229-490-6,6571-43-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74036,"2-Propenoic acid, 2-methyl-, eicosyl ester, polymer with hexadecyl 2-methyl-2-propenoate, isodecyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate",613-179-0,63197-48-8,Not Classified,Notified C&L,68,Not classified:68
74042,"5,6,7,8-tetrahydroquinoline",234-030-2,10500-57-9,Acute Tox. 4,REACH registration C&L,8,H302:6;H315:5;H319:5;Not classified:1;H335:2
74043,"toluene-2,4-diammonium sulphate;4-methyl-m-phenylenediamine sulfate",265-697-8,65321-67-7,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H350:0;H411:0;H319:0;H312:0;H317:0
74048,"Benzenemethanaminium, N,N,N-tributyl-, 4-hydroxy-1-naphthalenesulfonate (1:1)",600-321-1,102561-46-6,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,8,H411:7;H332:7;Not classified:1
74051,Lithium fluoride,232-152-0,7789-24-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,308,H302:46;H319:272;H301:229;H335:225;H315:229;H360:32;H311:4;H331:3;H412:3;Not classified:2;H330:1;H310:1
74055,2-nitromesitylene,210-054-9,603-71-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H335:41;H315:41;H302:41;H332:41;H319:41;H312:41;H224:3;H228:1
74057,2-thienylcarbonyl chloride,226-092-4,5271-67-0,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,82,H318:4;H314:82;H302:1;H335:1;H290:1
74058,"3-(4-carboxyphenyl)-2,3-dihydro-1,1,3-trimethyl-1H-indene-5-carboxylic acid",222-666-3,3569-18-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H335:38;H315:38;H400:38;H302:38;H410:38;H319:38
74059,"Sulphuric acid, chromium sodium salt",252-004-9,34415-65-1,Not Classified,Notified C&L,1,Not classified:1
74064,Trisodium nitrilotrimethanesulphonate,248-860-8,28138-78-5,Not Classified,Notified C&L,83,Not classified:83
74069,"1,2-dibromo-3,4,5,6-tetrafluorobenzene",212-564-7,827-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
74071,Heptacosane,209-792-4,593-49-7,Not Classified,Notified C&L,5,Not classified:5
74073,Parvaquone,223-734-5,4042-30-2,,Notified C&L,3,H302:2;H332:2;H312:2;Not classified:1
74074,"cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethyl toluene-p-sulphonate",288-058-5,85650-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H315:1;H319:1
74079,Poly (phenylsilsesquioxane),615-071-9,70131-69-0,Acute Tox. 2,Notified C&L,89,H330:83;H319:21;Not classified:6
74081,α-bromo(2H7)toluene,261-790-2,59502-05-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 1B;STOT RE 2,Notified C&L,38,H335:38;H315:38;H331:38;H350:38;H302:38;H373:38;H318:38
74083,"(Z,E)-tetradeca-9,11-dienyl acetate",250-242-8,30562-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74090,"bensultap (ISO);1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane",605-769-1,17606-31-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
74092,alpha-pinene and beta-pinene oligomers,608-613-0,31393-98-3,Aquatic Chronic 4,REACH registration C&L,34,H413:11;Not classified:23
74097,Mebezonium iodide,231-676-7,7681-78-9,Acute Tox. 3;STOT SE 2,Notified C&L,52,H371:51;H301:51;Not classified:1
74100,Isopentyl hexanoate,218-600-8,2198-61-0,Not Classified,Notified C&L,1631,Not classified:1631
74102,"Tetraethyl [1,4-phenylenebis(methylene)]bisphosphonate",224-902-0,4546-04-7,Acute Tox. 4,REACH registration C&L,7,H302:5;H335:1;H315:1;H319:1;Not classified:1
74103,Piperidine-3-carboxylic acid,207-873-9,498-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
74105,"oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide",413-230-5,122035-71-6,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
74107,"1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)",420-060-5,117663-11-3,Flam. Liq. 3;Org. Perox. D;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H411:0;H242:0
74108,"Sodium N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamidate",278-575-4,76918-62-2,Eye Dam. 1,REACH registration C&L,34,H318:34
74109,D-glucaric acid,201-768-1,87-73-0,Flam. Sol. 2;Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H228:1
74112,"Naphthenic acids, bismuth salts",288-470-5,85736-59-0,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,51,H317:4;H319:4;Not classified:44;H413:2;H412:1
74115,"(4R,5R,6S)-4-Nitrobenzyl 3-(diphenoxyphosphoryloxy)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate",618-646-2,90776-59-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,37,H317:36;H302:37
74118,"3,5-dinitroaniline",210-567-8,618-87-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,40,H301:39;H311:39;H331:39;H373:39;H315:1;H330:1;H300:1;H319:1;H310:1
74120,p-toluamide,210-600-6,619-55-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
74126,"Benzo[1,2-c:4,5-c']diacridine-6,9,15,18(5H,14H)-tetrone",224-600-9,4424-87-7,Not Classified,Notified C&L,10,Not classified:10
74127,3-methyl-2-butenenitrile,225-336-7,4786-24-7,Flam. Liq. 3;Acute Tox. 3,Notified C&L,1,H226:1;H301:1
74129,"D-gluconic acid, cyclic 4,5-ester with boric acid, calcium salt (2:1)",227-264-1,5743-34-0,Not Classified,REACH registration C&L,3,Not classified:3
74130,2-hexylidenecyclohexan-1-one,240-481-6,16429-07-5,Not Classified,Notified C&L,88,Not classified:88
74131,"3,5,5-trimethylhexyl formate",266-661-4,67355-38-8,Not Classified,Notified C&L,1374,Not classified:1374
74132,2-chlorothiophene,202-505-3,96-43-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H226:43;H335:41;H315:42;H319:42;H330:5;H301:6;H311:6;H225:5;H331:1;H302:1
74133,"4,8-diamino-1,5-dihydroxy-2-(4-hydroxyphenyl)anthraquinone",230-404-4,7098-08-0,Not Classified,Notified C&L,5,Not classified:5
74135,Triclocarban,202-924-1,101-20-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,180,H410:180;H400:174;H315:8;H319:8
74136,"1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate",411-700-4,140921-24-0,Skin Sens. 1,Harmonised C&L,0,H317:0
74137,Promestriene,254-361-6,39219-28-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1A,Notified C&L,1,H302:1;H332:1;H312:1;H360:1
74138,6-BROMO-2-METHYLQUINOLINE,618-062-8,877-42-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H335:45;H315:46;H334:40;H302:40;H318:40;H317:40;H319:6
74139,Di-''isononyl'' phthalate,249-079-5,28553-12-0,Not Classified,REACH registration C&L,632,Not classified:627;H332:2;H400:2;H361:1;H334:1
74142,Menthyl salicylate,201-909-7,89-46-3,Aquatic Chronic 4,Notified C&L,1,H413:1
74144,2-ethylhexyl acetate,203-079-1,103-09-3,Skin Irrit. 2,REACH registration C&L,2178,H315:1778;Not classified:399;H319:3
74146,Dibutyl sebacate,203-672-5,109-43-3,Not Classified,REACH registration C&L,463,Not classified:324;H335:136;H315:137;H319:137;H317:2;H302:1
74147,"1,3,5,7-tetramethyl-1,1,3,5,7,7-hexaphenyltetrasiloxane",253-922-2,38421-40-8,Not Classified,Notified C&L,36,Not classified:36
74149,Di-tert-nonyl pentasulphide,254-046-3,38622-35-4,Not Classified,Notified C&L,25,Not classified:25
74152,p-phenoxybenzoic acid,218-682-5,2215-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48
74154,Sodium 2-(2-butoxyethoxy)ethyl sulphate,244-737-8,22031-09-0,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
74155,"diethyl N-( {4-[2-(2-amino-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)]phenyl}carbonyl)-L-glutamate 4-methylbenzenesulfonate",605-383-3,165049-28-5,Not Classified,REACH registration C&L,2,Not classified:2
74157,"5-amino-3H-1,2,4-dithiazole-3-thione",229-933-3,6846-35-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H302:1;H373:1
74160,"Whey, proteins",293-803-2,91082-88-1,Not Classified,Notified C&L,22,Not classified:22
74161,"Benzenesulfonic acid, 4-hydroxy-, reaction products with formaldehyde, phenol and urea, ammonium salts",290-725-0,90218-49-8,Not Classified,Notified C&L,38,Not classified:38
74167,Methyl 1-hydroxy-2-naphthoate,213-434-2,948-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H315:41;H319:41
74169,4-formyl-2-methoxyphenyl acetate,212-920-1,881-68-5,Not Classified,Notified C&L,147,Not classified:88;H315:59;H319:59;H335:5;H351:1;H334:1;H413:1
74170,"Heptane-2,3-dione",202-472-5,96-04-8,Flam. Liq. 3;Skin Sens. 1B,Notified C&L,1491,H317:1346;H226:1491
74174,Tetrapotassium hexakis(cyano-C)ruthenate,239-097-1,15002-31-0,Skin Sens. 1,Notified C&L,2,H317:1;H335:1;H315:1;H319:1
74176,Anhydrite (Ca(SO4)),604-615-0,14798-04-0,Not Classified,Notified C&L,1,Not classified:1
74178,"Residues (petroleum), steam-cracked light, arom.;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C",310-057-6,102110-55-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
74179,"3-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one",201-231-1,79-89-0,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,222,H317:107;H411:221;H315:138;H319:98;H412:1
74182,4-bromoisoquinoline,216-244-8,1532-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H302:1;H332:1;H312:1
74183,"2,3-dimethylsuccinic acid",236-915-9,13545-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74186,"4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",267-158-2,67801-38-1,Not Classified,Notified C&L,233,Not classified:233
74187,"Glycerides, C16-18 and C18-unsatd.",266-948-4,67701-30-8,Not Classified,Notified C&L,138,Not classified:137;H412:1
74192,1-(morpholinocarbonylmethyl)piperazine,254-679-5,39890-46-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2;H312:2
74195,"1,1,3,3-tetramethylbutyl hydroperoxide",227-369-2,5809-08-5,Org. Perox. D;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,20,H331:15;H242:20;H302:20;H411:15;H314:15;H318:20;H317:15;H226:13;H315:4
74196,"1,4-dimethyl-5-[[4-[methylbenzylamino]phenyl]azo]-1H-1,2,4-triazolium acetate",281-638-9,84000-82-8,Not Classified,REACH registration C&L,10,Not classified:7;H318:3;H302:3;H411:3
74197,"Amides, tallow, hydrogenated, N,N-bis(hydroxyethyl), acetates (salts)",271-660-7,68603-52-1,Not Classified,Notified C&L,1,Not classified:1
74201,"Butyl dihydrogen phosphate, compound with 4-tetrapropyleneaniline (1:2)",269-017-0,68170-23-0,Not Classified,Notified C&L,1,Not classified:1
74203,2-chloro-1-nitro-4-(trifluoromethyl)benzene,206-936-8,402-11-9,,Notified C&L,6,H302:5;H335:6;H315:6;H319:6;H332:1;H312:1
74204,"2-isobutyl-4,5-dimethylthiazole",258-586-0,53498-32-1,Acute Tox. 4,Notified C&L,118,H302:78;Not classified:25;H335:14;H315:14;H319:14;H226:1
74209,Thioxanthen-9-one,207-749-4,492-22-8,Not Classified,Notified C&L,36,Not classified:36
74211,3-methylbut-2-enyl heptanoate,225-997-1,5205-10-7,Not Classified,Notified C&L,1,Not classified:1
74214,2-ethylhexyl (5-isocyanato-2-methylphenyl)-carbamate,273-133-7,68938-61-4,Acute Tox. 4;Resp. Sens. 1B,REACH registration C&L,2,H334:2;H413:2;H332:2
74216,Terbium (III) chloride hexahydrate,233-132-4,10042-88-3,,Notified C&L,6,H315:5;H319:5;Not classified:1
74218,Lithium 2-methylpropan-2-olate,217-611-5,1907-33-1,Flam. Sol. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,77,H318:5;H302:71;H314:77;H228:29;H251:48;H260:1;H250:1
74221,Bromohydroquinone,209-516-2,583-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
74229,5-Fluoro-2-methoxybenzonitrile,606-184-4,189628-38-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H302:5;H332:5;H312:5;H301:1;H331:1;H311:1
74230,Acridine,205-971-6,260-94-6,Acute Tox. 4,Notified C&L,49,H302:46;H335:10;H315:8;H332:5;H411:4;H312:5;H318:4;H319:7;H400:2;Not classified:1;H410:2
74234,"Methyl 2,4,5-trichlorophenoxyacetate",217-669-1,1928-37-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H335:41;H315:41;H400:41;H302:41;H410:41;H319:41
74241,Sodium [N-[4-(aminosulphonyl)phenyl]-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),304-027-1,94232-97-0,Not Classified,Notified C&L,1,Not classified:1
74245,"1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate",442-850-9,114772-40-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
74249,potassium 2-hydroxycarbazole-1-carboxylate,401-630-2,96566-70-0,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H335:0;H319:0
74250,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",222-036-8,3322-93-8,Eye Irrit. 2,Notified C&L,38,H319:38
74252,"1,1,1-trifluoropentane-2,4-dione",206-698-5,367-57-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,48,H302:48;H226:48;H332:43;H312:43;H335:6;H315:7;H319:7;H314:1
74254,"2-chlorodibenz[b,f][1,4]oxazepin-11(10H)-one",221-602-1,3158-91-6,Not Classified,REACH registration C&L,4,Not classified:4
74256,"2-chlorophenyl 2,2,2-trichloroethyl chlorophosphate",261-939-1,59819-52-2,Skin Corr. 1B,Notified C&L,38,H314:38
74258,"2,2-dimethyl-3-phenylpropionaldehyde",213-771-5,1009-62-7,Not Classified,REACH registration C&L,235,Not classified:235
74262,bis(trimethylsilyl)octylphosphonate,642-900-1,158074-31-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,36,H315:36;H319:36
74264,(methylsulphinyl)benzene,214-781-2,1193-82-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
74271,2-ethoxyaniline;o-phenetidine,202-356-4,94-70-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H301:0;H311:0;H331:0;H373:0
74272,"3,7-dimethyl-4,6-octadien-3-ol",242-360-3,18479-54-4,Not Classified,Notified C&L,233,Not classified:233
74274,"Cyclopenta[b]pyrrole-2-carboxylic acid, octahydro-, phenylmethyl ester, hydrochloride (1:1), (2S,3aS,6aS)-",617-991-6,87269-87-2,Aquatic Chronic 3,REACH registration C&L,4,H412:4
74276,"Heptanoic acid, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol",234-389-5,11138-45-7,Not Classified,Notified C&L,2,Not classified:2
74277,"p-[4,5-dihydro-4-[[2-methoxy-5-methyl-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid, sodium salt",263-417-9,62121-75-9,Not Classified,REACH registration C&L,19,Not classified:16;H334:3
74281,"Titanium 2-hydroxy-1,2,3-propanetricarboxylate (2:5)",923-927-0,,Eye Dam. 1,Notified C&L,2,H318:2;H411:1;H314:1;H400:1
74285,"N-nitro-4,5-dihydro-1H-imidazol-2-amine",611-182-1,5465-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H335:90;H315:91;H319:91
74289,3-nitrophenylacetonitrile,210-689-1,621-50-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
74290,[No public or meaningful name is available],457-610-9,,Pyr. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H250:56;H335:56;H315:56;H319:56
74299,"1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate",431-610-9,68860-54-8,Org. Perox. D;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0;H242:0
74302,Dicyclopropylmethanol,238-236-3,14300-33-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H315:1;H319:1
74304,"Tetrahydro-2,5-dimethoxyfuran-3-carbaldehyde",256-668-0,50634-05-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H335:40;H315:40;H302:40;H332:40;H319:40;H312:40
74305,"1,1,1-trifluoropropan-2-ol",206-773-2,374-01-6,Flam. Liq. 2;Skin Irrit. 2;STOT SE 3,Notified C&L,46,H335:46;H315:46;H225:42;H226:4;H319:7
74310,Decyl oleate,222-981-6,3687-46-5,Not Classified,REACH registration C&L,636,Not classified:636
74311,3-hydroxyhexanoic acid,600-248-5,10191-24-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
74313,"1,3-benzenediamine, 4-methyl-, sulfurized, heat-treated",215-429-0,1326-51-8,Not Classified,Notified C&L,5,Not classified:5
74317,2-(1-cyclohexen-1-yl)cyclohexan-1-one,216-120-3,1502-22-3,Not Classified,Notified C&L,233,Not classified:233
74320,"3,4-dichlorobenzenethiol",227-485-3,5858-17-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H302:44;H335:43;H315:44;H319:6;H301:1;H311:1;H331:1
74321,cis-2-tert-butylcyclohexyl acetate,243-718-1,20298-69-5,Aquatic Chronic 2,REACH registration C&L,195,H411:194;H412:1
74326,3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-N-phenylnaphthalene-2-carboxamide,229-245-3,6448-95-9,Not Classified,Notified C&L,84,Not classified:81;H412:1;H341:1;H334:1;H302:1;H317:1
74330,"Dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']manganate(2-)",268-144-9,68015-77-0,Not Classified,REACH registration C&L,155,Not classified:155
74331,"2-chloro-N-(2,6-diethyl-phenyl)-N-(2-propoxy-ethyl)-acetamide",610-630-3,51218-49-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197,H317:158;H410:197;H400:197;H315:40;H331:39;H319:1
74333,"Benzo[k,l]xanthene-3,4-dicarboxylic anhydride",609-230-1,36310-05-1,Acute Tox. 3,Notified C&L,38,H301:38
74334,Sulfalene,205-804-7,152-47-6,Skin Irrit. 2;Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,2,H361:2;H315:1;H319:1;H362:1;H302:1
74336,"3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-one",273-918-4,69225-59-8,,Notified C&L,2,H335:2;H315:2;H319:2
74343,Oct-2-yne,220-553-3,2809-67-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H315:39;H319:39;H225:40;H304:5;H226:4
74349,2-amino-2-methylpropanol 8-bromotheophyllinate,210-103-4,606-04-2,Acute Tox. 4,Notified C&L,39,H302:39
74356,"Sodium 4,4'-dinitrostilbene-2,2'-disulphonate",240-021-4,15883-59-7,Not Classified,Notified C&L,1,Not classified:1
74357,"Vanadium yttrium oxide (VYO4), bismuth and europium-doped",271-589-1,68585-80-8,Not Classified,Notified C&L,1,Not classified:1
74359,Ammonium acetate,211-162-9,631-61-8,Not Classified,REACH registration C&L,1756,Not classified:1663;H319:73;H302:22;H335:33;H315:34;H314:20;H290:1
74361,trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde,421-800-1,120578-03-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
74364,Molybdenum pentachloride,233-575-3,10241-05-1,Skin Corr. 1B,Notified C&L,68,H314:68;H318:1;H302:1;H317:1;H335:1
74366,"Fatty acids, castor-oil, potassium salts",232-388-4,8013-05-6,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
74369,"Fatty acids, tall-oil, compds. with triethylamine",268-925-4,68154-91-6,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H314:1
74370,6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide,430-500-8,204277-61-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
74371,"Resins, Aquilaria agallocha",305-227-1,94350-09-1,Not Classified,Notified C&L,61,Not classified:61
74372,Disodium tetrachloropalladate,237-502-6,13820-53-6,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H290:40;H400:89;H302:44;H410:89;H319:46;H317:89;H301:83;H318:83;H315:2;Not classified:1;H335:1
74374,N-methylphenethylamine,209-632-3,589-08-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H318:41;H302:41
74378,"4-(3-Butenyl)-4''-ethyl-2'-fluor-1,1':4',1''-terphenyl",619-966-5,825633-86-1,Aquatic Chronic 4,REACH registration C&L,1,H413:1
74379,"1,2-dichloropropane;propylene dichloride",201-152-2,78-87-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H302:0;H332:0;H350:0;H225:0
74383,1-(2-hydroxy-5-tert-nonylphenyl)ethan-1-one oxime,271-190-2,68517-09-9,Not Classified,Notified C&L,73,Not classified:71;H361:2;H317:2;H410:2;H315:2
74385,N-isopropylethylenediamine,243-125-8,19522-67-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,43,H314:43;H225:39;H224:4;H318:1
74390,"2,4,5-trimethyloxazole",243-952-4,20662-84-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H226:160;H335:119;H315:115;H319:119
74391,"Bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-N3,O4)magnesium",252-167-6,34717-03-8,Not Classified,Notified C&L,4,Not classified:4
74392,(Z)-hept-2-ene,229-242-7,6443-92-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:42;H319:42;H225:43
74393,Cyclohexylidenebis[tert-amyl] peroxide,239-741-1,15667-10-4,Flam. Liq. 3;Org. Perox. C;Skin Irrit. 2,REACH registration C&L,240,H226:57;H315:202;H242:202;H319:38
74397,Trimethoxyphenylsilane,221-066-9,2996-92-1,Flam. Liq. 3;Acute Tox. 4;STOT RE 2,REACH registration C&L,195,H302:120;H226:97;H373:107;H335:76;H315:127;H319:70;H336:32;Not classified:5
74401,Tricalcium silicon pentaoxide,235-336-9,12168-85-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,21,H318:20;H315:20;Not classified:1
74406,(Antipyrinylmethylamino)methanesulfonic acid sodium salt monohydrate,611-790-7,5907-38-0,Repr. 2,Notified C&L,117,H361:97;H413:14;H412:5;Not classified:1;H302:1;H373:1
74410,3-Bromo-2-(bromomethyl)propionic Acid,609-928-6,41459-42-1,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1
74413,3-nitrophthalimide,210-051-2,603-62-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
74415,"3,4,5,5-tetramethylhex-2-ene",254-281-1,39083-38-0,Flam. Liq. 1;Aquatic Chronic 3,REACH registration C&L,11,H412:11;H226:11
74416,"Fatty acids, C16-18, isononyl esters",292-960-4,91031-57-1,Not Classified,Notified C&L,7,Not classified:7
74418,Methylammonium chloride,209-795-0,593-51-1,Acute Tox. 4,REACH registration C&L,112,H302:107;H335:89;H315:90;H319:92;Not classified:3
74425,1-fluoro-2-nitrobenzene,216-088-0,1493-27-2,Acute Tox. 4;Acute Tox. 3;Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,165,H302:3;H411:4;H332:3;H372:3;H311:93;H301:124;H335:40;H315:77;H319:77;H373:38;H310:33;H330:5;H331:3;H312:1;H317:1
74426,Paraffin oils,232-384-2,8012-95-1,Asp. Tox. 1,Notified C&L,2839,H304:2051;Not classified:658;H413:173;H410:61;H319:108;H400:61;H226:17;H335:30;H315:28;H373:5;H336:1;H334:1;H372:2;H332:1;H341:1;H371:1;H318:1;H314:1
74428,Zirconium(4+) propan-2-olate,218-522-4,2171-98-4,Flam. Sol. 2,Notified C&L,38,H228:38
74429,"2,4-xylyloxyacetic acid",236-385-9,13334-49-1,Acute Tox. 4,Notified C&L,42,H302:38;H335:4;H315:4;H319:4
74431,tert-butylchlorodimethylsilane,242-042-4,18162-48-6,Flam. Sol. 1;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,264,H318:110;H411:17;H314:208;H228:163;H335:93;Not classified:58;H361:7;H225:5;H336:7;H373:7;H302:3;H304:3
74433,"4,4'-Isopropylidenediphenol, propoxylated",500-097-4,37353-75-6,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,203,H411:60;H315:69;Not classified:79;H412:55;H317:1;H319:1
74434,"Octadecanoic acid, branched and linear",269-214-1,68201-37-6,Not Classified,REACH registration C&L,1,Not classified:1
74435,"2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide",617-590-6,846023-24-3,Skin Sens. 1,REACH registration C&L,2,H317:2
74436,2-ethoxyphenol,202-358-5,94-71-3,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,54,H318:48;H317:6;H412:6;H302:46;H335:41;H315:48;H319:6;Not classified:2
74439,3-[4-(tert-butyl)phenoxy]benzaldehyde,274-109-9,69770-23-6,Aquatic Acute 1,Notified C&L,38,H400:38
74445,"Oils, wheat",614-801-3,68917-73-7,Not Classified,Notified C&L,61,Not classified:61
74448,"2,6-xylenol",209-400-1,576-26-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H301:0;H311:0;H314:0
74450,"Alkanes, iso-",613-579-5,64365-06-6,Not Classified,Notified C&L,37,Not classified:36;H304:1
74451,Potassium 6-hydroxynaphthalene-2-sulphonate,212-631-0,833-66-9,Not Classified,REACH registration C&L,78,Not classified:2;H319:76
74452,"7-aminonaphthalene-1,3,5-trisulphonic acid, sodium salt",280-636-5,83732-84-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,9,H315:9;H319:9
74453,Sodium 1-phenyl-1H-tetrazole-5-thiolate,239-121-0,15052-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74458,2-Bromo-5-iodopyrazine,612-970-8,622392-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
74460,"2,4,6-tris(pentadecafluoroheptyl)-1,3,5-triazine",244-521-3,21674-38-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74462,"1,3,4,6-tetrakis(butoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione",240-108-7,15968-37-3,Carc. 1B,Notified C&L,38,H350:38
74465,2-(1-methylcyclohexyl)-p-cresol,240-303-7,16152-65-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,17,H317:17;H315:17;H319:17
74468,Butyl heptanoate,226-707-6,5454-28-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
74471,Thymol acetate,208-442-8,528-79-0,Not Classified,Notified C&L,88,Not classified:88
74477,"ethyl 3,3-bis(tert-pentylperoxy)butyrate",403-320-2,67567-23-1,Flam. Liq. 3;Org. Perox. D;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H411:0;H242:0
74478,"Butanedioic acid, sulfo-, 4-C16-18-alkyl esters, disodium salts",290-840-6,90268-39-6,Not Classified,Notified C&L,11,Not classified:8;H318:3;H315:3
74481,2-chloro-4-(methylsulfonyl)benzoic acid,406-520-8,53250-83-2,Eye Dam. 1,Harmonised C&L,0,H318:0
74484,Dimethylsilane,214-184-7,1111-74-6,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,139,H220:139;H280:139;H340:40;H350:40
74485,"(5α)-17-allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride",206-611-0,357-08-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,97,H318:91;H302:97;H315:4;H319:4;H334:3;H332:3;H317:3;H361:1
74486,Silver cyanide,208-048-6,506-64-9,Met. Corr. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,61,H290:12;H301:6;H315:12;H400:57;H410:59;H318:12;H330:55;H300:55;H310:55;H413:1;H362:2
74489,"Hydrocarbons, C9-14, ethylene-manuf.-by-product",271-035-9,68514-34-1,Asp. Tox. 1;Carc. 2;Aquatic Chronic 2,REACH registration C&L,1,H304:1;H411:1;H351:1
74494,5α-androst-2-en-17-one,213-517-3,963-75-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2;H351:1;H361:1
74495,"Butyl dihydrogen phosphate, sodium salt",256-712-9,50683-26-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,10,H318:10;H315:10
74497,2-amino-6-chloropyrimidin-4-ol hydrate,214-785-4,1194-21-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H302:1;H335:1
74498,Bis(3-nitrophenyl) sulphone,214-965-2,1228-53-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
74499,1-(4-morpholinomethyl)-1H-benzotriazole,226-813-2,5472-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74500,C.I. Reactive Yellow 167,601-378-5,115682-10-5,Not Classified,Notified C&L,1,Not classified:1
74503,5-oxo-D-proline,223-735-0,4042-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
74504,Bacillus Ferment Filtrate Extract,924-436-4,68038-65-3,Acute Tox. 5;Skin Mild Irrit. 3;Eye Irrit. 2B,Notified C&L,1,H320:1;H303:1;H316:1
74506,DL-1-phenylpentan-2-ol,211-887-0,705-73-7,Not Classified,Notified C&L,88,Not classified:88
74511,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate and ethenylbenzene",608-050-0,27136-15-8,Not Classified,Notified C&L,172,Not classified:172
74513,"1,4-dichloro-2-iodobenzene",249-774-3,29682-41-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
74521,3-methyl-3-buten-2-ol,233-964-8,10473-14-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
74523,Sodium neodecanoate,250-692-5,31548-27-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,16,H412:14;H315:14;H319:14;Not classified:2
74524,C.I. Reactive Orange 86,617-511-5,83929-91-3,Not Classified,Notified C&L,1,Not classified:1
74526,"4,5,6,7-tetrahydro-1H-indazole",218-977-9,2305-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
74529,"[(2,4-dibromo-6-methylphenoxy)methyl]oxirane",278-084-5,75150-13-9,Not Classified,Notified C&L,6,Not classified:6
74535,"2,2-bis(hydroxymethyl)butanoic acid",424-090-1,10097-02-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
74537,"Naphthalenesulfonic acid, reaction products with formaldehyde and urea, sodium salts",296-394-9,92623-64-8,Not Classified,Notified C&L,1,Not classified:1
74539,"Jasmine, Jasminum officinale, ext.",289-960-1,90045-94-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1474,H315:1472;H302:1287;H411:1372;H319:1300;H317:1418;H410:131;H400:95;H360:52;Not classified:2
74545,"3,7-Dimethyl-6-octenamide",615-913-5,73127-86-3,Not Classified,REACH registration C&L,2,Not classified:2
74552,"2,5-bis(dodecyldithio)-1,3,4-thiadiazole",236-911-7,13539-12-3,,Notified C&L,1,Not classified:1
74554,Nonadecan-10-one,207-994-7,504-57-4,Skin Irrit. 2,Notified C&L,39,H315:39;H302:1;H335:1;H319:1
74559,5-[2-(methylthio)ethyl]-3-phenyl-2-thioxoimidazolidin-4-one,224-464-0,4370-90-5,Acute Tox. 3,Notified C&L,38,H301:38
74562,Ionomycin calcium salt,611-357-2,56092-82-1,Acute Tox. 4,Notified C&L,44,H302:44;H332:1;H312:1
74565,5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride,251-211-1,32780-64-6,Not Classified,Notified C&L,7,Not classified:2;H302:2;H361:2;H335:2;H315:2;H319:2;H411:2;H373:1
74566,"1,4-dithiane-2,5-diol",254-751-6,40018-26-6,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1451,H318:1421;H317:1449;H301:69;H400:28;H330:28;H410:28;H373:28;H302:1381;H412:1382;H335:1;H315:1;H319:1
74569,Cyclopentanol,202-504-8,96-41-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,54,H335:1;H315:1;H302:1;H226:54;H332:1;H319:1
74570,Tetrahexylammonium chloride,227-653-6,5922-92-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74572,Acetylcholine chloride,200-468-8,60-31-1,Skin Irrit. 2;STOT SE 3,Notified C&L,161,H335:160;H315:161;H319:45
74576,"4-(Pyridin-4-yl)-1,3-thiazole-2(3H)-thione",616-441-2,77168-63-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,0,No data
74578,"N,N-dibutylaniline",210-335-6,613-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:39;H319:39;H302:5;H332:5;H312:5
74580,10-Hydroxycamptothecin,613-598-9,64439-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74586,"Rose, Rosa damascena trigintipetala, ext.",308-773-9,98306-05-9,,Notified C&L,1,H351:1;H412:1;H341:1;H318:1;H317:1
74589,(1-ethoxyethylidene)malononitrile,226-521-5,5417-82-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H335:40;H315:40;H302:39;H332:39;H319:40;H312:39;H301:1;H331:1;H311:1
74595,4-hydroxy-1-methyl-2-quinolone,216-830-3,1677-46-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
74598,"Oils, fish, sulfonated, sodium salts",307-763-1,97722-13-9,Not Classified,Notified C&L,8,Not classified:8
74599,5-oxo-1-phenyl-2-thioxoimidazolidine-4-propionamide,234-153-1,10567-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74600,"2,5-dimethylpiperazine-1,4-diethanol",258-588-1,53503-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74604,"3-Oxazolidinecarboxylic acid, 4-(1-methylethyl)-2,5-dioxo-, phenylmethyl ester, (4S)-",605-141-7,158257-41-1,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,3,H317:3;H319:3
74607,"[4-[α-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium benzoate",271-270-7,68527-61-7,Acute Tox. 4;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H361:2;H302:2;H410:2;H318:2
74618,o-anisohydrazide,231-260-5,7466-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H315:3;H319:3
74620,"Mentha aquatica crispa, ext.",290-059-0,90063-98-2,Not Classified,Notified C&L,184,Not classified:184
74621,"Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione",408-250-6,,Flam. Liq. 2;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H225:0;H410:0;H332:0;H314:0;H317:0
74623,"Sulphuric acid, aluminium salt",233-329-5,10124-29-5,Eye Dam. 1,Notified C&L,9,H318:9
74625,3-(Bromomethyl)-2-chloro-4-(methylsulfonyl) benzoic acid,619-778-3,120100-05-2,Not Classified,Notified C&L,34,Not classified:33;H317:1;H301:1;H319:1
74630,sodium metabisulphite,231-673-0,7681-57-4,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H318:0;H302:0
74631,"Copper, 3-[[](3,4-dicyanophenyl)sulfonyl]-N-(2-hydroxypropyl)-1-propanesulfonamide-lithium 3-[[](3,4-dicyanophenyl)sulfonyl]-1-propanesulfonate reaction products complexes",445-470-1,569316-88-7,Eye Dam. 1,Notified C&L,2,H318:2
74633,"3-((4-((4-((5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo)-2-sulphophenyl)azo)-2,5-bis(2-hydroxyethoxy)phenyl)azo)-4,5-dihydroxy-naphthalene-2,7-disulphonic acid, mixed sodium/potassium salt",458-890-5,,Not Classified,Notified C&L,1,Not classified:1
74639,Sodium iodate,231-672-5,7681-55-2,Ox. Sol. 2;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,71,H272:65;H317:46;H302:56;H334:52;H271:6;Not classified:1
74641,Rosin oil,232-300-4,8002-16-2,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,4,H302:2;H304:2;H411:3;H315:2;Not classified:1
74642,isobutyl but-3-enoate,401-170-2,24342-03-8,Flam. Liq. 3,Harmonised C&L,0,H226:0
74645,Hexyl hexanoate,228-952-4,6378-65-0,Not Classified,REACH registration C&L,186,Not classified:183;H411:1;H413:2
74648,"Quaternary ammonium compounds, dicoco alkyldimethyl, nitrites",275-532-1,71487-01-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H400:39;H302:39;H410:36;H314:7;H318:6;Not classified:5
74649,4-nitrophenyl 4-[(aminoiminomethyl)amino]benzoate monohydrochloride,242-831-3,19135-17-2,Eye Dam. 1,Notified C&L,38,H318:38
74653,"Benzene, methyl-, mono-C15-36-branched alkyl derivs.",290-562-5,90193-59-2,Asp. Tox. 1,Notified C&L,1,H304:1
74657,Dimercury difluoride,237-747-9,13967-25-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H330:42;H300:42;H410:42;H373:42;H310:42
74661,"1-Dodecene, homopolymer, hydrogenated",604-769-9,151006-63-2,Not Classified,REACH registration C&L,7,Not classified:7
74663,schradan (ISO);octamethylpyrophosphoramide,205-801-0,152-16-9,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H310:0;H300:0
74667,(9S)-1-benzyl-9-hydroxycinchonanium chloride,273-915-8,69221-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
74668,"1-bromo-3,5-di-tert-butylbenzene",607-060-2,22385-77-9,Not Classified,Notified C&L,4,Not classified:2;H335:1;H315:1;H319:1;H413:1;H302:1
74670,"3-hydroxymethylpentane-2,4-diol",213-065-7,921-20-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
74677,Trimethyl-3-(trimethoxysilyl)propylammonium chloride,252-393-5,35141-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74681,Sodium (3-(trihydroxysilyl)propyl)methyl phosphonate,284-799-3,84962-98-1,Eye Irrit. 2,Notified C&L,43,H319:42;Not classified:1
74685,Sodium sulphanilate,208-208-5,515-74-2,Not Classified,REACH registration C&L,66,Not classified:63;H302:1;H332:1;H312:1;H412:1;H317:2;H315:1;H319:1
74687,"Residues (petroleum), hydrodesulfurized atmospheric tower;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-181-2,64742-78-5,Carc. 1B,Harmonised C&L,0,H350:0
74690,A mixture of: (Z)-oxacycloheptadec-11-en-2-one; (E)-oxacycloheptadec-11-en-2-one,427-750-5,,Not Classified,Notified C&L,46,Not classified:46
74698,Isobutyl 2-isobutoxy-2H-quinoline-1-carboxylate,253-925-9,38428-14-7,,Notified C&L,1,H335:1;H315:1;H319:1
74699,Pentacopper silicide,235-286-8,12159-07-8,,Notified C&L,4,H335:4;H315:4;H319:4
74700,"2-Butenedioic acid (2Z)-, polymer with 2-propenoic acid",608-320-8,29132-58-9,Met. Corr. 1,Notified C&L,184,H290:83;H318:60;H314:100;H319:1
74701,"5H-dibenz[b,f]azepine",205-970-0,256-96-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,54,H317:9;H410:9;H400:9;H302:42;H411:41;H335:1;H315:2;H319:2;H332:1;H312:1;H413:1
74702,Benzyltributylammonium chloride,245-787-3,23616-79-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,63,H302:62;H314:40;H315:14;H319:19;H318:5;Not classified:2;H335:2;H332:1;H312:1
74703,Anilinomethanesulphonic acid,203-076-5,103-06-0,Not Classified,Notified C&L,1,Not classified:1
74712,4-chlorobenzamide,210-601-1,619-56-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H302:42;H319:42;H335:4;H315:4
74714,Sodium p-chloro-m-cresolate,239-825-8,15733-22-9,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,211,H400:15;H412:15;H302:211;H410:15;H314:173;H318:164;H317:15;H312:158;H411:40;H335:13
74715,"β,β-dimethylstyrene",212-194-6,768-49-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H335:38;H315:39;H319:39
74717,Cyclopentadienylthallium,252-229-2,34822-90-7,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H330:43;H373:42;H411:43;H300:43
74718,Ethyl 3-aminocrotonate,230-782-0,7318-00-5,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,80,H318:10;H335:9;H314:26;Not classified:52;H315:3;H319:3
74719,Disodium methylenebisnaphthalenesulphonate,247-785-8,26545-58-4,,Notified C&L,51,Not classified:48;H315:2;H320:1;H335:1;H316:1
74720,allyl methacrylate;2-methyl-2-propenoic acid 2-propenyl ester,202-473-0,96-05-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H331:0;H400:0;H302:0;H226:0;H312:0
74723,trans-2-tert-butylcyclohexyl acetate,243-719-7,20298-70-8,Aquatic Chronic 2,Notified C&L,1,H411:1
74727,Bis(nitrato-O)dioxouranium,233-266-3,10102-06-4,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,4,H330:4;H373:4;H411:4;H300:4
74731,Androsterone acetate,214-612-2,1164-95-0,Carc. 2,Notified C&L,38,H351:38
74734,"Triphosphoric acid, sodium salt",237-004-9,13573-18-7,Not Classified,Notified C&L,1,Not classified:1
74735,"2-Naphthalenesulfonic acid, 6-amino-5-[[4-[(2-bromo-1-oxo-2-propenyl)amino]-2-sulfophenyl]azo]-, disodium salt",602-409-5,12225-98-8,Not Classified,Notified C&L,2,Not classified:2
74737,"3-(1,1,2,3,3,3-hexafluoropropoxy)propene",261-635-9,59158-81-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:39;H319:39;H225:39;H226:1
74739,C.I. Solvent Black 26,612-444-8,61814-15-1,Not Classified,Notified C&L,5,Not classified:5
74741,4-bromo-o-toluidine,209-519-9,583-75-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:41;H315:46;H302:43;H332:43;H319:46;H312:43;H301:4;H311:4
74744,Niclosamide,200-056-8,50-65-7,Aquatic Acute 1,Notified C&L,71,H400:69;H410:28;H319:1
74747,Bis(2-hydroxyethyl)ammonium hydrogen sulphate,244-221-2,21121-22-2,Eye Irrit. 2,Notified C&L,441,H319:441
74749,"Lecithins, hydrolyzed",288-318-8,85711-58-6,Not Classified,REACH registration C&L,127,Not classified:126;H317:1
74753,"1-Propanesulfonic acid, 3-[hexyl[(nonafluorobutyl)sulfonyl]amino]-2-hydroxy-, Monoammonium Salt",468-470-3,,Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1
74755,N-cyclohexylcyclohexanamine 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate,611-575-8,577953-88-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
74756,sodium pentachlorophenolate,205-025-2,131-52-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H335:0;H315:0;H351:0;H400:0;H330:0;H410:0;H319:0;H311:0
74759,4-(trifluoromethyl)anthranilic acid,206-937-3,402-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H335:4;H315:5;H319:5
74760,"Hydrocarbon waxes (petroleum), oxidized",265-205-1,64743-00-6,Eye Irrit. 2,REACH registration C&L,560,H319:535;Not classified:25;H317:83;H335:83;H315:83
74761,"1-(4-aminophenyl)-1,3,3-trimethylindan-ar-amine",269-014-4,68170-20-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
74764,"4-hydroxy-3,5-dimethoxybenzonitrile",700-251-2,72684-95-8,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,5,H412:4;H319:4;Not classified:1
74767,bis (5-tert-butyl-o-tolyle)disulfure,448-710-3,34493-12-4,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,1,H226:1;H411:1
74768,"Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C25-55, branched and cyclic",605-827-6,178603-66-2,Not Classified,Notified C&L,83,Not classified:83
74772,Disodium malate,211-627-6,676-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,111,H335:58;H315:58;H319:72;Not classified:39
74773,2-chloroethyl isocyanate,217-734-4,1943-83-5,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,50,H301:46;H335:45;H315:45;H331:42;H334:50;H226:50;H319:45;H330:4;H314:5;H302:4;H332:4;H312:4;H318:1;H311:1
74775,"1-isopropyl-2,2-dimethyltrimethylene diisobutyrate",229-934-9,6846-50-0,Repr. 2;Aquatic Chronic 3,REACH registration C&L,1229,H412:260;H361:215;Not classified:888;H373:55;H319:55;H411:24;H315:2
74779,"Ferula galbaniflua, ext.",296-925-4,93165-40-3,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,69,H400:61;H410:66;H304:68;H226:66;H317:69;H315:6;H411:3;H302:1
74780,"Methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate",201-908-1,89-43-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1604,H317:1295;H319:1295;Not classified:309
74782,Barium isononanoate,283-534-9,84681-75-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,5,H302:5;H332:5
74786,4-bromopyridinium chloride,243-128-4,19524-06-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H302:49;H335:48;H315:49;H319:49;H332:2;H312:3
74794,1-methyl-4-piperidyl diphenylglycolate,222-774-0,3608-67-1,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H335:1;H411:1;H319:1
74796,"2,5-dichlorobenzenethiol",227-486-9,5858-18-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;H302:6;H332:2;H312:2;H301:1;H311:1;H331:1
74805,"(3S-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione",224-832-0,4511-42-6,Eye Irrit. 2,REACH registration C&L,72,H319:52;H314:20;H335:5;H315:2
74808,"Glycerides, C14-18",266-945-8,67701-27-3,Not Classified,Notified C&L,75,Not classified:75
74809,Propisochlor,617-914-6,86763-47-5,Acute Tox. 4,Notified C&L,45,H312:40;H317:5;H410:5;H400:5
74811,"2-Phenazinol, 3-amino-",610-267-0,4569-77-1,,Notified C&L,34,Not classified:33;H302:1
74812,3-bromo-4-methylbenzoic acid,231-712-1,7697-26-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H301:39;H335:45;H315:46;H319:46
74816,N-(3-chloropropyl)piperidine hydrochloride,226-812-7,5472-49-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
74817,"tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)",411-470-5,141048-13-7,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
74818,"4-[4-[[2,5-dimethoxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid, sodium salt",263-418-4,62121-76-0,Not Classified,REACH registration C&L,8,Not classified:5;H334:3;H317:3
74822,"Tris(dioctyl phosphato-O'')(propan-2-olato)titanium, branched and linear",271-588-6,68585-79-5,Skin Corr. 1A;Eye Dam. 1,Notified C&L,19,H318:10;H314:10;Not classified:7;H335:2;H315:2;H319:2
74824,3-chloro-4-(dimethylamino)benzenediazonium tetrachlorozincate (2:1),270-235-3,68413-63-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
74833,2-methoxy-5-nitrobenzenediazonium,248-282-6,27165-17-9,Acute Tox. 4,Notified C&L,1,H302:1
74836,Dibutylammonium tetrafluoroborate(1-),235-162-3,12107-76-5,,Notified C&L,4,H335:4;H315:4;H319:4
74838,Veratronitrile,217-969-2,2024-83-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H335:42;H315:43;H302:42;H332:42;H319:43;H312:42;H301:1
74839,"Fatty amine, ethoxylated, sulfated, quaternized",925-331-6,,Aquatic Chronic 3,Notified C&L,31,H412:31
74840,(2-isopropylpent-4-enoyl)urea,208-443-3,528-92-7,Acute Tox. 4,Notified C&L,1,H302:1
74841,"[4-[p,p'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium m-[[p-anilinophenyl]azo]benzenesulphonate",265-449-9,65113-55-5,Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,67,H335:9;H400:9;H410:9;H318:9;H317:9;H302:47;Not classified:6;H319:5
74842,"Benzenemethanol, 2,¿4-¿dibromo-",613-974-2,666747-06-4,Not Classified,Notified C&L,7,Not classified:6;H315:1;H319:1
74843,2-chlorobutane,201-151-7,78-86-4,Flam. Liq. 2;Met. Corr. 1;Aquatic Chronic 3,REACH registration C&L,73,H290:5;H412:5;H225:73;H335:22;H315:22;H319:22
74846,"2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride",306-764-4,97404-02-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,175,H318:116;H317:116;H302:172;H411:109;H332:55;H312:55;H412:7;H335:3;H315:4;H319:4;H334:1;H410:1
74852,"4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt",426-900-7,,STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H335:0
74853,trans-Styrylacetic acid,606-243-4,1914-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74855,"2-Benzyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one, hydrochloride",917-844-9,,Not Classified,REACH registration C&L,4,Not classified:4
74857,"4-(morpholin-4-yl)-1,2,5-thiadiazol-3-ol",608-450-5,30165-97-0,Not Classified,REACH registration C&L,5,Not classified:2;H335:2;H315:2;H319:2;H302:1
74868,Disodium wolframate,236-743-4,13472-45-2,Acute Tox. 4,REACH registration C&L,576,H302:576;H315:5;H319:6;H335:2
74871,Titanium disulphate,248-749-4,27960-69-6,Not Classified,Notified C&L,1,Not classified:1
74872,Etidronic acid,220-552-8,2809-21-4,Met. Corr. 1;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,2230,H290:613;H302:1130;H318:1995;H413:579;H314:603;H315:99;H319:55;Not classified:35;H335:15;H332:10;H312:11;H411:1
74874,"2,6-dimethyloctan-2-ol",242-361-9,18479-57-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1614,H315:31;H319:31;Not classified:1583
74877,"sodium 1,2-bis[4-[4-{}{4-(4-sulfophenylazo)-2-sulfophenylazo}}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt",413-990-8,149850-31-7,Skin Sens. 1,Harmonised C&L,0,H317:0
74882,"Glycerides, C14-22 mono-, acetates",273-608-9,68990-54-5,Not Classified,Notified C&L,12,Not classified:12
74886,Isoquinolin-1-amine,216-243-2,1532-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
74888,Cobalt trichloride,233-574-8,10241-04-0,Acute Tox. 2;Acute Tox. 2,Notified C&L,10,H330:10;H300:10
74891,3-nitro-L-tyrosine,210-688-6,621-44-3,Not Classified,Notified C&L,1,Not classified:1
74892,Azelaoyl chloride,204-668-6,123-98-8,Skin Corr. 1B,Notified C&L,40,H314:40;H290:1;H318:1;H335:1
74894,Ergosterol,200-352-7,57-87-4,Not Classified,REACH registration C&L,46,Not classified:1;H413:39;H300:6
74898,N-phenyl-m-anisidine,202-921-5,101-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H335:42;H315:43;H319:44
74901,"1-Hexene, polymer with ethene",607-647-3,25213-02-9,Not Classified,Notified C&L,90,Not classified:90
74903,Dilutetium oxide silicate,235-337-4,12168-86-4,Not Classified,Notified C&L,2,Not classified:2
74913,Erbium trifluoride,237-356-3,13760-83-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:38;H311:38;H331:38;H335:5;H315:5;H319:5;H330:1;H310:1;H300:1
74914,"Gas oils (petroleum), light vacuum",265-059-9,64741-58-8,Asp. Tox. 1;Skin Irrit. 2;Acute Tox. 4;Carc. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,27,H315:21;H351:21;H373:21;H304:13;H332:21;H411:21;H226:10;Not classified:5;H413:1
74918,Dibromodifluoromethane,200-885-5,75-61-6,Ozone 1,Notified C&L,38,H420:38
74919,"5,5'-methylenebis(1H-benzotriazole)",239-903-1,15805-10-4,Flam. Sol. 2,Notified C&L,26,H228:17;H226:9
74920,Diiron nickel tetraoxide,235-335-3,12168-54-6,Skin Sens. 1,Notified C&L,43,H317:42;H350:4;Not classified:1
74921,(Z)-octadec-9-enylamine,204-015-5,112-90-3,Acute Tox. 4;Skin Corr. 1B;Asp. Tox. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H335:0;H400:0;H302:0;H304:0;H373:0;H410:0;H314:0
74922,"1,1,1,3,5,5,5-heptamethyl-3-octyltrisiloxane",241-881-3,17955-88-3,Not Classified,REACH registration C&L,77,Not classified:76;H335:1;H315:1;H319:1
74923,"3,3'-ethylenedioxybis(propylamine)",221-067-4,2997-01-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,11,H318:11;H302:2;H314:11;H317:8;H312:9
74924,Barium iron oxide,234-387-4,11138-11-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H302:43;H332:43;Not classified:1
74925,"Alcohols, C9-11, branched and linear, ethoxylated, sulfates, sodium salts",500-465-4,160901-28-0,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,124,H318:98;H315:124;H319:26
74927,Hafnium ditelluride,254-280-6,39082-23-0,,Notified C&L,4,H302:4;H332:4
74936,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-N-3-(isopropoxypropyl)benzenesulphonamidato(2-)]cobaltate(1-)",275-640-9,71566-55-7,Not Classified,REACH registration C&L,123,Not classified:91;H411:32
74938,Copper sulfate monohydrate,600-326-9,10257-54-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,27,H410:27;H302:27;H315:27;H319:27;H400:2
74940,copper thiocyanate,214-183-1,1111-67-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
74941,"1,3-benzodioxol-2-one",218-521-9,2171-74-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
74942,"3,4-xylyloxyacetic acid",236-386-4,13335-73-4,,Notified C&L,6,H335:5;H315:5;H319:5;H302:2;H332:1;H312:1
74946,"(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one",617-007-5,80214-83-1,Acute Tox. 4,Notified C&L,65,H302:65
74952,2-(methanesulfonyl)ethylamine hydrochloride,450-260-8,104458-24-4,Not Classified,Notified C&L,4,Not classified:2;H360:1;H335:1;H315:1;H302:1;H332:1;H319:1
74956,"Alkenes, C15-18",297-797-2,93762-80-2,Asp. Tox. 1,REACH registration C&L,241,H304:158;Not classified:83;H302:59
74957,"3,3'-(2-methylpiperazine-1,4-diyl)dipropan-2-ol",202-359-0,94-72-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H335:38;H315:38;H319:38
74958,3-methyl-1-phenylbutan-2-ol,211-886-5,705-58-8,Not Classified,Notified C&L,89,Not classified:88;H335:1;H315:1;H227:1;H302:1;H319:1
74961,"Hydrocarbons, C",307-659-6,97675-85-9,Carc. 1B,Harmonised C&L,0,H350:0
74962,"[1,1,2,2-2H4]ethane-1,2-[2H2]diol",239-122-6,15054-86-1,Acute Tox. 4,Notified C&L,38,H302:38
74965,Dilanthanum tricarbonate,209-599-5,587-26-8,Not Classified,REACH registration C&L,10,Not classified:9;H335:1;H315:1;H319:1
74966,"Acetamide, N-[5-[bis[2-(acetyloxy)ethyl]amino]-4-methoxy-2-[2-(5-nitro-2-thiazolyl)diazenyl]phenyl]-",603-862-1,134764-36-6,Not Classified,Notified C&L,1,Not classified:1
74970,Metacetamol,210-687-0,621-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:42;H315:44;H319:44;H302:1
74975,3-[(aminoiminomethyl)thio]propanesulphonic acid,244-520-8,21668-81-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,69,H412:2;H317:2;H302:29;H314:40;H312:27;H318:1
74977,"Kinase (phosphorylating), hexo-",232-611-5,9001-51-8,,Notified C&L,1,H334:1
74979,"1,3-dichloro-5-(methylsulphonyl)benzene",245-250-3,22821-89-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
74989,Chromium zinc oxide,256-848-9,50922-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,43,H350:38;H335:38;H315:38;H319:38;Not classified:5
74990,"Reaction mass of triphenyl[(2E,4E,6E)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]phosphonium acetate and triphenyl[(2Z,4E,6E)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]phosphonium acetate",700-300-8,,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H301:1;H331:1;H412:1;H361:1;H302:1;H226:1;H373:1;H370:1;H314:1;H318:1;H317:1;H311:1
74994,p-(trifluoromethoxy)benzenesulphonyl chloride,302-397-9,94108-56-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:39;H314:46;H290:1;H319:1;H335:1
74995,Diethyl nitromalonate,210-052-8,603-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
74996,"Tar bases, coal, toluidine fraction;Distillate Bases",293-767-8,91082-53-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
74998,Potassium dicyanoargentate,208-047-0,506-61-6,Met. Corr. 1;Acute Tox. 1;Acute Tox. 1;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,112,H290:10;H400:111;H330:112;H300:112;H410:111;H314:3;H318:65;H310:112;H311:3;H315:7
74999,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (1:1)",604-400-1,144-23-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
75000,3-(trimethylsilyl)-2-propyn-1-ol,226-094-5,5272-36-6,,Notified C&L,4,H301:4;H335:4;H315:4;H319:4
75004,Ipecac,232-385-8,8012-96-2,Not Classified,Notified C&L,3,Not classified:3
75005,"2,4-dinitrobenzenesulphenyl chloride",208-441-2,528-76-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H302:1;H332:1;H312:1;H228:1
75010,Paroxypropione,200-743-2,70-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:45;H315:46;H319:47;Not classified:1;H412:1
75011,Trifluoromethanesulphonic acid,216-087-5,1493-13-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,2331,H290:2184;H335:2271;H302:2320;H314:2331;H318:40;H312:44;H331:4;Not classified:2;H332:2;H413:2;H371:1
75012,"Hydrocarbons, C14-30, olefin-rich",271-036-4,68514-35-2,Asp. Tox. 1,REACH registration C&L,84,H304:84;H413:49;Not classified:33;H411:1
75013,Atropine sulphate,200-235-0,55-48-1,Acute Tox. 4;Acute Tox. 1,Notified C&L,4,H330:4;H302:2;H300:2
75015,Budesonide,257-139-7,51333-22-3,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Repr. 2,Notified C&L,37,H334:18;H361:33;H332:20;H312:19;H317:29;H412:13;H302:9;H372:9;H360:2;H315:4;H410:2;H335:2;H319:2;H373:1
75016,Aminoacetone hydrochloride,231-798-0,7737-17-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1
75018,"1,3-diethoxypropan-2-ol",223-736-6,4043-59-8,Eye Irrit. 2,Notified C&L,40,H319:38;H226:2
75021,Icosyl stearate,244-970-5,22413-02-1,Not Classified,Notified C&L,3,Not classified:3
75023,Sodium DL-3-methyl-2-oxopentanoate,266-503-4,66872-74-0,Not Classified,Notified C&L,1,Not classified:1
75024,"4,5-dihydro-2-methyl-1H-imidazole",208-596-6,534-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
75028,5-[[bis(benzyl)amino]acetyl]salicylamide,250-244-9,30566-92-8,Not Classified,REACH registration C&L,2,Not classified:2
75033,"4-[Difluor(3,4,5-trifluorphenoxy)methyl]-4'-ethyl-3,5-difluor-1,1'-biphenyl",608-461-5,303186-19-8,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
75034,4-fluorobenzonitrile,214-784-9,1194-02-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,55,H302:54;H332:49;H312:54;H335:7;H315:8;H319:8;H228:6;H301:1;H331:1;H311:1
75038,"pirimiphos-ethyl (ISO);O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate",245-704-0,23505-41-1,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H312:0;H400:0
75043,Calcium(2+) 12-hydroxyoctadecanoate,221-605-8,3159-62-4,Not Classified,REACH registration C&L,669,Not classified:669
75044,"4-amino-2,5-dimethoxy-N-phenylbenzenesulphonamide",257-821-4,52298-44-9,Acute Tox. 4,REACH registration C&L,35,H302:35
75045,"Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate",605-866-9,179688-26-7,Not Classified,Notified C&L,1,Not classified:1
75050,(E)-1-(6-Chloro-3-pyridinylmethyl)-N-nitroimidazolidin-2- ylideneamine,604-069-3,138261-41-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,310,H410:307;H302:309;H400:307;H332:1;H312:1;Not classified:1
75054,"Calcium, acetate C14-18 and C16-22-unsatd. fatty acid complexes",309-650-2,100683-82-7,Not Classified,Notified C&L,4,Not classified:4
75055,"N,N,N-triethylanilinium iodide",213-774-1,1010-19-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43,H335:42;H315:43;H331:38;H302:42;H319:43;H332:4
75056,1-(naphthalen-2-yl)ethan-1-amine,601-677-0,1201-74-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
75058,methyl-2-[(aminosulfonyl)methyl]benzoate,419-010-5,112941-26-1,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0
75062,3-nitro-p-anisic acid,201-906-0,89-41-8,Acute Tox. 4,Notified C&L,77,H302:38;Not classified:34;H335:4;H315:5;H319:5
75065,1-benzyl-4-(p-toluidino)piperidine-4-carboxamide,214-611-7,1164-72-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H302:38;H319:38;H400:38
75066,Potassium 1H-indole-3-acetate,219-049-6,2338-19-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H302:39;H335:39;H315:39
75068,sodium 1-octyl-1H-tetrazole-5-thiolate,422-410-2,,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1;H314:1
75069,C.I. Reactive Red 11,602-411-6,12226-08-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
75070,(2R)-(+)-Piperazine-2-carboxylic acid dihydrochloride,603-132-2,126330-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H315:44;H319:44
75071,2-chloroethanol;ethylene chlorohydrin,203-459-7,107-07-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Harmonised C&L,0,H330:0;H310:0;H300:0
75073,DCHA,464-070-8,,Acute Tox. 4;Skin Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:1;H410:2;H302:2;H341:2;H317:2
75074,Propafenone,258-955-6,54063-53-5,Acute Tox. 4,REACH registration C&L,2,H302:2
75077,"Mentha arvensis, ext.",290-058-5,90063-97-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1733,H315:1670;H302:274;H411:1607;H319:256;H317:1668;H412:51;H413:1;Not classified:40;H304:17;H400:7;H410:9;H226:9
75081,Barium iodate,234-152-6,10567-69-8,,Notified C&L,5,H302:5;H332:5;H272:1;Not classified:1
75090,"(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride",444-320-2,,Acute Tox. 4,Harmonised C&L,0,H302:0
75091,Shellac,232-549-9,9000-59-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,508,H302:236;H335:236;H315:242;H319:242;Not classified:266
75093,"2,5-bis(octyldithio)-1,3,4-thiadiazole",236-912-2,13539-13-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,214,H317:212;H332:118;H315:151;H319:151;H331:32;H412:23;Not classified:2;H302:1
75095,Cobaltocene,215-061-0,1277-43-6,Flam. Sol. 2;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 2,Notified C&L,44,H351:39;H334:39;H341:43;H317:43;H228:44
75104,(neodecanoato-O)phenylmercury,247-783-7,26545-49-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,67,H400:67;H330:67;H300:67;H410:67;H373:67;H310:67;H314:1;H318:1
75105,2-imidazol-4-ylethylamine--orthophosphoric acid (1:2),200-118-4,51-74-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,40,H335:39;H315:40;H334:39;H302:40;H318:39;H317:39;H319:1
75108,"(Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-[2,4,6-tris(1-phenylethyl)phenoxy]-, ammonium salt",601-612-6,119432-41-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,350,H412:257;H319:326;H410:71;Not classified:20;H318:1
75112,(4-formylphenyl)boronic acid,617-982-7,87199-17-5,Skin Corr. 1B;Skin Sens. 1,Notified C&L,64,H317:61;H314:41;H302:1;H332:1;H312:1;H335:1;H315:1;H319:1
75116,"Soybean oil, sulfated, ammonium salt",285-229-6,85049-58-7,Not Classified,Notified C&L,1,Not classified:1
75117,Aminocaproic acid,200-469-3,60-32-2,Not Classified,REACH registration C&L,153,Not classified:45;H319:107;H335:54;H315:54;H302:1
75118,Methylcyclopentane,202-503-2,96-37-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3,REACH registration C&L,426,H336:75;H304:190;H315:91;H225:418;H335:30;H331:23;H302:28;H319:31;H400:21;H410:21;H361:18;H411:30;H412:8;Not classified:3
75120,"Glycerides, C8-10 mono-, di- and tri-",294-594-0,91744-32-0,Not Classified,REACH registration C&L,33,Not classified:6;H315:27
75123,4-nitrophenyl α-D-glucopyranoside,223-189-3,3767-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75124,4-methylanthranilic acid,218-976-3,2305-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:4;H319:4
75128,(R)-Mecoprop dimethylamine salt,613-932-3,66423-09-4,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,63,H318:63;H302:63;H411:63
75133,"4-phenoxy-1,1'-biphenyl",223-504-4,3933-94-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H302:38;H319:38;H400:38
75136,benzyl [(2S)-1-[(2-aminoethyl)amino]-3-(4-ethoxyphenyl)propan-2-yl]carbamate dihydrochloride,606-946-6,221640-14-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H315:2;H302:2;H411:2;H318:2;H317:2
75137,Calcium diascorbate,227-261-5,5743-27-1,Not Classified,Notified C&L,34,Not classified:34
75138,2-methylquinolin-8-ol,212-562-6,826-81-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,223,H410:223;H411:3;H400:222;H315:2;H319:2
75140,Triacontan-1-ol,209-794-5,593-50-0,Not Classified,Notified C&L,3,Not classified:3
75141,"2-Propenoic acid, polymer with ethene, zinc salt",608-176-6,28208-80-2,,Notified C&L,1,H302:1
75142,"2,2-Dichloro-N-[1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide",600-513-5,104030-54-8,Aquatic Chronic 2,Notified C&L,127,H411:127
75147,"Acetic acid, chloro-, reaction products with 2-heptadecyl-4,5-dihydro-1H-imidazole-1-ethanol and sodium hydroxide",271-790-4,68608-63-9,Eye Irrit. 2,Notified C&L,3,H319:3
75149,isobutylisopropyldimethoxysilane,402-580-4,111439-76-0,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H226:0;H332:0;H315:0
75150,"α,α',2,5-tetramethylpiperazine-1,4-diethanol",258-589-7,53503-90-5,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H300:38;H319:38
75153,Dichlorodicyclopentylsilane,604-112-6,139147-73-2,,Notified C&L,1,H411:1;H314:1
75154,"Tetrahydro-2,2-dimethyl-5-oxo-3-furoic acid",201-233-2,79-91-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75155,"Benzene, mono-C4-9-alkyl derivs.",272-258-4,68784-56-5,Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,9,H336:9;H304:9;H411:9
75157,"Penta-1,3-diene",207-995-2,504-60-9,Flam. Liq. 2,Notified C&L,140,H225:127;Not classified:13;H304:13;H335:1
75160,"10,16-Docosadienoic acid, 11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-, (4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-",611-356-7,56092-81-0,Acute Tox. 4,Notified C&L,42,H302:42
75162,"Glycerides, vegetable-oil mono- and di-, hydrogenated",307-031-1,97488-92-1,Not Classified,REACH registration C&L,1,Not classified:1
75168,"Ethanol, 2,2'-iminobis-, N-[3-(C12-15-alkyloxy)propyl] derivs., N-oxides",275-530-0,71486-82-3,Not Classified,Notified C&L,59,Not classified:36;H412:23;H319:23
75175,Copper iodide,231-674-6,7681-65-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,362,H315:272;H400:349;H302:332;H411:103;H372:104;H318:113;H317:110;H335:251;H410:247;H319:247;H312:1
75176,4-hydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]naphthalenesulphonic acid,227-654-1,5924-52-7,Not Classified,REACH registration C&L,2,Not classified:2
75178,"2,4,5-trichlorobenzenesulphonic acid",228-950-3,6378-25-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
75179,Decan-5-ol,225-999-2,5205-34-5,Eye Irrit. 2,Notified C&L,1,H319:1
75183,"(Z)-hexa-1,4-diene",230-783-6,7318-67-4,Flam. Liq. 2;Acute Tox. 3;Asp. Tox. 1,Notified C&L,38,H304:38;H301:38;H225:38
75189,Methyl 3-bromobenzoate,210-569-9,618-89-3,,Notified C&L,2,H302:1;H332:1;H312:1;H335:1;H315:1;H319:1
75190,Cyclothiazide,218-859-7,2259-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H315:41;H319:41
75198,p-hydroxybenzamide,210-602-7,619-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:44;H315:45;H319:45;Not classified:6
75199,"Disodium 4,4'-bis[[4-anilino-6-[(2-carbamoylethyl)(2-hydroxyethyl)amino]-1,3,5,-triazin-2-yl]amino]stilbene-2,2'-disulphonate",248-420-5,27344-06-5,Not Classified,REACH registration C&L,69,Not classified:60;H314:9;H302:9;H335:9;H312:9
75205,1-[4-(dimethylamino)phenyl]-2-hydroxy-2-phenylethan-1-one,228-659-1,6317-85-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,40,H301:39;H335:39;H315:39;H400:39;H319:39;H302:1;H332:1;H312:1
75207,"5'-chloro-3-hydroxy-2',4'-dimethoxy-2-naphthanilide",202-182-9,92-72-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,75,H317:3;H411:2;H400:38;Not classified:33;H335:1;H315:1;H319:1
75210,Ammonium diamminetetrakis(thiocyanato-N)chromate(1-),237-003-3,13573-16-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H302:47;H332:47;H312:47;H400:5;H410:5;H335:3;H315:3;H412:2;H319:3;H350:1;H317:1
75212,Chloroquine bis(phosphate),200-055-2,50-63-5,Acute Tox. 4,Notified C&L,76,H302:75;H373:25;H360:25;H332:3;H312:3;H334:3;H317:3;H351:2;H335:1;H315:1;H361:1;H319:1;H362:1
75213,"Rosin, fumarated, polymer with glycerol",613-867-0,65997-10-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,3,H413:2;H317:2;H319:2;Not classified:1
75215,"1,1,2,3-tetrachlorobuta-1,3-diene",213-064-1,921-09-5,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Notified C&L,38,H330:38;H302:38;H314:38
75220,"Octyl (Z,Z)-6,6-dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaicosa-2,9-dienoate",241-107-4,17036-31-6,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H373:1;H400:1
75224,Testosterone propionate,200-351-1,57-85-2,Acute Tox. 4;Carc. 1B;Repr. 2,Notified C&L,85,H361:39;H302:83;H350:40;H362:24;H360:44;H351:43;H332:18;H312:17;H373:1;H410:1
75236,Lithium (2H)hydroxide,235-287-3,12159-20-5,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,39,H331:38;H301:38;H314:38;Not classified:1
75238,Vinasse and Distillery slops,293-805-3,91082-90-5,Not Classified,Notified C&L,5,Not classified:5
75239,Trimethylnonylammonium bromide,217-733-9,1943-11-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75240,"reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;dimethyl 1,2-benzenedicarboxylate",442-480-8,,Org. Perox. C;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H242:0;H302:0;H411:0;H314:0;H317:0
75242,"1-benzyl-1,2-dihydro-3H-indazol-3-one",218-680-4,2215-63-6,Acute Tox. 4,Notified C&L,44,H302:39;H335:5;H315:5;H319:5
75244,"3-chloro-N,N-dimethylaniline",229-935-4,6848-13-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,43,H302:43;H319:39;H332:5;H312:5;H315:1
75245,"Fatty acids, rape-oil, Et esters",295-384-1,92045-03-9,Not Classified,Notified C&L,1,Not classified:1
75249,"1,1-dimethyl-3-phenylpropyl acetate",203-077-0,103-07-1,Not Classified,Notified C&L,272,Not classified:234;H317:38
75252,"2,2,2-trifluoroethylamine hydrochloride",206-771-1,373-88-6,Acute Tox. 4,REACH registration C&L,47,H302:46;H332:41;H312:41;H335:5;H315:6;H319:6;H301:1;H311:1;H331:1
75253,"product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;sodium chloride",425-740-5,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
75254,4-chloro-4'-methylbutyrophenone,253-924-3,38425-26-2,Acute Tox. 3;Skin Sens. 1,Notified C&L,38,H317:38;H301:38
75255,"7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride",235-942-3,13055-82-8,Flam. Sol. 2;Self-heat. 2,Notified C&L,2,H252:1;H228:1;Not classified:1
75256,"5-(ethylthio)-1,3,4-thiadiazol-2-amine",247-169-9,25660-70-2,,Notified C&L,4,H335:4;H315:4;H319:4
75257,"(-)-1β-2(2´-Diethoxy-carbonyl-ethyl)-1α-ethyl-1,2,3,4,6,7,12,12b-α-octahydro-indolo[2,3-a]quinolizin",603-912-2,135266-72-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H315:2;H400:2;H410:2;H373:2;H319:2;H317:2
75261,"paclobutrazol (ISO); (2RS,3RS)-1-(4-chloro­phenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1-yl)pentan-3-ol",616-379-6,76738-62-0,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H361:0;H410:0;H302:0;H332:0;H319:0
75264,3-amino-4-methoxyphenylsulphonyl fluoride,207-870-2,498-74-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H314:42
75265,"Disodium 1-amino-9,10-dihydro-9,10-dioxo-4-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]anthracene-2-sulphonate",240-267-2,16102-99-1,Not Classified,REACH registration C&L,2,Not classified:2
75269,"Dodecylbenzenesulphonic acid, compound with 2,2'-iminodiethanol (1:1)",247-784-2,26545-53-9,,Notified C&L,137,H315:130;H318:61;Not classified:36;H302:4;H319:3;H412:1;H312:1
75270,2-phenylindole,213-436-3,948-65-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H318:39;H413:39;H335:39;H315:39;H334:2;H317:2;H411:2;Not classified:1
75271,"Brachylaena hutchinsii, ext.",294-928-5,91771-37-8,Not Classified,Notified C&L,1,Not classified:1
75273,Potassium dicyanoaurate,237-748-4,13967-50-5,Met. Corr. 1;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,166,H290:21;H315:20;H400:162;H330:166;H300:166;H410:161;H318:20;H317:83;H310:152
75274,1-(bromomethyl)-3-(trifluoromethyl)benzene,206-938-9,402-23-3,Skin Corr. 1B,Notified C&L,49,H314:49;H290:1;H318:1;H319:2;H335:1
75277,Lidofenin,261-636-4,59160-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75279,Bis(butan-2-olato)(triethyl orthosilicato-O''')aluminium,273-392-6,68959-06-8,,Notified C&L,4,H226:4;H315:4;H319:4
75283,4-phenylpiperidin-4-ol,255-089-0,40807-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
75284,"[1aS-(1aα,1bβ,2β,5aβ,6β,6aα)]-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-β-D-glucopyranoside",219-324-0,2415-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
75285,"2-amino-2,4-dimethylvaleronitrile",248-039-4,26842-43-3,Flam. Liq. 4;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3,Notified C&L,1,H301:1;H331:1;H227:1;H314:1;H317:1;H311:1
75287,Z-21,414-720-1,,Not Classified,Notified C&L,441,Not classified:441
75290,2-fluorophenyl isocyanate,240-804-0,16744-98-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:44;H315:45;H302:39;H226:45;H332:39;H319:45;H312:39;H301:6;H334:4;H330:5;H331:1;H311:1
75293,"Petrolatum (petroleum), oxidized;[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]",265-206-7,64743-01-7,Carc. 1B,Harmonised C&L,0,H350:0
75295,4-bromo-o-xylene,209-518-3,583-71-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,48,H335:45;H315:47;H400:39;H302:42;H319:47;H411:2;H332:1;H301:1;H311:1;H331:1;H410:1
75297,"Tetracarbonyl(η5-cyclopenta-2,4-dien-1-yl)vanadium",235-163-9,12108-04-2,,Notified C&L,4,H301:4;H335:4;H315:4;H330:4;H319:4;H311:4
75301,Yttrium barium copper oxide,619-720-7,107539-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H315:39;H319:39;H302:5;H332:4;H400:1;H410:1;H314:1;H318:1
75305,"2,3,4-trimethoxybenzoic acid",209-350-0,573-11-5,,Notified C&L,5,H335:4;H315:5;H319:5
75308,"Trihydrogen tris[P,P-dioctyl diphosphato(2-)-O'',O''''](propan-2-olato)titanate(3-), branched and linear",271-587-0,68585-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67,H335:23;H315:47;H319:34;H226:21;Not classified:16
75310,methyl 3-methyloctadecanoate,614-560-4,68517-10-2,Not Classified,REACH registration C&L,1,Not classified:1
75312,"Benzoic acid, 2-[(carboxymethyl)amino]-4-chloro-",619-416-4,99282-79-8,Not Classified,Notified C&L,7,Not classified:7
75313,"2,2-dichloro-1,3-benzodioxol",426-850-6,2032-75-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0;H226:0;H314:0
75314,"1,1,1,2,2,3,3,4,4,5,5-undecafluoro-5-iodo",211-350-0,638-79-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75316,POLY(DIMETHYLSILOXANE),615-070-3,70131-67-8,Not Classified,Notified C&L,847,Not classified:775;H319:70;H315:7;H373:1;H302:1;H335:1;H361:1
75317,"5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol",610-504-8,501-36-0,Eye Irrit. 2,Notified C&L,279,H319:264;H335:17;H315:20;H412:9;H341:9;H318:14;H302:3;H317:2;Not classified:1;H332:1;H312:1
75323,Disodium 7-[(aminocarbonyl)amino]-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate,227-530-7,5873-20-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,1,H335:1;H315:1;H351:1;H334:1;H373:1;H332:1;H319:1;H317:1
75324,4-methylcoumarin-6-ylmethyliminodiacetic acid,259-129-8,54375-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
75327,Chlorodimethylphenylsilane,212-193-0,768-33-2,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:2;H335:1
75329,"7 beta-Hydroxy-15 beta,16 beta-methylene-3 beta-pivaloyloxy-5-androsten-17-one",617-344-8,82543-09-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
75330,"2,2,4,4,6,6-hexamethylcyclotrisilazane",213-773-6,1009-93-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,REACH registration C&L,69,H318:5;H302:65;H335:42;H314:5;H315:38;H226:60;H319:38;Not classified:4
75338,"5,6-diphenyl-1,2,4-triazin-3(2H)-one",224-833-6,4512-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H302:42;H335:42;H315:42;H319:42
75339,sodium selenite,233-267-9,10102-18-8,Acute Tox. 2;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H300:0;H331:0
75340,2-methoxybenzyl alcohol,210-296-5,612-16-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,118,H302:116;H319:118;H335:115;H315:116
75346,Sodium rhenate,236-742-9,13472-33-8,Not Classified,REACH registration C&L,43,Not classified:1;H272:42;H335:38;H315:42;H319:42
75347,"N,N'-dicyclohexylmorpholine-4-carboxamidine",225-622-1,4975-73-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75349,"2,6-dimethyloct-7-en-2-ol",242-362-4,18479-58-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2336,H315:1627;H319:2120;Not classified:197;H335:1
75350,"Glycerides, isomerized C16-18 and C18-unsatd.",288-317-2,85711-57-5,Not Classified,Notified C&L,6,Not classified:6
75351,"reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)",414-150-3,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
75356,1-bromo-2-chloro-4-nitrobenzene,249-773-8,29682-39-1,,Notified C&L,5,H335:4;H315:5;H302:4;H373:4;H332:4;H319:5;H312:4
75358,3-chlorodiphenylamine,202-922-0,101-17-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75363,7-hexyloxepan-2-one,240-483-7,16429-21-3,Not Classified,Notified C&L,89,Not classified:89
75365,Octan-2-ol,204-667-0,123-96-6,Eye Dam. 1,REACH registration C&L,1796,H318:1443;H315:260;H319:347;H412:38;H335:35;Not classified:8;H226:3;H301:1
75372,Flucytosine,217-968-7,2022-85-7,Repr. 2,REACH registration C&L,94,H361:52;Not classified:35;H341:6;H351:3
75376,"Toluene-2,4,6-triyl triisocyanate",230-932-5,7373-26-4,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1;STOT SE 3;Carc. 2;Aquatic Chronic 3,Notified C&L,38,H335:38;H315:38;H351:38;H334:38;H330:38;H412:38;H319:38
75380,"2-amino-4-chloro-1,3-thiazole-5-carbaldehyde",616-405-6,76874-79-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
75383,"Oils, neat's-foot, sulfated, ammonium salts",293-396-1,91079-10-6,Not Classified,Notified C&L,1,Not classified:1
75389,Dipotassium succinate,211-628-1,676-47-1,Not Classified,Notified C&L,97,Not classified:86;H315:10;H319:10;H302:1
75396,"Balsams, Canada, sulfurized, iridium salts",307-812-7,97765-58-7,Flam. Sol. 1,Notified C&L,1,H228:1
75405,"Glycerides, C8-18 and C18-unsatd.",266-946-3,67701-28-4,Not Classified,REACH registration C&L,45,Not classified:45
75411,"tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate",231-711-6,7696-12-0,Acute Tox. 4;Carc. 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H351:0;H410:0;H302:0;H371:0
75417,"2,6-dichloro-1H-purine",226-681-6,5451-40-1,Acute Tox. 3,Notified C&L,199,H301:160;H317:35;H315:36;H319:36;H302:2;H332:1;H335:1;Not classified:1
75418,"Asphalt, sulfonated, sodium salt",269-212-0,68201-32-1,Not Classified,REACH registration C&L,63,Not classified:62;H315:1;H319:1
75419,Isoquinolin-N-oxide,216-242-7,1532-72-5,,Notified C&L,4,H315:4;H319:4
75420,"3,7-bis(diethylamino)phenoxazin-5-ium tetrachlorozincate (2:1)",264-355-5,63589-47-9,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,21,H318:18;H410:18;H301:19;H400:9;H331:9;Not classified:1;H334:1;H302:1;H319:1
75423,"Naphthenic oils (petroleum), complex dewaxed light;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-180-7,64742-76-3,Carc. 1B,Harmonised C&L,0,H350:0
75424,"(1Z,3R,4R,5S,6R,9R,10S,11S,12R,13R,15R)-10-[(2,6-dideoxy-3-C-methyl-3-O-methyl--L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)--D-xylo-hexopyranosyl]oxy]- 7,16-Dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one",619-419-0,99290-97-8,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,32,H334:2;H317:2;H412:29;H315:30;H335:1;H319:1
75427,Phenanthridin-6(5H)-one,213-804-3,1015-89-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75428,"Amines, N-tallow alkyltrimethylenedi-, oleates",263-186-4,61791-53-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,992,H318:812;H314:666;H315:279;H400:363;H410:101;H373:99;H411:99;H319:118;H412:19;H302:20;Not classified:6
75431,"5-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-4-methyl-, ethyl ester",605-268-8,161797-99-5,Eye Dam. 1,REACH registration C&L,45,H318:41;H335:4;H315:4;H319:4
75434,"reaction product of 2-(2-aminoethoxy)ethanol, boric acid, tall oil and oleic acid",925-687-2,,Not Classified,Notified C&L,1,Not classified:1
75436,"4-[(2,3-dichloro-4-oxocyclohexa-2,5-dien-1-yl)imino]phenyl acetate",246-503-0,24857-20-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75443,Methacrylaldehyde,201-150-1,78-85-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,144,H301:134;H400:85;H330:101;H225:134;H410:85;H341:85;H314:131;H311:131;H318:86;H315:10;H300:10;H350:10;H319:10;H310:10;H312:3
75444,"2-methoxy-6-pentylcyclohexa-2,5-diene-1,4-dione",604-781-4,15121-94-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H334:2;H302:2;H332:2;H312:2;H317:2
75447,poly[ethene-co-(butyl 2-propenoate)],607-803-0,25750-84-9,Not Classified,Notified C&L,36,Not classified:33;H412:3;H317:3
75450,Tetraamminepalladium(2+) tetrachloropalladate(2-),237-500-5,13820-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
75451,2-bromoethyl phenyl ether,209-634-4,589-10-6,Not Classified,REACH registration C&L,47,Not classified:2;H302:39;H335:44;H315:44;H319:44;H228:1
75457,"2,3,3-trichloroacrylic acid",218-856-0,2257-35-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H302:38;H314:42
75458,1-methylindole,210-057-5,603-76-9,,Notified C&L,9,H335:6;H315:8;H319:8;H302:1;H332:1;H312:1
75460,"3,7-dinitroso-1,3,5,7-tetraazabicyclo[3.3.1]nonane",202-928-3,101-25-7,Expl. 1.1;Self-react. A;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,72,H317:14;H240:1;H302:71;H201:1;H335:47;H332:48;H319:47;H228:61;H242:20;H301:1;H315:1;H341:2;H334:1;H304:1;H372:1;H371:1
75461,2-(p-chlorophenoxy)-2-methylpropionic acid,212-925-9,882-09-7,Acute Tox. 4,Notified C&L,46,H302:46;H351:1;H315:1;H319:1
75462,Calcium folinate,216-082-8,1492-18-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,52,H335:48;H315:49;H334:45;H319:49;H317:46;Not classified:2;H302:1;H332:1;H312:1
75464,1-bromo-4-(dimethoxymethyl)benzene,918-110-0,24856-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:2;H315:2;H319:2
75467,"2,5,7,10,11,14-hexaoxa-1,6-distibabicyclo[4.4.4]tetradecane",249-820-2,29736-75-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,15,H302:13;H332:13;H411:13;Not classified:2;H315:1
75473,"Naphthenic acids, manganese salts",215-650-2,1336-93-2,Skin Irrit. 2,Notified C&L,63,H315:49;Not classified:13;H226:4;H335:5;H319:5;H412:1;H302:1;H332:1;H312:1
75477,4-nitrophthalimide,201-905-5,89-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
75478,1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium thiocyanate,281-633-1,84000-76-0,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H318:2;H412:2
75479,"2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl acrylate",221-064-8,2993-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H411:4
75485,"Fatty acids, C14-18 and C16-18-unsatd., potassium salts",268-094-8,68002-80-2,Not Classified,Notified C&L,115,Not classified:76;H319:39
75495,2-isopropylideneaminooxyethyl (R)-2-[[]4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate,601-099-9,111479-05-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,129,H317:91;H411:89;H400:91;H332:38;H410:2
75497,Ethyl (4-butoxyphenyl)acetate,224-905-7,4547-58-4,,Notified C&L,1,H302:1
75498,4-(dimethylamino)phenol,210-604-8,619-60-3,,Notified C&L,7,H302:7;H335:7;H315:7;H319:7;H332:1
75500,"5-chloro-2-[2-[4-[(2-cyanoethyl)ethylamino]-o-tolyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",251-213-2,32783-03-2,Not Classified,Notified C&L,1,Not classified:1
75501,"N,N-dibutyloleamide",227-410-4,5831-80-1,Not Classified,REACH registration C&L,40,Not classified:40
75505,2-(octadecyloxy)pyridine,301-248-5,93982-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75508,"2,8-bis(trifluoromethyl)quinolin-4-ol",252-762-0,35853-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,57,H335:44;H315:45;H319:45;Not classified:11;H302:1
75509,"Tail gas (petroleum), cracked distillate hydrotreater separator;Refinery gas;[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-809-3,68478-29-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
75510,"Fatty acids, C6-10, Me esters",273-094-6,68937-83-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,189,H315:111;H319:111;Not classified:78
75511,N-[2-[bis(3-amino-3-oxopropyl)amino]ethyl]-N-[2-(stearoylamino)ethyl]stearamide monoacetate,269-296-9,68214-52-8,Not Classified,Notified C&L,32,Not classified:32
75513,Calcium 2-[(2-hydroxy-1-naphthyl)azo]-5-methylbenzenesulphonate,309-123-7,100063-59-0,Not Classified,Notified C&L,11,Not classified:11
75520,"L-Asparagine, N-[3-(diethylamino)propyl]-, N2-(C8-18 and C18-unsatd. alkyl) derivs., monosodium salts",307-261-2,97592-64-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H315:2;H319:2;H302:1
75523,Dimethylammonium chloride,208-046-5,506-59-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,257,H302:252;H315:243;H319:243;Not classified:7;H335:182
75526,"quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline",602-997-3,124495-18-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0
75534,"2-bromo-1,1-diethoxypropane",222-270-0,3400-55-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:40;H335:40;H315:40;H319:40
75543,3-amino-7-(dimethylamino)-2-methoxyphenoxazin-5-ium chloride,267-370-5,67846-56-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,84,H400:83;H302:84;H373:84;H411:84;H319:84;H317:84
75546,4-[(4-nitrophenyl)azo]-3-(propionamido)anilinodiethyl diacetate,216-249-5,1533-76-2,Not Classified,Notified C&L,1,Not classified:1
75547,"Alcohols, C14-18, ethoxylated propoxylated",614-209-5,68002-96-0,Aquatic Acute 1,Notified C&L,912,H400:573;H412:164;H330:125;Not classified:140;H226:18;H335:8;H319:21;H411:9;H302:6;H413:3;H318:4;H315:2
75548,"2-ethyl-5,5-dimethyl-1,3-dioxane",212-197-2,768-58-1,,Notified C&L,4,H226:4
75550,sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II),407-340-2,124719-24-0,Eye Dam. 1,Harmonised C&L,0,H318:0
75551,Iron tridocosanoate,243-645-5,20259-31-8,Not Classified,Notified C&L,2,Not classified:2
75552,4-chloro-4'-hydroxybutyrophenone,230-485-6,7150-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
75556,Ethyl N-(3-ethoxy-3-oxopropyl)-N-(2-phenylethyl)-β-alaninate,261-039-9,57958-47-1,Aquatic Chronic 2,REACH registration C&L,1,H411:1
75558,"m-fluoro-α,α,α-trichlorotoluene",206-931-0,401-77-4,,Notified C&L,4,H318:4;H302:4;H335:4;H315:4
75562,"Oleic acid, compound with 2-amino-2-methylpropan-1-ol (1:1)",268-793-8,68140-41-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,49,H412:2;H319:2;Not classified:47
75570,"2,5-dihydroxy-p-benzenediacetic acid",226-819-5,5488-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75573,"Ginkgo biloba, ext.",289-896-4,90045-36-6,Flam. Liq. 3,Notified C&L,1343,H226:1290;Not classified:47;H317:6;H335:1;H319:1
75575,Sulfamerazine sodium,204-851-0,127-58-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,42,H302:41;H332:41;H315:41;H319:41;Not classified:1;H312:1
75576,Benzylidene(methyl)amine,210-728-2,622-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:42;H319:42;H314:1
75577,"Residual oils (petroleum), clay-treated solvent-dewaxed;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]",309-711-3,100684-38-6,Carc. 1B,Harmonised C&L,0,H350:0
75578,"Benzenesulfonic acid, C16-24-alkyl derivs.",274-262-1,70024-67-8,Eye Irrit. 2,REACH registration C&L,448,H319:4;H318:441;H317:441;H314:444
75581,Diethyl (2-cyanoethyl)phosphonate,233-327-4,10123-62-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75583,1-(dimethoxymethyl)hexahydro-1H-azepine,251-282-9,32895-16-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,3,H335:3;H302:3;H226:3;H332:3;H319:3;H312:3
75586,"N,N-dicyclohexylbenzothiazole-2-sulphenamide",225-625-8,4979-32-2,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,158,H412:7;H317:113;H410:89;H400:89;H413:52;Not classified:4;H315:2;H302:1;H319:2;H335:1
75590,Ethylammonium bromide,209-797-1,593-55-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75592,Tramazoline hydrochloride,223-064-3,3715-90-0,Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H301:1;H411:1;H314:1
75593,"2,2'-[1,2-phenylenebis(oxy)]bisacetic acid",226-488-7,5411-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
75598,"(E)-{2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yloxy]phenyl}(5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime",607-448-1,248593-16-0,Skin Sens. 1;Aquatic Acute 1,Notified C&L,194,H317:156;H400:194;H351:38;H410:38;H302:38;H332:38
75600,"2-[2-(dimethylamino)ethoxy]ethyl N-{3-[2-(2-(dimethylamino)ethoxy)ethoxycarbonylaminomethyl]-3,5,5-trimethylcyclohexyl}carbamate",441-100-8,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H318:2;H317:2;H302:2;H412:2
75602,"1,4,7,10-tetraoxacyclododecane",206-036-5,294-93-9,Acute Tox. 1,Notified C&L,44,H330:44;H361:4;H315:4;H319:5
75604,Ilmenite (FeTiO3),235-334-8,12168-52-4,,Notified C&L,1,Not classified:1
75606,Lutetium trifluoride,237-355-8,13760-81-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:38;H311:38;H331:38;H335:5;H315:5;H302:4;H332:4;H319:5;H312:4;Not classified:1
75607,Phenyl salicylate,204-259-2,118-55-8,Skin Irrit. 2;Skin Sens. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,801,H361:2;H317:2;H411:5;H315:699;H335:687;H319:689;Not classified:99;H302:20;H331:8;H400:8;H332:8;H311:8
75609,Undecafluoro(nonafluorobutyl)cyclohexane,206-777-4,374-60-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H332:1;H312:1
75610,1-(CYCLOOCT-3-ENYL)-PROPAN-1-OL AND ISOMERS,476-140-5,899810-84-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1287,H412:1286;H317:1287;H315:1287
75612,"Sodium α-(3-bromo-5-isopropyl-4-oxo-2-methyl-2,5-cyclohexadienylidene)-2-(3-bromo-4-hydroxy-5-isopropyl-2-methylphenyl)toluenesulphonate",252-169-7,34722-90-2,Not Classified,Notified C&L,8,Not classified:8
75613,4-tert-butyl-m-cresol,218-732-6,2219-72-9,,Notified C&L,33,Not classified:33
75614,2-chloro-4-trifluoromethylaniline,254-674-8,39885-50-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Acute 1,Notified C&L,45,H301:39;H335:40;H315:45;H400:39;H332:44;H319:45;H311:39;H302:6;H312:5
75615,10H-phenothiazin-3-ol,217-663-9,1927-44-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H335:1;H315:1;H412:1;H302:1;H373:1;H319:1;H317:1
75616,selenium,231-957-4,7782-49-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H301:0;H331:0;H373:0
75619,4-(2'-oxobenzimidazolin-1'-yl)piperidine,243-950-3,20662-53-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H301:41;H335:41;H315:41;H319:41;H318:1;H302:3
75622,"Chromate(2-), [4-[(5-chloro-2-hydroxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][4-[4,5-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, disodium",283-607-5,84682-43-9,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2
75626,2-methoxyphenyl nicotinate,239-123-1,15057-98-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H317:38;H335:38;H315:38
75628,Bromomaleic anhydride,227-659-9,5926-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75629,2-methyldibenzofuran,230-789-9,7320-51-6,Aquatic Chronic 2,Notified C&L,38,H411:38
75633,o-(1H-pyrazol-3-yl)phenol,252-222-4,34810-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
75634,2-(4-isobutylphenyl)propionamide,261-793-9,59512-17-3,Acute Tox. 4,Notified C&L,39,H302:39
75635,"Undecylbenzenesulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",263-334-8,61931-76-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
75636,"12H-Phthaloperin-12-one, 8,9,10,11-tetrachloro-",615-690-4,71902-17-5,Not Classified,Notified C&L,31,Not classified:31
75639,Ferromagnetic iron lignosulfonate,609-650-5,39331-38-9,Not Classified,Notified C&L,59,Not classified:59
75641,"Glycerides, C16-18 mono-, di- and tri-, hydrogenated, acetates",294-599-8,91744-37-5,Not Classified,Notified C&L,1,Not classified:1
75643,N-[4-(Methylamino)-benzoyl]-L-glutamic acid,610-925-7,52980-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75644,"N,N'-bis(1-methylethyl)benzene-1,4-diamine",224-213-5,4251-01-8,Skin Corr. 1A,Notified C&L,16,H317:16;H314:16
75648,3-Amino-7-diethylamino-2-methyl-5-phenylphenazinium chloride,613-376-1,6378-81-0,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H317:1;H410:1;H400:1
75651,N-(2-hydroxyethyl)salicylamide,246-076-0,24207-38-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75654,"Fatty acids, tall-oil, magnesium salts",266-942-1,67701-23-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,73,H315:62;H319:62;Not classified:6;H361:5;H317:1
75655,N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate,416-790-9,143052-96-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
75658,"D-Fructose, 1,6-bis(dihydrogen phosphate), trisodium salt",253-778-0,38099-82-0,Not Classified,Notified C&L,3,Not classified:3
75661,"Ethanol, 2,2'-iminobis-, N-coco alkyl derivs., N-oxides",263-180-1,61791-47-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,181,H318:180;H315:180;H400:180;H302:3;H314:1;H411:1
75663,"ε-Caprolactone, oligomeric reaction products with propylidynetrimethanol",500-099-5,37625-56-2,Not Classified,REACH registration C&L,214,Not classified:131;H318:83;H315:83
75665,Sodium m-xylene-4-sulphonate,212-567-3,827-21-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H302:38;H315:38;H319:38
75666,Bismuth sodium trioxide,235-455-6,12232-99-4,Acute Tox. 4,Notified C&L,45,H302:45;H335:5;H315:5;H319:5
75668,"2(3H)-Benzofuranone, 3-[5,7-bis(1,1-dimethylethyl)-2-oxo-3(2H)- benzofuranylidene]-5,7-bis(1,1-dimethylethyl)-, (3E)-",429-490-8,75540-64-6,Skin Sens. 1B,Notified C&L,83,H317:83
75671,1-Brom-4-pentylbenzol,610-687-4,51554-95-1,Aquatic Chronic 4,Notified C&L,39,H413:38;H318:1;Not classified:1;H411:1;H315:1
75676,asbestos,601-801-3,12172-73-5,Carc. 1A;STOT RE 1,Harmonised C&L,0,H372:0;H350:0
75682,2-bromononane,218-688-8,2216-35-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
75686,POLYUREA GREASE THICKENER,434-210-2,,Not Classified,REACH registration C&L,2,Not classified:2
75689,Iron difluoride,232-155-7,7789-28-8,Skin Corr. 1B,Notified C&L,235,H314:231;H318:38;H330:4;H301:4;H311:4
75692,Disodium phthalate,240-106-6,15968-01-1,Not Classified,REACH registration C&L,52,Not classified:51;H335:1
75694,fenobucarb (ISO);2-butylphenyl methylcarbamate,223-188-8,3766-81-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
75697,2-methyloctanenitrile,219-914-8,2570-96-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
75701,4'-chloro-3-hydroxy-2-naphthanilide,202-189-7,92-78-4,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,72,H317:1;H319:72;H411:38
75703,"Guar gum, carboxymethyl 2-hydroxypropyl ether, sodium salt",614-287-0,68130-15-4,Not Classified,Notified C&L,99,Not classified:60;H334:38;H318:1
75704,Acetolactatedecarboxylase,618-520-7,9025-02-9,Resp. Sens. 1,Notified C&L,32,H334:32
75706,Tripoli,603-514-9,1317-95-9,STOT RE 1,Notified C&L,221,H372:189;H332:35;H319:37;H373:30;H350:2
75708,"Alcohols, C12-16-branched",292-331-4,90604-38-9,Not Classified,Notified C&L,1,Not classified:1
75709,"2,4-dichlorobenzonitrile",229-493-2,6574-98-7,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,46,H412:2;H319:46;H302:44;H312:6;H335:5;H315:6;H332:4;H301:2;H331:1;H311:1
75710,2'-Bromo-4'-methylacetanilide,612-156-2,614-83-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75716,4-(2-aminoethyl)phenol,200-115-8,51-67-2,Not Classified,REACH registration C&L,139,Not classified:92;H335:44;H315:45;H319:45;H318:1;H314:1;H302:1
75717,5-methyl-1H-indole-3-ethylamine monohydrochloride,213-777-8,1010-95-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75719,isopentyl acetate,204-662-3,123-92-2,Flam. Liq. 3,Harmonised C&L,0,H226:0
75722,"Di(isooctadecanoic) acid, diester with oxydi(propanediol)",267-821-6,67938-21-0,Not Classified,REACH registration C&L,96,Not classified:96
75724,Dimethyloctadecyl(3-sulphopropyl)ammonium hydroxide,236-124-9,13177-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
75725,4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol,244-665-7,21928-50-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H302:3;H335:2;H315:4;H319:4
75728,1-(3-phenylpropyl)-2-methylpyridinium bromide,405-930-4,10551-42-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H319:0
75730,Chlorhexidine,200-238-7,55-56-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,120,H318:41;H410:112;H400:110;H335:45;H315:77;H334:41;H319:80;H302:35;H373:35;H411:8
75731,Docosyl stearate,244-971-0,22413-03-2,Not Classified,REACH registration C&L,9,Not classified:9
75733,"1- (2,2-dimethyl-6-methylenecyclohexyl)-2-buten-1-one",609-060-8,35087-49-1,Skin Sens. 1,Notified C&L,234,H317:234
75737,Moxisylyte hydrochloride,213-519-4,964-52-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:38;H312:38
75738,DL-piperidine-2-carboxylic acid,223-737-1,4043-87-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
75740,disodium 4-(5-sulfido-1H-tetrazol-1-yl)benzoate,433-140-1,,Skin Sens. 1,Notified C&L,1,H317:1
75741,"Formic acid, compd. with N-(2-aminoethyl)-N'-[2-[(2-aminoeth yl)amino]ethyl]-1,2-ethanediamine polymer with (chloromethyl )oxirane, N-methyl-N-2-propenyl-2-propen-1-amine and N-2-pro penyl-2-propen-1-amine, hydrochloride sulfate (salt)",605-594-0,170904-72-0,Aquatic Chronic 2,Notified C&L,37,H411:37
75742,Phenyl trifluoroacetate,207-911-4,500-73-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H335:43;H315:43;H319:43;H318:1;H314:1
75749,"2,2,4-trimethylhexane",240-807-7,16747-26-5,Flam. Liq. 2,Notified C&L,39,H225:39;H304:1
75750,"1,2,3,6-tetrahydrophthalic anhydride",201-605-4,85-43-8,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H317:0;H334:0;H412:0
75751,"1,1,3-trichloroacetone",213-063-6,921-03-9,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H301:39;H400:40;H330:40;H410:40;H314:40;H318:2;H300:1
75752,C4-C10 branched and linear hydrocarbons (light) – Naphtha,481-730-0,848301-65-5,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;STOT SE 3;Repr. 2;STOT RE 2,REACH registration C&L,10,H315:10;H400:10;H361:10;H225:3;H336:10;H304:10;H373:10;H410:10;H224:7;H335:4
75753,Reaction products of Zinc oxide and Glycerol,700-107-9,87189-25-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H410:2;H400:85
75754,2-chloro-N-ethylacetanilide,254-283-2,39086-61-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,194,H317:194;H302:194
75760,2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methylbenzothiazolium methyl sulphate,239-094-5,15000-59-6,Acute Tox. 4,Notified C&L,43,H302:39;H319:2;Not classified:2
75761,Nonafluorohexyl Trimethoxysilane,619-574-4,85877-79-8,Aquatic Chronic 2,Notified C&L,24,H411:22;H315:2;H319:2;H335:1
75763,"5-[4,5-dihydro-5-oxo-3-[(1-oxooctadecyl)amino]-1H-pyrazol-1-yl]-2-phenoxybenzenesulphonic acid",247-390-0,25985-53-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
75765,"Tetrasodium 2,4-diamino-3-[[2-sulfo-4-[[4-sulfophenyl]azo]phenyl]azo]-5-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-benzenesulfonate",460-480-6,,Not Classified,Notified C&L,1,Not classified:1
75769,"4-[(3,3-dimethylbicyclo[2.2.1]hept-2-yl)methyl]-2-methylcyclohexan-1-one",272-665-7,68901-22-4,Not Classified,Notified C&L,114,Not classified:104;H412:10;H317:10
75770,"3,4-difluorobenzoyl chloride",278-570-7,76903-88-3,Skin Corr. 1B,Notified C&L,45,H314:45;H319:1;H335:1;H290:1;H318:1
75773,Methyl 2-pyridylacetate,216-759-8,1658-42-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H319:41;H302:2;H332:1
75776,"1H-Xantheno[2,1,9-def]isoquinoline-5,9-disulfonic acid, 2,3-dihydro-1,3-dioxo-2-[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]-, sodium salt (1:3)",610-182-9,444087-59-6,Not Classified,Notified C&L,14,Not classified:14
75781,"Neodecanoic acid, compound with 2-aminoethanol (1:1)",282-229-8,84145-06-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
75784,Lead diiodate,247-168-3,25659-31-8,Ox. Sol. 3;Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H272:38;H302:38;H373:38;H332:38;H410:38;H360:38
75786,"Bis[2,2-bis[(allyloxy)methyl]butyl] maleate",274-712-7,70636-59-8,,Notified C&L,27,Not classified:27
75787,Phytosterols,619-079-3,949109-75-5,Not Classified,REACH registration C&L,97,Not classified:97
75788,Chlorodimethyloctylsilane,242-044-5,18162-84-0,Flam. Liq. 3;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,237,H318:10;H226:9;H411:9;H314:233;Not classified:5;H335:1;H290:1
75791,4-methyloctane,218-687-2,2216-34-4,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,2,H304:1;H226:1;H225:1
75792,"Benzene, di-C8-16-alkyl derivs.",272-010-5,68648-88-4,Not Classified,Notified C&L,56,Not classified:33;H312:23
75801,Potassium(VI) osmiate dihydrate,243-247-1,19718-36-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,3,H330:1;H301:1;H311:1;H318:2;H290:1;H272:1;H332:1;H314:1;H312:1
75802,Chromium carbide,235-160-2,12105-81-6,,Notified C&L,8,H228:4;Not classified:4
75805,"(3aα,4α,5α,7α,7aα)-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde",261-861-8,59691-23-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,35,H317:35;H411:35
75806,"2,5-difluoroterephthalic acid",211-508-9,655-14-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
75807,N-L-alanyl-L-histidine,221-845-3,3253-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
75808,4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzenesulphonamide,240-486-3,16432-45-4,Aquatic Chronic 4,Notified C&L,33,H413:33
75810,nickel(II) neodecanoate,287-469-7,85508-44-7,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H372:0;H317:0;H360:0
75812,"1,1,2,2-Tetrafluoroethyl 2,2,2-Trifluoroethyl Ether",459-330-2,,STOT SE 3,Notified C&L,1,H336:1
75813,"Amines, C12-14-alkyl, C6-10-alkyl phosphates",271-663-3,68603-55-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,101,H412:5;H315:7;H400:4;H319:77;H317:12;H302:13;Not classified:5;H413:1;H318:1
75818,Tetrachlorobis(4-cymene)diruthenium(II),435-530-5,52462-29-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H319:1
75819,"Rosin, reaction products with acrylic acid",280-192-2,83137-13-7,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,20,H317:15;H315:2;Not classified:5
75824,"3-[(2-mercapto-1-methylpropyl)thio]butan-2-ol, monosodium salt",267-155-6,67801-35-8,STOT SE 3,Notified C&L,10,H335:10
75826,"3-amino-N,N-dimethylbenzylamine",248-747-3,27958-77-6,Skin Sens. 1;Eye Dam. 1,Notified C&L,40,H318:39;H317:38;H302:2;H335:2;H315:2;H319:1
75827,"1,2,4-Thiadiazole-3-acetic acid, 5-[(ethoxycarbonyl)amino]-, methyl ester",604-728-5,150215-07-9,Not Classified,Notified C&L,1,Not classified:1
75828,4'-methylacetoacetanilide,219-327-7,2415-85-2,Acute Tox. 4,Notified C&L,12,H302:11;H301:1
75834,"Titanate (2-), bis[P,P-dioctyl diphosphato (2-)-κO ´´, κO´´´´] [1,2-ethanediolato (2-)-κO, κO']-, dihydrogen, branched and linear, cmpd. with 2-(dimethylamino) ethyl methacrylate (1:2)",606-395-1,198840-67-4,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,Notified C&L,10,H318:9;H317:9;H314:9;H302:1;H335:1;H315:1;H319:1
75835,4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride,600-728-4,106261-49-8,,Notified C&L,13,H334:9;H302:12;H315:12;H319:12;H335:3;H332:1;H312:1;Not classified:1
75836,Bromo(2H3)methane,214-186-8,1111-88-2,Ozone 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 2;STOT RE 2;Aquatic Acute 1,Notified C&L,38,H301:38;H335:38;H315:38;H331:38;H400:38;H059:38;H341:38;H373:38;H319:38
75842,2-(N-METHYL-N-(2-PYRIDYL)-AMINO)-ETHANOL,602-493-3,122321-04-4,,Notified C&L,7,H302:5;H335:5;H315:6;H319:6;H318:1;H361:1;H336:1;H412:1
75846,Tetrasodium orthosilicate,236-741-3,13472-30-5,,Notified C&L,4,H335:4;H314:4
75847,Tridecanol (mixture of isomers),607-896-8,26248-42-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
75848,Phenylbis(trifluoroacetato-O)iodine,220-308-0,2712-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H242:1
75849,"3,3,4,4,4-pentafluorobutan-2-ol",206-776-9,374-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75854,"Propanenitrile, 3-(C12-15-alkyloxy) derivs.",271-860-4,68610-36-6,Not Classified,Notified C&L,22,Not classified:22
75858,2-[2-(2-isopropoxyethoxy)ethoxy]ethanol,249-772-2,29681-21-8,Not Classified,Notified C&L,1,Not classified:1
75860,Sodium 3-methyl-2-oxovalerate,223-063-8,3715-31-9,Not Classified,Notified C&L,2,Not classified:2
75861,"2,4,6-triisobutyl-1,3,5-trioxane",269-012-3,68165-40-2,Acute Tox. 4,Notified C&L,233,H302:233
75862,"(S)-2,3-dihydroxypropyl palmitate",251-283-4,32899-41-5,Not Classified,Notified C&L,1,Not classified:1
75863,Histidine,200-745-3,71-00-1,Not Classified,REACH registration C&L,334,Not classified:126;H302:208;H332:208;H315:208;H319:208
75867,4-morpholinobenzophenone,246-447-7,24758-49-4,Aquatic Acute 1,Notified C&L,38,H400:38
75869,"Residual oils (petroleum), carbon-treated solvent-dewaxed;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]",309-710-8,100684-37-5,Carc. 1B,Harmonised C&L,0,H350:0
75870,"N,N''-methylenebis(urea)",236-918-5,13547-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,86,H335:73;H315:73;H319:86
75871,"Rose, Rosa alba, ext.",297-122-1,93334-48-6,Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,77,H351:77;H412:77;H341:77;H319:77;H317:77
75872,nitric acid ... %;nitric acid …% [C ≤ 70 %],231-714-2,7697-37-2,,,0,H272:0;H330:0;H314:0
75874,"1-Dodecene, dimer, hydrogenated",604-768-3,151006-61-0,Asp. Tox. 1;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,2,H413:1;H304:1;H332:2;H412:1
75875,Etamsylate,220-090-7,2624-44-4,Eye Irrit. 2,Notified C&L,41,H319:35;Not classified:5;H361:1
75878,1-[bis[3-(dimethylamino)propyl]amino]propan-2-ol,266-587-2,67151-63-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,213,H318:190;H302:213;H314:213;H332:115;H312:115;H372:26;H412:1
75879,"3-(O,O-Diisobutyldithiophosphoryl)-2-methylpropanoic acid",608-009-7,268567-32-4,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,89,H318:89;H317:89;H412:88
75881,p-(phenylthio)benzyl alcohol,228-658-6,6317-56-2,Not Classified,Notified C&L,3,Not classified:2;H302:1;H335:1;H315:1;H319:1
75883,"Reaction product of m-tolylidene diisocyanate (247-722-4) and ethylenediamine (203-468-6) and amines, hydrogenated tallow alkyl (262-976-6) and (Z)-octadec-9-enylamine (204-015-5)",926-023-4,,Not Classified,Notified C&L,1,Not classified:1
75896,Sodium 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate,231-670-4,7681-54-1,Acute Tox. 1,Notified C&L,1,H300:1
75898,Bis(dipentylphenyl) hydrogen phosphate,264-629-4,64051-38-3,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1B;Aquatic Acute 1,Notified C&L,22,H317:22;H226:22;H314:22;H400:22
75902,"Phosphoric acid, C16-20-branched and linear alkyl esters, compds. with diethanolamine",307-064-1,97489-23-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
75904,5-chloromethyloxazolidin-2-one,245-137-9,22625-57-6,Acute Tox. 3,Notified C&L,40,H301:38;H315:2;H319:1;H318:1;H335:1
75905,"Fatty acids, C16-18, lead salts",292-966-7,91031-62-8,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H351:7;H400:7;H360:7;H302:7;H410:7;H332:7;H372:7;H362:7
75907,"4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide",425-850-3,125971-96-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
75908,"1-(pyren-1-yl)-1H-pyrrole-2,5-dione",255-702-1,42189-56-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
75912,(2E)-2-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methylidene}-3-methylbutanoic acid,609-581-0,387868-07-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
75917,Ethyl 2-phenyl-3-furoate,256-663-3,50626-02-3,Not Classified,Notified C&L,88,Not classified:88
75918,"1H-Pyrrole-2-acetic acid, 1-(2-chloroethyl)-3-(methoxycarbonyl)-, methyl ester",601-476-8,117422-10-3,Acute Tox. 4,Notified C&L,1,H302:1
75919,Pentaamminechlororhodium dichloride,237-505-2,13820-95-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
75922,"Oleic acid, ethoxylated",500-015-7,9004-96-0,Not Classified,Notified C&L,1361,Not classified:627;H319:592;H315:140;H412:52;H302:20
75923,Tetryzoline hydrochloride,208-329-3,522-48-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H302:44;H335:43;H315:43;H319:43
75925,"1,2-Cyclohexanedicarboxylic acid, 1,2-diisononyl ester",605-439-7,166412-78-8,Not Classified,Notified C&L,136,Not classified:136
75931,Iron(3+) octanoate,221-519-0,3130-28-7,Not Classified,Notified C&L,9,Not classified:5;H226:2;H315:1;H317:1;H302:1
75932,"2',4'-Dibromoacetanilide",607-224-3,23373-04-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
75937,C.I. Disperse Orange 45,602-308-6,12223-27-7,Skin Sens. 1,Notified C&L,1,H317:1
75938,"1,2,3-Propanetriol, oligomers, docosanoate",613-583-7,64366-79-6,Not Classified,REACH registration C&L,84,Not classified:84
75939,"2,3-dimethoxy-5-methyl-p-benzoquinone",210-100-8,605-94-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
75940,"1,1-cyclohexanediacetic acid monoamide",449-430-4,,Not Classified,Notified C&L,4,Not classified:4
75945,4-chlorophenyl salicylate,220-949-6,2944-58-3,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38,H317:38;H400:38
75948,2-[bis(2-aminoethyl)amino]ethanol,261-141-3,58145-14-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H302:1;H317:1;H312:1
75951,tert-butyl L-prolinate,220-558-0,2812-46-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:39;H335:39;H315:39;H319:1
75953,"4,4'-dimethylbiphenyl",210-337-7,613-33-2,Not Classified,REACH registration C&L,4,Not classified:4
75957,"Bis[2,8-di(trifluoromethyl)quinolin-4-yl-2-pyridyl] ketone",252-763-6,35853-55-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,REACH registration C&L,40,H302:1;H332:1;H312:1;H400:1;H413:38;H301:38;Not classified:1
75958,1-[4-(trans-4-Ethylcyclohexyl)-1-cyclohexen-1-yl]-4-trifluor methoxybenzen,610-751-1,519057-99-9,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
75959,"Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;Petroleum gas",307-769-4,97722-19-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
75960,"3-[4-[5-(tert-butyl)-2-oxo-1,3,4-oxadiazol-3(2H)-yl]-3-chlorophenyl]-1,1-dimethylurea",251-879-4,34205-21-5,Acute Tox. 4,Notified C&L,38,H302:38
75961,Sodium dioctyl sulfosuccinate,216-684-0,1639-66-3,Acute Tox. 4,Notified C&L,10,H302:9;Not classified:1
75963,4-chlorophenylacetonitrile,205-418-9,140-53-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,48,H301:40;H335:45;H315:46;H331:44;H319:46;H311:44;H300:8;H312:1
75966,4-iodobenzoic acid,210-603-2,619-58-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:46;H319:46;H302:1;H332:1;H312:1
75967,"o-xylene-α,α'-diol",210-293-9,612-14-6,Acute Tox. 4,Notified C&L,3,H302:2;H332:1;H335:1;H315:1;H319:1
75968,(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide,605-416-1,165800-03-3,STOT RE 1,Notified C&L,139,H372:129;H361:3;H302:2;H332:1;H312:1;H373:6;H319:1;H411:1
75970,2-(pyridin-3-yl)ethan-1-ol,672-991-3,6293-56-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H302:1
75971,"4,4-Diethoxy-N,N-dimethyl-1-butanamine",601-109-1,1116-77-4,Eye Dam. 1,Notified C&L,49,H318:41;H335:6;H315:7;H319:5;H302:4;H314:3
75973,"Olean-12-en-28-oic acid, 3-[[2-O-(6-deoxy-α-l-mannopyranosyl)-α-l-arabinopyranosyl]oxy]-23-hydroxy-, O-6-deoxy-α-l-mannopyranosyl-(1→4)-O-β-d-glucopyranosyl-(1→6)-β-d-glucopyranosyl ester, (3β,4α)-",238-072-2,14216-03-6,Acute Tox. 4,Notified C&L,44,H302:41;Not classified:2;H335:1
75977,"1,10-phenanthroline",200-629-2,66-71-7,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H400:0
75980,6-amino-5-chloro-2-cyclopropylpyrimidine-4-carboxylic acid,617-769-9,858956-08-8,Aquatic Chronic 3,Notified C&L,156,H412:156
75984,p-nitrophenyl α-D-xylopyranoside,233-572-7,10238-28-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
75988,"1,1,1,2,2,3,3,4,4,5,5,6,6,-tridecafluorotetradecane",432-570-5,,Not Classified,REACH registration C&L,3,Not classified:3
75989,"simetryn (ISO);2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine",213-801-7,1014-70-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
75990,"2,2'-dihydroxy-4,4'-dimethoxybenzophenone",205-027-3,131-54-4,Aquatic Chronic 2,REACH registration C&L,194,H411:1;Not classified:148;H335:44;H315:45;H319:45
75992,"bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate",430-700-5,10138-36-0,Skin Sens. 1,Harmonised C&L,0,H317:0
75993,"2,3-dimethylbenzoic acid",210-058-0,603-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
75994,2-chloro-6-fluoro-phenol,433-890-8,2040-90-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Muta. 1B;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H340:0;H361:0;H302:0;H411:0;H314:0;H317:0
75995,N-butyl-2-(4-morpholinylcarbonyl)benzamide,407-730-2,104958-67-0,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H319:0
75997,9-bromophenanthrene,209-351-6,573-17-1,Not Classified,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
75998,"9,10-dibutoxyanthracene",452-120-1,,Aquatic Chronic 4,Notified C&L,1,H413:1
75999,Methyl 1-[(2’-cyanobiphenyl-4-yl) methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate,604-137-2,139481-44-0,Not Classified,REACH registration C&L,2,Not classified:2
76002,"2,4-dimethylpenta-2,3-diene",213-679-5,1000-87-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H225:38;H304:38;H319:38
76003,Dimethylaminoacetonitrile,213-140-4,926-64-7,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,Notified C&L,99,H315:57;H330:56;H300:98;H226:97;H318:55;H310:98;H319:44;H225:1;H301:1;H335:1;H311:1
76004,Framycetin sulphate,223-969-3,4146-30-9,Repr. 2;STOT RE 2,Notified C&L,12,H361:11;H373:10;H302:2;H332:2;H315:1;H312:1
76010,4-chloro-3-ethylphenol,237-991-6,14143-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,197,H335:195;H315:197;H319:197
76013,"Octadecylamine, reaction products with 4,4'-methylenediphenyl diisocyanate",928-226-3,,Not Classified,Notified C&L,1,Not classified:1
76014,Pyridostigmine bromide,202-929-9,101-26-8,Acute Tox. 2;Acute Tox. 2;Skin Sens. 1;Acute Tox. 1,Notified C&L,59,H317:39;H310:39;H300:43;H330:40;H301:16;H331:16;H361:1;H334:1;H370:1;H362:1
76015,"Hydrocarbons, C14-C18, n-alkanes, isoalkanes, cyclics, <2% aromatics",927-632-8,,Asp. Tox. 1,REACH registration C&L,447,H304:447
76018,"3-(2,6-dichlorophenyl)-3-oxopropiononitrile",275-488-3,71463-50-8,Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38
76019,reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;sodium naphthylethylbenzenesulfonate,405-760-0,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H317:0;H412:0
76026,"1,1,2,2,3,4-hexafluoro-3,4-bis(trifluoromethyl)cyclobutane",221-065-3,2994-71-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H225:38
76029,"9,10-dihydroanthracene",210-336-1,613-31-0,Aquatic Acute 1,Notified C&L,39,H400:39
76031,Iron tripalmitate,243-646-0,20259-32-9,Not Classified,Notified C&L,6,Not classified:6
76034,"1,4-dioxane",204-661-8,123-91-1,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Harmonised C&L,0,H351:0;H335:0;H319:0;H225:0
76035,4-ethylbenzoic acid,210-605-3,619-64-7,,Notified C&L,8,H335:6;H315:7;H319:8;Not classified:1;H302:1
76038,"Concentrated by-product obtained after the fermentation of molasses/sugar/other feedstock, using different strains, in the production of alcohol, yeast and other organic substances",919-670-9,,Not Classified,Notified C&L,1,Not classified:1
76039,Genévrier rameaux,616-801-9,8002-68-4,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,230,H400:157;H410:157;H304:167;H226:205;H317:167;H315:74;H411:10;H319:8
76041,"[(2E)-6,6,-Dimethylhept-2-en-4-yn-1-yl](methyl)(naphthalen-1-ylmethyl)amine hydrochloride",616-640-4,78628-80-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,239,H410:231;H400:216;H335:134;H315:134;H319:134;H361:4;H302:1;Not classified:2;H372:1
76043,"Dihydro-3-(tetrapropenyl)furan-2,5-dione",247-781-6,26544-38-7,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,431,H413:164;H317:192;H319:375;H315:234;Not classified:31;H334:30;H302:14;H335:26;H332:8;H318:3;H411:2
76045,Copper bis(2-ethylhexanoate),205-731-0,149-11-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H335:49;H315:49;H319:49;Not classified:7;H361:5;H302:7;H317:1;H410:1;H400:1
76046,2-amino-5-chlorothiazole hydrochloride,259-680-4,55506-37-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,42,H335:38;H315:38;H302:42;H318:38;H317:38
76048,"Hydrocarbons, C9-C11, n-alkanes, isoalkanes, cyclics, <2% aromatics",927-356-8,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3,Notified C&L,21,H304:21;H336:21;H226:21
76053,"Phosphinic acid, P,P-diethyl-, zinc salt (2:1)",608-215-7,284685-45-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,65,H318:65;H410:65;H400:65
76056,N-(1H-indol-3-ylmethylene)cyclohexylamine,301-249-0,93982-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76057,N-[2-[(3-amino-3-oxopropyl)stearoylamino]ethyl]-N-[2-(stearoylamino)ethyl]stearamide monoacetate,269-297-4,68214-54-0,Not Classified,Notified C&L,32,Not classified:32
76058,lithium bis(fluorosulfonyl)imide,924-516-9,,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H318:2;H301:2;H314:2;H412:2
76060,(E)-p-nitrocinnamic acid,212-924-3,882-06-4,,Notified C&L,5,H341:5;H335:5;H315:5;H319:5
76062,reaction mass of cis- and trans-cyclohexadec-8-en-1-one,401-700-2,3100-36-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
76067,4-butyl-N-[(4-ethoxybenzylidene]aniline,249-821-8,29743-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
76069,"Sea buckthorn, Hippophae rhamnoides, ext.",290-292-8,90106-68-6,Not Classified,Notified C&L,45,Not classified:42;H302:1;H226:2;H319:1
76070,"1,2-Cyclopropanedicarboxylic acid, 1-(4-methylphenyl)-",601-233-6,113111-32-3,Not Classified,Notified C&L,1,Not classified:1
76071,"Oils, lemon, psoralen-free",614-790-5,68916-89-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,88,H317:88;H304:88;H411:88;H315:88
76073,4-ethyl-o-cresol,218-733-1,2219-73-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H302:1;H335:1;H315:1
76075,Ammonium titanyl oxalate monohydrate,600-678-3,10580-03-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H335:38;H315:38;H302:42;H332:38;H319:38;H312:42
76078,4-(dimethylammonio)piperidinium dichloride,225-486-3,4876-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76085,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium thiocyanate",281-634-7,84000-77-1,Not Classified,Notified C&L,2,Not classified:2
76086,"Disodium 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-1H-imidazolium hydroxide",238-306-3,14350-97-1,Not Classified,Notified C&L,3,Not classified:3
76087,"Disodium [2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)][2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphophenyl)-1H-pyrazol-4-yl]azo]benzoato(3-)]chromate(2-)",283-608-0,84682-44-0,Not Classified,Notified C&L,1,Not classified:1
76088,"3,7,11-trimethyldodeca-1,6,10-trien-3-yl acetate",218-978-4,2306-78-7,Not Classified,Notified C&L,265,Not classified:265
76089,"Bis(N,N-dimethylpropane-1,3-diamine-N)[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]cobalt(1+) chloride",284-943-5,84989-53-7,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H318:1;H317:1;H410:1;H400:1;Not classified:9
76092,4-hydroxy-3-methoxycinnamic acid,214-490-0,1135-24-6,Not Classified,REACH registration C&L,251,Not classified:6;H335:245;H315:245;H319:245
76096,"Benzenesulfonic acid, mono-C16-24-alkyl derivs., calcium salts",274-263-7,70024-69-0,Not Classified,REACH registration C&L,742,Not classified:60;H317:653;H412:127;H413:51;H334:15;H319:17;H315:4
76098,N-isopropylaniline,212-196-7,768-52-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,77,H335:39;H315:38;H330:39;H302:77;H319:39;H361:1;H332:1;H317:1
76101,"Reaction mass of (3RS)-1-[(1RS,3SR,6SR)-2,2,3,6-tetramethylcyclohexyl]hexan-3-ol and (3RS)-1-[(1SR,3RS,6RS)-2,2,3,6-tetramethylcyclohexyl]hexan-3-ol",478-330-3,95851-08-4,Skin Sens. 1B;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,76,H413:76;H317:76;H336:2;H315:13
76102,"Diammonium hydrogen 2-amino-4-[(4-amino-3-sulphonatophenyl)(4-imino-3-sulphonatocyclohexa-2,5-dien-1-ylidene)methyl]toluene-3-sulphonate",268-486-9,68109-73-9,Not Classified,Notified C&L,1,Not classified:1
76103,"Fatty acids, C14-18 and C16-18-unsatd., compds. with morpholine",268-095-3,68002-81-3,,Notified C&L,36,Not classified:36
76107,"6-(2,3-dibromopropionamido)-3-[[5-(2,3-dibromopropionamido)-2-sulphophenyl]azo]-4-hydroxynaphthalene-2-sulphonic acid",251-212-7,32781-74-1,Not Classified,Notified C&L,7,Not classified:7
76108,"Oxirane, ethyl-, (S)-",608-509-5,30608-62-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Carc. 2,Notified C&L,39,H351:39;H225:39;H302:39;H332:39;H314:38;H312:39;H335:1;H315:1;H361:1;H373:1;H319:1
76110,"Sodium [2S-[2α,5α,6β(S*)]]-3,3-dimethyl-7-oxo-6-[[[[(2-oxoimidazolidin-1-yl)carbonyl]amino]phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",253-347-7,37091-65-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H334:39;H317:40;H332:1
76111,"3-bromo-α,α,α-trifluorotoluene",206-932-6,401-78-5,Flam. Liq. 3,Notified C&L,50,H226:50;H335:10;H315:10;H319:11
76115,3'-Chloro-4'-fluoroacetophenone,608-330-2,2923-66-2,,Notified C&L,9,H335:8;H315:9;H319:9
76121,Sulfapyridine sodium,204-850-5,127-57-1,Not Classified,Notified C&L,1,Not classified:1
76125,"2,6-dichloro-1-fluoropyridiniumtetrafluoroborate",427-400-1,140623-89-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H314:0;H317:0
76126,Ammonium carbamate,214-185-2,1111-78-0,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,205,H318:181;H302:205;H315:135;H319:10;H335:4;Not classified:1
76131,Ethyl acetamidocyanoacetate,225-624-2,4977-62-2,,Notified C&L,4,H302:4;H335:4;H315:4;H319:4
76135,"(5α)-4,5-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one hydrochloride",206-610-5,357-07-3,Acute Tox. 4;Acute Tox. 2;Acute Tox. 1,Notified C&L,47,H330:38;H302:38;H310:38;H301:9;H315:9;H334:9;H361:9;H319:9;H317:9;H311:9
76147,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-9-octadecenyl-.omega.-hydroxy-, (Z)-",610-863-0,52581-71-2,Not Classified,Notified C&L,60,Not classified:59;H319:1
76149,Ytterbium trifluoride,237-354-2,13760-80-0,Not Classified,REACH registration C&L,221,Not classified:5;H335:178;H315:178;H319:178;H301:38;H311:38;H331:38;H302:5;H332:5;H312:5;H413:1
76150,"1,3-dichloro-5,5-dimethylhydantoin",204-258-7,118-52-5,Ox. Sol. 3;Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Aquatic Acute 1,REACH registration C&L,128,H400:75;H272:67;H302:128;H314:79;H317:25;H335:51;H315:49;H319:49;H334:40;H410:3;H318:2
76152,2-isopropyl-1H-imidazole-1-propiononitrile,265-448-3,65109-28-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H301:1;H315:1
76154,3-methyl-2-[(1-methyl-2-phenyl-1H-indol-3-yl)azo]thiazolium chloride,255-785-4,42373-04-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,43,H400:2;H302:2;H410:2;H318:2;H317:2;H335:38;H315:38;H319:40;Not classified:1
76155,"Amines, C18-22-tert-alkyl, (chloromethyl)phosphonates (2:1)",279-138-0,79357-73-6,Not Classified,Notified C&L,7,Not classified:7
76159,"Benzenesulfonic acid, 5,5'-azoxybis[2-[2-[2-sulfo-4-[[4-[(4-sulfophenyl)azo]phenyl]azo]phenyl]ethenyl]-",604-816-3,151780-53-9,Not Classified,Notified C&L,1,Not classified:1
76160,"3,4-dichlorobenzonitrile",229-494-8,6574-99-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,46,H412:2;H319:46;H302:44;H312:44;H335:43;H315:44;H332:42;H301:1
76166,Lithium vanadium trioxide,239-124-7,15060-59-0,,Notified C&L,4,H302:4;H332:4;H319:4;H335:4
76169,"Fatty acids, tallow, compds. with diethanolamine",266-943-7,67701-25-1,Not Classified,Notified C&L,38,Not classified:37;H318:1;H315:1
76170,Calcifediol,242-990-9,19356-17-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Notified C&L,42,H330:38;H301:39;H311:38;H372:42;H310:2;H300:2;H360:1;H361:2;H302:1;H373:1;H315:1
76172,"Hexasodium p,p'-[m-phenylenebis[imino(6-chloro-1,3,5-triazine-2,4-diyl)imino(8-hydroxy-3,6-disulphonato-1,7-naphthylene)azo]]dibenzoate",280-194-3,83137-16-0,Not Classified,Notified C&L,1,Not classified:1
76173,5-hydroxy-2-methylpyridine 1-oxide,246-075-5,24207-00-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
76176,N-(5-aminopentyl)-5-(dimethylamino)naphthalene-1-sulphonamide,233-326-9,10121-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76179,"Ethyl 3,7-dimethylocta-2,6-dienoate",235-948-6,13058-12-3,Not Classified,Notified C&L,88,Not classified:88
76189,"Quaternary ammonium compounds, tri-C8-10-alkylmethyl, chlorides",264-120-7,63393-96-4,Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,270,H301:168;H400:247;H410:270;H373:8;H314:217;H318:174;H360:12;H361:87;H315:53;H302:102;Not classified:2
76190,Fluoromethane,209-796-6,593-53-3,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,129,H220:128;H280:128;H221:1
76191,Phenyl (3-phenyloxiranyl) ketone,226-487-1,5411-12-1,Skin Sens. 1,Notified C&L,43,H317:38;H335:4;H315:5;H319:5
76192,Sodium hydrogen phthalate,212-568-9,827-27-0,Not Classified,Notified C&L,3,Not classified:2;H335:1
76196,"2,4,5-trimethoxypropen-1-ylbenzene",226-096-6,5273-86-9,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,166,H412:103;H302:166
76200,"4,5-dihydroxy-1-(hydroxymethyl)imidazolidin-2-one",243-951-9,20662-57-1,Not Classified,Notified C&L,1,Not classified:1
76202,"1,1'-[(2-hydroxypropane-1,3-diyl)bis[oxy(6-hydroxy-2,1-phenylene)]]bisethan-1-one",240-302-1,16150-44-0,Not Classified,REACH registration C&L,9,Not classified:6;H302:3;H332:2;H312:2
76205,Thallium (III) acetate sesquihydrate,219-913-2,2570-63-0,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H330:43;H373:43;H411:43;H300:43
76206,"3,3-Dimethoxyestr-5(10)-en-17-one",606-278-5,19257-34-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
76208,potassium bifluoride;potassium hydrogen difluoride,232-156-2,7789-29-9,Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H301:0;H314:0
76209,2-aminopyrazine,225-748-7,5049-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:48;H319:48;H228:1
76210,Dilithium phthalate,240-105-0,15968-00-0,Not Classified,Notified C&L,2,Not classified:2
76211,Buturon,223-187-2,3766-60-7,Acute Tox. 4;Acute Tox. 3,Notified C&L,38,H302:38;H311:38
76213,Cesium fluoroaluminate,604-086-6,138577-01-2,Not Classified,REACH registration C&L,66,Not classified:2;H301:38;H314:38;H318:26;H373:26;H412:26
76219,5-bromonicotinic acid,244-065-5,20826-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,143,H335:141;H315:142;H319:142;H302:1
76220,"Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11β)-",216-995-1,1715-33-9,Acute Tox. 4;Carc. 2,Notified C&L,39,H302:38;H351:38;Not classified:1
76222,Geranyl chloride,611-062-9,5389-87-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76223,"2-chloro-1,4-naphthoquinone",213-776-2,1010-60-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H315:5;H319:5;H335:1;Not classified:1;H301:1;H412:1;H317:1
76229,"5-[4-(trans-4-Ethylcyclohexyl)-1-cyclohexen-1-yl]-1,2,3-trifluorbenzene",605-186-2,159560-06-2,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
76233,Disodium tri(cyano-C)cuprate(2-),238-155-3,14264-31-4,Acute Tox. 2;Acute Tox. 1;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H300:1;H373:1;H332:1;H411:1;H318:1;H317:1;H371:1;H310:1
76236,Bauxite,603-521-7,1318-16-7,Not Classified,Notified C&L,104,Not classified:104
76240,(2R)-2-(2-oxopyrrolidin-1-yl)butanamide,600-348-9,102767-28-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,118,H302:104;H319:104;H361:7;H373:6;Not classified:2;H334:1;H336:3;H362:1;H360:2;H413:1;H341:1;H335:1;H315:1
76247,Hydrogen hydroxy[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(1-),269-447-9,68239-52-1,Not Classified,REACH registration C&L,2,Not classified:2
76249,"2,5-dihydro-2,5-dimethoxy-2-methylfuran",244-972-6,22414-24-0,Flam. Liq. 3,Notified C&L,39,H226:39
76252,bis(4-hydroxy-N-methylanilinium) sulphate,200-237-1,55-55-0,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H373:0;H317:0
76254,"Distillates (petroleum), straight-run light;Low boiling point naphtha;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",270-077-5,68410-05-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
76266,4-Mercaptobenzoic Acid,600-825-1,1074-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:41;H315:42;H319:42;H301:2;H332:2;H312:2;Not classified:1
76267,"cyclohexane-1,2-dicarboxylic anhydride",201-604-9,85-42-7,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H317:0;H334:0
76269,2-Methoxy-4-(trifluoromethyl)pyridine,606-870-3,219715-34-1,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,104,H302:104;H226:104;H411:88;H412:16
76270,3-hydroxy-2-naphthanilide,202-188-1,92-77-3,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,168,H317:83;H411:86;H335:84;H315:85;H302:83;H332:83;H319:85;Not classified:1
76271,"2,4,6-triisopropylbenzenesulphonohydrazide",254-282-7,39085-59-1,,Notified C&L,5,H335:4;H315:5;H319:5;H228:1
76272,"Benzenesulfonic acid, C8-14-alkyl derivs., sodium salts",296-787-5,93062-35-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H302:1;H315:1
76273,D-cysteine,213-062-0,921-01-7,Acute Tox. 4,Notified C&L,39,H302:39
76278,"[3aR-(3aα,5aβ,9aα,9bβ)]-dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan",229-861-2,6790-58-5,Not Classified,REACH registration C&L,1595,Not classified:1595
76279,"Tar oils, brown-coal;Light Oil;[The distillate from lignite tar boiling in the range of approximately 80°C to 250°C (176°F to 482°F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]",302-674-4,94114-40-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
76284,"Glycine, N-(phosphonomethyl)-, ammonium salt (1:1)",609-830-3,40465-66-5,Aquatic Chronic 2,Notified C&L,122,H411:122
76286,tert-pentyl perbenzoate,224-831-5,4511-39-1,Not Classified,Notified C&L,6,Not classified:5;H226:1;H242:1
76288,Bis(triphenylphosphine)nickel(II) chloride,238-154-8,14264-16-5,Skin Sens. 1;Carc. 1B;Aquatic Chronic 3,Notified C&L,45,H412:38;H317:40;H350:40;H302:6;H332:1;H314:1;H312:1;H318:1;Not classified:1;H334:1
76289,"1,2,3,4,5,6,7,8-octahydroacridine",216-758-2,1658-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76294,Bis[tris(hydroxyethyl)ammonium] sulphate,230-934-6,7376-31-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,264,H318:89;H315:174;H226:84;H319:85;Not classified:90
76302,5-chloroindoline,247-167-8,25658-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
76305,3-methyloctane,218-686-7,2216-33-3,Flam. Liq. 2,Notified C&L,43,H225:38;H335:4;H315:4;H400:4;H224:4;H336:4;H304:5;H410:4;H319:4;H226:1
76306,"4,4'-isopropylidenediphenyl dimethacrylate",221-846-9,3253-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
76307,"1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid",601-205-3,112811-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H302:1
76308,"1,1,2-trimethylcyclohexane",230-400-2,7094-26-0,Flam. Liq. 2,Notified C&L,4,H225:4
76311,"2-Naphthalenesulfonicacid, 6-amino-5-[2-[5-chloro-2-(2-chlorophenoxy)phenyl]diazenyl]-4-hydroxy-,sodium salt (1:1)",600-411-0,103241-64-1,Aquatic Chronic 2,Notified C&L,3,H411:3
76312,γ-butyrolactone,202-509-5,96-48-0,Acute Tox. 4;Eye Dam. 1;STOT SE 3,REACH registration C&L,3892,H318:2486;H302:3641;H336:2259;H319:1162;H331:449;H315:458;Not classified:251;H332:21;H312:18;H335:4;H341:4;H371:3;H304:1
76313,4-nitro-2-(trifluoromethyl)anisole,211-507-3,654-76-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,40,H318:38;H314:40;H319:1;H335:1
76321,"4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3-buten-2-one",245-542-0,23267-57-4,Not Classified,Notified C&L,113,Not classified:113
76322,"Glycerides, C12-18",266-944-2,67701-26-2,Not Classified,REACH registration C&L,119,Not classified:119
76325,"Cetraria islandica, ext.",283-950-0,84776-25-0,Not Classified,Notified C&L,2,Not classified:2
76326,3-methylisonicotinonitrile,231-491-1,7584-05-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
76329,4-bromo-3-methylbenzoic acid,231-713-7,7697-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
76330,Azacyclotridecane,206-037-0,295-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76332,3-(hydroxymethyl)nonan-2-one,267-154-0,67801-33-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,647,H315:647;H319:647
76340,"2,2-dichlorocyclopropylbenzene",219-326-1,2415-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
76341,Decan-5-olide,211-889-1,705-86-2,Aquatic Chronic 2,REACH registration C&L,1669,H411:18;Not classified:1650;H319:1
76344,"Glycerides, rape oil mono- and di-",297-849-4,93763-31-6,Not Classified,Notified C&L,2,Not classified:2
76347,"2-Pyrrolidineethanamine, 1-methyl-, (2S)-",610-005-5,422545-95-7,,Notified C&L,1,H318:1;H302:1;H335:1;H315:1
76349,Decyltrimethoxysilane,422-350-7,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H315:2;H319:2
76352,"4,4'-bis[(4-anilino-6-methoxy-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonic acid",230-857-8,7342-13-4,Not Classified,Notified C&L,3,Not classified:3
76353,"Sodium [6R-[6α,7β(R*)]]-7-[(hydroxyphenylacetyl)amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",250-009-0,30034-03-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H334:38;H319:38;H317:38
76357,pyrazole-1-carboxamidine monohydrochloride,429-520-1,4023-02-3,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H373:0;H318:0;H317:0
76358,Octafluoropropane,200-941-9,76-19-7,Press. Gas (Liq.),REACH registration C&L,197,H280:175;Not classified:22;H281:1;H336:1;H373:1
76359,Thulium trifluoride,237-353-7,13760-79-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H301:39;H311:39;H331:39;H335:5;H315:5;H302:4;H332:4;H319:5;H312:4;Not classified:1
76366,"[4-(2-hydroxyethoxy)-1,3-phenylene]diammonium sulphate",274-713-2,70643-20-8,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,28,H318:21;H317:26;H302:26;H411:22;H319:6;Not classified:1;H335:2;H315:1
76367,"Poly[oxy[(hydroxymethyl)-1,2-ethanediyl]], α-(9Z)-9-octadecenyl-ω-hydroxy- (9CI)",618-509-7,9022-76-8,,Notified C&L,2,H315:2;H319:2;H400:1
76368,"Phosphoric acid, dodecyl ester, compd. with 2-aminoethanol",278-948-1,78564-59-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3
76369,"1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, (2R)-, (2E)-2-butenedioate (1:1)",926-246-7,99581-17-6,Not Classified,Notified C&L,1,Not classified:1
76371,"Dichloro[(1,2,5,6-η)-cycloocta-1,5-diene]palladium",235-161-8,12107-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:39;H315:41;H319:42;H302:2;H332:2;H312:1;H413:1;H290:1;H228:1
76373,propan-1-ol;n-propanol,200-746-9,71-23-8,Flam. Liq. 2;Eye Dam. 1;STOT SE 3,Harmonised C&L,0,H318:0;H336:0;H225:0
76374,Narwedine (+/-),605-454-9,1668-86-6,Acute Tox. 4;Eye Irrit. 2;Muta. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H341:1;H319:1
76379,(octyloxy)acetaldehyde,258-582-9,53488-14-5,Not Classified,Notified C&L,88,Not classified:88
76384,Sodium 3-methyl-2-oxobutanoate,223-062-2,3715-29-5,Not Classified,Notified C&L,1,Not classified:1
76392,(2-hydroxyethyl)ammonium 2-mercaptopropionate,259-050-9,54266-38-5,Met. Corr. 1,Notified C&L,1,H290:1
76393,Sodium hydrogen succinate,220-871-2,2922-54-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
76395,4-(indol-3-yl)butyric acid,205-101-5,133-32-4,Acute Tox. 3;Skin Irrit. 2,Notified C&L,156,H301:154;H315:153;H335:62;H319:64;H361:1;H302:2;H331:2;H332:1;H300:1;H311:1
76396,Borane - 2-Picoline Complex,609-767-1,3999-38-0,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 1,Notified C&L,129,H330:83;H301:83;H311:83;H228:83;H261:45;H315:46;H319:45;H335:45;H302:1;H318:1
76397,8-(phenylamino)-5-[[4-[(3-sulphophenyl)azo]-1-naphthyl]azo]naphthalene-1-sulphonic acid,246-448-2,24758-50-7,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2
76404,Iodo(triphenylphosphino)copper,256-296-9,47107-74-4,Aquatic Chronic 4,REACH registration C&L,1,H413:1
76405,"1-Dodecene, polymer with 1-decene, hydrogenated",604-767-8,151006-60-9,Asp. Tox. 1,Notified C&L,9,H304:7;Not classified:1;H413:1
76407,"2,5-dihydro-5-thioxo-1H-tetrazole-1-methanesulphonic acid",266-586-7,67146-22-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76408,Diethyl 4-oxoheptanedioate,228-657-0,6317-49-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
76409,[No public or meaningful name is available],453-440-4,610271-60-8,Skin Sens. 1B,Notified C&L,24,H317:24
76416,Clobetasone,258-953-5,54063-32-0,Not Classified,Notified C&L,1,Not classified:1
76419,12-oxo-N-phenyl-12H-phthaloperine-6-sulphonamide,278-868-7,78197-01-0,Not Classified,Notified C&L,2039,Not classified:2039
76420,fenaminosulf (ISO);sodium 4-dimethylaminobenzenediazosulphonate,205-419-4,140-56-7,Acute Tox. 3;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H301:0;H312:0
76422,"2,2'-azobis[2-methylbutyronitrile]",236-740-8,13472-08-7,Self-react. D;Acute Tox. 4,REACH registration C&L,881,H302:874;H242:636;H225:177;H412:136;H228:42;Not classified:6;H301:1;H373:1;H315:1;H319:1
76427,2-Chloro-5-iodotoluene,601-441-7,116632-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
76430,Fluorodimethoxyborane,206-694-3,367-46-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
76431,o-vinylanisole,210-294-4,612-15-7,Flam. Liq. 3,Notified C&L,38,H226:38
76434,(1-hydroxydodecylidene)diphosphonic acid,425-230-2,16610-63-2,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H314:0;H400:0
76438,"Hexadecan- l-ol, ethoxylated",500-014-1,9004-95-9,Aquatic Chronic 2,REACH registration C&L,782,H411:8;H315:535;Not classified:167;H318:56;H302:71;H319:23;H400:34;H412:19;H410:1
76444,Halometasone,256-664-9,50629-82-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,2,H302:1;H332:1;H312:1;H351:1;H361:1
76445,"Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C20-40, branched and cyclic",605-826-0,178603-65-1,Not Classified,Notified C&L,83,Not classified:83
76446,"2-amino-3,5-dibromobenzaldehyde",256-841-0,50910-55-9,Acute Tox. 4,REACH registration C&L,57,H302:6;H319:50;Not classified:1;H315:3;H335:1;H317:1
76448,"3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea",406-370-3,58890-25-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
76449,"Polyamine derivative, quaternized",925-620-7,123502-44-3,Not Classified,Notified C&L,37,Not classified:31;H411:6
76451,Dioxybenzone,205-026-8,131-53-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,62,H317:2;H411:2;H335:53;H315:55;H319:55;Not classified:5
76454,"1-methylethane-1,2-diyl dipalmitate",251-581-4,33587-20-1,Not Classified,Notified C&L,11,Not classified:11
76455,N-(tert-butoxycarbonyl)-S-(p-methoxybenzyl)-L-cysteine,242-695-5,18942-46-6,Not Classified,Notified C&L,1,Not classified:1
76459,demeton-S-methylsulphon (ISO);S-2-ethylsulphonylethyl dimethyl phosphorothioate,241-109-5,17040-19-6,Acute Tox. 3;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H411:0;H312:0
76464,N-(4-sodiooxyphenyl)-p-benzoquinone monoimine,226-524-1,5418-32-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76466,Verapamil hydrochloride,205-800-5,152-11-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,394,H330:290;H301:394;H311:336;H300:156;H331:45;H335:51;H315:49;H412:48;H302:42;H319:49;H360:1;H362:1;H361:1;H310:1;H411:1
76471,(Z)-non-6-en-1-ol,252-764-1,35854-86-5,Not Classified,Notified C&L,154,Not classified:154
76472,"Fatty acids, vegetable-oil, Me esters, sulfurized",276-337-4,72102-30-8,Not Classified,REACH registration C&L,65,Not classified:63;H411:2
76473,"1-(2,6,6-trimethyl-4-oxocyclohex-2-enyl)buten-3-yl acetate",283-169-5,84551-78-0,Not Classified,Notified C&L,25,Not classified:25
76483,2-(2-sulphonatoethyl)isothiouronium,247-391-6,25985-57-3,Not Classified,REACH registration C&L,2,Not classified:2
76484,"2,3,3-trimethyl-3H-indole",216-685-6,1640-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H335:48;H315:50;H319:50;H412:1;H302:1;H373:1
76486,"Fatty acids, C16-18, magnesium salts",292-967-2,91031-63-9,Not Classified,Notified C&L,142,Not classified:142
76487,"Amines, coco alkyldimethyl",263-020-0,61788-93-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,506,H302:501;H314:501;H400:449;H318:179;Not classified:36
76490,"3,3-dimethylbutylamine",239-749-5,15673-00-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
76495,2-aminopropan-1-ol,201-156-4,78-91-1,Not Classified,Notified C&L,55,Not classified:55
76496,1-deoxy-1-(ethylamino)-D-glucitol,238-073-8,14216-22-9,Not Classified,Notified C&L,2,Not classified:2
76499,1-[4-(trans-4-Propylcyclohexyl)-1-cyclohexen-1-yl]-4-trifluormethoxybenzene,918-322-3,,Not Classified,REACH registration C&L,3,Not classified:3
76500,Reactive Yellow 504,402-330-4,,Not Classified,Notified C&L,2,Not classified:2
76504,Sodium tridecylbenzenesulphonate,247-536-3,26248-24-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
76505,isooctane,247-861-0,26635-64-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H225:0;H336:0;H304:0;H410:0
76507,Bilirubin,211-239-7,635-65-4,Not Classified,Notified C&L,2,Not classified:2
76509,o-nitrophenyl β-D-xylopyranoside,233-571-1,10238-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76514,3-(trifluoromethoxy)benzoic acid,213-802-2,1014-81-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:48;H319:48
76515,Menadiol di(acetate),209-352-1,573-20-6,Eye Dam. 1,Notified C&L,41,H318:38;Not classified:3
76519,5-chlorothiophene-2-sulfonamide,700-252-8,53595-66-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
76522,C.I. Acid Red 143,601-088-9,11140-80-0,Not Classified,Notified C&L,1,Not classified:1
76523,2-(4-methoxyphenyl)-4-benzopyrone,223-968-8,4143-74-2,Acute Tox. 4,Notified C&L,39,H302:38;H315:1;H319:1
76524,3-nitro-o-toluidine,210-059-6,603-83-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,47,H301:47;H331:47;H373:46;H411:47;H311:47;H315:1;H319:1
76526,"2,4-dichlorophenylacetic acid",243-248-7,19719-28-9,Eye Irrit. 2,REACH registration C&L,139,H413:1;H319:136;H335:137;H315:138
76528,"Benzoic acid, compound with cyclohexylamine (1:1)",221-516-4,3129-92-8,Flam. Sol. 1;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,85,H302:61;H319:6;H228:6;H332:54;H312:54;Not classified:24
76529,4-nitrophenyl palmitate,216-084-9,1492-30-4,Skin Sens. 1,Notified C&L,38,H317:38
76532,"2H-naphth[1,8-cd]isothiazole 1,1-dioxide",210-055-4,603-72-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
76534,"Fatty acids, C18 and C18-unsatd., Me esters",273-092-5,68937-81-5,Not Classified,Notified C&L,114,Not classified:114
76538,Tall oil,232-304-6,8002-26-4,Not Classified,REACH registration C&L,896,Not classified:797;H317:97;H400:26;H410:25;H341:25;H370:25;H314:25;H372:25;H318:25;H360:25;H412:1;H319:1
76539,"1,3-bis(trichloromethyl)benzene",212-923-8,881-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H318:1;H314:1
76540,N-isopropyl-1-piperazineacetamide,254-676-9,39890-42-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
76544,Hyaluronidase,232-614-1,9001-54-1,Not Classified,Notified C&L,1,Not classified:1
76548,"1H-Pyrrolizine-1,7-dicarboxylic acid, 2,3-dihydro-, 1-methyl ester",618-893-6,92992-17-1,Not Classified,Notified C&L,2,Not classified:2
76550,[2H4]ammonium [2H]hydroxide,235-332-7,12168-30-8,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H400:1
76553,3-pyridylacetic acid,229-148-6,6419-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,203,H335:202;H315:203;H319:203;H302:1;H332:1
76554,Alamethicin,608-040-6,27061-78-5,Acute Tox. 3,Notified C&L,41,H301:41
76556,Ethyl L-lysinate dihydrochloride,223-340-3,3844-53-9,,Notified C&L,4,H335:4;H315:4;H319:4
76557,Rufocromomycin,223-501-8,3930-19-6,Acute Tox. 2,Notified C&L,38,H300:38
76558,4-cyanobenzoic acid,210-606-9,619-65-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,46,H335:44;H315:45;H302:46;H332:42;H319:45;H312:42
76564,"Dodecanoic acid, ester with 1,2,3-propanetriol, acetylated",294-597-7,91744-35-3,Not Classified,Notified C&L,23,Not classified:23
76566,"2-{[(2,6-DICHLOROPHENYL)METHYL]OXY}ETHANOL",617-700-2,85309-91-7,Flam. Liq. 3;Acute Tox. 4,Notified C&L,2,H302:2;H226:1;H318:1;H315:1
76568,"2-methylpentane-1,5-diyl diisocyanate",252-224-5,34813-62-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
76575,"Scarlet HS 5050, notification presscake",453-810-5,,Aquatic Chronic 2,Notified C&L,37,H411:37
76577,N-[2-[(3-amino-3-oxopropyl)[2-[bis(3-amino-3-oxopropyl)amino]ethyl]amino]ethyl]stearamide monoacetate,269-294-8,68214-48-2,Not Classified,Notified C&L,32,Not classified:32
76580,"(Z)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one",245-843-7,23726-92-3,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1607,H317:1607;H411:1309;H315:1296
76585,Methyl 2-bromobutyrate,221-699-0,3196-15-4,Skin Corr. 1B,Notified C&L,46,H314:45;H317:1;H302:1;H411:1;H315:1;H290:1;H318:2
76593,"1,2-bis(chloromethyl)benzene",210-291-8,612-12-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,53,H335:46;H315:7;H400:13;H302:13;H410:13;H319:7;H314:46;H330:6;Not classified:3;H290:1;H318:1
76595,"4-Hexenoic acid, 3-hydroxy-, homopolymer",608-000-8,26811-78-9,Not Classified,Notified C&L,33,Not classified:33
76596,Hexacosan-1-ol,208-044-4,506-52-5,Not Classified,Notified C&L,91,Not classified:91
76602,Fludarabine,244-525-5,21679-14-1,Acute Tox. 4,Notified C&L,41,H302:40;H335:2;H315:2;H361:2;H341:3;H332:2;H373:2;H319:2;H312:2
76603,[(hexadecyloxy)methyl]oxirane,240-104-5,15965-99-8,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,39,H317:1;H315:39;H335:38;H319:38
76609,"Laurel SME, ext.",616-794-2,8002-41-3,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Muta. 2;Carc. 2;STOT SE 2;Aquatic Chronic 2,Notified C&L,198,H351:197;H304:197;H341:197;H226:198;H411:196;H317:198;H371:169;H315:27;H412:1;H319:3
76611,5-chlorouracil,217-339-7,1820-81-1,,Notified C&L,1,H302:1
76612,4-bromo-1-(bromomethyl)-2-fluorobenzene,278-412-7,76283-09-5,Acute Tox. 3;Skin Corr. 1B,Notified C&L,47,H301:40;H314:47;H331:1;H311:1;H412:1;H302:3;H312:1;H318:1
76614,"2,4-dihydroxybenzophenone",205-029-4,131-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1885,H335:1333;H315:1342;H319:1664;Not classified:135;H317:83;H361:56;H411:82;H412:17;H410:3;H400:4
76615,o-phenylbenzoic acid,213-432-1,947-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
76617,2-(methylsulphonyl)-10H-phenothiazine,245-701-4,23503-68-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,9,H335:6;H315:4;H302:7;H336:4;H319:4;H317:6;H412:1;H373:1;H350:1;H332:1;H312:1;H372:1;H360:1
76620,7-[(2-O-D-apio-β-D-furanosyl-β-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one,247-780-0,26544-34-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H335:2;H315:2;H319:2
76625,"α,α,α,3-tetrafluorotoluene",206-933-1,401-80-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H335:50;H315:51;H319:51;H225:49
76626,"2,2,6,6-tetramethylpiperidine",212-199-3,768-66-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,REACH registration C&L,90,H302:42;H226:87;H332:28;H314:35;H301:49;H335:54;H315:55;H319:55;H290:1;Not classified:1;H331:2;H225:2;H312:1;H311:1;H318:3
76627,"Benzenesulfonic acid, mono-C19-28-alkyl derivs., calcium salts, overbased",274-264-2,70024-72-5,Not Classified,Notified C&L,442,Not classified:442
76631,"acephate (ISO);O,S-dimethyl acetylphosphoramidothioate",250-241-2,30560-19-1,Acute Tox. 4,Harmonised C&L,0,H302:0
76632,(dicyclopropylmethyl)amine,236-451-7,13375-29-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,Notified C&L,1,H318:1;H302:1;H226:1;H314:1
76633,2-cyclohexylidenecyclohexanone,213-779-9,1011-12-7,Not Classified,Notified C&L,233,Not classified:233
76635,Butyl 2-bromo-2-methylpropionate,262-141-6,60277-69-2,Skin Irrit. 2,Notified C&L,1,H315:1
76636,1-(4-chlorophenyl)cyclohexanecarbonitrile,264-872-6,64399-28-6,Eye Irrit. 2,Notified C&L,38,H319:38
76643,"4-(benzoylamino)-2,5-diethoxybenzenediazonium tetrachlorozincate (2:1)",226-817-4,5486-84-0,Acute Tox. 4;Carc. 2,Notified C&L,78,H302:42;H351:42;Not classified:36
76650,"Acetic acid, reaction products with bisphenol A diglycidyl ether and hexamethylenediamine",600-369-3,102923-07-9,Not Classified,Notified C&L,1,Not classified:1
76651,2-ethylhexane-1-thiol,230-854-1,7341-17-5,Flam. Liq. 3;Eye Irrit. 2;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,72,H334:38;H226:72;H319:39;H412:38;H302:33;H332:33;H312:33;H315:1
76657,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and butanol",925-599-4,,Not Classified,Notified C&L,83,Not classified:83
76658,Bromo(3-bromopropyl)triphenylphosphorus,222-770-9,3607-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H341:1
76663,chlorine,231-959-5,7782-50-5,Press. Gas;Ox. Gas 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H335:0;H315:0;H331:0;H400:0;H270:0;Not classified:0;H319:0
76666,phthalic anhydride,201-607-5,85-44-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H335:0;H315:0;H334:0;H302:0;H318:0;H317:0
76668,Polyvinyl alcohol,618-340-9,9002-89-5,Not Classified,Notified C&L,470,Not classified:360;H371:88;H302:21;H332:1;H228:1;H360:1
76673,"1,2-ethane-[2H4]diol",218-730-5,2219-51-4,Acute Tox. 4,Notified C&L,38,H302:38
76674,"2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan",440-030-5,338735-71-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,Harmonised C&L,0,H318:0;H413:0;H315:0
76676,"reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)",417-660-4,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
76679,"1,4-dimethoxy-2-nitrobenzene",201-903-4,89-39-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,71,H412:33;H302:70;H332:32;H312:32;H319:38
76680,"N,N''-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",216-994-6,1715-30-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H335:90;H315:90;H319:90
76681,"Fatty acids, C16-18 and C18 unsatd., triesters with trimethylolpropane",268-092-7,68002-78-8,Not Classified,REACH registration C&L,31,Not classified:31
76689,1-chloro-4-[(methylthio)methyl]benzene,227-657-8,5925-82-6,Acute Tox. 4,Notified C&L,38,H302:38
76690,Chloro-2-thienylmercury,227-481-1,5857-39-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H330:38;H300:38;H410:38;H373:38;H310:38
76691,2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate,240-488-4,16432-81-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:22;H315:22;H319:22;H317:17;H411:16;Not classified:6
76692,"Reaction product of esterfication of pentaerythritol with pentanoic acid, heptanoic acid and 3,5,5-trimethylhexanoic acid",451-200-3,,Not Classified,REACH registration C&L,6,Not classified:6
76693,disodium 7-acetamido-4-hydroxy-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate,615-688-3,71902-15-3,Not Classified,Notified C&L,2,Not classified:2
76699,C.I. Acid Brown 266,612-249-8,61724-23-0,Not Classified,Notified C&L,36,Not classified:36
76705,Podophyllum (resin),232-546-2,9000-55-9,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 1;Repr. 1B,Notified C&L,45,H330:45;H300:45;H314:45;H310:45;H360:45
76706,"Fatty acids, tall-oil, compds. with 2-amino-2-methyl-1-propanol",266-940-0,67701-21-7,Not Classified,Notified C&L,57,Not classified:57
76711,sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate,420-800-7,,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H410:0;H318:0;H317:0
76712,Dicyanamide,207-998-9,504-66-5,Not Classified,Notified C&L,1,Not classified:1
76716,Tetrabismuth triacontagermanium dodecaoxide,235-457-7,12233-56-6,,Notified C&L,5,H335:5;H315:5;H319:5
76720,AO-119-110,442-150-3,,Not Classified,Notified C&L,1,Not classified:1
76728,Pentafluoroiodobenzene,212-565-2,827-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
76729,Ethyl 3-amino-3-ethoxyacrylate hydrochloride,609-003-7,34570-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76745,Maghemite (Fe2O3),601-772-7,12134-66-6,Not Classified,Notified C&L,1,Not classified:1
76747,Glycerol 1-stearate,204-664-4,123-94-4,Not Classified,Notified C&L,400,Not classified:400
76755,Sodium cumenesulphonate,248-983-7,28348-53-0,Eye Irrit. 2;STOT SE 3,Notified C&L,1629,H335:1339;H319:1510;Not classified:119;H315:54
76757,"6'-(diethylamino)-1',3'-dimethylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",244-667-8,21934-68-9,Not Classified,Notified C&L,12,Not classified:12
76760,"Ginseng, Panax quinquefolium, ext.",289-898-5,90045-38-8,Flam. Liq. 3,Notified C&L,1361,H226:1318;Not classified:43
76761,4-(p-fluorophenyl)butyric acid,209-631-8,589-06-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H318:38;H302:38;H335:5;H315:5;H319:5
76762,"Fats and Glyceridic oils, margosa",616-798-4,8002-65-1,Not Classified,Notified C&L,61,Not classified:60;H413:1;H361:1
76767,[2H14]methylcyclohexane,233-325-3,10120-28-2,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,43,H315:43;H225:43;H336:43;H304:43;H411:43;Not classified:1
76771,"Phosphonium, tetrakis(hydroxymethyl)-, sulphate (2:1) (salt), polymer with urea.",613-239-6,63502-25-0,Acute Tox. 3;Skin Sens. 1A;Eye Irrit. 2;Repr. 2;Repr. 2;STOT RE 2;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 1,REACH registration C&L,9,H301:4;H361:4;H410:4;H373:4;H319:4;H317:4;H401:3;H412:5;H314:5;H302:5;H312:5
76779,"N,1,1,1-tetramethyl-N-(trimethylsilyl)silylamine",213-061-5,920-68-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H226:41;H335:39;H315:39;H319:39;H318:2;H314:2
76782,"Soaps, stocks, rice bran-oil, acidulated, hydrogenated",297-124-2,93334-50-0,Not Classified,Notified C&L,1,Not classified:1
76785,Polydextrose,614-467-9,68424-04-4,Not Classified,Notified C&L,2,Not classified:2
76788,Hydrazine dihydrobromide,245-543-6,23268-00-0,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H330:1;H300:1;H314:1;H318:1;H310:1
76789,4-[[5-(anilino)carbonyl-2-methoxyphenyl]azo]-3-hydroxy-N-(3-nitrophenyl)naphthalene-2-carboxamide,229-246-9,6448-96-0,Not Classified,REACH registration C&L,68,Not classified:68
76791,N-[3-(dimethylamino)propyl]stearamide monoacetate,236-291-8,13282-70-7,Not Classified,Notified C&L,6,Not classified:4;H331:2;H400:2;H302:2;H411:2;H318:2;H317:2
76796,"Allyl 3,5,5-trimethylhexanoate",275-536-3,71500-37-3,Acute Tox. 4,Notified C&L,258,H302:258
76797,"Quaternary ammonium compounds, di-C16-18-alkyldimethyl, chlorides",295-835-2,92129-33-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,187,H318:187;H410:187;H400:184;H226:11;H314:44;H315:3
76801,"6,8,25,27-tetrahydrobisnaphtho[2',3':6,7]indolo[2,3-c:2',3'-c']dinaphtho[2,3-i:2',3'-i']benzo[1,2-a:5,4-a']dicarbazole-5,7,9,14,19,24,26,28,33,38-decaone",239-092-4,14999-97-4,Not Classified,Notified C&L,8,Not classified:8
76802,Trifluoroacetonitrile,206-542-6,353-85-5,Press. Gas (Comp.);Acute Tox. 2,Notified C&L,39,H330:39;H280:39
76808,3-BUTYL-2-(1-ETHYLPENTYL)OXAZOLIDINE,605-389-6,165101-57-5,Aquatic Chronic 2,Notified C&L,137,H411:92;H314:40;Not classified:5
76810,Prochlorperazine maleate,201-511-3,84-02-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H332:40;H312:40;H318:1;H317:1;H411:1
76814,"2,4,6-trimethoxybenzonitrile",219-917-4,2571-54-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H332:38;H319:38;H312:38
76816,Copper concentrate obtained from Cu-Zn ore by flotation,619-464-6,999999-99-4,Not Classified,Notified C&L,108,Not classified:96;H372:6;H373:6;H335:1;H315:2;H319:1;H226:2;H412:3;H350:2;H360:3;H304:1;H411:1;H317:1;H290:1
76818,"N,N-diethyl-4-nitroaniline",218-685-1,2216-15-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H301:1;H335:1;H315:1;H331:1;H319:1;H311:1
76819,"C-dodecyl hydrogen 2-sulphosuccinate, compound with 2-aminoethanol (1:1)",276-216-6,71963-21-8,Not Classified,Notified C&L,1,Not classified:1
76820,N-(butoxymethyl)methacrylamide,225-929-0,5153-77-5,Acute Tox. 4,REACH registration C&L,115,H302:43;Not classified:72;H335:40;H315:40;H319:40;H340:1;H350:1;H373:1;H332:1;H317:1
76821,Holmium trifluoride,237-352-1,13760-78-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:38;H311:38;H331:38;H335:5;H315:5;H302:4;H332:4;H319:5;H312:4;H330:1;H310:1;H300:1
76823,1-Methyl-3-phenylpiperazine,610-888-7,5271-27-2,Acute Tox. 3;Skin Corr. 1B,Notified C&L,47,H301:39;H314:39;H315:7;H412:7;H302:8;H312:7;H318:7
76825,Zirconium nitride,247-166-2,25658-42-8,,Notified C&L,6,H335:5;H315:5;H319:5;H228:4;Not classified:1
76826,Potassium (S)-lactate,288-752-8,85895-78-9,Not Classified,REACH registration C&L,9,Not classified:9
76830,nickel selenate,239-125-2,15060-62-5,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H372:0;H317:0;H360:0
76834,Zirconium acetate,231-492-7,7585-20-8,Eye Dam. 1,REACH registration C&L,178,H318:129;H315:39;H319:44;H335:15;Not classified:5
76839,Sulfisomidine,208-204-3,515-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
76841,Difluormethoxychinoloncarbonsäureethylester,620-302-1,112811-71-9,,Notified C&L,57,Not classified:33;H412:24
76846,"Ashes (residues), plant",297-049-5,93333-79-0,Not Classified,REACH registration C&L,19,Not classified:19
76849,α-(2-thienyl)glycine,244-225-4,21124-40-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
76851,"N-[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-N-methylamine hydrochloride",617-905-7,866783-13-3,Not Classified,REACH registration C&L,5,Not classified:1;H373:2;H302:1;H332:1;H312:1;H413:1;H335:1;H315:1;H319:1
76853,1-(2-ethoxyphenyl)piperazinium chloride,280-190-1,83081-75-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H312:39
76855,"1-Propanaminium, 3-[[9,10-dihydro-4-(methylamino)-9,10-dioxo-1-anthracenyl]amino]-N,N-dimethyl-N-propyl-, bromide (1:1)",638-750-1,502453-61-4,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,57,H412:44;H302:57;H315:7;H319:7
76860,1-cyclohexylethanol,214-780-7,1193-81-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,245,H319:41;H315:241;H312:244;H302:5;H335:1
76864,"Oils, palm kernel, oleins",293-399-8,91079-13-9,Not Classified,Notified C&L,1,Not classified:1
76867,"1,4-Benzenedicarboxylic acid, 1,4-dimethyl ester, manuf. of, by-products from, polymers with diethylene glycol",615-151-3,70749-97-2,Not Classified,Notified C&L,20,Not classified:20
76869,"Adipic acid, compound with hexane-1,6-diamine (1:1)",222-037-3,3323-53-3,Not Classified,REACH registration C&L,153,Not classified:153
76870,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononan-1-oic acid",200-944-5,76-21-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H302:38;H315:38;H319:38;H314:2
76872,α-cyclohexylmandelic acid,224-380-4,4335-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43,H335:41;H315:42;H319:3;H318:39;H302:1
76873,"3,3'-dimethoxybiphenyl-4,4'-di(diazonium) zinc chloride",238-153-2,14263-94-6,,Notified C&L,1,H302:1;H350:1
76874,Allyl isobutyrate,239-821-6,15727-77-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
76876,3-chloro-3-methylbut-1-yne,214-188-9,1111-97-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H302:41;H332:41;H312:41;H225:46;H335:7;H315:7;H319:7
76877,"3,6,9,12-tetraoxatetracosan-1-ol",226-097-1,5274-68-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,187,H315:111;H319:124;H335:39;H400:59;H410:53;Not classified:36;H412:14;H302:15;H318:27
76878,4-tert-butyl-1-chlorobenzene,223-598-7,3972-56-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,33,H335:33;H315:33;H302:33;H332:33;H318:33
76882,β-cyclodextrine methyl ethers,411-120-1,,Not Classified,Notified C&L,36,Not classified:36
76888,"N-[2-(3,4-dimethoxyphenyl)ethyl]formamide",238-237-9,14301-36-1,Not Classified,REACH registration C&L,1,Not classified:1
76891,"Ferrate(1-), [[α,α'-[1,2-ethanediyldi(imino-κN)]bis[2-(hydroxy-κO)-4-methylbenzeneacetato-κO]](4-)]-, potassium",605-829-7,178667-57-7,Not Classified,Notified C&L,1,Not classified:1
76894,"(E) 1,3-undecadien-5-yne and (Z) 1,3-undecadien-5-yne",605-441-8,166432-52-6,Skin Sens. 1,Notified C&L,55,H317:55;H413:24;H315:24
76902,Polyethylene,618-339-3,9002-88-4,Not Classified,Notified C&L,816,Not classified:809;H412:5;H335:2
76903,"N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine",262-679-1,61260-55-7,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,247,H290:175;H412:175;H302:175;H314:175;H318:104;Not classified:72
76907,1-butyl-3-ethylthiourea,251-285-5,32900-06-4,Not Classified,Notified C&L,23,Not classified:23
76910,DL-3-(4-fluorophenyl)alanine,200-113-7,51-65-0,Acute Tox. 2,Notified C&L,42,H300:38;H302:3;H332:1;H312:1;H301:1
76914,"m-(3,4-dichlorophenoxy)benzaldehyde",279-069-6,79124-76-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H302:38;H410:38;H318:38;H317:38
76916,"4-Amino-5-chloro-2,1,3-benzothiodiazole",457-490-8,,Aquatic Chronic 2,Notified C&L,1,H411:1
76917,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5'-(1,2-diazenediyl)bis-",607-578-9,25157-64-6,Not Classified,REACH registration C&L,34,Not classified:34
76919,"1,1',1''-(1,1,3-trimethyl-5-methylenepentane-1,3,5-triyl)tribenzene",263-624-4,62604-62-0,Not Classified,Notified C&L,1,Not classified:1
76921,Suxamethonium chloride,200-747-4,71-27-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,28,H301:26;H335:19;H315:20;H332:18;H319:20;H311:18;H330:1;H340:1;H300:1;H334:1;H372:1
76925,N-(4-hydroxyphenyl)-p-benzoquinone monoimine,207-913-5,500-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
76926,Metasilicic acid,231-716-3,7699-41-4,Eye Irrit. 2;STOT SE 3,Notified C&L,104,H335:94;H319:94;Not classified:5;H373:4;H332:1
76928,1-(4-chlorobutoxy)-3-methylbenzene,275-769-0,71648-39-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H335:38;H315:38
76937,Ethyl orange,236-916-4,13545-67-0,,Notified C&L,4,H335:4;H315:4;H319:4
76942,Propiomazine hydrogen maleate,222-661-6,3568-23-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H317:1;H302:1;H411:1
76945,"Fatty acids, tall-oil, C12-15-alkyl esters, sulfated, sodium salts",270-307-4,68424-50-0,Aquatic Chronic 3,REACH registration C&L,1,H412:1
76946,Ammonium naphthalene-2-sulphonate,253-343-5,37087-01-7,Not Classified,Notified C&L,1,Not classified:1
76947,"A mixture of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)",601-483-6,117527-94-3,Aquatic Chronic 2,Notified C&L,503,H411:503
76948,Tris[11-[2-(pent-2-en-1-yl)oxiranyl]undec-9-enoato-O1](propan-2-olato)titanium,272-316-9,68797-79-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H335:1;H315:1;H319:1
76950,"4-(trans-4-Pentylcyclohexyl)-2,6-difluorbenzonitril",618-139-6,88308-37-6,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
76951,Strontium bromide,233-969-5,10476-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
76954,"Benzyldimethyl[2-[2-[4-(1,1,3,3-tetramethylbutyl)tolyloxy]ethoxy]ethyl]ammonium hydroxide",247-537-9,26248-39-5,Flam. Liq. 2,Notified C&L,39,H225:38;H302:1;H314:1
76955,Sodium m-[(4-amino-3-methoxyphenyl)azo]benzenesulphonate,228-581-8,6300-07-8,Not Classified,REACH registration C&L,2,Not classified:2
76956,"Sodium 1-amino-4-(cyclohexylamino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",224-460-9,4368-56-3,Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,119,H413:22;H319:21;Not classified:45;H341:40;H412:14
76957,propylenediamine,201-155-9,78-90-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H314:0;H302:0;H226:0;H312:0
76960,Methyl 4-(chlorocarbonyl)benzoate,230-937-2,7377-26-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,41,H302:39;H314:41;H290:1;H318:1
76963,"Diisooctyl 2,2'-[(dimethylstannylene)bis(thio)]diacetate",247-862-6,26636-01-1,Acute Tox. 4;Skin Sens. 1;Repr. 2;STOT RE 1;Aquatic Chronic 3,Notified C&L,56,H412:55;H361:55;H302:56;H372:55;H317:55
76964,"Phenol, ethoxylated",500-013-6,9004-78-8,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,270,H318:102;H302:137;H315:140;H319:135;H412:7;H350:7;H341:7;H332:7;H373:7;Not classified:1;H335:1
76965,Copper(2+) sulphate,242-692-9,18939-61-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H315:14;H400:14;H410:14;H302:14;H319:14
76970,5-nitro-o-toluidine hydrochloride,256-960-8,51085-52-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H301:0;H331:0;H351:0;H412:0;H311:0
76972,3-methyl-3-butenyl acetate,225-996-6,5205-07-2,Flam. Liq. 3,REACH registration C&L,115,H226:115
76973,"N,N-bis(2,3-epoxypropyl)-o-toluidine",254-755-8,40027-50-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,20,H317:19;H302:19;H315:19;H319:19;Not classified:1
76974,"Protein hydrolyzates, rice bran",305-224-5,94350-05-7,Not Classified,REACH registration C&L,53,Not classified:53
76978,4-(Methylthio)phenylacetic Acid,605-270-9,16188-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
76980,5-nitropyridin-2-ol,226-525-7,5418-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
76983,Tetramethylammonium chloride,200-880-8,75-57-0,Acute Tox. 2;Acute Tox. 3;Skin Irrit. 2;STOT SE 1;Aquatic Chronic 2,REACH registration C&L,208,H315:122;H300:115;H411:65;H370:65;H311:119;Not classified:56;H335:55;H319:58;H301:38;H312:24;H410:1
76984,"2,6,6-trimethylbicyclo[3.1.1]heptane-1-thiol",259-684-6,55511-33-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
76986,"2-Butenoic acid, 4,4,4-trifluoro-3-(methylamino)-, ethyl ester",601-768-5,121303-76-2,,Notified C&L,5,H314:4;H335:1;H315:1;H319:1
76988,ethyl methyl carbonate,613-014-2,623-53-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H226:73;H335:42;H315:68;H319:69;H225:9;H302:3;H332:3;H312:3;Not classified:2
76990,"2,2'-[[3-acetamido-4-[(4-nitrophenyl)azo]phenyl]imino]diethyl diacetate",216-247-4,1533-74-0,Not Classified,Notified C&L,64,Not classified:64
76991,"1,1'-(2-phenylethylidene)bis(1H-indole)",267-157-7,67801-37-0,Not Classified,Notified C&L,88,Not classified:88
76994,Acid Orange 86,602-036-8,12220-07-4,,Notified C&L,37,Not classified:34;H319:3
76997,"α-(Benzoylamino)-4-hydroxy-N,N-dipropylbenzenepropanamide",611-485-9,57227-09-5,Acute Tox. 4,Notified C&L,1,H302:1
77002,"4-Aminobenzoic acid, 2-ethylhexyl ester",607-885-8,26218-04-2,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H319:1;H400:1
77012,MONO-DODECYL SUCCINATE,606-815-3,21668-03-1,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H319:38
77015,"4-Cyclohexene-1,2-dicarboxylic acid, 1-[3-(3-carboxy-1-oxopropoxy)-2,2-dimethylpropyl] ester",600-565-9,1044777-82-3,Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H335:1;H319:1
77016,chlorpropham (ISO);isopropyl 3-chlorocarbanilate,202-925-7,101-21-3,Carc. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0;H351:0
77018,2-(vinyloxy)propane,213-142-5,926-65-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H225:2
77021,Glibenclamide,233-570-6,10238-21-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,222,H413:216;H302:213;H335:1;H315:1;H319:1;H370:2;H361:2;H336:1;H362:1;Not classified:1
77023,benzyl 2-(5-bromo1H-indole-3-carbonyl)pyrrolidine-1-carboxylate,921-090-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H302:2;H315:2;H319:2
77024,(2-hydroxyethyl)methylbis[2-(oleoyloxy)ethyl]ammonium methyl sulphate,306-600-1,97338-06-2,,Notified C&L,38,H315:38
77025,Diethylammonium dihydrogen phosphate,268-485-3,68109-72-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H335:91;H315:91;H319:91
77027,6-METHYL HEPTANAL,613-393-4,63885-09-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1374,H315:1374;H319:1364;H226:477
77031,ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate,414-210-9,147379-38-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
77036,Phenethyl isothiocyanate,218-855-5,2257-09-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1640,H302:1639;H319:1634;H335:39;H315:39;H334:40;H332:43;H312:43;H317:39;H314:6;H400:1
77037,(3-aminopropyl)silanetriol,261-145-5,58160-99-9,Not Classified,Notified C&L,144,Not classified:144
77044,3-(methylthio)hexanal,253-929-0,38433-74-8,Not Classified,Notified C&L,89,Not classified:79;H319:10
77047,Tetramethylammonium iodide,200-881-3,75-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H335:53;H315:54;H319:54;H301:4;H302:2;H332:1;H312:1
77052,"Chamomile oil, German",628-919-8,8002-66-2,Aquatic Chronic 3,Notified C&L,231,H412:165;H315:66;H317:1;H319:1
77053,disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate,413-600-6,6527-62-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
77054,Phenanthren-9-amine,213-431-6,947-73-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H335:101;H315:101;H319:101
77056,4-methyl-m-anisic acid,230-486-1,7151-68-0,,Notified C&L,3,H301:1;H311:1;H331:1;H335:2;H315:2;H319:2
77057,4-formylbenzoic acid,210-607-4,619-66-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,51,H302:2;H315:51;H319:51;H335:48
77066,"2-Propanol, 1,1',1'',-nitrilotris, acetate",427-360-5,,Not Classified,REACH registration C&L,3,Not classified:3
77067,"2,4-dihydroxy-N-(2-hydroxyethyl)benzamide",246-077-6,24207-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
77068,(S)-Glycidyl Trityl Ether,603-374-9,129940-50-7,,Notified C&L,5,H335:4;H315:5;H319:5
77069,4-[(4-ethoxybenzylidene)amino]benzonitrile,246-445-6,24742-30-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
77070,"(3,4,5-trifluorophenyl)boronic acid",604-355-8,143418-49-9,,Notified C&L,10,H335:8;H315:8;H319:9;H302:3;Not classified:1;H411:1
77071,"(E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one",245-842-1,23726-91-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,646,H317:645;H411:176;H315:175;Not classified:1
77072,1-(p-chlorophenyl)cyclopropanecarbonitrile,264-871-0,64399-27-5,Eye Irrit. 2,Notified C&L,39,H319:39;H335:1;H315:1
77073,N-(3-amino-3-oxopropyl)-N-[2-[(3-amino-3-oxopropyl)[2-(stearoylamino)ethyl]amino]ethyl]stearamide monoacetate,269-295-3,68214-50-6,Not Classified,Notified C&L,32,Not classified:32
77076,1-[(2-methoxyphenyl)azo]-2-naphthol,214-968-9,1229-55-6,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,38,H317:2;H319:2;H350:33;Not classified:3
77078,N-methyl-N-vinylacetamide,221-698-5,3195-78-6,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT RE 1,REACH registration C&L,125,H319:125;H302:125;H372:85;H312:125;H335:40;H315:40;H226:40
77079,"Disodium 4-hydroxy-3-phenylazo-5-((p-tolyl)sulphonylamino)naphthalene-2,7-disulphonate",229-931-2,6844-74-2,Not Classified,Notified C&L,12,Not classified:11;H315:1;H319:1
77087,(-)-2-aminobutyric acid,216-083-3,1492-24-6,Skin Sens. 1,Notified C&L,54,H317:52;H335:2;H315:2;H319:2
77088,Tetracosanol,208-043-9,506-51-4,Not Classified,REACH registration C&L,117,Not classified:103;H412:4;H319:10;H411:6;H400:6;H335:2;H225:2;H302:2;H336:2;H410:4;H312:2;H318:2
77095,N-[3-(phenylamino)allylidene]aniline monohydrochloride,248-862-9,28140-60-5,Skin Corr. 1C;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H315:3;H319:3
77098,1-Brom-4-butylbenzol,609-932-8,41492-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:43;H318:1;H410:1;Not classified:1
77101,"1,2-Ethanediamine, polymer with 1,3-diisocyanatomethylbenzene, reaction products with oleylamine",614-504-9,68441-69-0,Not Classified,Notified C&L,1,Not classified:1
77108,"Formaldehyde, oligomeric reaction products with acetone and diphenylamine",500-011-5,9003-80-9,Skin Sens. 1;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,86,H413:84;H317:84;H373:84;H319:2
77116,isobutyl (2Z)-3-aminobut-2-enoate,610-915-2,52937-90-3,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1,H317:1;H302:1;H319:1
77117,Diammonium dihydrogen ethylenediaminetetraacetate,244-063-4,20824-56-0,Acute Tox. 4;STOT RE 2,REACH registration C&L,197,H373:89;H332:114;Not classified:6;H317:55;H315:22;H319:22
77118,1-((pyrrolidine-1-carbonyl)methyl)piperazine,254-677-4,39890-45-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H332:1;H319:1;H312:1
77119,"Potassium 1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propanesulphonate",297-723-9,93762-10-8,Not Classified,Notified C&L,33,Not classified:33
77121,"Rape oil, Me esters, residues",308-943-2,99035-75-3,Not Classified,Notified C&L,1,Not classified:1
77122,Pyrazol-3-ylamine,217-338-1,1820-80-0,Not Classified,REACH registration C&L,50,Not classified:2;H302:45;H314:46;H317:5;H335:1;H315:2;H319:2;H332:1;H312:1
77123,"2,6-dimethyl-8,8-bis(2-phenylethoxy)octan-2-ol",299-726-0,93894-29-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H400:1
77124,"Fructofuranosidase, β-",232-615-7,9001-57-4,Resp. Sens. 1,REACH registration C&L,15,H334:15;Not classified:1
77125,2-(4-((3-Chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)phenoxy)propanoic acid,615-015-3,69806-34-4,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,71,H318:71;H302:71;H412:71
77132,"α,α,α-trifluoro-m-iodotoluene",206-934-7,401-81-0,Skin Corr. 1B,Notified C&L,58,H314:53;H335:6;H315:5;H319:6;H290:1;H318:1
77133,m-(dimethylamino)benzyl alcohol,245-700-9,23501-93-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
77134,4-butoxyphenylacetic acid,224-904-1,4547-57-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:45;H335:43;H315:44;H319:44
77135,"Fatty acids, C14-18 and C16-18 unsatd., triesters with trimethylolpropane",268-093-2,68002-79-9,Not Classified,Notified C&L,115,Not classified:115
77137,"1H-Pyrazole-4-carboxylic acid, 1-methyl-3-(trifluoromethyl)-, ethyl ester",601-100-2,111493-74-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
77138,"Benzenesulfonic acid, mono-C19-28-alkyl derivs., sodium salts",274-265-8,70024-73-6,Not Classified,Notified C&L,567,Not classified:441;H413:126
77139,4-ethylbenzyl alcohol,212-198-8,768-59-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
77140,"1-[(3,3-diphenylpropyl)(methyl)amino]-2-methyl-2-propanol",700-254-9,100442-33-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
77144,"trans-4-(trans-4-Ethylcyclohexyl)-cyclohexancarbonicacid-(3,4,5-trifluorphenyl)ester",605-953-1,181943-55-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
77154,(Z)-hex-3-enyl valerate,252-761-5,35852-46-1,Not Classified,Notified C&L,115,Not classified:115
77159,5-acetamido-2-nitrobenzoic acid,224-461-4,4368-83-6,,Notified C&L,5,H335:4;H315:5;H319:5
77160,(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride,426-200-1,172015-79-1,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H372:0;H318:0;H317:0
77161,Climbazole,253-775-4,38083-17-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,229,H410:169;H302:228;H400:124;H412:52;Not classified:1;H411:1
77163,1-phenylbiguanide monohydrochloride,200-239-2,55-57-2,Acute Tox. 4,Notified C&L,77,H302:40;Not classified:37
77164,5-nitro-2-thenoic acid,228-654-4,6317-37-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
77166,"Poly(1-pentene-2,3,3,4,4,5,5-heptafluoro-co-ethene-co-tetrafluoroethene)",432-060-2,,Not Classified,Notified C&L,1,Not classified:1
77177,"Hydrocarbons, C1-4;Petroleum gas;[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0.5 °C (– 263 °F to 31 °F).]",271-032-2,68514-31-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
77182,Disodium 2-hydroxyethyliminodi(acetate),205-187-4,135-37-5,Acute Tox. 4;Eye Irrit. 2;Carc. 2,REACH registration C&L,96,H302:41;H319:41;H351:41;Not classified:55
77188,Nicotinoyl chloride hydrochloride,243-648-1,20260-53-1,Skin Corr. 1B,Notified C&L,44,H314:44;H290:1;H318:2
77189,"Fatty acids, C5-10, esters with dipentaerythritol",275-093-6,70983-72-1,Not Classified,Notified C&L,534,Not classified:534
77191,"Sodium [3-[[2,4-dihydroxy-5-[(4-nitro-2-sulphophenyl)azo]phenyl]azo]-2-hydroxy-5-nitrobenzene-1-sulphonato(4-)]ferrate(1-)",284-412-8,84878-22-8,Not Classified,Notified C&L,139,Not classified:139
77192,"2,4,5,6-Pyrimidinetetramine, hydrochloride (1:2)",610-924-1,52980-67-3,,Notified C&L,1,H335:1;H315:1;H319:1
77198,4'-methoxyacetanilide,200-114-2,51-66-1,Acute Tox. 4,Notified C&L,46,H302:46;H332:1;H312:1
77199,3-amino-5-chloro-4-hydroxybenzenesulphonic acid,227-482-7,5857-94-3,Eye Irrit. 2,REACH registration C&L,1,H319:1
77201,1-(4-nitrophenyl)piperidine,229-492-7,6574-15-8,,Notified C&L,4,H335:4;H315:4;H319:4
77205,Ribostamycin sulphate,258-783-1,53797-35-6,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,39,H332:38;H312:38;H360:39
77208,Thiodi(acetic acid),204-663-9,123-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,118,H335:3;H315:3;H319:3;H314:115;H290:1;H318:1
77209,Ethyl N-methoxy-N-methylcarbamate,614-934-7,6919-62-6,Flam. Liq. 3,Notified C&L,38,H226:38
77210,Sodium icosyl sulphate,236-125-4,13177-49-6,Not Classified,Notified C&L,6,Not classified:6
77213,"Fatty acids, tall-oil, compds. with isopropanolamine",266-941-6,67701-22-8,Not Classified,Notified C&L,482,Not classified:447;H315:34;H319:2
77214,"N-alpha-Fmoc-Nw-(2,2,4,6,7-penatamethyldihydrobenzofuran-5-sulfonyl)-L-arginine",604-954-4,154445-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:41;H315:41;H319:41;Not classified:3;H302:1;H332:1;H312:1;H318:1
77218,"Stearic acid, cerium salt",233-324-8,10119-53-6,Not Classified,Notified C&L,1,Not classified:1
77219,Hydrazine Monohydrate,616-584-0,7803-57-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,301,H301:295;H400:298;H330:194;H350:299;H410:300;H314:300;H317:300;H311:266;H331:105;H226:136;H370:33;H372:34;H318:36;H310:33;H300:5;Not classified:1;H340:1;H361:1;H341:1
77222,GREY KK 81896,433-510-0,,,Notified C&L,2040,H412:2040
77224,"[1,3,8,16,18,24-hexabromo-2,4,9,10,11,15,17,22,23,25-decachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",238-238-4,14302-13-7,Not Classified,Notified C&L,224,Not classified:223;H319:1
77226,1-allyl-3-phenyl-2-thiourea,230-855-7,7341-63-1,Acute Tox. 3,Notified C&L,38,H301:38
77227,2-(octyloxy)benzoic acid,608-139-4,27830-12-2,Acute Tox. 4,REACH registration C&L,2,H302:2;H332:1;H312:1
77233,"5,6,7,8-tetrahydroquinoxaline",252-002-8,34413-35-9,Not Classified,Notified C&L,144,Not classified:96;H335:43;H315:48;H319:48
77235,Benzphetamine hydrochloride,226-489-2,5411-22-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,40,H361:40;H301:40;H311:39;H331:39
77239,"Fatty acids, tall-oil, monoesters with sorbitan",263-181-7,61791-48-8,Aquatic Chronic 2,Notified C&L,87,H411:83;Not classified:4
77241,Methoxyammonium chloride,209-798-7,593-56-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,341,H315:285;H351:286;H400:337;H412:282;H302:289;H312:288;H372:285;H318:286;H317:298;H314:56;H301:10;H290:4;H410:3;H319:2;H332:2;Not classified:1;H373:1;H252:2
77242,"Flue dust, precious metal refining",308-496-3,98072-44-7,Skin Sens. 1;Carc. 1A;Repr. 1A;STOT RE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H350:3;H410:3;H372:3;H317:3;H360:3;H301:1;H340:1;H331:1;H334:1;H314:2;H318:2;H302:1;H332:1;H401:1
77243,Dibromoacetic acid,211-165-5,631-64-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,41,H314:41;H302:38;H332:38;H312:38
77247,3-chloro-2-hydroxypropionic acid,216-993-0,1713-85-5,Skin Corr. 1B,Notified C&L,39,H314:39
77248,(2R)-2-Phenylbutyric Acid,618-983-5,938-79-4,,Notified C&L,5,H302:5;H315:4;H319:4
77249,"Disodium 5-[[4'-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]salicylate",229-149-1,6420-03-7,Carc. 1B,Notified C&L,38,H350:38
77254,"2-[2-(3,3-dimethyloxiranyl)vinyl]-2,3-dimethyloxirane",223-185-1,3765-28-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H225:38
77255,2'-deoxyadenosine 5'-(tetrahydrogen triphosphate),217-662-3,1927-31-7,Not Classified,Notified C&L,1,Not classified:1
77256,"Reaction product of ""Fatty acids, C16-18 (even numbered) and C18-unsaturated"" and ""reaction mass of 1,3-alkanediol, 2-(hydroxymethyl)-2-[(methoxymethoxy)methyl]- and 1,3-heteromonocycle-5,5-dimethanol",484-360-8,,Not Classified,REACH registration C&L,2,Not classified:2
77257,"1,4-dibromobut-2-yne",218-731-0,2219-66-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H315:1;H319:1
77258,Thallium fluoride,232-154-1,7789-27-7,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H330:43;H373:43;H411:43;H300:43
77265,"Peppermint, American, ext.",308-770-2,98306-02-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1469,H317:1456;H411:1465;H315:1466;H319:68;Not classified:3
77267,5-phenylhex-4-en-2-one,252-398-2,35151-11-2,Not Classified,Notified C&L,88,Not classified:88
77268,Sodium diisopropylbenzenesulphonate,248-984-2,28348-54-1,Not Classified,Notified C&L,8,Not classified:8
77270,"Glycerides, C16-18 mono-, di- and tri-, citrates",294-598-2,91744-36-4,Not Classified,Notified C&L,10,Not classified:10
77275,Dichloromethyltrimethylsilane,227-658-3,5926-38-5,Flam. Liq. 3,Notified C&L,38,H226:38
77276,"4,4'-methylenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",611-275-7,55492-52-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,60,H317:60;H315:60;H319:60;H411:1
77277,Phenyl nicotinate,222-428-9,3468-53-9,Eye Dam. 1,Notified C&L,43,H318:43;H317:4;H335:4;H315:5
77280,4-(3-cyclohexen-1-yl)pyridine,274-715-3,70644-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77281,"Hexasodium 2,2'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-[(3-amino-3-oxopropyl)(2-hydroxyethyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bis(benzene-1,4-disulphonate)",267-702-9,67906-33-6,Not Classified,Notified C&L,5,Not classified:5
77283,"1,2-Difluoro-4-iodobenzene (stabilized with Copper chip)",613-520-3,64248-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H302:1
77291,"4,5-dihydro-1H-imidazole",207-999-4,504-75-6,Acute Tox. 4;Skin Corr. 1B;Repr. 2,Notified C&L,1,H361:1;H302:1;H314:1
77300,"1,2,3-Propanetriol, cyclic ether with (2-methylphenyl)methanediol",603-732-4,1333-09-1,Not Classified,Notified C&L,36,Not classified:36
77301,D-ribose,200-059-4,50-69-1,Not Classified,REACH registration C&L,152,Not classified:152
77305,"Copolymer of hexanedioic acid and 1,5-pentanediol",607-985-1,26678-02-4,Not Classified,REACH registration C&L,1,Not classified:1
77309,"Fatty acids, tall-oil, sesquiesters with sorbitan",263-182-2,61791-49-9,Not Classified,Notified C&L,500,Not classified:500
77311,"1-[(2,4-dinitrophenyl)azo]-2-naphthol",222-429-4,3468-63-1,Not Classified,REACH registration C&L,887,Not classified:375;H317:24;H201:22;H319:450;H341:39;H351:38;H228:2
77312,"Oxybis(2-hydroxypropane-3,1-diyl) didocosanoate",298-007-9,93776-81-9,Not Classified,Notified C&L,1,Not classified:1
77314,"1,1,1-trifluoroiodoethane",206-541-0,353-83-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48;H302:1;H332:2;H312:2
77315,Dimethylphosphinic chloride,214-187-3,1111-92-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:44
77316,3-methylheptan-4-one,239-820-0,15726-15-5,Flam. Liq. 3,Notified C&L,1,H226:1
77317,"4-nitroso-2,6-xylenol",236-382-2,13331-93-6,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H301:38;H319:38
77318,"1,3-Dioxolane-4-carboxaldehyde, 2,2-dimethyl-, (4S)-",606-982-2,22323-80-4,,Notified C&L,1,Not classified:1
77325,"3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, (3R)-",616-691-2,794466-70-9,Skin Corr. 1B,Notified C&L,33,H314:33
77327,Docosanoic acid,204-010-8,112-85-6,Not Classified,REACH registration C&L,160,Not classified:156;H335:4;H315:4;H319:4
77329,"(Z)-N-(3-aminopropyl)-N(or N')-9-octadecenylpropane-1,3-diamine",301-482-8,94021-90-6,Acute Tox. 4;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1,Notified C&L,1,H302:1;H373:1;H314:1;H400:1
77331,1-nitro-2-phenoxybenzene,218-684-6,2216-12-8,Skin Irrit. 2,Notified C&L,42,H315:42;H335:4;H319:4
77334,"disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate",401-320-7,5719-73-3,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
77337,5-chloro-1H-indole-3-ethylamine,223-184-6,3764-94-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
77338,Pipamazine,201-512-9,84-04-8,Acute Tox. 4,Notified C&L,1,H302:1
77339,"2-[2-(2-Carboxy-benzoylamino)-ethoxymethyl]-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester",608-671-7,318465-73-5,Skin Sens. 1B;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H317:1;H373:1;H402:1;H302:1
77341,"3,3,4,4,4-pentafluorobut-1-ene",206-775-3,374-27-6,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,2,H220:2;H280:2
77342,Disperse Blue 20302/2078,473-120-8,,Not Classified,Notified C&L,1,Not classified:1
77351,"N,N'-hexane-1,6-diylbis(12-hydroxyoctadecanamide)",611-260-5,55349-01-4,Not Classified,REACH registration C&L,27,Not classified:3;H413:24;H317:23
77357,"Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4,5-trifluoro-3-methoxy-β-oxo-, ethyl ester",601-204-8,112811-70-8,Not Classified,Notified C&L,1,Not classified:1
77358,"2,2,2-trifluoro-1-(4-fluorophenyl)ethan-1-one",211-509-4,655-32-3,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:41;H319:41;H228:41
77361,Cycloheptapentylose,231-493-2,7585-39-9,Not Classified,REACH registration C&L,175,Not classified:174;H335:1;H315:1;H319:1
77367,Dipotassium oxalate hydrate,613-722-1,6487-48-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,139,H302:139;H312:139;H319:38;H315:38
77370,3'-chloroacetoacetanilide,219-328-2,2415-87-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
77375,"1,4,8,11-tetraazacyclotetradecane",206-039-1,295-37-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:45;H315:47;H319:47;H314:1;H302:1;H312:1
77378,Ammonium diethyldithiocarbamate,244-224-9,21124-33-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77381,4-(4-amino-1-naphthylazo)benzenesulphonic acid,223-060-1,3713-23-3,Not Classified,Notified C&L,1,Not classified:1
77385,"(6R,7R)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",611-363-5,56187-47-4,Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H361:1;H302:1;H372:1
77386,Potassium hydrogen diacetate,224-217-7,4251-29-0,Not Classified,Notified C&L,4,Not classified:3;H318:1
77388,"Olibanum, acetylated",294-511-8,91723-08-9,Not Classified,Notified C&L,25,Not classified:25
77390,MALEIC ANHYDRIDE COPOLYMER WITH SODIUM ACRYLATE,610-814-3,52255-49-9,Not Classified,Notified C&L,212,Not classified:192;H319:20
77391,3-nitrosalicylaldehyde,226-098-7,5274-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H335:54;H315:55;H319:55;H302:1
77393,"[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonium hydrogen maleate",276-455-6,72200-76-1,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
77395,Zirconium oxide,258-784-7,53801-45-9,Not Classified,Notified C&L,9,Not classified:9
77396,5-fluoro-1H-indole-3-ethylamine monohydrochloride,220-307-5,2711-58-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:4;H315:4;H319:4;H302:1;H332:1;H312:1
77401,Dioctadec-9-enyl phosphonate,264-626-8,64051-29-2,Not Classified,Notified C&L,35,Not classified:26;H315:9
77402,"1-bromo-4-(1,1-dimethylethyl)benzene",223-599-2,3972-65-4,,Notified C&L,9,H335:9;H315:9;H319:9;H302:1;H332:1;H312:1
77403,"Bis(glycinato-kappaN,kappaO)iron",606-444-7,20150-34-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,87,H302:2;H332:2;H312:2;H315:83;H319:83;Not classified:2
77404,"Fatty acids, linseed-oil, epoxidized, Me esters",275-094-1,70983-82-3,Not Classified,Notified C&L,1,Not classified:1
77420,"Butanedioic acid, sulfo-, monoesters with lanolin alcs., disodium salts",290-844-8,90268-43-2,Not Classified,REACH registration C&L,2,Not classified:2
77425,"3,5-bis-tert-butylsalicylic acid",243-246-6,19715-19-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:39;H335:39;H315:40;H319:40
77430,"3,4-dimethylbenzophenone",219-916-9,2571-39-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
77432,"Protein hydrolyzates, wheat germ",305-225-0,94350-06-8,Not Classified,Notified C&L,62,Not classified:61;H317:1
77433,"2,3-dimethylanisole",220-948-0,2944-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77434,"1,4-bis({3-[2-(2-hydroxyethoxy)ethoxy]propyl}amino)anthracene-9,10-dione",918-760-5,,Not Classified,Notified C&L,1,Not classified:1
77440,"N,N'-diacetylbenzidine",210-338-2,613-35-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;Carc. 1B,Harmonised C&L,0,H350:0;H302:0;H341:0;H332:0;H312:0
77441,"(7aR,cis)3,4,7a,10a-tetrahydro-5-methoxy-1H,12H-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c]chromene-1,12-dione",214-615-9,1165-39-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,3,H330:3;H310:3;H300:3;H350:3
77442,α-methylthiophen-2-ethanol,263-415-8,62119-81-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
77444,Disodium oxybis[decylbenzenesulphonate],274-342-6,70146-13-3,Eye Dam. 1,Notified C&L,162,H318:100;Not classified:47;H411:56;H319:15
77445,iprovalicarb (ISO); isopropyl [(2,604-209-3,140923-17-7,Carc. 2,Harmonised C&L,0,H351:0
77448,2-(chloromethyl)benzonitrile,210-292-3,612-13-5,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,40,H302:38;H335:38;H315:38;H318:2;H301:2;H314:2
77451,"9-Octadecenamide, N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, (9Z)-",611-142-3,54422-45-6,,Notified C&L,2,H413:2
77458,LUMILUX ROT CD 360,418-810-1,,Not Classified,Notified C&L,1,Not classified:1
77461,Sodium mercaptoacetate,206-696-4,367-51-1,Met. Corr. 1;Acute Tox. 3;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,243,H290:23;H317:141;H301:107;H312:107;H361:84;H373:84;H302:133;H315:116;H319:63;H311:18;Not classified:3;H335:3
77466,2-cyclopropylaniline,221-600-0,3158-73-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,4,H335:3;H315:3;H302:4;H332:3;H319:3;H312:3
77468,N-hydroxyoctanamide,230-936-7,7377-03-9,Not Classified,REACH registration C&L,9,Not classified:2;H335:7;H315:7;H319:7
77470,5-amino-2-chlorobenzenesulphonic acid,201-830-8,88-43-7,Skin Sens. 1,REACH registration C&L,42,H317:40;Not classified:1;H335:1;H315:1;H319:1
77472,"3,7,11,15-tetramethylhexadecane-1,2,3-triol",277-923-2,74563-64-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,66,H413:26;H317:66;H315:66;H319:1
77479,"Poly(oxy-1,2-ethanediyl), α-butyl-ω-hydroxy-",500-012-0,9004-77-7,Eye Dam. 1,REACH registration C&L,646,H318:253;H319:175;Not classified:142;H302:84;H312:76;H315:29;H335:8;H226:8;H336:8;H332:1
77482,nickel(II) isodecanoate,287-468-1,85508-43-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H341:0;H372:0;H317:0;H360:0
77483,Tetramethylene distearate,251-583-5,33587-21-2,Not Classified,Notified C&L,3,Not classified:3
77484,N-phenyl-3-(trifluoromethyl)aniline,202-926-2,101-23-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H413:38;H302:39;H319:38
77485,Tetrahydro-2-methylfuran,202-507-4,96-47-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,310,H318:76;H302:78;H315:173;H225:215;H336:81;H319:142;H335:61;H301:3;Not classified:1;H332:1
77487,"2,2',4,4'-tetrahydroxybenzophenone",205-028-9,131-55-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,331,H317:123;H302:317;H412:83;H319:186;H335:98;H315:103;Not classified:13
77489,"Oleic acid, compound with (Z)-N-octadec-9-enylpropane-1,3-diamine",254-754-2,40027-38-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,36,H400:34;H302:21;H373:1;H411:1;H314:2;H318:33;H315:33;H301:13;Not classified:1;H319:1
77493,"1,2,3,3-tetramethyl-3H-indolium iodide",226-526-2,5418-63-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
77494,[2H]hydrogen chloride,231-715-8,7698-05-7,Press. Gas (Comp.);Skin Corr. 1A;Acute Tox. 3,Notified C&L,47,H331:39;H314:47;H280:39;H335:8;H318:1
77500,Dichromium tricarbonate,229-247-4,6449-00-9,Not Classified,Notified C&L,1,Not classified:1
77504,"7-Benzothiazolesulfonic acid, 2-[4-[[4-[[3-[2-[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]diazenyl]-4-sulfophenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]-6-methyl-, sodium salt (1:2)",617-736-9,85665-95-8,Not Classified,Notified C&L,1,Not classified:1
77508,C.I. Acid Orange 107,602-037-3,12220-08-5,,Notified C&L,1,H317:1
77509,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (3:1), ether with α-[3-(dodecyldimethylammonio)-2-hydroxypropyl]-ω-hydroxypoly(oxy-1,2-ethanediyl) chloride (1:1)",602-914-0,123005-57-2,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,162,H410:126;H319:126;H400:126;Not classified:36
77510,Didodecylnaphthalene,249-154-2,28680-67-3,,Notified C&L,1,Not classified:1
77511,"Hexasodium naphth[2',3':6,7]indolo[2,3-c]dinaphtho[2,3-a:2',3'-i]carbazole-5,10,15,17,22,24-hexyl hexasulphate",245-841-6,23725-15-7,Not Classified,Notified C&L,3,Not classified:3
77513,"η-1H-indol-1-yl-α,α,ε-trimethyl-1H-indole-1-heptanol",267-156-1,67801-36-9,Not Classified,Notified C&L,234,Not classified:234
77517,"1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-lanolin acyl derivs., Et sulfates",276-339-5,72102-40-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,33,H410:15;H319:20;H400:15;H315:18
77518,C.I. Acid Brown 282,601-994-4,12219-65-7,Not Classified,Notified C&L,9,Not classified:8;H412:1
77522,(±)-α-[(methylamino)methyl]vanillyl alcohol hydrochloride,212-922-2,881-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77527,Dextropropoxyphene hydrochloride,216-683-5,1639-60-7,Acute Tox. 3,Notified C&L,46,H301:46;H318:4;H411:4;H362:4;H373:1;H331:1;H334:1;H336:1;H317:1;H330:1;H311:1
77530,(2-hydroxytrimethylene)bis[(3-chloro-2-hydroxypropyl)dimethylammonium] dichloride,251-951-5,34348-46-4,Not Classified,Notified C&L,37,Not classified:37
77532,Sodium 1-propyl 9(or 10)-(sulphooxy)octadecanoate,271-192-3,68517-12-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,28,H315:28;H319:28
77535,2-chloropropan-1-ol,201-154-3,78-89-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H226:1;H332:1;H319:1;H312:1
77536,"Amines, (hydrogenated tallow alkyl)dimethyl",263-022-1,61788-95-2,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,38,H410:18;H302:38;H314:38;H400:38;H318:4
77538,"desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine",213-800-1,1014-69-3,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H312:0;H400:0
77539,(trimethylsilyl)acetonitrile,242-169-5,18293-53-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H301:38;H335:39;H315:39;H331:38;H226:39;H319:39;H311:38;H302:1;H332:1;H312:1
77540,"octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate",413-550-5,,Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0,H318:0;H315:0
77542,"Bis[(3,4-epoxycyclohexyl)methyl] adipate",221-518-5,3130-19-6,Skin Sens. 1B,REACH registration C&L,147,H317:29;Not classified:61;H302:55;H319:70;H335:14;H315:1;H413:2
77543,"(R*,R*)-α,4-dimethyl-α-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol",208-205-9,515-69-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,274,H317:224;H411:266;Not classified:5;H300:3
77545,"N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine",429-640-2,52870-46-9,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H319:0;H400:0
77546,Triethylammonium acetate,225-995-0,5204-74-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,122,H335:118;H315:118;H319:118;H318:4;H314:4
77549,"4,4a,6,7,8,8a-hexahydro-1,4-methanonaphthalen-5(1H)-one",257-251-6,51519-65-4,Not Classified,Notified C&L,88,Not classified:54;H302:34;H315:34
77554,8-[(tributylstannyl)oxy]quinoline,226-820-0,5488-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77561,Benzenepentacarboxylic acid,216-441-9,1585-40-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
77563,"2-ethylhexyl dihydrogen phosphate, compound with N,N,N-triethylamine (1:1)",919-097-4,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,83,H318:83;H302:83;H335:83;H315:83
77565,Potassium hydride,231-704-8,7693-26-7,Water-react. 1;Skin Corr. 1B,Notified C&L,43,H314:43;H260:43;H318:1
77569,"isoxaben (ISO);N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide",407-190-8,82558-50-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
77571,"Fatty acids, coco, decyl esters",297-365-3,93455-79-9,Not Classified,Notified C&L,7,Not classified:7
77583,"Melaleuca alternifolia, ext.",285-377-1,85085-48-9,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,1931,H315:1903;H302:1912;H304:1903;H226:1856;H332:122;H411:1898;H319:1723;H317:1786;Not classified:18;H312:1;H413:1;H335:1;H336:1
77585,Octacosanoic acid,208-041-8,506-48-9,Not Classified,Notified C&L,2,Not classified:2
77586,Dirhenium heptasulphide,234-882-5,12038-67-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H315:1;H319:1;H301:1;H331:1
77587,"Dipotassium 1,5-dihydroxypentane-1,5-disulphonate",269-696-3,68310-08-7,Not Classified,Notified C&L,1,Not classified:1
77589,Bornan-2-one,200-945-0,76-22-2,Flam. Sol. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 2,REACH registration C&L,2047,H315:115;H332:1859;H318:26;H371:1456;H228:1939;H373:389;H302:486;H360:38;H335:88;H319:99;H225:66;H301:10;H411:13;H330:7;Not classified:2;H341:1;H271:1;H312:1
77590,(cyanomethyl)triphenylphosphonium chloride,224-383-0,4336-70-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H335:42;H315:43;H302:42;H332:42;H319:43;H312:42;H301:1
77593,"Chromate(2-), [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)][3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-N-phenylbenzenesulfonamidato(2-)]-, disodium",260-564-0,57108-69-7,Aquatic Chronic 2,Notified C&L,31,H411:31
77595,2-chloro-3-nitropyridine,226-799-8,5470-18-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H301:39;H335:46;H315:47;H319:47;H302:6;Not classified:1;H331:1;H311:1
77601,Itaconic anhydride,218-518-2,2170-03-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H335:45;H315:46;H302:40;H319:46;H317:2
77604,"2,2-diphenylbutyric acid",224-177-0,4226-57-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
77605,benzothiazole-2-thiol,205-736-8,149-30-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0
77614,"4,4,4-Trifluorocrotyl alcohol",614-064-8,674-53-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,4,H314:3;H302:4;H332:3;H312:3;H335:1;H315:1;H226:1;H319:1
77615,Aluminium tri(hexanolate),245-546-2,23275-26-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H320:1;H315:1;H319:1
77619,N-hydroxyoleamide,233-728-4,10335-69-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H335:1;H315:1;H319:1
77622,"6,7-dihydroxy-2-benzopyrone",206-161-5,305-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48
77623,Manganese diformate,221-842-7,3251-96-5,,Notified C&L,4,H302:4
77627,"N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide",287-466-0,85508-41-4,Skin Sens. 1B,REACH registration C&L,28,H317:23;Not classified:5
77632,"Alkenes, C12-14, hydroformylation products, distn. lights",298-699-2,93821-14-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,61,H317:61;H410:61;H315:61
77635,"Triethyl 1-propene-1,2,3-tricarboxylate",226-318-1,5349-99-5,,Notified C&L,43,Not classified:33;H226:10
77637,Mercaptamine,200-463-0,60-23-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H302:41;H335:40;H315:41;H319:41
77639,Pyridine-3-methanol N-oxide,230-187-6,6968-72-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
77640,Betazole dihydrochloride,205-345-2,138-92-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
77650,"4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl pivalate",620-105-0,952490-01-6,Repr. 2;STOT RE 2,Notified C&L,1,H361:1;H373:1
77651,3-bromotoluene,209-702-3,591-17-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:47;H302:48;H226:40;H319:47;H332:2;H312:2
77652,"Hydrocarbons, C",295-794-0,92128-94-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
77653,3-methoxybutan-1-ol,219-741-8,2517-43-3,Not Classified,REACH registration C&L,562,Not classified:210;H226:352
77654,"α,α,α-trifluoro-p-xylene",228-124-2,6140-17-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:46;H335:44;H315:45;H319:45
77656,"(R*,S*)-4,4'-(1,2-diethylethylene)bis(phenol)",201-518-1,84-16-2,Carc. 1B,Notified C&L,39,H350:39;H315:1;H302:1;H332:1;H319:1;H312:1
77661,"Wood, hydropyrolyzed",302-678-6,94114-43-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,11,H315:11;H302:11;H312:11;H319:11;H317:11
77662,POLYETHYLENE TEREPHTALATE,607-507-1,25038-59-9,Not Classified,Notified C&L,168,Not classified:165;H312:1;H413:1;H319:1
77665,"2,2'-([1,1'-biphenyl]-4,4'-diyldivinylene)bis(benzenesulphonic) acid",254-121-0,38775-22-3,Not Classified,Notified C&L,3,Not classified:3
77667,trans-3-methoxycinnamic acid,228-049-5,6099-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
77669,"Benzeneacetaldehyde, cyclic acetal with glycerol",249-934-2,29895-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1735,H302:1735;H315:15;H319:15
77671,Bis(p-methylbenzylidene)sorbitol,611-185-8,54686-97-4,Not Classified,Notified C&L,83,Not classified:83
77676,2-amino-5-chlorobenzophenone oxime,241-999-5,18097-52-4,Not Classified,REACH registration C&L,130,Not classified:92;H335:38;H315:38;H319:38
77678,4-(mercaptomethyl)benzoic acid,254-286-9,39088-65-8,Acute Tox. 4,Notified C&L,38,H302:38
77679,"Hydrocarbons, C",307-662-2,97675-88-2,Carc. 2,Harmonised C&L,0,H351:0
77682,reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;1-ethyldodecyl;1-propylundecyl;1-butyldecyl;1-pentylnonyl;1-hexyloctyl,407-740-7,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H315:0
77684,Sodium 4-(glycolloylamino)phenylarsonate,231-680-9,7681-83-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H301:38;H331:38;H400:38
77685,"2,2,2-trifluoro-1-(3-nitrophenyl)ethan-1-one",211-516-2,657-15-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H315:25;H319:25;H302:1;H332:1;H312:1
77686,L-2-amino-3-methylbutan-1-ol,217-975-5,2026-48-4,Eye Irrit. 2,Notified C&L,52,H319:47;H315:8;Not classified:4;H335:2;H314:1
77691,dinickel silicide,235-033-1,12059-14-2,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H400:0;H350:0;H410:0;H372:0;H317:0
77694,(S)-2-hydroxy-2-methylsuccinic acid,228-350-1,6236-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77703,"gon-5-ene-3,17-dione, 13-ethyl-11-methylene-, cyclic bis(1,2-ethanediyl acetal)",620-091-6,56294-43-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H351:1;H361:1;H302:1;H332:1;H312:1
77704,Tetraheptylammonium bromide,224-459-3,4368-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
77706,"Methyl 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthyl]azo]benzoate",230-249-2,6985-92-8,Not Classified,Notified C&L,6,Not classified:6
77707,Dihydrogen hexafluorotitanate(2-),241-460-4,17439-11-1,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,REACH registration C&L,118,H290:103;H301:104;H331:104;H314:117;H311:105;H330:12;H310:11;H300:12;H318:1;Not classified:1
77710,5-Chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methyl-4-pyrimidinamine,603-407-7,130339-07-0,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H410:157;H302:157;H332:157;H400:157
77713,Inositol nicotinate,229-485-9,6556-11-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:41;H319:41;Not classified:1
77718,"Phosphoric acid, mixed cetyl and stearyl esters",284-707-1,84962-12-9,Skin Irrit. 2;Aquatic Acute 1,Notified C&L,5,H315:4;H400:4;H319:1
77719,Triethylammonium dihydrogen phosphate,252-528-8,35365-94-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
77720,"Di(µ-2,2´,2´´-nitrilotris(ethanol)-diperchlorato)dinatrium",605-047-6,156157-97-0,Unst. Expl.;Eye Dam. 1;STOT RE 2,Notified C&L,1,H318:1;H200:1;H373:1
77721,"HEXANEDIOIC ACID, POLYMER WITH N-(2-AMINOETTHYL)-1,2-ETHANEDIAMINE, REACTION PRODUCTS WITH DIMETHYLEMINE AND EPICHLORIDRIN",614-622-0,68583-79-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,65,H410:41;H400:41;H411:16;Not classified:8
77725,Reaction products of Guaiacol and Camphene,920-179-7,,Aquatic Chronic 2,Notified C&L,1,H411:1
77728,2-methylpropan-2-[2H]ol,223-597-1,3972-25-6,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H335:39;H332:39;H319:39;H225:39;Not classified:1
77729,Myristamide,211-343-2,638-58-4,Skin Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H335:38;H315:38
77732,Deuterium oxide,232-148-9,7789-20-0,Not Classified,REACH registration C&L,198,Not classified:197;H335:1;H315:1;H319:1
77735,"1,2-dicarbadodecaborane(12)",240-897-8,16872-09-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:39;H312:39;H302:5;H228:5;H315:1;H319:1
77743,"Amines, polyethylenepoly-, pentaethylenehexamine fraction",303-389-8,94166-91-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,57,H400:57;H302:57;H410:57;H314:57;H312:57;H317:57
77755,"3-[(2,4-dihydro-2,4-dimethyl-3H-1,2,4-triazol-3-ylidene)hydrazono]-1-methyl-2-phenyl-3H-indolium chloride",255-178-4,41025-67-6,Not Classified,Notified C&L,3,Not classified:3
77756,Tripotassium hexacyanocobaltate,237-742-1,13963-58-1,Not Classified,REACH registration C&L,50,Not classified:5;H301:39;H311:39;H331:39;H351:5;H302:5;H332:4;H312:4;H317:5;H400:1;H330:1;H300:1;H410:1;H373:1;H310:1
77757,Heptyl isovalerate,260-170-9,56423-43-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
77760,Pentadecane,211-098-1,629-62-9,Asp. Tox. 1,REACH registration C&L,291,H304:287;H336:8;Not classified:5;H335:4;H315:4;H319:4
77763,"sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate",401-870-8,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
77764,"cis-1,4-dimethylcyclohexane",210-840-1,624-29-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3,Notified C&L,68,H336:61;H304:61;H315:60;H225:68;H335:22;H411:23
77773,Dibutyl carbonate,208-816-0,542-52-9,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,117,H318:104;H317:86;H412:105;H315:19;H335:9;Not classified:3;H319:1
77774,6-nitroindoline,243-257-6,19727-83-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:40;H315:41;H319:41;H302:6;H341:4;H332:6;H312:6
77777,"Dipotassium 3,4,5,6-tetrabromophthalate",242-604-9,18824-74-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,3,H318:2;H317:3;H315:2
77778,"N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)ethylamino]-4-methoxyphenyl]acetamide",245-098-8,22578-86-5,Not Classified,Notified C&L,2,Not classified:2
77779,2-chloroethyl vinyl ether,203-799-6,110-75-8,Flam. Liq. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H301:39;H335:38;H315:39;H225:38;H319:39;H302:2;H226:3;Not classified:1
77781,trinickel bis(orthophosphate),233-844-5,10381-36-9,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H400:0;H334:0;H350:0;H410:0;H372:0;H317:0
77785,"(Z)-4,4-dimethylpent-2-ene",212-102-4,762-63-0,Not Classified,Notified C&L,3,Not classified:3
77787,"3,4-dimethyl-5-pyrazolone",229-608-6,6628-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
77789,N-ethyl-3-trimethoxysilyl-2-methyl-propanamine,437-720-3,227085-51-0,Eye Dam. 1,Harmonised C&L,0,H318:0
77792,Sodium p-chlorobenzenesulphinate,238-811-9,14752-66-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:38;H319:41;H335:3;H315:3
77793,O-benzyl-L-valine toluene-p-sulphonate,240-702-6,16652-76-9,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,3,H317:3;H319:3
77794,"propylene oxide;1,2-epoxypropane;methyloxirane",200-879-2,75-56-9,Flam. Liq. 1;Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 1B;Carc. 1B,Harmonised C&L,0,H335:0;H340:0;H331:0;H350:0;H224:0;H302:0;H319:0;H311:0
77796,"methamidophos (ISO);O,S-dimethyl phosphoramidothioate",233-606-0,10265-92-6,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H330:0;H311:0;H300:0;H400:0
77798,1-bromododecane,205-587-9,143-15-7,Skin Irrit. 2,REACH registration C&L,145,H315:87;Not classified:58;H335:84;H319:85;H411:1;H302:1
77799,Pigment Orange 79,607-520-2,250640-08-5,Not Classified,REACH registration C&L,86,Not classified:86
77800,"Tetrabutylphosphonium acetate, compound with acetic acid",241-764-7,17786-43-5,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT SE 1,Notified C&L,69,H301:69;H330:69;H225:69;H370:69;H311:69;H412:1
77801,"1-[2,3-dihydro-1,1,2,6-tetramethyl-3-(1-methylethyl)-1H-inden-5-yl]ethan-1-one",268-799-0,68140-48-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1608,H410:39;H302:1608;H400:39
77802,"9-Octadecenoic acid (Z)-, 2-mercaptoethyl ester, reaction products with dichlorodimethylstannane, sodium sulfide(Na2S) and trichloromethylstannane",270-476-4,68442-12-6,Acute Tox. 4;Skin Sens. 1;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H400:56;H361:56;H302:56;H373:56;H410:56;H317:56
77805,"2,6,6-trimethylbicyclo[3.1.1]heptane-3-ol",207-466-6,473-54-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H319:88;H302:54;H315:64;H312:54;H311:34
77809,Alcloxa,215-262-3,1317-25-5,Eye Irrit. 2,Notified C&L,4,H319:3;Not classified:1
77813,Isosorbide Diesters,700-073-5,,Not Classified,REACH registration C&L,8,Not classified:8
77820,"Dioctadecyl 3,3'-thiodipropionate",211-750-5,693-36-7,Not Classified,REACH registration C&L,527,Not classified:399;H302:68;H312:68;H412:56;H413:5;H373:5
77827,p-[2-(dimethylamino)ethoxy]benzaldehyde,239-234-5,15182-92-0,Not Classified,Notified C&L,1,Not classified:1
77829,"2-methoxy-4-nitrobenzenediazonium naphthalene-1,5-disulphonate (2:1)",263-324-3,61925-55-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
77832,"Origanum virens, ext.",294-366-0,91721-65-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1287,H317:1287;H302:1287;H411:1287;H314:1287
77833,Dimethenamid,618-045-5,87674-68-8,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,124,H400:83;H410:83;H302:124;H332:83;H317:83;H411:38
77835,Ethylene carbonate,202-510-0,96-49-1,Acute Tox. 4;Eye Irrit. 2;STOT RE 2,REACH registration C&L,537,H302:248;H373:247;H319:398;Not classified:87;H335:47;H315:71;H318:53
77838,1-imino-1H-isoindol-3-amine,222-426-8,3468-11-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,164,H301:119;H315:163;H411:35;H318:162;H317:35;H351:83;H311:83;H335:45;H319:2;H412:1
77844,Copper sulfate pentahydrate,616-477-9,7758-99-8,Not Classified,Notified C&L,2529,Not classified:2040;H318:213;H302:454;H410:429;H400:432;H315:278;H319:275;H413:56;H301:35;H361:3;H341:3;H373:3;H370:3;H317:3;H334:2;H310:1
77846,"Gaultheria procumbens, ext.",289-888-0,90045-28-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1479,H302:1441;H319:1341;H318:41;H315:38;Not classified:37;H412:1;H361:1
77848,N-ethyl-2-(isopropyl)-5-methylcyclohexanecarboxamide,254-599-0,39711-79-0,Aquatic Chronic 3,REACH registration C&L,1512,H412:28;Not classified:1426;H318:43;H302:42;H319:15
77849,"Benzenesulfonic acid, hydroxymethyl-, reaction products with formaldehyde and urea, sodium salts",296-386-5,92623-56-8,Not Classified,Notified C&L,31,Not classified:31
77851,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and m-phenylenebis(methylamine)",920-294-2,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 3,Notified C&L,2,H331:1;H412:1;H302:2;H314:2;H317:2;H332:1;H411:1
77852,4-ethoxybenzyl alcohol,228-283-8,6214-44-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
77854,N-2-thienylacetamide,235-939-7,13053-81-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
77855,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone",207-741-0,491-70-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H335:51;H315:52;H319:52;Not classified:1
77860,2-methylaminoethanol;N-methylethanolamine;N-methyl-2-ethanolamine;N-methyl-2-amino ethanol;2-(methylamino)ethanol,203-710-0,109-83-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H314:0;H302:0;H312:0
77862,"1-iodo-2,4-dinitrobenzene",211-908-3,709-49-9,Skin Sens. 1,Notified C&L,43,H317:42;H335:4;H315:5;H319:5
77863,"Kaur-16-en-18-oic acid, 13-[(O-β-D-glucopyranosyl-(1.fwdarw.2)-O-[β-D-glucopyranosyl-(1.fwdarw.3)]-β-D-glucopyranosyl)oxy]-, β-D-glucopyranosyl ester, (4α)-",611-696-6,58543-16-1,Not Classified,Notified C&L,182,Not classified:182
77866,Heptacosan-14-one,208-815-5,542-50-7,Aquatic Chronic 4,Notified C&L,58,H413:38;Not classified:20
77868,"sodium 5-mercapto-3-oxo-2,3-dihydro-1,2-thiazole-4-carboxylate",610-355-9,475112-25-5,Skin Sens. 1,REACH registration C&L,1,H317:1
77870,"N,N'-(1,4-phenylenedicarbonyl)diglycine",245-099-3,22578-94-5,Not Classified,Notified C&L,1,Not classified:1
77871,"2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane",417-650-1,88128-57-8,STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H373:0
77872,"3-[2-chloro-5-(trifluoromethyl)phenyl]-1,1-dimethylurea",220-305-4,2711-20-8,Eye Irrit. 2,Notified C&L,38,H319:38
77873,"(1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]",274-572-7,70331-94-1,Aquatic Chronic 4,REACH registration C&L,41,H413:6;Not classified:20;H412:15
77874,Hydroxy-5-methyl-3-hexanone/2,607-413-0,246511-74-0,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,10,H331:10;H335:10;H315:10;H319:10
77879,Aminomercury chloride,233-335-8,10124-48-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H400:42;H330:42;H300:42;H410:41;H373:41;H310:42;Not classified:1
77881,"Quaternary ammonium compounds, benzylbis(hydroxyethyl)rosin alkyl, chlorides",270-086-4,68410-70-8,Skin Corr. 1B,Notified C&L,20,H314:20
77882,"tert-Butyl rel-(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate",603-330-9,129332-29-2,Not Classified,REACH registration C&L,3,Not classified:2;H313:1
77885,"1-(2,6-dichlorophenyl)-3-methylurea",275-497-2,71463-58-6,Acute Tox. 3,Notified C&L,38,H301:38
77886,3-nitrobenzohydrazide,210-572-5,618-94-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48;H302:1
77890,Dec-1-en-1-yl ethyl ether,440-020-0,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H315:1;H400:1
77896,acrylonitrile,203-466-5,107-13-1,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;STOT SE 3;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H335:0;H315:0;H331:0;H350:0;H225:0;H411:0;H318:0;H317:0;H311:0
77897,"Alcohols, C12-15-branched and linear",292-334-0,90604-40-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,58,H410:51;H400:58
77899,1-propoxypropan-2-ol,216-372-4,1569-01-3,Flam. Liq. 3;Eye Irrit. 2,REACH registration C&L,2887,H226:2858;H319:1076;H335:578;H315:580;H336:41;H302:36;H332:36;H312:36;H304:16;Not classified:8
77901,"3,5-dinitrosalicylaldehyde",219-551-5,2460-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
77903,fluoroboric acid ... %,240-898-3,16872-11-0,Skin Corr. 1B,Harmonised C&L,0,H314:0
77911,"(Z)-3-(9-octadecenyloxy)propane-1,2-diol",209-787-7,593-31-7,Not Classified,Notified C&L,1,Not classified:1
77915,"2,3-dihydroxybutanedioic acid",610-885-0,526-83-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
77916,"1,1-dimethyl-3-[octahydro-4,7-methano-1H-inden-1(or 2)-yl]urea",249-245-7,28805-78-9,Acute Tox. 4;Acute Tox. 3,Notified C&L,39,H302:38;H311:38;Not classified:1
77917,1-nitrohexane,211-467-7,646-14-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
77918,"tricyclazole (ISO);5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole",255-559-5,41814-78-2,Acute Tox. 4,Harmonised C&L,0,H302:0
77919,"Gases (petroleum), reforming hydrotreater;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]",270-785-4,68478-02-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
77923,"Methyl (9-cis)-hydrogen-6,6'-diapo-ψ,ψ-carotenedioate",230-248-7,6983-79-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,16,H335:10;H315:10;H331:10;H302:10;H319:10;H311:10;Not classified:6
77927,"Disodium 3-[[4'-[(6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-1-sulphonate",229-250-0,6449-35-0,Not Classified,Notified C&L,1,Not classified:1
77928,"2,6-dinitrophenol",209-357-9,573-56-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H331:0;H373:0;H411:0;H311:0
77931,Potassium phosphinate,231-967-9,7782-87-8,Not Classified,REACH registration C&L,3,Not classified:3
77932,"S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate",402-290-8,85702-90-5,Flam. Liq. 3;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H226:0
77939,Disodium tetrathionate,233-260-0,10101-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
77940,"Fatty acids, C18-unsatd., dimers, polymers with ethylenediamine, piperazine and sebacic acid",614-313-0,68139-81-1,Not Classified,Notified C&L,13,Not classified:13
77942,"Fatty acids, tall-oil, epoxidized, 2-ethylhexyl esters",263-024-2,61789-01-3,Not Classified,Notified C&L,118,Not classified:98;H315:20;H319:20
77947,Yellow PE 3420,403-900-5,,Not Classified,REACH registration C&L,40,Not classified:40
77949,1H-imidazole-4-carboxylic acid,214-017-8,1072-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
77951,"Naphthenic oils (petroleum), catalytic dewaxed light;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-173-9,64742-69-4,Carc. 1B,Harmonised C&L,0,H350:0
77954,"Hydrocarbons, C11-C14, n-alkanes, isoalkanes, cyclics, <2% aromatics",926-141-6,,Asp. Tox. 1,REACH registration C&L,38,H304:38;H226:1
77956,Polychlorobiphenyls (PCB 1254),601-021-3,11097-69-1,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H302:38;H373:38;H400:38;Not classified:3
77958,3-chloro-p-toluonitrile,244-381-3,21423-81-4,Flam. Sol. 2,Notified C&L,39,H228:38;H315:1;H302:1;H332:1;H319:1;H312:1
77959,(±)-butan-2-ol,240-029-8,15892-23-6,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H336:0;H226:0;H335:0;H319:0
77964,(carboxymethyl)dimethyl-3-[(1-oxodecyl)amino]propylammonium hydroxide,277-599-2,73772-45-9,Eye Dam. 1,Notified C&L,29,H318:21;H319:8
77965,4-(2-aminoethyl)aniline,236-739-2,13472-00-9,Skin Corr. 1B,Notified C&L,44,H314:44;H302:5;H332:5;H312:5;H318:1
77966,"[1,1'-bicyclohexyl]-1-carboxylic acid",262-131-1,60263-54-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
77972,"1,2-dihydro-1-methyl-5H-tetrazole-5-thione",236-132-2,13183-79-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H335:57;H315:67;H319:67;H302:10;H332:9;H312:9;H314:1;H228:2
77973,3-hydroxy-p-anisaldehyde,210-694-9,621-59-0,Not Classified,REACH registration C&L,58,Not classified:7;H335:50;H315:51;H319:51
77976,"2,2-bis(hydroxymethyl)-1,3-propanediyl bismethacrylate",248-045-7,26846-58-2,,Notified C&L,1,H335:1;H315:1;H319:1
77979,"Acetamide, N-(2,4-dinitrophenyl)-, reaction products with phthalic anhydride and sodium sulfide (Na2(Sx))",215-421-7,1326-40-5,Not Classified,Notified C&L,6,Not classified:6
77982,"2,7-dimethylacridin-3,6-yldiamine hydrochloride",205-194-2,135-49-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,39,H335:38;H315:39;H351:38;H302:38;H332:38;H319:39;H312:38
77983,"Corn, flour, acid-modified",271-198-6,68525-85-9,Not Classified,Notified C&L,1,Not classified:1
77984,"Sodium [6R-[6α,7β(Z)]]-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",264-915-9,64485-93-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,117,H334:108;H317:116;H335:10;H315:10;H319:10;H302:1;H332:1;H312:1
77987,1-bromohexadecane,204-008-7,112-82-3,Skin Irrit. 2,REACH registration C&L,63,H315:63;H335:40;H319:42
77988,(diethylamino)acetonitrile,221-130-6,3010-02-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,179,H301:179;H335:1;H315:1;H330:84;H350:1;H226:179;H411:84;H319:58;H317:1;H310:84;H331:93;H311:95;H318:38;H316:1
77994,Chlorambucil,206-162-0,305-03-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,45,H301:45;H335:40;H315:43;H350:43;H319:43;H362:4;H340:4;H373:3;H317:4;H360:6;H341:1;H370:1;H372:1;H311:1
77999,Chlorbenside,203-084-9,103-17-3,Acute Tox. 4,Notified C&L,41,H302:38;Not classified:3
78005,"Combretum micranthum, ext.",283-955-8,84776-30-7,Flam. Liq. 3,Notified C&L,1,H226:1
78007,"Slimes and Sludges, battery scrap, antimony- and lead-rich",310-061-8,102110-60-1,Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H350:1;H302:2;H410:2;H332:2;H372:2;H360:2;H351:1
78009,(5-bromo-2-fluorophenyl)methanamine hydrochloride,606-496-0,202865-69-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H319:40;H302:2;H332:1;H312:1
78011,(2-chloro-4-nitrophenyl)hydrazine,259-917-1,55950-68-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
78012,"D-Ins(1,4,5)P3, 6Na",600-866-5,108340-81-4,Eye Irrit. 2,Notified C&L,38,H319:38
78015,"2,5-dimethylhexa-1,5-diene",211-003-3,627-58-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H225:43;H304:43;H319:43
78017,"6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one",403-830-5,89331-94-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
78020,C.I. Pigment Green 18,601-657-1,12001-99-9,Not Classified,Notified C&L,12,Not classified:11;H335:1;H315:1;H319:1
78025,"Butanoic acid, 4-(dimethylamino)-4-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester",611-161-7,544714-08-1,Not Classified,Notified C&L,88,Not classified:88
78026,"4-(2,6,6-trimethylcyclohex-2-ene-1-yl)-but-3-ene-2-one",204-841-6,127-41-3,Not Classified,REACH registration C&L,1730,Not classified:1647;H411:8;H334:45;H412:27;H317:3
78028,Clomipramine hydrochloride,241-344-3,17321-77-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,58,H335:38;H315:38;H302:58;H332:39;H319:38;H312:39;H410:16;H361:15;H400:15;H370:1;H372:1;H270:1
78030,Sodium octanoate,217-850-5,1984-06-1,,Notified C&L,115,Not classified:72;H315:43;H319:42;H335:3;H361:1
78031,"[1R-(1R*,4Z,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene",204-267-6,118-65-0,Not Classified,Notified C&L,88,Not classified:88
78033,Xanthan gum,234-394-2,11138-66-2,Not Classified,Notified C&L,2616,Not classified:2163;H315:452;H319:452;H317:1
78034,Methylphosphonic dichloride,211-634-4,676-97-1,Skin Corr. 1B;Acute Tox. 2,Notified C&L,42,H330:42;H314:42
78037,"2-ethylhexanol, ethoxylated, phosphated, sodium salt",601-122-2,111798-26-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,53,H315:53;H319:49;H318:4;H412:2
78038,"Curcuma zedoaria, ext.",284-637-1,84961-49-9,Flam. Liq. 3,Notified C&L,90,H226:79;Not classified:10;H315:1;H304:2;H411:1;H317:2;H412:1
78040,Zirkonoxyfluorid,603-037-6,12518-37-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78043,6-bromo-1H-purine,212-187-8,767-69-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,128,H335:128;H315:128;H319:128
78045,Pentafluoronitrobenzene,212-915-4,880-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H302:1
78050,"Naphthalenesulfonic acid, bis(1-methylethyl)-, Me derivs., sodium salts",272-715-8,68909-82-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,220,H318:1;H302:1;H315:157;H319:157;Not classified:63
78051,"(6β)-6,19-epoxyandrost-4-ene-3,17-dione",433-490-3,6563-83-3,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
78053,"Carnation, Dianthus caryophyllus, ext.",289-653-2,89958-29-2,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,121,H412:121;H317:121;H319:48;H226:12
78054,"1,1'-Bicyclohexyl, 4-ethoxy-4'-propyl-, (trans,trans)-",619-170-8,95756-62-0,Not Classified,Notified C&L,1,Not classified:1
78056,6-Hydroxynicotinaldehyde,600-791-8,106984-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:4;H315:4;H319:4
78060,"9-(3-methylbut-2-enyloxy)-7H-furo[3,2-g]chromen-7-one",207-581-1,482-44-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H335:100;H315:100;H302:100;H319:100;H317:99;H301:1
78063,"octasodium;3-[[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-10,15,20,25,30,35,40-heptakis(2-carboxylatoethylsulfanylmethyl)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methylsulfanyl]propanoate",608-974-4,343306-79-6,Acute Tox. 4,Notified C&L,58,H302:52;Not classified:5;H334:1
78065,Isobutyl (S)-2-chloropropionate,280-349-5,83261-15-8,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,122,H317:84;H302:122;H335:38;H315:38;H319:38
78068,"N,N'-methanetetraylbis[1,1,1-trimethylsilylamine]",213-673-2,1000-70-0,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H225:38;H302:44;H319:44;H226:6
78073,"2,4,6-trimethylbenzyl chloride",216-440-3,1585-16-6,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1
78075,Lead selenide,235-109-4,12069-00-0,Acute Tox. 3;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H301:42;H331:38;H400:42;H302:38;H373:42;H332:38;H410:42;H360:42;H330:4
78076,2-butyl-4-chloro-5-formylimidazole,410-260-0,83857-96-9,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
78079,3-chloroanisole,220-642-7,2845-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:3;H319:3;Not classified:1
78081,"3,6-dichlorosalicylic acid",222-275-8,3401-80-7,Aquatic Chronic 3,Notified C&L,90,H412:90;H335:1;H315:1;H319:1
78084,Magnesium dihydride,231-705-3,7693-27-8,Water-react. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,70,H315:39;H319:39;H260:70;H228:31
78088,4-(3-chloro-1-methoxypropyl)toluene,230-186-0,6968-70-3,Acute Tox. 3,Notified C&L,38,H301:38
78090,"1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts",451-430-4,500717-36-2,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H317:0;H412:0
78093,2-Hydroxy-4-methoxybenzophenone-5-sodium sulfonate,613-918-7,6628-37-1,Skin Sens. 1,Notified C&L,1,H317:1
78096,Ethyl isobutyrate,202-595-4,97-62-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1688,H315:70;H319:68;H225:1687;H335:44;H411:1
78097,5-methylfuran-2(3H)-one,209-701-8,591-12-8,Skin Sens. 1,Notified C&L,1556,H317:1556
78099,"5,12-bis(phenylethynyl)naphthacene",242-605-4,18826-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78101,"Magnesium, bromoethynyl-",610-098-2,4301-14-8,Water-react. 2;Skin Corr. 1B,Notified C&L,64,H261:38;H314:64;H260:26;H225:26
78102,"Bleomycin, sulfate (salt)",232-925-2,9041-93-4,Muta. 1B;Carc. 2;Repr. 2,Notified C&L,44,H361:39;H340:42;H351:41;H301:2;H331:2;H334:1;H350:2;H317:2;H335:1;H315:1;H319:1;H360:2;H311:1;H371:1
78104,Vanadium disilicide,234-908-5,12039-87-1,Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38
78105,2-acetylthioethyltrimethylammonium bromide,246-570-6,25025-59-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78114,"chlorthion;O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate",207-902-5,500-28-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H332:0;H312:0
78116,Triacontanoic acid,208-042-3,506-50-3,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
78117,"3-(phenylmethylene)pentane-2,4-dione",224-382-5,4335-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78121,Strontium hydroxide,242-367-1,18480-07-4,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,104,H318:10;H314:102;H302:90;H335:2;H315:2
78122,Metformin,211-517-8,657-24-9,Not Classified,Notified C&L,3,Not classified:2;H302:1
78127,"Propanenitrile, 3-[[2-(acetyloxy)ethyl][4-[2-(2,6-dichloro-4-nitrophenyl)diazenyl]phenyl]amino]-",602-303-9,12223-23-3,,Notified C&L,1,H412:1
78130,pyridate (ISO);pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate;O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate,259-686-7,55512-33-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H410:0;H302:0;H317:0
78131,Erythritol,205-737-3,149-32-6,Not Classified,REACH registration C&L,137,Not classified:136;H335:1;H315:1;H319:1
78133,"Cinchona succirubra, ext.",283-953-7,84776-28-3,Flam. Liq. 3,Notified C&L,27,H226:27
78138,2-isopropylnaphthalene,217-976-0,2027-17-0,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H317:38;H410:38;H319:38;H400:38;Not classified:3
78141,Lexmark Black Pigment,431-150-9,,Not Classified,Notified C&L,1,Not classified:1
78152,"Sulfuric acid, zirconium salt, basic",283-244-2,84583-91-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78155,"(±)-13-ethyl-3-methoxygona-2,5(10)-dien-17-one",228-351-7,6236-40-4,Aquatic Chronic 4,REACH registration C&L,1,H413:1
78156,3-methylbenzylamine,202-890-8,100-81-2,Skin Corr. 1B,Notified C&L,48,H314:48;H318:1;H227:1
78158,"2,3-dimethylanthracene",210-328-8,613-06-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H318:38;H413:38;H335:38;H315:38
78159,4-hydroxyphenethylammonium chloride,200-462-5,60-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,171,H335:169;H315:171;H319:55;H412:1;H371:1
78165,"(E)-1-bromo-3,7-dimethylocta-2,6-diene",228-123-7,6138-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:52;H315:52;H319:48;H318:4
78166,"(S)-2-fluoro-α-methyl[1,1'-biphenyl]-4-acetic acid",257-263-1,51543-39-6,Acute Tox. 3,Notified C&L,38,H301:38
78167,"1,2,2,6,6-pentamethylpiperidin-4-ol",219-292-8,2403-89-6,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,236,H302:223;H411:72;H314:218;H318:31;H317:157;Not classified:12;H315:1;H319:1
78170,o-terphenyl,201-517-6,84-15-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,56,H335:51;H315:47;H400:43;H302:56;H319:47;H410:5;Not classified:2
78174,"Nonylphenol ethoxylate phosphate ester, potassium salt",614-624-1,68584-47-4,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,59,H318:56;H411:59;H315:3;H319:3;H226:1
78175,"1H-Benzimidazole-5,7-disulfonic acid, 2,2'-(1,4-phenylene)bis-, sodium salt (1;2)",605-910-7,180898-37-7,,Notified C&L,59,Not classified:59
78176,Nitrendipine,254-513-1,39562-70-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,157,H332:130;H312:130;H361:24;Not classified:2;H413:1;H336:1
78181,"Benzoic acid, 3,5-diamino-2,4-bis[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-6-[2-(2-sulfophenyl)diazenyl]-",608-338-6,292827-64-6,Not Classified,Notified C&L,3,Not classified:3
78182,"Mentha citrata, ext.",285-378-7,85085-49-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1411,H315:1411;H319:1380;H412:1393;H317:1378;H411:2
78183,Tungsten hexachloride,236-293-9,13283-01-7,Skin Corr. 1B;STOT SE 3,REACH registration C&L,64,H335:3;H314:64;H302:1;H341:1;H332:1
78184,(R)-quinuclidin-3-ol,246-857-6,25333-42-0,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,23,H302:16;H314:21;H318:2;H228:12;H317:9;Not classified:2;H335:1;H315:1;H319:1
78185,(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-),402-340-9,32760-80-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
78189,"1-bromo-2-chloro-1,1,2-trifluoroethane",206-544-7,354-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78191,"2,2'-Methylenebis(4-aminophenol) dihydrochloride",440-850-3,27311-52-0,Acute Tox. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H300:2;H410:2;H372:2;H319:2
78198,Zirconium tetrachloride,233-058-2,10026-11-6,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,70,H290:42;H314:70;H334:22;H302:29;H332:23;H312:23;H317:22;H335:5;H318:1
78200,"tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate",405-150-4,106028-58-4,Skin Sens. 1,Harmonised C&L,0,H317:0
78201,"Naphthalenesulfonic acid, sodium salt (1:1), polymer with formaldehyde",618-441-8,9008-63-3,Not Classified,Notified C&L,6,Not classified:6
78202,"Ethyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide",607-417-2,24683-21-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:1;H312:1
78203,"2,2,3,3,3-pentafluoropropyl acrylate",206-608-4,356-86-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H335:43;H302:38;H226:45;H332:38;H319:44;H312:38;H315:6;H411:4;H225:1
78206,"Hydrocarbons, C",307-661-7,97675-87-1,Carc. 1B,Harmonised C&L,0,H350:0
78213,"(1-methylethylidene)di-4,1-phenylene tetraphenyl diphosphate",425-220-8,5945-33-5,Not Classified,REACH registration C&L,579,Not classified:10;H413:569
78216,2-amino-4-chlorobenzenesulphonamide,223-965-1,4140-83-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
78217,Titanium carbide nitride (Ti2CN),603-147-4,12654-86-3,,Notified C&L,4,H228:4
78219,9402E,416-640-2,,Not Classified,Notified C&L,37,Not classified:37
78222,L-pyrrolidine-2-carboxylic acid,219-740-2,2517-04-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2
78230,"4,4-dimethylpent-1-ene",212-101-9,762-62-9,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,40,H304:40;H225:39
78232,"2-Propenoic acid, C>20-alkyl esters",292-061-7,90530-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H411:1;H335:1;H315:1;H319:1
78233,2-amino-6-nitro-4-(tert-pentyl)phenol,280-465-6,83488-02-2,Not Classified,Notified C&L,83,Not classified:83
78237,alkali fluorosilicates(K),240-896-2,16871-90-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H311:0;H331:0
78243,"Alcohols, C12-15-branched and linear, reaction products with ammonia-diethylene glycol reaction product morpholine derivs. residues and epichlorohydrin",292-336-1,90604-42-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1;H314:1
78247,Copper difluoride,232-147-3,7789-19-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:40;H314:41;H302:6;H332:6;H312:2
78248,1-ethoxypropan-2-ol;2PG1EE;1-ethoxy-2-propanol;propylene glycol monoethyl ether,216-374-5,1569-02-4,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0,H336:0;H226:0
78249,2-methylaziridine;propyleneimine,200-878-7,75-55-8,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Eye Dam. 1;Acute Tox. 2;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H330:0;H300:0;H350:0;H225:0;H411:0;H318:0;H310:0
78250,"2,6,6-trimethylbicyclo[3.1.1]heptane",207-467-1,473-55-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,309,H304:234;H226:309;H411:37
78253,1-(benzimidazol-2-yl)guanidine,226-527-8,5418-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78255,"Aluminum, oxo tall-oil fatty acids complexes",271-796-7,68608-70-8,Not Classified,Notified C&L,3,Not classified:3
78257,1-fluorotetradecane,209-788-2,593-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78258,(S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-trityl-1H-imidazol-4-yl)propionic acid,439-640-4,,Not Classified,Notified C&L,1,Not classified:1
78265,Isoquinol-5-ylamine,214-408-3,1125-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:46;H319:45;H302:6;H332:2;H312:1
78268,Tetrodotoxin,224-458-8,4368-28-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,41,H330:41;H310:41;H300:41
78270,C.I. Acid Brown 237,615-629-1,71872-21-4,Not Classified,Notified C&L,2,Not classified:2
78271,Octyl stearate,203-666-2,109-36-4,Not Classified,Notified C&L,1,Not classified:1
78272,"Phosphoric acid, tallow alkyl esters",271-851-5,68610-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H335:6;H315:6;H319:6
78273,N-[tert-butoxycarbonyl]-S-trityl-L-cysteine,244-674-6,21947-98-8,Not Classified,Notified C&L,3,Not classified:3
78274,"Fatty acids, tall-oil, C12-15-branched alkyl esters",295-389-9,92045-08-4,Not Classified,Notified C&L,1,Not classified:1
78278,"1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, chloride (1:1)",601-367-5,1154-78-5,Not Classified,Notified C&L,1,Not classified:1
78279,"2-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzoic acid",250-830-4,31837-42-0,Not Classified,REACH registration C&L,479,Not classified:479
78281,"Trisodium 3,3',3''-phosphinetriyltris(benzene-1-sulphonate)",264-596-6,63995-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;Not classified:1
78282,4-methylpentanenitrile,208-817-6,542-54-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H302:2;H226:2;H315:2;H319:2;H335:1;H332:1;H312:1
78284,Nadolol,255-706-3,42200-33-9,Not Classified,Notified C&L,2,Not classified:1;H302:1
78285,Ytterbium tribromide,237-350-0,13759-89-2,,Notified C&L,5,H335:5;H315:5;H319:5
78288,tert-butyldiphenylphosphine,227-848-6,6002-34-2,Not Classified,Notified C&L,1,Not classified:1
78291,alumane caesium hydride hydrofluoride,434-690-3,138577-01-2,Not Classified,Notified C&L,4,Not classified:1;H318:3;H373:2;H412:3;H372:1
78296,"Ethyl 2,3-dichloropropionate",229-607-0,6628-21-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
78298,"1,4-Dimethoxy-2-fluorobenzene",617-387-2,82830-49-7,Acute Tox. 4,Notified C&L,45,H302:38;H315:7;H319:7;H335:2
78300,"Benzene, 1,2-difluoro-4-[(1E)-2-[(trans,trans)-4'-pentyl[1,1'-bicyclohexyl]-4-yl]ethenyl]-",600-805-2,107215-69-0,Not Classified,Notified C&L,1,Not classified:1
78301,"2H-Benzimidazol-2-one, 5-amino-1-ethyl-1,3-dihydro-",607-011-5,223745-04-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,31,H317:31;H302:31
78302,osmium tetraoxide;osmic acid,244-058-7,20816-12-0,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H330:0;H310:0;H300:0;H314:0
78305,Alpha-chloro-5-methyl-2-nitrotoluene,266-359-2,66424-91-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H314:38
78306,"(1R)-2-(benzylamino)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol",600-381-9,1030385-16-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3,H318:2;H411:2;H315:2;Not classified:1
78307,"Naphtha (petroleum), catalytic reformed light, arom.-free fraction;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C",285-510-3,85116-59-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
78309,"reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;methacrylamide;2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide",412-790-8,,Muta. 2;Carc. 1B;STOT RE 2,Harmonised C&L,0,H341:0;H350:0;H373:0
78314,Undec-9-enal,205-586-3,143-14-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,153,H411:122;H315:153;H319:153;H412:31;H317:32
78317,"Benzaldehyde, 5-chloro-2-methoxy-",615-105-2,7035-09-8,,Notified C&L,5,H335:5;H315:5;H319:5
78318,4-methylindole,240-262-5,16096-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,93,H335:92;H315:93;H319:93
78321,"Barium, 1,4-bis (C13-rich C11-14-isoalkyl) 2-sulfobutanedioate phosphate complex",931-037-9,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
78322,Tri-μ-carbonylnonacarbonyltetracobalt,241-763-1,17786-31-1,,Notified C&L,4,H301:4;H331:4;H351:4;H317:4;H228:4
78325,"Chromium, 1-[[2-hydroxy-4(or 5)-nitrophenyl]azo]-2-naphthalenol complex",263-326-4,61931-53-1,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,14,H317:1;H319:1;Not classified:13
78326,3-(m-tert-butylphenyl)-2-methylpropionaldehyde,263-580-6,62518-65-4,Repr. 1B,REACH registration C&L,137,H360:50;H317:100;H302:100;H411:15;H315:1;H361:1
78327,Molybdenum disulphide,215-263-9,1317-33-5,Not Classified,Notified C&L,1499,Not classified:1190;H332:246;H335:73;H315:65;H319:73;H351:9;H302:8;H413:1
78328,(R)-2-amino-3-phenylpropanol,226-086-1,5267-64-1,Skin Corr. 1B,REACH registration C&L,50,H314:49;H315:1;H319:1;H318:1
78330,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C10-12-alkyl ethers, sodium salts",614-665-5,68610-66-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
78331,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium chloride,246-730-5,25198-22-5,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,11,H318:11;H317:2;H410:2;H400:2;H412:9
78336,Myristonitrile,211-099-7,629-63-0,Not Classified,Notified C&L,1563,Not classified:1520;H302:43;H315:1;H332:1;H319:1;H312:1
78338,"1,5-bis(5-nitro-2-furyl)penta-1,4-dien-3-one",218-443-5,2152-70-7,Eye Irrit. 2,Notified C&L,38,H319:38
78340,Tripotassium diaquaoctachloro-μ-nitridodiruthenate(3-),250-017-4,30051-65-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:1;H319:1;H302:1;H332:1
78341,"Oxirane, 2-methyl-, polymer with oxirane, monobutyl ether, phosphate",615-323-8,71662-44-7,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,963,H318:962;H412:962;H319:1
78342,"α,2,2,3-tetramethylcyclopent-3-ene-1-butyraldehyde",265-456-7,65114-03-6,Not Classified,Notified C&L,88,Not classified:88
78344,7-chloro-4-hydroxyquinoline-2-carboxylic acid,241-913-6,18000-24-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
78346,Aminothiazole,202-511-6,96-50-4,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,REACH registration C&L,61,H302:61;H335:3;H319:47;H341:5;H315:3;Not classified:2;H332:1;H312:1;H412:1
78355,Magnesium bisphosphinate,260-318-2,56663-33-3,Not Classified,Notified C&L,1,Not classified:1
78357,Polyurethane Resin,618-503-4,9018-04-6,Aquatic Chronic 2,Notified C&L,10,H411:10
78358,"5,5'-[ethylenebis(iminotrimethylene)]bis[3,8-diamino-6-phenylphenanthridinium] dichloride dihydrochloride",263-325-9,61926-22-5,Water-react. 3;Skin Corr. 1B;Eye Dam. 1;Carc. 2,Notified C&L,38,H318:38;H261:38;H314:38;H351:38
78364,"Slags, elec. furnace smelting, iron silicate",310-060-2,102110-59-8,Not Classified,REACH registration C&L,20,Not classified:20
78365,chloroacetonitrile,203-467-0,107-14-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H301:0;H311:0;H331:0
78367,Acridinium chloride,241-762-6,17784-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
78368,"Phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Bu) esters, zinc salts",270-478-5,68442-22-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,452,H318:452;H411:452;H315:452
78370,"8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione",613-975-8,666816-98-4,Not Classified,REACH registration C&L,85,Not classified:2;H412:83
78371,"1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-one",604-446-2,144850-45-3,Skin Sens. 1;Aquatic Acute 2,Notified C&L,2,H317:1;H401:1;Not classified:1
78373,"Naphtha (petroleum), hydrodesulfurized thermal cracked light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",285-511-9,85116-60-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
78374,Methyl 4-nitrobenzenesulphonate,228-282-2,6214-20-6,Skin Irrit. 2,Notified C&L,38,H315:38
78377,boric acid,233-139-2,10043-35-3,Repr. 1B,Harmonised C&L,0,H360:0
78379,"Fatty acids, olive-oil, lauryl esters",295-679-5,92113-71-8,Not Classified,Notified C&L,2,Not classified:2
78381,4-propylaniline,220-271-0,2696-84-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H315:40;H319:40;H302:6;H332:6;H312:6
78384,"N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide",423-530-8,152828-23-4,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H372:0
78387,"Gases (petroleum), reformer make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-784-9,68478-01-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
78389,1-(4-fluorophenyl)pentan-1-one,211-907-8,709-24-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H335:1;H315:1
78390,"1,2,3,4,5-pentamethyl-1H-pyrrole",212-188-3,767-76-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
78395,"Sulphuric acid, iron salt",233-336-3,10124-49-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H302:29;H315:29;H319:29;Not classified:2
78402,"1,3,3a,4,5,6,7,8,9,10,11,13a-dodecahydrocyclododeca[c]furan",255-080-1,40785-62-4,Not Classified,Notified C&L,88,Not classified:88
78404,"Collinsonia canadensis, ext.",289-722-7,89997-84-2,Not Classified,Notified C&L,1,Not classified:1
78407,"Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate, monosodium salt",241-059-4,16980-89-5,Not Classified,Notified C&L,1,Not classified:1
78408,"2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide",443-980-9,221215-20-9,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
78410,"1-(2,6-dichlorophenyl)-3-isopropylurea",275-496-7,71463-57-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
78413,"Glycerides, C18-36 mono-, di- and tri-",305-509-4,94581-11-0,Not Classified,Notified C&L,2,Not classified:2
78416,5-[1-methyl-2-(3-methylthiazolidin-2-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid,247-164-1,25651-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
78419,6-chloro-o-cresol,201-760-8,87-64-9,,Notified C&L,6,H335:6;H315:4;H400:5;H302:4;H332:4;H312:4;H318:4;H301:2;H331:2;H314:2;H311:2
78427,"3,5-dimethoxy-4-propoxybenzaldehyde",620-249-4,39075-26-8,Skin Sens. 1B,REACH registration C&L,1,H317:1
78428,2-(3-Methyl-4-nitro-pyridin-2-ylmethanesulfinyl)-1Hbenzoimidazole,604-288-4,142384-07-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78429,N-(hydroxymethyl)formamide,235-938-1,13052-19-2,Acute Tox. 3;Repr. 1B,Notified C&L,44,H311:25;H360:44
78430,"Gaultheria odorata, ext.",289-887-5,90045-27-5,Acute Tox. 4,Notified C&L,1,H302:1
78434,"Natural gas, dried",270-085-9,68410-63-9,Flam. Gas 1,Notified C&L,155,H220:155;H280:23
78441,Octenylsuccinic acid,249-244-1,28805-58-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,88,H318:86;H314:86;H302:13;H315:1;H319:1;H332:1;H312:1
78443,1-bromoethyl acetate,609-807-8,40258-78-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H315:1;H319:1
78447,TKP 50048,433-930-4,,Not Classified,Notified C&L,84,Not classified:84
78448,"Aluminium tris(2,4-pentanedionato-O,O')",237-741-6,13963-57-0,Acute Tox. 3;Eye Irrit. 2,Notified C&L,249,H301:82;H319:233;H335:144;H315:146;H300:166;H317:120;H318:15;Not classified:2;H331:1;H311:1
78450,Isobutyl stearate,211-466-1,646-13-9,Not Classified,Notified C&L,25,Not classified:23;H318:2;H315:2;H319:2
78452,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, octadecyl ester",215-654-4,1337-33-3,Not Classified,Notified C&L,1,Not classified:1
78456,monobenzone;4-hydroxyphenyl benzyl ether;hydroquinone monobenzyl ether,203-083-3,103-16-2,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H319:0
78457,"3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide",415-730-9,151338-11-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
78464,"5'-Inosinic acid, 2'-deoxy-, disodium salt",239-090-3,14999-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78466,3-azidosulfonylbenzoic acid,405-310-3,15980-11-7,Self-react. C;Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H318:0;H317:0;H373:0;H241:0
78467,C.I. Acid Yellow 166,602-111-5,12220-86-9,Not Classified,Notified C&L,2,Not classified:2
78476,"1,1'-tellurobisethane",211-002-8,627-54-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,95,H330:56;H301:95;H311:95;H331:39;H226:40
78478,"Hydrocarbons, C",307-660-1,97675-86-0,Carc. 1B,Harmonised C&L,0,H350:0
78481,Ethyl 5-bromo-2-chlorobenzoate,616-279-2,76008-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78482,SODIUM SULPHIDE HYDRATE,608-114-8,27610-45-3,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,53,H290:39;H301:43;H314:53;H400:53;H311:4
78483,Trimethylphosphine oxide,211-633-9,676-96-0,,Notified C&L,4,H302:4;H335:4;H315:4;H319:4
78487,"Carbamimidothioic acid, methyl-, methyl ester, monohydriodide",609-907-1,41306-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:38;H319:38;H302:4;Not classified:1
78488,C.I. Reactive Yellow 84,612-808-6,61951-85-7,Not Classified,Notified C&L,15,Not classified:15
78489,"Paraffin oils (petroleum), catalytic dewaxed heavy;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-174-4,64742-70-7,Carc. 1B,Harmonised C&L,0,H350:0
78490,"8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one",700-257-5,31251-41-9,Not Classified,REACH registration C&L,105,Not classified:4;H302:101;H411:99;H312:1
78491,3-amino-3-methylbutan-1-ol,255-865-9,42514-50-1,Acute Tox. 4,Notified C&L,84,H302:83;H412:1;H314:1;H227:1
78494,Medronic acid,217-851-0,1984-15-2,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:2;H335:1;H302:1;H312:1
78498,4-(heptyloxy)benzoic acid,239-995-3,15872-42-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
78499,"Insulin (ox), 8A-l-threonine-10A-l-isoleucine-",235-703-3,12584-58-6,Not Classified,Notified C&L,16,Not classified:16
78501,"Distillates (petroleum), steam-cracked, C",305-750-5,95009-23-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
78505,C.I. Direct Yellow 142,615-685-7,71902-08-4,,Notified C&L,2,Not classified:2
78510,"1H-Pyrazole-3-carboxylic acid, 4,4'-[carbonylbis[imino(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azo]]bis[4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, octasodium salt",274-455-0,70224-84-9,Not Classified,Notified C&L,2,Not classified:2
78511,"3,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde",272-323-7,68804-33-1,Skin Irrit. 2,REACH registration C&L,1,H315:1
78515,"2-chloro-1,1-diethoxyethane",210-695-4,621-62-5,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,48,H412:2;H302:46;H226:48;H335:3;H315:3;H319:4;H332:1;H312:1
78517,"Benzenesulfonic acid, mono-C12-18 alkyl derivs., compds. with triethanolamine",272-015-2,68648-96-4,Eye Irrit. 2,Notified C&L,1,H319:1
78523,"Soybean oil, epoxidized",232-391-0,8013-07-8,Not Classified,REACH registration C&L,1098,Not classified:1096;H315:2;H336:1;H304:1;H411:1
78524,"Iron, diazotized 4-amino-3-hydroxy-7-nitro-1-naphthalenesulfonic acid-diazotized 2-amino-4-nitrophenol-resorcinol coupling products copper sodium complexes",308-953-7,99148-47-7,Not Classified,Notified C&L,4,Not classified:4
78526,(hydroxymethyl)urea,213-674-8,1000-82-4,,Notified C&L,1,H335:1;H315:1;H319:1
78529,2-bromo-3-nitrobenzoic acid,209-356-3,573-54-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:42;H319:42
78531,Oleic acid,204-007-1,112-80-1,Not Classified,Notified C&L,2147,Not classified:1331;H315:776;H319:512;H335:188;H412:1;H226:1
78533,Sodium hydrogenselenite,231-966-3,7782-82-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H301:45;H331:46;H400:47;H410:47;H373:47;H300:2;H330:1
78540,5-[(2-cyano-4-nitrophenyl)azo]-6-[(2-hydroxyethyl)amino]-4-methyl-2-[[3-(2-phenoxyethoxy)propyl]amino]nicotinonitrile,264-501-8,63833-78-3,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H317:2;H410:2;H411:2
78543,Allyltriphenylphosphonium chloride,242-368-7,18480-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
78548,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium thiocyanate,281-877-9,84051-88-7,Eye Irrit. 2,Notified C&L,2,H319:2
78549,Polypropoxalated dibutyl pyrophosphoric acid,614-412-9,68310-51-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H315:20;H319:20
78551,"Propanenitrile, 3-[ethyl[4-[2-(4-nitrophenyl)diazenyl]phenyl]amino]-",602-302-3,12223-22-2,Not Classified,Notified C&L,1,Not classified:1
78552,"Isophthalic acid, oligomeric reaction products with adipic acid, hexane-1,6-diol, phthalic anhydride and propylidynetrimethanol",500-250-5,72259-84-8,Not Classified,Notified C&L,8,Not classified:8
78554,1-bromo-2-fluorobenzene,214-018-3,1072-85-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H226:48;H335:42;H315:42;H319:48;H302:7;H332:1;H312:1
78558,5-chloro-4-(4-methylphenyl)-1H-imidazole-2-carbonitrile,601-672-3,120118-14-1,Acute Tox. 4;Aquatic Chronic 1,REACH registration C&L,4,H410:3;H302:4;H335:1;H315:1;H332:1;H319:1;H312:1
78559,"1-bromo-2,4-dichlorobenzene",214-778-6,1193-72-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;H302:2;H332:2;H312:2
78562,"2,4-dinitro-1-phenoxybenzene",219-627-8,2486-07-9,Eye Irrit. 2,Notified C&L,38,H319:38
78565,"[R-(E)]-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)pent-1-en-3-one",204-842-1,127-42-4,Aquatic Chronic 2,Notified C&L,1503,H411:1502;H317:114;H315:122;H319:41;H412:1;H410:1
78567,"(S)-2,2-dimethylcyclopropanecarboxamide",278-334-3,75885-58-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
78569,"7-benzamido-4-hydroxy-3-[[p-[(p-sulphophenyl)azo]phenyl]azo]naphthalene-2-sulphonic acid, sodium salt, compound with 2,2',2''-[nitrilotris(ethyleneoxy)]triethanol",298-910-8,93840-46-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:2;H412:1
78570,Diclomezine,613-092-8,62865-36-5,Acute Tox. 3,Notified C&L,128,H331:128
78571,"Safflower oil, Me ester",273-127-4,68938-50-1,Not Classified,Notified C&L,1,Not classified:1
78573,hydroxylammonium chloride;hydroxylamine hydrochloride,226-798-2,5470-11-1,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H290:0;H315:0;H351:0;H400:0;H302:0;H373:0;H319:0;H312:0;H317:0
78574,Tungsten disilicide,234-909-0,12039-88-2,Not Classified,REACH registration C&L,2,Not classified:2
78580,"Clove, ext.",284-638-7,84961-50-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1723,H317:1718;H304:1684;H315:1394;H319:1683;H302:49;H312:44;H303:2;H316:2;H401:2;H313:1;H412:1;H335:2;H334:3;H411:1;H226:2;H413:1
78581,4-(3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid,262-509-6,60875-16-3,Acute Tox. 4,Notified C&L,38,H302:38
78588,"2-(3,4-dihydroxyphenyl)-3-(β-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one",207-580-6,482-36-0,Acute Tox. 4,Notified C&L,5,H302:5
78589,3-bromobutyric acid,220-082-3,2623-86-1,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1;H302:1
78590,"Orthophosphoric acid, oligomeric reaction products with 4,4'-isopropylidenediphenol -1-chloro-2,3-epoxypropane co-oligomer",500-175-8,67846-40-6,Not Classified,Notified C&L,230,Not classified:230
78592,"1,2-bis(3-methylphenoxy)ethane",402-730-9,54914-85-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
78594,Olaquindox,245-832-7,23696-28-8,Acute Tox. 4;Resp. Sens. 1,Notified C&L,43,H334:39;H302:42;H317:4;H340:1;H351:1;H361:1;H341:1;H411:1
78596,"Ethyl hydrogen heptane-1,7-dioate",251-346-6,33018-91-6,,Notified C&L,6,H315:6;H319:6;H335:1
78597,4-nitrophenyl chloroformate,231-706-9,7693-46-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,60,H318:3;H335:50;H314:58;H302:4;H332:4;H315:2;H319:2;H301:3;H331:3;H311:3
78598,"Mucopolysaccharides, cartilage",296-623-2,92875-07-5,Not Classified,Notified C&L,1,Not classified:1
78600,"Estra-1,3,5(10)-triene-3,17β-diol 17-(benzenepropionate)",247-690-1,26443-03-8,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,17,H360:17;H332:16;H312:16;H351:16;H372:1;H350:1
78603,"Hydrocarbons, C4-7, C5-rich, isoprene-purifn. by-product",295-415-9,92045-34-6,,Notified C&L,1,H412:1;H302:1;H224:1
78606,"Thiocyanic acid, compound with 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane",257-829-8,52302-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78608,3-fluorobenzylamine,202-891-3,100-82-3,Skin Corr. 1B,Notified C&L,47,H314:47;H318:2;H302:1;H332:1;H312:1;H227:1
78609,"Balsams, copaiba, sulfurized, platinum salts",272-832-4,68916-35-8,Flam. Sol. 1,Notified C&L,2,H228:1;H317:1
78613,Ethyl acetimidate,213-676-9,1000-84-6,,Notified C&L,1,H335:1;H315:1;H319:1
78614,"4,5-dimethylsalicylic acid",261-140-8,58138-52-6,,Notified C&L,1,H302:1;H335:1;H315:1;H319:1
78619,Benzyl(2-hydroxyethyl)dimethylammonium chloride,230-619-3,7221-40-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
78620,Nonyl undecyl phthalate,265-603-5,65185-89-9,Not Classified,Notified C&L,1,Not classified:1
78625,"Ammonium α,4-dihydroxy-3-methoxytoluene-α-sulphonate",268-382-3,68083-34-1,Not Classified,Notified C&L,1,Not classified:1
78630,Adeka 25R1,923-642-1,106392-12-5,,Notified C&L,56,Not classified:43;H332:13
78632,"2,2,6,6-tetramethylpiperidin-4-ol",219-291-2,2403-88-5,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1,REACH registration C&L,178,H317:166;H302:111;H314:170;H318:101;H413:16;Not classified:5;H335:2;H315:3;H319:3
78636,"Fatty acids, castor-oil, sodium salts",232-390-5,8013-06-7,Not Classified,Notified C&L,3,Not classified:3
78637,"N-(2,3-epoxypropyl)phthalimide",226-710-2,5455-98-1,Eye Dam. 1,Notified C&L,63,H318:62;H335:2;H315:2;H319:1;H341:1
78639,Methyl 3-(bromomethyl)-2-benzofurancarboxylate,261-428-3,58763-73-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
78640,Orange UD-008,479-090-2,,Aquatic Chronic 3,Notified C&L,37,H412:37
78641,2-[(3-aminopropyl)methylamino]ethanol,255-615-9,41999-70-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,32,H302:32;H314:32;H312:32;H318:32;H317:32
78643,"1,2-Difluor-4-[2-(4-trans-propyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl]-benzene",600-803-1,107215-66-7,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
78644,"5-chloro-1,2-benzisothiazol-3(2H)-one",224-385-1,4337-43-3,Not Classified,Notified C&L,33,Not classified:33
78646,2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine dimethanesulphonate,257-495-3,51888-09-6,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,3,H334:1;H317:3;H302:3;H318:2;H411:2;H332:1;H312:1
78655,"Ethyl (1,1-dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetate",607-416-7,24683-20-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:1;H312:1
78656,(1-hydroxycyclopentyl)phenylacetic acid,246-733-1,25209-52-3,,Notified C&L,1,H302:1
78658,"4-(1,3-diphenylbutyl)-o-xylene",260-245-6,56525-86-1,Not Classified,Notified C&L,12,Not classified:12
78661,"Disodium 3-[(2,4-dimethyl-5-sulphonatophenyl)azo]-4-hydroxynaphthalene-1-sulphonate",224-909-9,4548-53-2,Not Classified,REACH registration C&L,276,Not classified:276
78665,"Cinchona officinalis, ext.",283-952-1,84776-27-2,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,2,H317:2;H302:2
78666,toluidine sulphate (1:1),208-741-3,540-25-0,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H301:0;H331:0;H351:0;H400:0;H319:0;H317:0;H311:0
78668,Niobium pentachloride,233-059-8,10026-12-7,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,47,H302:47;H335:1;H314:47;H332:39;H312:39;H318:2
78670,Tetradecane,211-096-0,629-59-4,Asp. Tox. 1,REACH registration C&L,1691,H304:1687;H315:83;H336:67;Not classified:4;H319:4;H413:1
78674,"Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates",296-019-9,92201-88-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H410:2;H315:40;H319:2;H400:2;H411:20
78675,Diethyl allylmalonate,218-072-9,2049-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:39;H319:39;Not classified:1
78676,(2-bromo-5-fluorophenyl)methanol,606-492-9,202865-66-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H302:41;H319:40;H318:2;H335:1;H315:1
78678,"Alkenes, C10-14-branched and linear, C12-rich",298-697-1,93821-12-6,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,22,H304:22;H410:22;H226:19;H400:21;H336:9
78679,"1,4-diiodobenzene",210-842-2,624-38-4,,Notified C&L,7,H335:7;H315:7;H319:7
78680,[No public or meaningful name is available],481-910-9,,Skin Sens. 1B;Eye Irrit. 2,Notified C&L,25,H317:25;H319:25
78681,"4,5-dihydro-2-heptadecyl-1H-imidazole-1-ethylamine",221-133-2,3010-23-9,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:33;H314:38;H400:33;H411:5;Not classified:1
78682,1-(5-methyl-2-furyl)ethan-1-one,214-779-1,1193-79-9,Acute Tox. 4,Notified C&L,1590,H302:1590
78683,"2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane",413-900-7,85954-11-6,Skin Sens. 1;Carc. 2,Harmonised C&L,0,H317:0;H351:0
78684,Didodecyldimethylammonium chloride,222-274-2,3401-74-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H315:5;H319:5;H302:1
78685,Ethyl (Z)-2-amino-α-(methoxyimino)thiazol-4-acetate,264-912-2,64485-88-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
78686,5-ethylbarbituric acid,219-743-9,2518-72-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78688,Triphenylphosphine oxide,212-338-8,791-28-6,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,208,H412:200;H302:203;H303:1;H335:41;H315:42;H319:42;Not classified:6;H411:1
78690,N-[3-[(3-aminopropyl)amino]propyl]stearamide,255-703-7,42195-41-5,Not Classified,Notified C&L,37,Not classified:37
78694,3-nitrophenetole,210-691-2,621-52-3,Acute Tox. 4,Notified C&L,38,H302:38
78695,"2-ethylhexyl dihydrogen phosphate, compound with 2,2',2''-nitrilotriethanol (1:2)",268-493-7,68109-82-0,Not Classified,Notified C&L,5,Not classified:3;H319:2
78696,4-(tertbutyl)-2-hydroxycyclohexyl-2-methylprop-2-enoate,603-306-8,128840-36-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H335:1;H315:1;H319:1;H413:1;H317:1
78702,"N,N-dimethyl-4-nitrosoaniline",205-343-1,138-89-6,Self-heat. 1;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H301:42;H335:38;H315:39;H251:43;H319:39;H317:38;H351:4;H373:4;H311:4;H228:4;Not classified:1;H302:1
78703,"Glycine, N-methyl-, N-tallow acyl derivs.",291-364-1,90387-87-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,25,H318:25;H315:25;H400:25
78705,"4,4'-(2,3-dimethyltetramethylene)dipyrocatechol",207-903-0,500-38-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,258,H302:258;H335:219;H315:258;H319:258;H301:1
78710,Benzyl L-prolinate hydrochloride,240-700-5,16652-71-4,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
78714,"Bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-N3,O4)zinc",262-207-4,60388-02-5,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
78716,"Glycerides, palm-oil mono-, di- and tri-, hydrogenated, 2,3-bis(acetyloxy)butanedioates",294-636-8,91744-71-7,Not Classified,Notified C&L,1,Not classified:1
78718,Manganese(II) isooctanoate,253-508-1,37449-19-7,Not Classified,Notified C&L,14,Not classified:12;H335:1;H315:2;H302:1;H332:1;H319:1;H312:1
78719,Aluminum sodium oxide,234-391-6,11138-49-1,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,145,H290:91;H318:78;H314:120
78722,2-methylenedecan-1-al,244-979-4,22418-65-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H315:1;H400:1
78723,Dilithium zirconium trioxide,234-760-1,12031-83-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
78726,"(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol",620-176-8,864070-44-0,Repr. 2,Notified C&L,3,H361:2;H362:1
78736,"Phosphoric acid, C12-14-alkyl esters, ammonium salts",291-872-3,90506-14-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,7,H318:6;H315:7;H302:1;H319:1
78737,Flurazepam,241-591-7,17617-23-1,Acute Tox. 4;STOT SE 3,REACH registration C&L,42,H302:42;H336:2;H373:1
78740,L-lysine dihydrochloride,211-518-3,657-26-1,Not Classified,Notified C&L,1,Not classified:1
78742,"1,2,3-trimethylcyclohexane",216-838-7,1678-97-3,Flam. Liq. 2,Notified C&L,1,H225:1
78744,Tetraglyceryl monoisostearate,618-794-8,91824-88-3,Not Classified,Notified C&L,37,Not classified:37
78745,Terbium trinitrate,233-138-7,10043-27-3,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,11,H318:2;H410:2;H400:2;H272:8;H335:7;H315:7;H319:7;Not classified:1
78748,Prifinium bromide,225-051-8,4630-95-9,Acute Tox. 4,Notified C&L,6,H302:6
78752,8-methylnonyl nonan-1-oate,203-665-7,109-32-0,Not Classified,Notified C&L,2,Not classified:2
78758,"Fatty acids, olive-oil, decyl esters",297-367-4,93455-81-3,Not Classified,Notified C&L,1,Not classified:1
78768,"Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;Petroleum gas",270-782-8,68477-99-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
78769,"6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one",212-558-4,826-73-3,Not Classified,Notified C&L,1,Not classified:1
78771,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate",286-170-9,85187-82-2,Not Classified,Notified C&L,2,Not classified:2
78772,"2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol",274-570-6,70321-86-7,Not Classified,REACH registration C&L,629,Not classified:245;H412:184;H413:154;H335:70;H315:71;H319:71;H336:37
78774,"Pyridine, 2-(1,2-dibromo-2-phenylethyl)",620-238-4,6294-62-8,Not Classified,Notified C&L,1,Not classified:1
78775,Calcium thiosulphate,233-333-7,10124-41-1,Not Classified,REACH registration C&L,3,Not classified:3
78776,Caesium nitrate,232-146-8,7789-18-6,Ox. Sol. 1;Acute Tox. 4;Repr. 2,REACH registration C&L,109,H361:1;H302:2;H271:1;H272:108;H335:99;H315:99;H319:99;Not classified:1
78777,4-pyridylmethanol,209-590-6,586-95-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:38;H335:38;H315:43;H319:43
78780,C.I. Direct Violet 99,618-240-5,89106-93-4,Not Classified,Notified C&L,1,Not classified:1
78781,"Fatty acids, C8-18, Me esters",292-969-3,91031-65-1,Not Classified,Notified C&L,3,Not classified:3
78782,o-butyl-aniline,220-272-6,2696-85-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H302:1;H332:1;H312:1
78784,[(9-oxo-9H-thioxanthen-2-yl)oxy]acetic acid,282-803-8,84434-05-9,Aquatic Chronic 3,REACH registration C&L,3,H412:3
78786,Phenyl 4-chlorobutyrate,259-369-3,54839-22-4,Acute Tox. 4;Skin Sens. 1;STOT SE 3,Notified C&L,38,H317:38;H302:38;H335:38
78789,hexahydro-3-methylphthalic anhydride,260-566-1,57110-29-9,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H317:0;H334:0
78792,"Naphthenic acids, copper salts;copper naphthenate",215-657-0,1338-02-9,Flam. Liq. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H226:0;H400:0
78801,"2H-1-Benzopyran-2-methanol, a,a'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, (aR,a'R,2R,2'S)-rel-",601-527-4,118457-14-0,Acute Tox. 4,REACH registration C&L,2,H302:2;H335:1;H315:1;H361:1;H332:1;H319:1
78803,2-methylanthracene,210-329-3,613-12-7,Aquatic Acute 1,Notified C&L,42,H400:38;H302:4;H332:3;H312:4
78804,"Polyaniline (emeraldine salt) long chain, grafted to lignin",608-886-6,335349-50-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
78807,Bis[hydroxyguanidinium] sulphate,228-749-0,6345-29-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H335:2;H315:2;H302:2;H332:2;H319:2;H312:2
78813,Tris[oxalato(2-)]disamarium,221-844-8,3252-68-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
78819,ethyl lactate;ethyl DL-lactate,202-598-0,97-64-3,Flam. Liq. 3;Eye Dam. 1;STOT SE 3,Harmonised C&L,0,H318:0;H226:0;H335:0
78820,"3a,4,5,6,7,7a-hexahydro-2,6(or 3,6)-dimethyl-4,7-methano-1H-inden-5-ol",304-293-9,94248-21-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,290,H317:290;H302:290;H319:290
78823,2-[4-hydroxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-yl)phenol,609-119-8,35354-74-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,159,H335:89;H315:89;H302:89;H411:95;H319:114;H318:45
78826,"Formaldehyde polymer with 1,3-benzenediol, [1,1'-biphenyl]-ar, ar'-diol and [1,1'-biphenyl] triol",613-849-2,65876-95-1,Not Classified,Notified C&L,41,Not classified:33;H302:7;H315:7;H319:8;H400:7
78827,1-bromo-2-fluoroethane,212-100-3,762-49-2,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Ozone 1,Notified C&L,45,H335:45;H315:45;H300:45;H225:45;H319:45;H420:45;H310:45
78828,2-ethylaminoethanol,203-797-5,110-73-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,154,H318:145;H302:153;H314:114;H311:66;H319:1;H315:1;H412:1;H336:1;H317:1
78829,Alexidine,245-096-7,22573-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
78830,"N,N'-bis(3-aminopropyl)ethylenediamine",234-147-9,10563-26-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,177,H302:173;H314:135;H318:108;H317:112;H311:107;H335:38;H315:38;H319:38;H310:40;H332:22;H312:4;H412:1
78839,"(1R,6S)- 4,7,7-Trimethyl-3-oxabicyclo[4.1.0]hept-4-en-2-one",615-077-1,70174-49-1,Not Classified,REACH registration C&L,1,Not classified:1
78842,2-ethoxy-2-methylbutane,618-804-0,919-94-8,Flam. Liq. 2;Asp. Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H305:2;H315:2;H225:3;H336:2;H319:2;Not classified:3
78843,Aksepillen,616-542-1,7789-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H335:62;H315:62;H319:62;Not classified:41
78844,"Heptanoic acid, mixed esters with pentaerythritol and valeric acid",270-474-3,68441-94-1,Not Classified,Notified C&L,19,Not classified:19
78845,"2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one",430-170-5,114625-74-0,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
78846,2-hydroxypropyl benzoate,253-340-9,37086-84-3,Not Classified,Notified C&L,64,Not classified:64
78848,Phenyl anthranilate,233-608-1,10268-69-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
78849,"Butanoic acid, 4-[[4-[7-chloro-6-(1,1-dimethylethyl)-3H-pyrazolo[1,5-b][1,2,4]triazol-2-yl]phenyl]amino]-4-oxo-, tetradecyl ester",604-870-8,152827-98-0,Eye Irrit. 2,Notified C&L,4,H319:1;H317:1;H411:1;H413:2
78852,allylamine,203-463-9,107-11-9,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H331:0;H225:0;H411:0;H311:0
78854,"1,3-bis(hydroxymethyl)imidazolidin-2-one",205-264-2,136-84-5,Not Classified,Notified C&L,39,Not classified:37;H302:1;H319:1;H317:1;H351:1
78857,2-bromo-10H-phenothiazine,927-779-8,66820-95-9,Acute Tox. 4,REACH registration C&L,2,H302:2
78858,2-Bromo-4-fluoroanisole,610-229-3,452-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
78860,"Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate",278-405-9,76258-20-3,,Notified C&L,1,H314:1
78862,2-(4-chloro-3-sulphamoylbenzoyl)benzoic acid,226-089-8,5270-74-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38
78863,(Z)-octadec-6-enoic acid,209-789-8,593-39-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:39;H319:39;Not classified:1
78866,"(1,3,4,5,6,7-hexahydro-1,3-di­oxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",214-619-0,1166-46-7,Acute Tox. 4;Carc. 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H351:0;H410:0;H302:0;H371:0
78867,Hexaflumuron,617-865-0,86479-06-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H332:38;H400:39
78870,Dimanganese trioxide,215-264-4,1317-34-6,Not Classified,REACH registration C&L,500,Not classified:15;H335:364;H315:482;H302:345;H332:344;H319:482;H312:304;H413:39;H373:1
78878,"4-isopropyl-2,2,5,5-tetramethyl-1,3-dioxane",263-322-2,61920-45-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,88,H317:88;H314:88;H318:36
78879,Methyl carbamate,209-939-2,598-55-0,Eye Irrit. 2;Carc. 2,REACH registration C&L,652,H319:646;H351:649;H335:495;H315:496;H302:2;H312:1;Not classified:1
78883,Bis(2-chloro-1-methylethyl) (2-chloro-1-methylethyl)phosphonate,230-779-4,7316-55-4,Acute Tox. 4,Notified C&L,38,H302:38
78884,"1,3-dimethylbutylamine",203-549-6,108-09-8,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,39,H302:39;H314:39;H225:39;H318:1;H311:1
78885,Octadecylguanidine monohydrochloride,245-780-5,23604-21-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78891,5-methylheptan-3-one oxime,245-010-8,22457-23-4,Aquatic Chronic 3,REACH registration C&L,1643,H412:52;H319:1289;Not classified:302
78892,"Oxidase, thiol",232-851-0,9029-39-4,Resp. Sens. 1,Notified C&L,1,H334:1
78893,"α,2,5-trimethylbenzyl alcohol",251-294-4,32917-52-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H335:1;H315:1
78898,MUSCOVITE,603-531-1,1318-94-1,,Notified C&L,45,Not classified:25;H319:20
78899,".alpha.-Undecyl-.omega.-hydroxypoly(oxy-1,2-ethanediyl), branched and linear",603-182-5,127036-24-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,1010,H318:913;H302:912;H319:89;Not classified:8
78903,Benzenesulfonyl cyanide,607-345-1,24224-99-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H301:38;H311:38;H331:38
78907,Trimethyl(vinyloxy)silane,228-281-7,6213-94-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H225:44
78911,"2-Imidazolidinone, 1-(2-aminoethyl)-, N,N-bis[2-hydroxy-3-(2-propenyloxy)propyl] and N-[2-hydroxy-3-(2-propenyloxy)propyl] derivs.",291-480-2,90412-00-3,Not Classified,Notified C&L,181,Not classified:181
78912,"Fatty acids, C18-22, compds. with triethanolamine",297-423-8,93571-95-0,Not Classified,Notified C&L,1,Not classified:1
78913,"2,2',2''-nitrilotrisethyl tri(dihydrogenphosphate)",268-796-4,68140-45-4,Not Classified,Notified C&L,1,Not classified:1
78914,5-hydroxy-2-phenyl-4-benzopyrone,207-743-1,491-78-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
78915,"dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)",278-404-3,76253-60-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
78919,Ethyl 2-bromovalerate,210-450-1,615-83-8,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H335:40;H314:44;H290:1;H318:1;H315:1;H319:1
78920,(Z)-9-cycloheptadecen-1-one,208-813-4,542-46-1,Not Classified,Notified C&L,184,Not classified:146;H315:38
78922,Yttrium triiodide,236-737-1,13470-38-7,Skin Sens. 1;Resp. Sens. 1;Carc. 2,Notified C&L,43,H334:39;H317:39;H351:39;H335:4;H315:4;H319:4
78924,Diisopropyl sulphide,224-225-0,4253-89-8,Eye Irrit. 2;STOT SE 3,Notified C&L,1417,H335:1415;H319:1416;H225:130;H315:40;H226:1
78926,1-methylheptyl cyclopent-2-ene-1-acetate,301-094-9,93981-12-5,Acute Tox. 4,Notified C&L,1,H302:1
78927,Methyl 3-chloropropionate,227-844-4,6001-87-2,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H226:1;H335:1;H315:1
78928,2-methoxyethylamine,203-712-1,109-85-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,49,H314:49;H225:49;H302:7;H318:3;H412:1;H312:1
78929,"Dihydro-2,2-dioctyl-6H-1,3,2-oxathiastannin-6-one",221-218-4,3033-29-2,STOT SE 2,REACH registration C&L,3,H371:3
78930,N-carbamoylaspartic acid,236-134-3,13184-27-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
78931,Oxine-copper,233-841-9,10380-28-6,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1,Notified C&L,93,H330:70;H315:85;H319:87;H400:71;H335:16;Not classified:5;H302:2;H371:2;H332:1;H331:1
78934,"Hexasodium 4,4'-bis[[4-chloro-6-[[3-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-sulphonatophenyl]amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",274-454-5,70224-83-8,Skin Sens. 1,Notified C&L,11,H317:9;H318:2;H371:2;H412:2
78935,"Chromium(3+) hydrogen {(6E)-6-[(2Z)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinylidene]cyclohexa-2,4-dien-1-ylidene}methanediolate (1:1:2)",612-348-6,61725-75-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,176,H410:176;H400:176
78936,"Oleic acid, compound with 2,2'-iminodiethanol (1:1)",237-740-0,13961-86-9,Not Classified,Notified C&L,92,Not classified:54;H331:23;H318:13;H361:13;H373:13;H315:14;H319:2
78937,"Chromium, 4-hydroxy-3-[(2-hydroxy-1-naphthalenyl)azo]benzenesulfonamide 4-hydroxy-5-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]-1,3-benzenedisulfonate sodium complexes",277-813-4,74313-68-1,Not Classified,Notified C&L,2039,Not classified:2039
78938,"Disodium 3-hydroxynaphthalene-2,7-disulphonate",205-196-3,135-51-3,Not Classified,REACH registration C&L,79,Not classified:38;H315:40;H319:40;H335:1;H302:1;H332:1;H312:1
78941,"Glycerides, coco",295-412-2,92045-31-3,Not Classified,Notified C&L,15,Not classified:15
78942,Stearonitrile,211-345-3,638-65-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H312:38;H319:1
78945,Zopiclone,256-138-9,43200-80-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,110,H335:102;H315:103;H361:101;H302:110;H332:102;H319:104;H312:102;H411:7;H360:4;H336:4;H362:6;H373:5;H318:2;H351:1;H410:1;H331:1
78946,AKPT-1,469-680-8,,Not Classified,Notified C&L,1,Not classified:1
78947,Diphenyl tolyl phosphate,247-693-8,26444-49-5,Acute Tox. 4,Notified C&L,591,H302:195;H410:442;H400:395;H312:25;H412:25;H411:12;H371:6;H332:4
78949,4-benzylaminophenol,203-082-8,103-14-0,,Notified C&L,5,H302:5;H315:1;H319:1
78953,"1,2,3,4-tetrafluoro-5,6-diiodobenzene",220-303-3,2708-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H315:41;H319:41
78956,N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate,247-161-5,25646-71-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H302:0;H400:0
78958,Ethyl 2-formamido-α-oxothiazol-4-acetate,265-299-4,64987-03-7,,REACH registration C&L,44,H302:5;H335:44;H315:44;H319:44
78959,Dibenzyl azodicarboxylate,219-508-0,2449-05-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H335:50;H315:50;H319:50;H228:1
78964,Molybdenum tungsten disilicide,925-777-1,,Not Classified,Notified C&L,1,Not classified:1
78967,(3-((2-aminoethyl)amino)propyl)silanetriol Homopolymer,614-442-2,68400-09-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,26,H317:22;H319:22;Not classified:4
78976,"Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately -20°C to 190°C (-4°F to 374°F).]",285-512-4,85116-61-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
78977,"2-BROMO-4,6-DIFLUOROPHENOL",619-323-9,98130-56-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H302:2;H332:1;H312:1
78982,(methylthio)pyrazine,244-675-1,21948-70-9,Not Classified,Notified C&L,132,Not classified:88;H318:38;H302:39;H335:43;H315:43;H319:5;H332:1;H312:1
78987,trans-decahydroquinoline,212-189-9,767-92-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,40,H335:39;H315:40;H302:39;H411:39;H319:40
78988,"1,2,3,6-tetrahydro-3,6-methanophthalic anhydride",212-557-9,826-62-0,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H317:0;H334:0
78990,"Gases (petroleum), recycle, hydrogen-rich;Refinery gas;[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]",270-783-3,68478-00-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H340:0;H350:0
78992,2-methyl-5-nitro-1H-benzimidazole,217-259-2,1792-40-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H302:39;H335:39;H315:39
